<SEC-DOCUMENT>0001159036-23-000029.txt : 20230324
<SEC-HEADER>0001159036-23-000029.hdr.sgml : 20230324
<ACCEPTANCE-DATETIME>20230324160421
ACCESSION NUMBER:		0001159036-23-000029
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		26
FILED AS OF DATE:		20230324
DATE AS OF CHANGE:		20230324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HALOZYME THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001159036
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				880488686
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32335
		FILM NUMBER:		23759861

	BUSINESS ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 794-8889

	MAIL ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HALOZYME THERAPEUTICS INC
		DATE OF NAME CHANGE:	20040312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL YACHT SERVICES INC
		DATE OF NAME CHANGE:	20010912
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>halo-20230324.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:d427a237-d92d-477a-97f4-29c1176891df,g:b34a9be0-a49e-4e04-951f-b4dd4f76c1d4,d:0608c1aac05343459aa8f80c42d50fe0--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2022q4" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:halo="http://www.halozyme.com/20230324" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>halo-20230324</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="dei:EntityCentralIndexKey" id="f-2">0001159036</ix:nonNumeric><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="dei:DocumentType" id="f-3">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="dei:AmendmentFlag" id="f-4">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="halo-20230324.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic233aab1402747439a99eaeeed8ebeec_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aa4e90521e74fbda5fc78c806b80fcf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27d40edd3894424da8813a26e8d6173b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f31ca4805ad4f31bf9686ab3097fe4d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951348a08ad147db83dd0bb1e4382682_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia04ec946f88c42e5882937b764c87374_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib406196d7595400897664d81791bb3f0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia09b21b978d940d7b4cc0ab07d252950_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6b9a40f09ae4019950c233f8e16c789_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6726fe3095004f08aee055c5fc65a129_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e8b974a7fb4565bf9cd80e6b9a30fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea6d01c149b4df1a874f34555a8ea73_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i486c1364dde840db9e11001f598305b4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25825bb1d27d459fa7e4cda106965d40_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a313ba358404f54813109f614f52c34_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8189d53cb944b81afe0d84f0854abf5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66ff6d5bd97145479f89a20ad42fd15a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff7284bcbaf42cf850afd12ab927c00_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7230eccd63144b181cd7473b5e92360_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87a6bad5804241ee912f12ab5ba61df3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3ba339385284259ba286ed4270a14a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f94abe5308e43378c7f5196dcbd8017_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0218f246c624e68baa4cf97406a96ac_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2176be3bb204ee1b5cb0212d4e70bd8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb7b7c9fc8e4cc8b741377634d02e07_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i052e13dd0ce144449177390340355420_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6eac36125f8409589042ca5c735ab4f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief61f2c54ea74e2f8aae9d1e44bbb344_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i860099e12a694c44b167d75f32a8a497_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d54128f996942f3b0b87b094ef4a4a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f864ec9bf24217b9cfe061a82096f7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3f6d8398a7b458eaacca7ac3fdd0c35_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae581e574ec480d840feb807df086cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3f9165ecacd456ca5dac168f8ea3db0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79a81987b87747ad91a4f6b085db1629_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34373954fe8e4556ac5d61e920cfeff5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief15cebdc51a48808cec748bb98ec8c6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7f0a86c0cb84565be52505cbee9db9b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i476176300b1742fe94ad802bfc6aee95_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2a90f9c80e4bed99a628adfd8e5349_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0608c1aac05343459aa8f80c42d50fe0_1"></div><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SCHEDULE 14A </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXY STATEMENT PURSUANT TO SECTION 14(a) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="margin-top:8pt;padding-left:11.25pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;padding-left:11.25pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box:</span></div><div style="margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:4.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Materials Pursuant to &#167;240.14a-12</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="dei:EntityRegistrantName" id="f-1">Halozyme Therapeutics, Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Name of Registrant as Specified in Its Charter)</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of Filing Fee (Check all boxes that apply):</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_4"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20230324_g1.jpg" alt="halo-20230324_g1.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"/></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;24, 2023 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Stockholder: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are cordially invited to attend the 2023 Annual Meeting of Stockholders of Halozyme Therapeutics, Inc., which will be held on May&#160;5, 2023, at 8:00 a.m. Pacific Time. The meeting will be online only, so there is no physical meeting location.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notice of Annual Meeting of Stockholders and a Proxy Statement, which describes the formal business to be conducted at the meeting, follow this letter. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important that you use this opportunity to take part in the affairs of Halozyme Therapeutics, Inc. by voting on the business to come before this meeting. Whether or not you plan to attend the Annual Meeting online, we hope you vote as soon as possible to assure your representation. You can vote your shares over the Internet, by telephone or if you requested printed proxy material by mail, by using a traditional proxy card. Instructions on each of these voting methods are outlined in the enclosed proxy statement. Regardless of the number of shares you own, your careful consideration of, and vote on, the matters before our stockholders is important. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of Halozyme&#8217;s Annual Report on Form 10-K accompanies these proxy materials for your information. At the Annual Meeting, we will review Halozyme&#8217;s activities over the past year and our plans for the future. The Board of Directors and management look forward to seeing you at the Annual Meeting. </span></div><div style="margin-top:12.6pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely yours, </span></div><div style="padding-left:306pt;text-indent:-45pt"><img src="halo-20230324_g2.jpg" alt="halo-20230324_g2.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:188px"/></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ELEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> I. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ORLEY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, M.B. Ch.B., M.R.C.P. </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">President and Chief Executive Officer</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:92.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_10">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_13">PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_13">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_19">SOLICITATION AND VOTING</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_19">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_22">PROPOSAL NO. 1 - ELECTION OF DIRECTORS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_22">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_25">CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_25">16</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_28">PROPOSAL NO. 2 - ADVISORY (NON-BINDING) VOTE ON EXECUTIVE COMPENSATION</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_28">(SAY-ON-PAY)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_28">20</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_657">PROPOSAL NO. 3 - ADVISORY (NON-BINDING) VOTE ON THE FREQUENCY OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_657">22</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_31">PROPOSAL NO. 4 - RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_31">23</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_34">REPORT OF THE AUDIT COMMITTEE</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_34">25</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_37">EXECUTIVE COMPENSATION AND RELATED INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_37">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_58">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_58">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_61">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_61">AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_61">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_64">STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_64">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_67">TRANSACTION OF OTHER BUSINESS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_67">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_70">DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0608c1aac05343459aa8f80c42d50fe0_70">60</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20230324_g1.jpg" alt="halo-20230324_g1.jpg" style="height:74px;margin-bottom:5pt;vertical-align:text-bottom;width:184px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12390 El Camino Real </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">San Diego, California 92130 </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">To Be Held on May&#160;5, 2023 </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO THE STOCKHOLDERS OF HALOZYME THERAPEUTICS, INC.: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby given that the Annual Meeting of the Stockholders of Halozyme Therapeutics, Inc., a Delaware corporation, will be held on May&#160;5, 2023, at 8:00 a.m. Pacific Time. The meeting will be online only, so there is no physical meeting location. The Annual Meeting is being held for the following purposes: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect three Class I directors to hold office for a three-year term and until their respective successors are elected and qualified; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve, by a non-binding advisory vote, the compensation of our Named Executive Officers;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve, by a non-binding advisory vote, the frequency of holding future advisory votes regarding the compensation of our Named Executive Officers; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To transact such other business as may properly come before the Annual Meeting. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be able to attend the Annual Meeting, submit questions and vote during the live webcast by visiting </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/HALO2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and entering the 16 digit control number included in your Notice of Internet Availability, on your proxy card, or voting instruction form, or in the instructions you received by email.  Please refer to the additional logistical details and recommendations in the accompanying proxy statement. Only stockholders of record at the close of business on March&#160;6, 2023 are entitled to notice of, and to vote at, this Annual Meeting and any adjournment or postponement thereof. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends that you vote FOR each of the nominees to the Board of Directors named in the accompanying Proxy Statement, FOR Proposals 2 and 4, and FOR conducting the advisory vote on named executive officer compensation on an annual basis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-top:9pt;padding-left:306pt;text-indent:-45pt"><img src="halo-20230324_g3.jpg" alt="halo-20230324_g3.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:225px"/></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mark Snyder</span></div><div style="margin-top:3pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Vice President, General Counsel, </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Corporate Secretary </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;24, 2023</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Annual Meeting of Stockholder To Be Held on May&#160;5, 2023 </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Proxy Statement and the 2022 Annual Report to Stockholders and the means to vote by Internet are available at www.proxyvote.com. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IMPORTANT: You are cordially invited to attend the virtual meeting online. Whether or not you expect to attend the virtual meeting online, please vote as soon as possible by using the Internet or telephone or for those receiving paper copies of these proxy materials by completing, signing, dating and mailing your proxy card in the accompanying postage-paid envelope. Even if you have voted by proxy, you may still vote in person if you attend the virtual meeting online. </span></td></tr></table></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_13"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying proxy is solicited on behalf of the Board of Directors of Halozyme Therapeutics, Inc., a Delaware corporation (&#8220;Halozyme&#8221; or the &#8220;Company&#8221;), for use at Halozyme&#8217;s Annual Meeting of Stockholders to be held online  on May&#160;5, 2023 at 8:00 a.m. Pacific Time and at any adjournment or postponement thereof, for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. This Proxy Statement, notice, the notice of internet availability of the proxy materials, and the proxy card are first being made available and/or mailed to stockholders on or about March&#160;24, 2023. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_16"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL MEETING AGENDA AND BOARD OF DIRECTORS VOTE RECOMMENDATIONS</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders are being asked to vote on each of the following items at the Annual Meeting:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The election of three Class I director nominees named in this Proxy Statement to the Board of Directors, each to serve a three-year term and until their respective successors are elected and qualified;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The approval of a non-binding advisory resolution approving the compensation of our Named Executive Officers; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The approval of a non-binding advisory resolution regarding the frequency of holding future advisory votes regarding the compensation of our Named Executive Officers; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends that you vote FOR the nominees to the Board of Directors named in this Proxy Statement, FOR Proposals 2 and 4, and FOR conducting the advisory vote on named executive officer compensation on an annual basis.</span></div><div id="i0608c1aac05343459aa8f80c42d50fe0_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOLICITATION AND VOTING </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only stockholders of record as of the close of business on March&#160;6, 2023, the record date for the Annual Meeting, will be entitled to vote at the meeting and any adjournment or postponement thereof. As of that date, we had 135,415,332 shares of common stock outstanding, all of which are entitled to vote with respect to all matters to be acted upon at the Annual Meeting. Each stockholder of record as of that date is entitled to one vote for each share of common stock held by him or her. Our Bylaws provide that a majority of all of the shares of the stock entitled to vote, whether present in person or represented by proxy, shall constitute a quorum for the transaction of business at the meeting. When a quorum is present at the meeting, all matters other than the election of directors and the advisory vote on the frequency of holding future advisory votes regarding the compensation of our named executive officer compensation, will be determined by a majority in voting power of the shares present in person or represented by proxy and entitled to vote on the matter. The election of directors will be determined by a majority in voting power of the shares present in person or represented by proxy at the meeting and voting on the matter.  The frequency of holding future advisory votes regarding the compensation of our named executive officer compensation that receives the highest number of votes will be considered the advisory vote of our stockholders. Votes for and against, abstentions and &#8220;broker non-votes&#8221; will each be counted as present for purposes of determining the presence of a quorum.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted by rules adopted by the Securities and Exchange Commission, we are furnishing our proxy statement, 2022 Annual Report to Stockholders and proxy card over the internet to most of our stockholders. This means that most of our stockholders will initially receive only a Notice of Internet Availability of Proxy Materials containing instructions on how to access the proxy materials over the Internet. If you would like to receive a paper copy of the proxy materials, the Notice of Internet Availability of Proxy Materials contains instructions on how you can request copies of these documents at no cost to you.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting of Proxies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All valid proxies received before the meeting will be exercised. All shares represented by a proxy will be voted, and where a proxy specifies a stockholder&#8217;s choice with respect to any matter to be acted upon, the shares will be voted in accordance with that specification. If no choice is indicated on the proxy provided by a stockholder of record, the shares will be voted for the nominees, for proposals 2 and 4 and for conducting the advisory vote on named executive officer compensation on an annual basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may vote by attending the Annual Meeting online, by using the Internet or telephone to submit a proxy or by completing and returning a proxy by mail, if you requested printed proxy material by mail </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Internet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To vote by Internet, go to </span><span style="background-color:#ffffff;color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.proxyvote.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Internet voting is available 24 hours a day, although your vote by Internet must be received by 11:59 p.m. Eastern Time on May 4, 2023. You will need the control number found either on the Notice of Internet Availability of Proxy Materials or on the proxy card if you are receiving a printed copy of these </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materials. If you vote by Internet, you should not return your proxy card or voting instruction card. If you hold your shares in &#8220;street name&#8221; as explained below, please refer to the voting instruction form or notice provided to you by your broker, bank or other holder of record for Internet voting instructions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Telephone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To vote by telephone, call </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1-800-690-6903</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and follow the instructions. Telephone voting is available 24 hours a day, although your vote by telephone must be received by 11:59 p.m. Eastern Time on May 4, 2023. You will need the control number found on your Notice of Internet Availability of Proxy Materials, voting instruction form or on the proxy card if you are receiving a printed copy of these materials. If you vote by telephone, you should not return your proxy card or voting instruction card. If you hold your shares in &#8220;street name&#8221; as explained below, please refer to the Notice of Internet Availability of Proxy Materials or voting instruction card provided to you by your broker, bank or other holder of record for telephone voting instructions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Mail.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If you requested printed proxy materials by mail, by completing, signing and returning the proxy card in the prepaid and addressed envelope enclosed with proxy materials delivered by mail, you are authorizing the individuals named on the proxy card to vote your shares at the Annual Meeting in the manner you indicate. You are encouraged to sign and return the proxy card even if you plan to attend the Annual Meeting so that your shares will be voted if you are unable to attend the Annual Meeting. If you receive more than one proxy card, it is an indication that your shares are held in multiple accounts. Please complete, sign and return all proxy cards to ensure that all your shares are voted. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Online During Annual Meeting. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are entitled to participate in the Annual Meeting if you were a shareholder as of the close of business on March&#160;6, 2023, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee. To be admitted to the Annual Meeting at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/HALO2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, you must enter the control number found on your  Notice of Internet Availability of Proxy Materials, proxy card, or voting instruction form you previously received. You may vote during the Annual Meeting by following the instructions available on the meeting website during the meeting. The meeting&#8217;s virtual attendance format will provide you the ability to participate and ask questions in writing during the meeting.  Whether or not you plan to participate in the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one of the methods described in the proxy materials for the Annual Meeting. If your shares are registered directly in your name with our transfer agent, EQ by Equiniti, you are considered the stockholder of record and you have the right to vote in person at the Annual Meeting. If your shares are held in the name of your broker or other nominee, you are considered the beneficial owner of shares held in &#8220;street name.&#8221; Beneficial owners whose stock is held in the name of a bank, broker or other nominee generally will receive instructions for voting from their banks, brokers or other nominees, rather than directly from us. You can vote your shares held through a bank, broker or other nominee by following the voting instructions sent to you by that institution. Shares for which you are the beneficial owner but not the stockholder of record may also be voted electronically during the Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revocability of Proxies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A stockholder giving a proxy has the power to revoke it at any time before it is exercised by delivering to the Secretary of Halozyme a written instrument revoking the proxy or by executing duly executed proxy with a later date, or by attending the Annual Meeting online and voting in person.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broker Non-Votes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A broker non-vote occurs when a broker submits a proxy card with respect to shares held in street name on behalf of a beneficial owner but is prohibited from voting on a particular matter because the broker has not received voting instructions from the beneficial owner and therefore does not have discretion to vote the beneficial owner&#8217;s shares with respect to that matter. Under the rules that govern brokers who are voting with respect to shares held in street name, brokers have the discretion to vote such shares on routine matters, but not on non-routine matters. Routine matters include the ratification of our independent registered public accounting firm. Non-routine matters include the election of directors and the two advisory votes on executive compensation matters.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Solicitation of Proxies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We will bear the entire cost of soliciting proxies for the upcoming meeting. In addition to soliciting stockholders by mail through our employees, we will request banks, brokers and other custodians, nominees and fiduciaries to solicit customers for whom they hold our stock and will reimburse them for their reasonable, out-of-pocket costs. We may use the services of our officers, directors and others to solicit proxies, personally or by telephone, without additional compensation.</span></div><div><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_22"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 1</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELECTION OF DIRECTORS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a classified Board of Directors that currently consists of three Class I directors, three Class II directors and three Class III directors. Our directors are elected for a term of three years, with one class of directors up for election every year. At the 2023 Annual Meeting of Stockholders, we will be electing three Class I directors, while the Class II directors will be elected at the 2024 Annual Meeting of Stockholders and the Class III directors will be elected at the 2025 Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class I nominees recommended by the Board of Directors for election at the 2023 Annual Meeting are: Bernadette Connaughton, Moni Miyashita and Matthew L. Posard. Ms. Connaughton, Ms. Miyashita and Mr. Posard are current members of our Board of Directors and, if elected, they will serve as directors until our Annual Meeting in 2026 or until their successors are elected and qualified. If any nominee declines to serve or becomes unavailable for any reason, or if a vacancy occurs before the election (although we know of no reason to anticipate that this will occur), the proxies may be voted for such substitute nominees as our Board of Directors may designate.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Majority Voting Standard</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws provide that in any election of one or more directors at a meeting at which a quorum is present, other than in a contested election, each director shall be elected by the vote of a majority of the votes cast by the stockholders with respect to the director. If a director does not receive in an election, other than a contested election, a majority of the votes, the director must tender his or her resignation to the Board of Directors. Within 90 days after the date of the certification of the election results, the Nominating and Corporate Governance Committee of the Board of Directors (or other committee that may be designated by the Board of Directors) will make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. The Board of Directors will promptly act on such committee&#8217;s recommendation and publicly disclose within four business days on a Current Report on Form 8-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) its decision and the rationale behind such decision.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a quorum is present at the meeting, election of each of the three nominees for Class I directors requires the affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and voting on the matter.  Abstentions and broker non-votes will have no effect on the outcome of the vote.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends a vote &#8220;FOR&#8221; each of the nominees named above.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Candidate Expertise Selection Criteria</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee, with input from the Board of Directors, has determined that the following areas of expertise are of particular importance in providing appropriate oversight of the Company&#8217;s business and operations.  Accordingly, the Nominating and Corporate Governance Committee seeks candidates for the Board of Directors from diverse professional backgrounds in order to ensure that the Board of Directors is comprised of individuals possessing extensive expertise in one or more of the following areas:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.216%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Skill</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Rationale</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicine and Science</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a Company directly and indirectly involved in the development, approval and commercialization of drugs, expertise in medicine and science is a key to the ongoing assessment of potential new technologies we may acquire.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Business Leadership and Operations<br/></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in, and knowledge of, the pharmaceutical business contributes to deep understanding of business strategy, operations, key performance indicators and the competitive environment.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complementary Business/Industry Segment Experience</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diverse experience gained from adjacent and complementary industries contributes to identification and evaluation of new opportunities and ideas.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Business</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Business experience adds to our understanding of diverse business environments, economic conditions and cultural perspectives that informs our global business initiatives and strategy.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Human Capital Management</span></div><div><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of our strategy requires the development and retention of highly skilled and diverse set of leaders and team members.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance and Capital Markets</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience overseeing financial transactions provides knowledge and skills necessary to evaluate and oversee the Company&#8217;s design and implementation of financial and capital allocation strategies.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M&amp;A</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in the identification, negotiation and execution of M&amp;A transactions provides knowledge to oversee the Company&#8217;s potential M&amp;A activities.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Management</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in risk management contributes to the identification, prioritization, assessment and mitigation of significant risk facing the company.</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its review of each director&#8217;s professional experience and background, the Nominating and Corporate Governance Committee has determined that our current board members possess expertise in the following areas noted below:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Director</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Medicine and Science</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pharma Business Leadership and Operations</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Complementary Business/Industry Segment Experience</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">International Business</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Human Capital Management</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance and Capital Markets</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">M&amp;A</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Management</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jean-Pierre Bizzari, M.D.</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernadette Connaughton</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">James M. Daly</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey W. Henderson</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Connie L. Matsui</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matthew L. Posard</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen I. Torley, M.B. Ch.B., M.R.C.P.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon responses received from each of our directors with respect to diversity, the Company&#8217;s Board of Directors is currently comprised of individuals from the following diverse backgrounds:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:36.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Diversity Matrix (As of March&#160;24, 2023)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Number of Directors</span></div></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">9</span></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Female</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Male</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Non-Binary</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Did Not Disclose Gender</span></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part I: Gender Identity</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Directors</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part II: Demographic Background</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">African American or Black</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alaskan Native or Native American</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Asian</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Hispanic or Latinx</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Native Hawaiian or Pacific Islander</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">White</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Two or More Races or Ethnicities</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LGBTQ+</span></div></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Did Not Disclose Demographic Background</span></div></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Nominated for Election at the 2023 Annual Meeting</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Bernadette Connaughton</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 64)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2018</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Compensation Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, International Business, Human Capital Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Company Public Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:   </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Editas Medicine, Inc., a clinical stage biotechnology company               </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Syneos Health Inc., a biopharmaceutical services company               </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Zealand Pharma A/S, a biotechnology company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the Board of Directors.  Ms. Connaughton retired from Bristol-Myers Squibb Pharmaceutical Company, a multinational pharmaceutical company, where she served in senior management positions from 2004 to October 2017.  She most recently served as Bristol-Myers Squibb&#8217;s President, Intercontinental Region.  Ms. Connaughton was recently a member of the board of directors of Visterra, Inc., a private clinical stage biotechnology company, acquired by Otsuka. She also previously served on the European Federation of Pharmaceutical Industry Association, Patient Access and European Markets Committees. Ms. Connaughton received her BA from Johns Hopkins University and her MBA from The Wharton School, University of Pennsylvania.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Connaughton&#8217;s extensive experience in business and operations was developed during her 30-year career at Bristol-Myers Squibb where she built a consistent track record of achieving sales growth, improving profitability and transforming operational models in U.S. and international markets. She built expertise and demonstrated success across a wide range of therapeutic areas, including cardiovascular, metabolic diseases, virology and oncology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">International Business</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Through her positions leading large global business regions for Bristol Myers Squibb, Ms. Connaughton brings deep experience in international markets. Specific achievements include developing and leading execution of the multi-year strategy for the successful commercialization of Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Daklinza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. She most recently served as President Intercontinental Region, which included China, Latin America, Central and Eastern Europe and Middle East. Other positions included President, European Markets, Canada and Australia; President, Intercontinental Region; and President, Japan, Pacific Rim, Australia and Canada.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of her senior management positions, Ms. Connaughton led diverse, cross-functional teams, building the capabilities to successfully develop and commercialize pharmaceutical products. She has broad experience selecting and developing talent and building high performance teams with the skills, motivation and culture to achieve sustainable results.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described in Ms. Connaughton&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Connaughton has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) international business and (iii) human capital management.  Ms. Connaughton&#8217;s extensive operations and commercialization experience in the pharmaceutical industry including the development of successful commercialization strategies for a number of oncology products and her consistent track record of achieving sales growth provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Ms. Connaughton should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Moni Miyashita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 67)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Nominating and Corporate Governance Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Complementary Business/Industry Segment Expertise, International Business, M&amp;A, Risk Management</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Miyashita brings over 25 years of global experience leading business transformations and building new businesses through strategy, new business models, and mergers &amp; acquisitions. Since May 2019, she has served as the Chief Strategy Officer of Valo Health, LLC, a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence computation.  Prior to Valo Health, from August 2015 to May 2019, she was a Partner at Innosight Consulting, where she provided growth strategy consulting services for businesses in the biotech, healthcare and technology industries. From 2011 to 2015, she was a Senior Advisor at McKinsey where she advised senior executive leadership teams on executing strategic M&amp;A.  Prior to McKinsey, she served as Vice President, Corporate Development at IBM Corporation, an information technology company, from 1998 to 2011. She received her BS degree in marketing from the University of Colorado and her MBA from the University of Denver.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Complementary Business/Industry Segment Expertise</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2019, Ms. Miyashita joined Valo Health as Chief Strategy Officer where she develops and drives complex business models, building a disruptive technology platform, and applying it to drug discovery, clinical development, and strategic partnerships across a regulated pharmaceutical ecosystem.  While serving as Partner at Innosight Consulting, she advised and supported CEOs and their executive leadership teams on disruptive growth strategies in the biotech and healthcare industries. While serving as Senior Advisor at McKinsey, Ms. Miyashita provided global advisory services on M&amp;A to executive and senior leadership teams across the pharmaceutical, biotech, and healthcare industries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">International Business and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During her tenure as Vice President at IBM, Ms. Miyashita was a key architect in developing and executing M&amp;A globally, anchored on strategy, with successful deal flow, transaction execution and post-merger integration.  This strategy and effort resulted in over 40 quarters of double-digit earnings per share growth and creating the highest revenue and market capitalization in IBM&#8217;s history.  Prior to this position, Ms. Miyashita had executive positions in IBM Asia.  While serving as Senior Advisor at McKinsey, Ms. Miyashita helped build McKinsey&#8217;s M&amp;A practice and provided global advisory services to executive and senior leadership teams in the Americas, Europe, and Asia on transforming and growing their businesses through M&amp;A.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">Human Capital Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Miyashita has extensive human capital management experience having led human capital integration efforts in over 100 acquisitions during her tenure as Vice President at IBM.  In her prior roles at McKinsey and Innosight, she advised chief executive officers and executive leadership teams on human capital management matters as they transitioned their companies </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">when executing transformational M&amp;A transactions or when transforming their core business.  In her current role at Valo Health, she influences the human capital management needed to build a novel platform to accelerate drug discovery and development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During her tenure as Vice President at IBM, Ms. Miyashita was involved in over 100 acquisitions or transactions and multiple business carve outs for divestiture from IBM to other companies which included developing cross functional processes and approaches to manage risk. Under her leadership, cross functional teams prepared for and passed multiple business audits to ensure risk was identified, mitigated and managed for executing all acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Board Service Selection Criteria:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As further described in Ms. Miyashita&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Miyashita has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) complementary business and industry experience, (ii) international business, (iii) Human Capital Management, (iv) M&amp;A and (v) Risk Management.  Ms. Miyashita&#8217;s extensive experience in developing and executing complex corporate transactions and her experience providing strategy execution advice to senior leadership teams provide our Board with valuable strategic and operational expertise, leading the Nominating and Corporate Governance Committee to determine that Ms. Miyashita should serve as one of our directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Matthew L. Posard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 55)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2013</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Nominating and Corporate Governance Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Medicine and Science, Complementary Business/Industry Segment Expertise, International Business, Human Capital Management, M&amp;A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Public Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">DermTech, Inc. (Chairman), a precision dermatology company                                                                         </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nautilus Biotechnology, Inc., (Chairman) a development stage life sciences company </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Talis Biomedical, a developer of diagnostic tests for infectious diseases</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Posard brings over 30 years of general management and commercialization experience in the biotechnology and diagnostics industry to the Board of Directors.  He is Founding Principal of Explore DNA, a life sciences executive consulting firm, a position he has held since March 2016.  Since 2017, he has provided advisory services to CEOs for several emerging life sciences companies.  From February 2017 to April 2018, Mr. Posard served as President and Chief Commercial Officer of GenePeeks, Inc., a genetic research company.  From March 2015 to April 2016, he served as Chief Commercial Officer of Trovagene, Inc., a molecular diagnostic biotechnology company. From February 2006 to February 2015, he held various commercial and general management positions at Illumina, Inc., a genomics company focusing on DNA sequencing, including senior executive positions overseeing Global Sales, Marketing, and General Manager of Clinical and Consumer Genomics as well as New and Emerging Markets.  Mr. Posard holds a BA degree in Management Science from the University of San Diego.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Medicine and Science</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Posard has deep expertise introducing novel and transformative products to medical and research markets while scaling organizations efficiently.  He is a Founding Principal of Explore DNA and provides advisory services to executive officers of several emerging life sciences companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Complementary Business/Industry Segment Expertise</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Posard adds to his biotech expertise with deep knowledge in the diagnostics area, having served in senior positions at Illumina, Biosite, Inc. and Gen-Probe, Inc.  At Illumina he was part of the executive management team that led the company to its first $1 billion in revenue.  At Biosite he was instrumental in the successful introduction of the company&#8217;s BNP congestive heart failure biomarker and its BNP co-marketing collaboration with Beckman Coulter.  At Gen-Probe, Mr. Posard helped the company attain leading market positions in DNA probe-based infectious disease diagnostics and blood banking.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Posard has extensive international business experience, having served as the Vice President of Global Sales for Illumina where he led an international commercial sales team.  He also served as Senior Vice President and General Manager of Illumina&#8217;s Translational and Consumer Genomics and New and Emerging Markets business units and was responsible for over $100 million of sales growth in his first year in this position.  This experience provided substantial exposure to commercial markets around the world.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In his senior commercial marketing positions with various companies, Mr. Posard has managed and led a number of large and diverse marketing teams.  A seasoned executive in the genomics and life science space, Mr. Posard has extensive background in effectively scaling organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has served on the board of directors and in senior leadership positions at a variety of startup and emerging companies and has extensive experience in the area of mergers and acquisitions in the biotech and diagnostics space.  In his position as advisor to senior executives of life science companies, he has provided guidance and effective consultation in the execution of strategic acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described in his biography, the Nominating and Corporate Governance Committee believes Mr. Posard has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors:  (i) medicine and science, (ii) complementary business and industry segment expertise, (iii) international business, (iv) human capital management and (v) M&amp;A. Mr. Posard's general management, sales and marketing experience including the successful launch of products and management of sales operations provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Mr. Posard should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Directors Continuing in Office Until the 2024 Annual Meeting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Jean-Pierre Bizzari</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 68)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2015</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Nominating and Corporate Governance Committee, Compensation Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Medicine and Science, Pharma Business Leadership and Operations and International Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Public Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: </span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ADC Therapeutics SA, a biotechnology company                                                     </span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Pieris Pharmaceuticals, Inc., iTeos Therapeutics S.A., Onxeo S.A, Compugen Ltd. and Transgene SA, Nordic Nanovector ASA. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Bizzari brings more than 30 years of pharmaceutical and biotech industry expertise to the Board of Directors. He retired from Celgene Corporation, a global pharmaceutical company, having served as Executive Vice President and Global Head of Oncology from October 2012 to December 2015 and as Senior Vice President for Clinical Development Oncology from 2008 to October 2012. While at Celgene, Dr. Bizzari oversaw the development and approval of a number of leading oncology products.  Dr. Bizzari is a Doctor of Medicine and a graduate of the Nice Medical School and a specialist in oncology (training in Toronto and Montreal).  Dr. Bizzari was also an assistant in the medical oncology department at La Piti&#233;-Salp&#234;tri&#232;re hospital in Paris.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Medicine and Science </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Jean-Pierre Bizzari served in senior positions at Celgene from 2008 to 2015, most recently as Executive Vice President, group head, and clinical oncology development. Prior to this, he spent 15 years as Vice President, Clinical Development Oncology at Rh&#244;ne-Poulenc Rorer, Aventis and as Vice President, Clinical Oncology Development at Sanofi-Aventis and has been involved in the clinical development of multiple anticancer agents such as Taxotere</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Eloxatin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Vidaza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Irinotecan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (CPT-11). Dr. Bizzari is a world-renowned oncology expert and is a member of the scientific advisory board of the French National Cancer Institute (INCa) and is chair of the New Drug Advisory Committee at the European Organization of Research and Treatment of Cancer (EORTC). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations and International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In his position as an oncology leader accountable for the execution of a broad range of large clinical studies, Dr. Bizzari led or provided valuable input into a broad range of topics including oncology development strategy for Celgene and Rh&#244;ne Poulenc Rorer, regulatory strategy,  regulatory environment, safety assessment, global studies and market (including Japan and China), manufacturing needs and strategy, biostatistics and data communication. Dr. Bizzari has extensive experience serving on the boards of directors for several international companies.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Dr. Bizzari&#8217;s biography, the Nominating and Corporate Governance Committee believes that Dr. Bizzari has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) medicine and science, (ii) pharma business leadership and operations and (iii) international business.  Dr. Bizzari&#8217;s track record of success in developing strategies that have resulted in global approvals for some of the world&#8217;s most important cancer drugs provides our Board with valuable strategic expertise in both oncology drug development and global commercialization, leading the Nominating and Corporate Governance Committee to determine that Dr. Bizzari should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Barbara Duncan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (age 58)<br/>Director Since: 2023</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Audit Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Pharma Business Leadership and Operations, International Business, Finance and Capital Markets, M&amp;A</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adaptimmune Therapeutics, plc</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Atea Pharmaceuticals, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fusion Pharmaceuticals, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jounce Therapeutics, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ovid Therapeutics, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Aevi Genomics Medicine, Inc., Immunomedics, Inc., Innoviva, Inc. ObsEva S.A.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan brings over 16 years of pharmaceutical and biotechnology industry experience to the Board of Directors.  She retired from Intercept Pharmaceuticals, Inc., a biopharmaceutical company, where she served as Chief Financial Officer and Treasurer from May 2009 to June 2016.  From 2001 to 2009, Ms. Duncan held various senior leadership roles of increasing responsibility at DOV Pharmaceutical, Inc., a biotechnology company, including Chief Financial Officer and ultimately serving as Chief Executive Officer prior to DOV&#8217;s sale in 2010 to Euthymics Bioscience, Inc. Prior to joining DOV, Ms.&#160;Duncan served as Vice President of Corporate Finance&#8201;-&#8201;Global Healthcare at Lehman Brothers Inc. from 1998 to 2001, and as Director of Corporate Finance at SBC Warburg Dillon Read Inc. from 1994 to 1998. She also worked for PepsiCo, Inc. from 1989 to 1992 in its international audit division, and was a certified public accountant in the audit division of Deloitte &amp; Touche LLP from 1986 to 1989. Ms. Duncan received her BBA from Louisiana State University and her MBA from the Wharton School of the University of Pennsylvania.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: As further described in Ms. Duncan&#8217;s biography, the Nominating and Corporate Governance Committee believes that Ms. Duncan has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) finance and capital markets, (iii) international business and (iv) M&amp;A.  Ms. Duncan&#8217;s extensive industry and financial experience, including her experience as chief financial officer at public biopharmaceutical companies, combined with her business acumen and experience serving on other public biopharmaceutical boards, provide our Board with valuable expertise, leading the Nominating and Corporate Governance Committee to determine that Ms. Duncan should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">James M. Daly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 61)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2015</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As previously disclosed, Mr. Daly has notified the Company of his intention to resign from the Board effective at the end of the 2023 calendar year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Audit Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Pharma Business Leadership and Operations, International Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acadia Pharmaceutical, Inc., a biopharmaceutical company</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">argenx S.E, a biopharmaceutical company</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Bellicum Pharmaceuticals, Inc., a biopharmaceutical company</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Madrigal Pharmaceuticals, Inc., a biopharmaceutical company</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Chimerix, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Daly brings more than 30 years of experience leading U.S. and global pharmaceutical businesses to the Board of Directors. He retired from Incyte Corporation, a biopharmaceutical company, where he served as Executive Vice President and Chief Commercial Officer from October 2012 to June 2015. Prior to Incyte, Mr. Daly served in various senior management and commercial positions at Amgen, Inc., a global pharmaceutical company, from January 2002 to December 2011. Prior to Amgen, he worked at GlaxoSmisthKline from 1985 to 2001 in various positions of increasing responsibilities. Mr. Daly earned a BS degree in Pharmacy and his MBA from the University at Buffalo.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Over the course of his career, Mr. Daly has built market-leading global franchises across multiple therapeutic categories, with a particular focus in oncology. As Executive Vice President and Chief Commercial Officer at Incyte Corporation, he was instrumental in re-accelerating the launch of Jakafi&#174;, and driving sustained future growth. At Amgen he oversaw multiple successful U.S. product launches, including Aranesp&#174;, Neulasta&#174;, Vectibix&#174;, Nplate&#174;, Xgeva&#174; and Prolia&#174;.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In his position as Senior Vice President of North America Commercial Operations, Global Marketing and Commercial Development for Amgen, Mr. Daly led P&amp;L responsibility for all U.S. and Canadian businesses and had oversight for global commercialization strategy for new product launches. In this position he gained experience in multiple diverse healthcare systems. While at GSK, Mr. Daly worked in the German affiliate in Hamburg, Germany.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Board Service Selection Criteria: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As further described in Mr. Daly&#8217;s biography, the Nominating and Corporate Governance Committee believes Mr. Daly has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations and (ii) international business. Mr. Daly&#8217;s extensive commercial, business development and leadership experience at biopharmaceutical companies including his involvement in the successful launch of pharmaceutical products, management of large commercial operations and his experience serving on the board of directors at other biopharmaceutical companies provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Mr. Daly should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Continuing in Office Until the 2025 Annual Meeting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Jeffrey W. Henderson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(age 58)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2015</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Board Chair</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Audit Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, Complementary Business/Industry Segment Experience, International Business, Human Capital Management, Finance and Capital Markets, M&amp;A, Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Public Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: </span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Becton Dickinson and Company, a medical technology company               </span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fibrogen, Inc., a biotechnology company</span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Qualcomm, Inc., a wireless communications and semiconductor company</span></div><div style="text-indent:72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Henderson brings nearly 30 years of financial, commercial and pharmaceutical industry expertise to the Board of Directors. He has served as President of JWH Consulting LLC, an investment and business advisory firm, since January 2018.  From 2015 to 2019, he served as a Healthcare Advisory Director to Berkshire Partners LLC.  Mr. Henderson previously served as the Chief Financial Officer of Cardinal Health, Inc., a multinational health care services company, from May 2005 to November 2014, and in an executive capacity until his retirement from Cardinal in August 2015. From 1998 to 2005, Mr. Henderson held various senior management positions at Eli Lilly and Company, a multinational pharmaceutical company, including President and General Manager, Eli Lilly Canada, Inc. and Controller and Treasurer of Eli Lilly, Inc.  He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations and International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Henderson gained deep experience in a broad range of business and operational topics during his nearly 10-year tenure as Chief Financial Officer for Cardinal Health, a $100 billion health care products and services company. During a portion of this tenure he was also responsible for commercial operations in China and Canada.  These experiences built on prior expertise, specifically gained  in pharmaceuticals, when he served as general manager of Eli Lilly Canada and Controller/Treasurer of Eli Lilly Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Complementary Business/Industry Segment Experience</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a member of the board of directors of Becton Dickinson, a leading global medical technology company, and during his time as an executive at Cardinal Health, Mr. Henderson has gained a deep exposure to, and experience in, key aspects of the medical device business and market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Finance and Capital Markets and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In his almost 15 years experience as Chief Financial Officer at Cardinal Health and Controller/Treasurer at Eli Lilly, Mr. Henderson gained extensive experience in finance and capital markets. During his tenure at Cardinal Health, the company acquired more than 30 companies, spun-off or sold multi-billion-dollar businesses and expanded into new geographic locations and market segments.  During his time with the PE firm of Berkshire Partners, he was involved in the identification, evaluation and execution of  multiple acquisition opportunities in the healthcare sector.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In his positions as a Chief Financial Officer for Cardinal Health and Controller/Treasurer at Eli Lilly, Mr. Henderson played a key role in risk identification and risk mitigation. Further, Mr. Henderson has been operationally accountable for commercial operations in both China (Cardinal Health) and Canada (Eli Lilly and Cardinal Health). These unique experiences in both staff and line roles enable a broad perspective on identifying potential risks and risk management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Human Capital Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Henderson has substantial experience leading organizations with multi-thousands of employees, including related aspects of organizational and compensation/incentive design.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  As further described in Mr. Henderson&#8217;s biography, the Nominating and Corporate Governance Committee believes Mr. Henderson has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors:  (i) pharma business leadership and operations, (ii) complementary business and industry segment experience, (iii) international business, (iv) human capital management, (v) finance and capital markets, (vi) M&amp;A and (vii) risk management.  Mr. Henderson&#8217;s extensive experience serving in executive leadership positions, including as Chief Financial Officer with large publicly-traded healthcare and pharmaceutical corporations, combined with his business acumen and judgment, including his qualifications as an audit committee financial expert, provide our Board with valuable financial, strategic and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Mr. Henderson should serve as one of our directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Connie L. Matsui</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 69)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2006  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Compensation Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, International Business, Human Capital Management, Risk Management, M&amp;A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Public Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:      </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Artelo Biosciences, Inc. a biopharmaceutical company                                                              </span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sutro Biopharma, Inc., a biopharmaceutical company</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Matsui brings 30 years of pharmaceutical and biotech industry expertise to the Board of Directors. She retired from Biogen Idec Inc., a biotechnology company, in January 2009 as the Executive Vice President, Knowledge and Innovation Networks. She served as an Executive Committee member at both Biogen Idec and IDEC Pharmaceuticals, a predecessor of Biogen Idec. Among the many major roles she played after joining IDEC Pharmaceuticals in November 1992 was Senior Vice President, overseeing investor relations, corporate communications, human resources, project management and strategic planning. Prior to entering the biotechnology industry, Ms. Matsui worked for Wells Fargo Bank in general management, marketing and human resources.  She received her BA and MBA from Stanford University.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Matsui gained deep experience in a broad range of business and operational topics during her tenure at IDEC Pharmaceuticals and then Biogen Idec, overseeing human resources, alliance management, investor relations, corporate communications, project management and strategic planning. In addition, she served as Collaboration Chair for the late stage development and commercialization of rituximab (tradenames: Rituxan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, MabThera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) in partnership with Roche and Genentech, a position requiring strong alliance management and business expertise.  She also served as project team leader for the late stage development and commercialization of Zevalin, the first FDA-approved radioimmunoconguate for the treatment of cancer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In her Collaboration Chair position for rituximab, Ms. Matsui served as the IDEC member of the collaboration oversight team with counterparts from Roche, Genentech and Zenyaku Kogyo, responsible for progress on all aspects of late stage development, manufacturing, regulatory approval and global commercialization.  In addition, as IDEC&#8217;s Project Leader for Zevalin, she worked with leadership at global partner Schering AG based in Germany and radioisotope supplier Nordion, which had nuclear  facilities in Canada and Belgium.  At Biogen Idec, she was directly responsible for staff teams based in the U.S. and Europe.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Matsui also led Human Resources at IDEC Pharmaceuticals and Biogen Idec, where key experiences included the growth of IDEC from a 100-employee R&amp;D entity to a 1,000-employee fully integrated biotech company and, ultimately, to 4,000 employees worldwide following the merger of equals between IDEC and Biogen. Prior to this position, Ms. Matsui also held  various operating positions, including a senior Human Resources position in the banking industry, where experiences were gained in the area of human capital management and integration of merged and acquired entities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As Co-Integration lead for the Biogen IDEC merger of equals, Ms. Matsui was engaged in assessing merger feasibility and strategic acceleration potential and had a leading role in communication and implementation of merger plans.  This experience included the divestiture of IDEC&#8217;s large scale manufacturing plant and successful integration by Genentech and, later on, assimilation of a small-molecule company in San Diego.  Ms. Matsui has also guided multiple nonprofit mergers to optimization and facilitated the rapid assimilation of acquired banks and savings &amp; loans while at Wells Fargo.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In her more than 30 years in the biotech industry, initially as an executive officer and then while serving on the board of directors for biotechnology and pharmaceutical companies, Ms. Matsui has provided guidance to companies in a highly regulated industry in managing and mitigating risks in the following areas: corporate restructuring, financing transactions, data communication, employee retention and ESG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Ms. Matsui&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Matsui has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) international business, (iii) human capital management, (iv) risk management and (v) M&amp;A.  Ms. Matsui's operational experience, including her extensive knowledge of the biotechnology industry, her service in other public company management teams and her prior business experience, combined with her business acumen and judgment, provide our Board with valuable management and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Ms. Matsui should serve as one of our directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Helen I. Torley, M.B. Ch.B., M.R.C.P. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 60)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2014</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">President and Chief Executive Officer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Medicine and Science, Pharma Business Leadership and Operations, Human Capital Management, Finance and Capital Markets, Risk Management </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Quest Diagnostics Incorporated, a diagnostic information services company</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr Torley brings over 30 years of drug development, drug commercialization and general management expertise in pharmaceutical and biotechnology to the Board of Directors.  She has served as CEO of Halozyme since 2014, successfully leading the company through a critical strategic transition in 2019. Dr Torley previously served as Chief Commercial Officer at Onyx Pharmaceuticals from 2011-2013, leading the successful US launch for Kyprolis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Carfilzomib), until the acquisition of Onyx by Amgen in 2013. From 2002-2011 Dr Torley held several senior commercial positions at Amgen including Vice President and General Manager US Bone Health and Vice President and General Manager US Nephrology. In these positions she led the successful launches of Prolia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(denosumab) and Sensipar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (cinacalcet) and significantly grew Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Epoetin alfa) and Aranesp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(darbepoetin alfa) revenue. From 1997-2002 she held a range of senior sales and marketing leadership positions at Bristol Myers Squib. She began her industry career at Sandoz, which merged with Ciba-Geigy to become Novartis in 1996, where she held a range of positions of increasing responsibility in Clinical Development, culminating in the position of Vice President of Medical Affairs, responsible for overseeing the design and conduct of a broad portfolio of clinical studies across nephrology, rheumatology, oncology and CNS indications.  She received her M.B.Ch.B. degree (US equivalent to MD) from the University of Glasgow, Scotland and her M.R.C.P from the Royal College of Physicians, Glasgow, Scotland. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Medicine and Science </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Torley is a trained physician who while in clinical practice specialized in Internal Medicine and Rheumatology. She served in leadership positions at Sandoz/Novartis from1990 to 1997, most recently as Vice President, Medical Affairs where she oversaw the design and conduct of Phase 1 through 4 clinical  studies across multiple disease areas.  While at Sandoz/Novartis she led clinical development programs for new products being evaluated in organ transplantation and rheumatoid arthritis and wrote and submitted New Drug Application filings. She has led and played key strategic positions in multiple successful FDA Advisory Committee meetings including for Neoral</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(cyclosporin) in Rheumatoid Arthritis, Neoral (cyclosporin) in Organ Transplantation, Epogen&#174; (Epoetin alfa) in anemia in chronic renal failure and HyQvia (immune Globulin infusion 10% with Recombinant Human Hyaluronidase) in Primary Immune Deficiency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Torley gained deep experience in a broad range of business and operational topics in her commercial positions. In particular, as General Manager of Bone Health and Nephrology at Amgen and as Chief Commercial Officer at Onyx, she was responsible for hiring and leading sales and marketing organizations, including hiring and training a more than 650-person team for a new drug launch, working on policy topics related to her products and leading three successful new product launches. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Torley has substantial experience leading large organizations, ranging from 120 to approximately 700 people.  Her human capital management experiences include hiring and successfully onboarding large new sales teams into an established culture and effective reorganizations as dictated by changes in strategy. She has a strong focus on and understanding of the important role organizational culture, diverse teams, talent development and accountability play in driving results and success. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Finance and Capital Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As CEO of Halozyme, Dr. Torley has gained experience in Finance and Capital Markets including direct experience with raising $1 billion through follow-on offerings and through two convertible debt offerings, and executing two share repurchase programs resulting in over $600 million in capital returned to stockholders to date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In her position as CEO of Halozyme, Dr. Torley plays a key role in risk identification and mitigation. In addition, in her previous positions with other organizations as Chief Commercial Officer and General Manager in which she was accountable for commercial launches, a key accountability was risk identification and mitigation. This wide range of experiences enable a broad perspective on identifying potential risks and executing appropriate mitigations strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As further described in her biography, the Nominating and Corporate Governance Committee believes Dr. Torley has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) medicine and science, (ii) pharma business leadership and operations, (iii) human capital management, (iv) finance and capital markets and (v) risk management. Dr. Torley's extensive commercial and operational experience, including successful launches of products, and her deep knowledge of the biotechnology industry and the competitive environment, her service as our Chief Executive Officer, combined with her business acumen and judgment, provide our Board with valuable commercial and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Dr. Torley should serve as one of our directors.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors (or &#8220;Board&#8221;) has determined that, other than Dr.&#160;Torley, Jeffrey W. Henderson, Jean-Pierre Bizzari, M.D., Bernadette Connaughton, James M. Daly, Barbara Duncan, Connie L. Matsui, Moni Miyashita, and Matthew L. Posard is an independent director within the meaning set forth under applicable rules of the NASDAQ Stock Market. Dr. Torley does not meet the requirements for director independence because she serves as the President and Chief Executive Officer of Halozyme</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has separated the Chief Executive Officer and Board Chair positions to: (i)&#160;provide a stronger corporate governance structure; (ii)&#160;improve overall Board effectiveness; and (iii)&#160;enhance communication between management and the Board. Mr. Henderson began serving as the non-employee Chair of the Board of Directors in May 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Tenure</span></div><div style="margin-top:4.5pt;text-align:center"><img src="halo-20230324_g4.jpg" alt="halo-20230324_g4.jpg" style="height:349px;margin-bottom:5pt;vertical-align:text-bottom;width:441px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Sessions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent directors generally meet in executive session without management present each time the Board holds its regularly scheduled meetings. The Chair of the Board of Directors, acts as the presiding director for such executive sessions of independent directors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Meetings and Committees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors held sixteen meetings during the fiscal year ended December&#160;31, 2022. The Board of Directors has three standing committees: (i)&#160;Audit Committee; (ii)&#160;Compensation Committee; and (iii)&#160;Nominating and Corporate Governance Committee. During the last fiscal year, each director attended at least 75% of the total number of meetings of the Board for the period in which they served as a director and the committees of the Board on which such director served during that period. Our standing committees are currently comprised of the following directors:</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:5.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.906%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit Committee</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation <br/>&#160;Committee</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating / Corporate <br/>Governance Committee</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Daly</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley, M.D. Ch.B., M.R.C.P.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Audit Committee are Jeffrey W. Henderson (Chair), James M. Daly and Barbara Duncan. All members of the Audit Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market and Rule 10A-3 of the Exchange Act, and each of them is able to read and fundamentally understand financial statements. Mr. Henderson and Ms. Duncan are &#8220;audit committee financial experts,&#8221; as defined in the rules of the Securities and Exchange Commission. The Audit Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary purpose of the Audit Committee is to oversee our accounting and financial reporting processes and the functions of the Audit Committee include retaining our independent registered public accounting firm, reviewing its independence, reviewing and approving the planned scope of its annual audit, reviewing and approving any fee arrangements with our independent registered public accounting firm, overseeing its audit work, reviewing and pre-approving any non-audit services that may be performed by the independent registered public accounting firm, reviewing the adequacy of our accounting and financial controls, reviewing our critical accounting policies and reviewing and approving any related party transactions. The Audit Committee held five meetings during the fiscal year ended December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information regarding the Audit Committee is set forth in the Report of the Audit Committee contained in this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Compensation Committee are Bernadette Connaughton (Chair), Connie Matsui and Jean-Pierre Bizzari, M.D. All members of the Compensation Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market, and qualify as non-employee directors as defined in Rule 16b-3 under the Securities  Exchange Act. The Compensation Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary purpose of the Compensation Committee is to discharge the Board&#8217;s responsibilities relating to compensation and benefits of our executive officers. More specifically, the Compensation Committee reviews and approves the salary and annual cash incentive earned by the Chief Executive Officer and other executive officers; approves equity awards to executive officers; approves employment and severance agreements of executive officers; and reviews the compensation of non-employee directors for service on the Board of Directors and its committees. The Compensation Committee held five meetings during the fiscal year ended December&#160;31, 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Nominating and Corporate Governance Committee are Matthew L. Posard (Chair), Jean-Pierre Bizzari, M.D, and Moni Miyashita. All members of the Nominating and Corporate Governance Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market. The Nominating and Corporate Governance Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary responsibilities of the Nominating and Corporate Governance Committee are to (i)&#160;identify individuals qualified to become Board members; (ii)&#160;select, or recommend to the Board, director nominees for each election of directors; (iii)&#160;develop and recommend to the Board criteria for selecting qualified director candidates; (iv)&#160;consider committee member qualifications, appointment and removal; (v)&#160;recommend applicable corporate governance principles, codes of conduct and compliance mechanisms, and (vi)&#160;provide oversight in the evaluation of the Board and each committee. The Nominating and Corporate Governance Committee held five meetings during the fiscal year ended December&#160;31, 2022.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Board membership, the Nominating and Corporate Governance Committee&#8217;s goal is to assemble a Board of Directors that brings a variety of perspectives and skills derived from high quality business and professional experience. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no stated minimum criteria for director nominees. The Nominating and Corporate Governance Committee also believes it is appropriate for at least one key member of management to participate as a member of the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Halozyme Board of Directors believes that our Board should have diversity of knowledge base, professional experience and skills, and actively seeks director candidates who bring diversity of age, gender, nationality, race, ethnicity and sexual orientation. When considering whether to recommend any candidate for inclusion in the Board&#8217;s slate of recommended director nominees, including candidates recommended by our stockholders, the Nominating and Corporate Governance Committee will review the candidate&#8217;s integrity, business acumen, age, experience, commitment, diligence, conflicts of interest, existing time commitments and the ability to act in the interests of all stockholders. Once a potential qualified candidate is identified, multiple members of the Nominating and Corporate Governance Committee will interview that candidate. The committee may also ask the candidate to meet with non-committee members of the Board and/or members of management and, if the committee believes a candidate would be a valuable addition to the Board, it will recommend that candidate to the full Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of its charter and our Corporate Governance Guidelines, the Nominating and Corporate Governance Committee will consider qualified director candidates suggested by our stockholders. Stockholders may recommend individuals for the Nominating and Corporate Governance Committee to consider as potential director candidates by submitting the candidate&#8217;s name, contact information and biographical information in writing to the &#8220;Halozyme Nominating and Corporate Governance Committee&#8221; c/o Corporate Secretary, 12390 El Camino Real, San Diego, California 92130. The biographical information and background materials of any such candidate will be forwarded to the Nominating and Corporate Governance Committee for its review and consideration. The committee&#8217;s review process for candidates identified by our stockholders is essentially identical to the review process for candidates identified by the committee. In addition to the process discussed above regarding the consideration of the Nominating and Corporate Governance Committee of candidates suggested by our stockholders, our Bylaws contain provisions that address the process by which a stockholder may nominate an individual to stand for election to our Board at our Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board is responsible for reviewing and assessing business enterprise risk and other major risks facing the Company, and evaluating management&#8217;s approach to addressing such risks. Periodically, our Board reviews key risks facing the Company, plans for addressing these risks and the Company&#8217;s risk management practices overall. In connection with these reviews, our Board members rely on information from external sources as well as on their individual experiences identifying and managing business enterprise risk for other entities both within and outside of our industry. In addition, the committees of our Board consider and address risk as they perform their respective committee responsibilities. For example, financial risks are overseen by our Audit Committee and our Compensation Committee periodically reviews the most important enterprise risks to ensure that our compensation programs do not encourage excessive risk-taking. All committees report to the full Board as appropriate, including when a matter rises to the level of a material or enterprise risk.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior management team is responsible for day-to-day risk management and regularly reports on risks to our full Board or a relevant committee. Our legal, finance and regulatory areas serve as the primary monitoring and evaluation function for company-wide policies and procedures, and manage the day-to-day oversight of the risk management strategy for our business. This oversight includes identifying, evaluating, and addressing potential risks that may exist at the enterprise, strategic, financial, operational, compliance and reporting levels.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the division of risk management responsibilities described above is an effective approach for identifying and addressing the risks facing our Company, and that the leadership structure of our Board is effective in implementing this approach.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESG and Corporate Responsibility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme continues to build a sustainable, environmentally conscious business while fulfilling our mission of bringing disruptive solutions that can significantly improve patient experiences and outcomes for emerging and established therapies.  We are driven by our mission and dedicated to our sustainability efforts across our entire ecosystem internally and externally.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see the discussion under the heading &#8220;Human Capital Management&#8221; in the Business section of our Annual Report on Form 10-K (which accompanies this Proxy Statement) for additional information on our human capital priorities and programs.  We also recognize that certain stakeholders (such as customers, employees and non-governmental organizations) as well as some stockholders may be interested in more detailed information about our ESG programs and sustainability efforts.  We encourage you to review the information available on our website at www.halozyme.com under the section titled &#8220;Responsibility&#8221; where our 2022 Environmental, Social &amp; Governance Report can be accessed.  Information on our website is not part of this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybersecurity</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate Enterprise Risk Management program, which includes information technology and cybersecurity risk, is reviewed quarterly by the CEO and Halozyme Leadership Team, and annually by the Halozyme Board of Directors. Additionally, Halozyme&#8217;s CEO is briefed quarterly and the Audit Committee is briefed annually or as determined by CIO and CEO, on our cybersecurity program. Our cybersecurity strategy is based on four fundamental areas: policy, procedure, people and technology. Halozyme maintains policies and procedures that describe our employees&#8217; responsibilities for accessing computerized systems, handling data and information, and reporting cybersecurity events in a timely manner. The Board of Directors receives educational updates from outside experts on key emergent topics. All employees and contractors are required to complete formal training on these policies. Halozyme has a well-defined and proven Business Continuity Plan (BCP). The IT Disaster Recovery Plan and the IT Incident Response Plan, which are standalone components of Halozyme&#8217;s BCP, provide the framework and guidance to manage risk.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Communications with Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders may communicate with any and all directors by transmitting correspondence by mail addressed as follows: &#8220;Halozyme Board of Directors&#8221; c/o Corporate Secretary, 12390 El Camino Real, San Diego, California 92130. The Corporate Secretary will transmit as soon as practicable such communications to the identified director addressee(s), unless there are safety or security concerns that mitigate against further transmission of the communication as determined by the Corporate Secretary. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Attendance at Annual Meetings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Corporate Governance Guidelines state that all directors shall make every effort to attend the Company&#8217;s Annual Meeting of Stockholders. All eight of our then-serving directors attended our Annual Meeting of Stockholders in 2022.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Conduct and Ethics and Corporate Governance Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a Code of Conduct and Ethics that applies to all of our employees, officers and directors. The Board has also adopted Corporate Governance Guidelines. Copies of these documents are available on our website at: www.halozyme.com. Amendments to or waivers of our Code of Conduct and Ethics granted to any of our directors or executive officers will be published promptly within four business days on our website, www.halozyme.com.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that the information on our website is not incorporated by reference in this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the directors who served on the Compensation Committee during 2022 has ever been an officer or employee of ours or had a relationship in 2022 requiring disclosure under applicable SEC regulations. None of our executive officers currently serves, or served during 2022, on the compensation committee or board of directors of any other entity that has an executive officer serving as a member of our Board of Directors or Compensation Committee.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 2</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVISORY (NON-BINDING) VOTE </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ON EXECUTIVE COMPENSATION (SAY-ON-PAY)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory vote on executive compensation is a non-binding vote on the compensation of our Named Executive Officers, as described in the Compensation Discussion and Analysis section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure, set forth in this Proxy Statement. Please read the Executive Compensation and Related Information section of this Proxy Statement for a detailed discussion about our executive compensation programs, including information about the fiscal year 2022 compensation of our Named Executive Officers. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory vote on executive compensation is not a vote on our general compensation policies, the compensation of our Board of Directors, or our compensation policies as they relate to risk management. The Dodd-Frank Wall Street Reform and Consumer Protection Act requires that we hold the advisory vote on executive compensation at least once every three years. Upon the recommendation of our stockholders at our 2017 Annual Meeting of Stockholders, our Board of Directors determined that we will hold the advisory vote on executive compensation annually until the next required non-binding stockholder advisory vote on the frequency of future non-binding stockholder advisory votes on the compensation of our Named Executive Officers. In connection with Proposal 2, we are holding an advisory vote on the frequency of the stockholder vote on executive Compensation. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proposal No. 3&#8212; Advisory (Non-Binding) Vote On The Frequency Of An Advisory Vote On Executive Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Accordingly, as required by Section 14A of the Securities Exchange Act of 1934, as amended, we are asking our stockholders to cast an advisory vote to approve the executive compensation as described in this Proxy Statement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have many compensation practices that ensure consistent leadership, decision-making and actions without taking inappropriate or unnecessary risks. These compensation practices are discussed in detail in the Compensation Discussion and Analysis section of this Proxy Statement and have the following objectives:</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Properly align the interests of our stockholders with those of our executive leadership team;</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reward actions and achievements that are consistent with the short- and long-term goals of Halozyme&#8217;s business strategy; and</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Remain competitive to attract, retain and motivate employees with relevant experience and skills needed to achieve our business goals. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vote solicited by this Proposal No. 2 is advisory, and therefore is not binding on the Company, our Board of Directors or our Compensation Committee, nor will its outcome require the Company, our Board of Directors or our Compensation Committee to take any action. Moreover, the outcome of the vote will not be construed as overruling any decision by the Company, the Board of Directors or the Compensation Committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because this non-binding, advisory resolution primarily relates to the compensation of our Named Executive Officers that has already been paid or contractually committed, there is generally no opportunity for us to revisit these past decisions. However, our Board of Directors, including our Compensation Committee, values the opinions of our stockholders and, to the extent there is any significant vote against the Named Executive Officer compensation as disclosed in this Proxy Statement, we will consider our stockholders&#8217; concerns and evaluate what actions, if any, may be appropriate to address those concerns.&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders will be asked at the Annual Meeting to approve the following resolution pursuant to this Proposal No. 2: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOLVED, that the stockholders of Halozyme Therapeutics, Inc. approve, on an advisory basis, the compensation of the Company&#8217;s Named Executive&#160;Officers,&#160;disclosed pursuant to&#160;Item 402 of Regulation S-K in the Company&#8217;s Definitive Proxy Statement for the 2023 Annual Meeting of Stockholders</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval of this resolution requires the affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the matter. Abstentions will be treated as votes &#8220;against&#8221; the proposal. Broker non-votes will have no effect on the outcome of the vote. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors believes that the compensation of our Named Executive Officers, as described in the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Discussion and Analysis and the tabular disclosures and accompanying narrative disclosures under the heading &#8220;Executive Compensation and Related Information&#8221; is appropriate for the reasons stated above. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Therefore, the Board of Directors unanimously recommends a vote &#8220;FOR&#8221; approval of the compensation for our Named Executive Officers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_657"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPOSAL NO. 3</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ADVISORY (NON-BINDING) VOTE ON THE FREQUENCY OF AN ADVISORY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VOTE ON EXECUTIVE COMPENSATION</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dodd-Frank Act also requires that at least every six years we hold a separate advisory (non-binding) stockholder vote to advise on whether the Say-on-Pay vote should occur every one, two or three years. You have the option to vote for any one of the three options or to abstain on the matter. For the reasons described below, our Board continues to recommend that an advisory vote on executive compensation every year is the best approach.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has determined that an advisory vote on executive compensation every year is the best approach for the company based on a number of considerations, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">Annual votes will allow stockholders to provide the company with their direct input on the compensation philosophy, policies and practices as disclosed in the proxy statement every year;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">Annual votes are consistent with company policies of annually seeking input from, and engaging in discussions with, the company&#8217;s stockholders on corporate governance matters and executive compensation philosophy, policies and practices; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Less frequent votes could allow an unpopular pay practice to continue too long without timely feedback.</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board believes that giving our stockholders the right to cast an advisory vote every year on their approval of the compensation arrangements of our named executive officers is a good corporate governance practice and is in the best interests of our stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may cast your vote on your preferred voting frequency by choosing the option of one year, two years, three years or abstain from voting when you vote in response to the resolution set forth below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOLVED, that the stockholders of Halozyme Therapeutics, Inc. determine, on an advisory basis, that the frequency with which the stockholders of the company shall have an advisory vote on executive compensation, as disclosed pursuant to the compensation disclosure rules of the SEC, is:</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Choice 1 - every year;</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Choice 2 - every two years;</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Choice 3 - every three years; or</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Choice 4 - abstain from voting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vote Required</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The choice of frequency that receives the highest number of votes will be considered the advisory vote of our stockholders. Abstentions and broker non-votes will not affect the outcome of this proposal.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because your vote is advisory, it will not be binding upon the Board of Directors. However, the Board of Directors will take into account the outcome of the vote when considering the frequency of future advisory votes on executive compensation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This vote may not be construed (1) as overruling a decision by the company or our Board of Directors or (2) to create or imply any change or addition to the fiduciary duties of the company or our Board of Directors.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recommendation</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The Board of Directors unanimously recommends that you vote for the option of once every year as the frequency with which stockholders are provided an advisory vote on executive compensation, as disclosed pursuant to Item 402 of Regulation S-K of the SEC rules.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders are not voting to approve or disapprove the Board of Directors&#8217; recommendation. Stockholders may choose among the four choices included in the resolution set forth above.</span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_31"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 4</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RATIFICATION OF SELECTION OF </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board of Directors of Halozyme has selected Ernst &amp; Young LLP as the independent registered public accounting firm to audit the consolidated financial statements of Halozyme for the fiscal year ending December 31, 2023. Ernst &amp; Young LLP has acted in such capacity since its appointment on June 28, 2006. A representative of Ernst &amp; Young LLP is expected to be present at the Annual Meeting of Stockholders, with the opportunity to make a statement if the representative desires to do so, and is expected to be available to respond to appropriate questions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm is not required by our Bylaws or otherwise. However, the Board of Directors is submitting the selection of Ernst &amp; Young LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee in its discretion may appoint a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the matter shall ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. Abstentions will be treated as votes &#8220;against&#8221; the proposal. Broker non-votes will have no effect on the outcome of the vote.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors Recommendation </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors unanimously recommends a vote &#8220;FOR&#8221; the ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. </span></div><div style="margin-top:12.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL ACCOUNTING FEES AND SERVICES </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the aggregate fees billed to Halozyme for the fiscal years ended December&#160;31, 2022 and 2021 by Ernst &amp; Young LLP:</span></div><div style="margin-top:5pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:73.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.045%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.046%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,784,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Related Fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041,638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Audit Fees consist of fees billed for professional services rendered for the audit of the Company&#8217;s consolidated annual financial statements, including the audit of internal control over financial reporting and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings or engagements. </span></div><div style="margin-top:3pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Tax Fees consist of fees billed for professional services rendered for tax compliance and tax advice. </span></div><div style="margin-top:3pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">All Other Fees consist of fees for products and services other than the services reported above.</span></div><div style="margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:85.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Audit Committee&#8217;s policy is to pre-approve all audit and permissible non-audit services provided by our independent registered public accounting firm. These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of services. The independent registered public accounting firm and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent registered public accounting firm in accordance with this pre-approval policy. The Chair of the Audit Committee is also authorized, pursuant to delegated authority, to pre-approve additional services on a case-by-case basis, provided that such approvals are communicated to the full Audit Committee at its next meeting. All of the services of Ernst &amp; Young LLP for 2022 and 2021 described above were pre-approved by the Audit Committee.</span></div><div style="height:85.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_34"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">REPORT OF THE AUDIT COMMITTEE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee oversees the Company&#8217;s financial reporting process on behalf of the Board of Directors and is comprised solely of independent directors as defined by the Nasdaq listing standards and Rule 10A-3 of the Securities Exchange Act of 1934. The Audit Committee is governed by a charter which describes in greater detail the full responsibilities of the Audit Committee. The Company&#8217;s management has the primary responsibility for the consolidated financial statements, for maintaining effective internal control over financial reporting, and for assessing the effectiveness of internal control over financial reporting. In fulfilling its oversight responsibilities, the Audit Committee reviews the consolidated financial statements, internal control over financial reporting, audit matters and reports from management. In connection with these reviews, the Audit Committee meets with management and the independent registered public accounting firm (Ernst &amp; Young LLP) at least once each quarter. These meetings include, whenever appropriate, executive sessions in which the Audit Committee meets separately with the independent registered public accounting firm, internal auditors, management personnel and legal counsel. The meetings of the Audit Committee are designed to facilitate and encourage communication among the Audit Committee, the Company, the Company&#8217;s internal audit function and the independent registered public accounting firm. The Audit Committee is directly and solely responsible for the appointment, compensation, retention, and oversight of the independent registered public accounting firm. The Audit Committee regularly considers the independence, qualifications, audit and non-audit fees and services, and performance of the independent registered public accounting firm.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has reviewed and discussed with the independent registered public accounting firm, which is responsible for expressing an opinion on the conformity of the audited consolidated financial statements with U.S. generally accepted accounting principles, its judgments as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (PCAOB) and the Securities and Exchange Commission, and other applicable regulations. In addition, the Audit Committee reviewed and discussed with Ernst &amp; Young LLP matters related to its independence, including a review of non-audit services and the written disclosures and the letter from Ernst &amp; Young LLP to the Audit Committee required by the PCAOB regarding its communications with the Audit Committee concerning Ernst &amp; Young LLP&#8217;s independence. The Audit Committee concluded that Ernst &amp; Young LLP is independent from the Company and its management.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee discussed with the Company&#8217;s independent registered public accounting firm the overall scope and plans for their respective audits. The Audit Committee has met the independent registered public accounting firm, with and without management present, to discuss the results of their examinations; their evaluations of the Company&#8217;s internal control, including internal control over financial reporting; the critical audit matters addressed during the audit and the overall quality of the Company&#8217;s financial reporting.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also reviewed and discussed with management and the independent registered public accounting firm the Company&#8217;s audited consolidated financial statements and related schedule the results of management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting and the independent registered public accounting firm&#8217;s audit of internal control over financial reporting for the year ended December&#160;31, 2022. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board of Directors, and the Board of Directors has approved, that the audited consolidated financial statements and management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting be included in the Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed by the Company with the Securities and Exchange Commission. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;AUDIT COMMITTEE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Jeffrey W. Henderson (Chair)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;James M. Daly</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Barbara Duncan</span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_37"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION AND RELATED INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DISCUSSION AND ANALYSIS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee oversees the compensation program for the Company&#8217;s executive officers. In this role, the Compensation Committee reviews and approves all compensation decisions relating to our executive officers listed in the table below (referred to in this proxy statement as our &#8220;Named Executive Officers&#8221; or &#8220;NEOs&#8221;).  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NEOs for 2022 are:</span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.567%"><tr><td style="width:1.0%"></td><td style="width:36.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Financial Officer (&#8220;CFO&#8221;)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elaine D. Sun </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former Senior Vice President, Chief Financial Officer (&#8220;CFO&#8221;)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, General Counsel, Chief Compliance Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technical Officer</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Ms. LaBrosse was appointed as CFO on February 2, 2022.</span></div><div style="text-align:justify;text-indent:13.7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Sun separated employment from Halozyme on February 2, 2022.</span></div><div style="text-indent:13.7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span></div><div style="text-indent:13.7pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Executive Compensation Highlights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program ties a substantial portion of each executive&#8217;s overall compensation to the achievement of key strategic, financial and operational goals and aligns the interests of executive officers with stockholders by annually awarding long-term equity-based incentives, in the form of time-vesting restricted stock units (&#8220;RSUs&#8221;), performance-vesting stock units (&#8220;PSUs&#8221;) and stock options. Consistent with this approach, the compensation of our NEOs for 2022 featured:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">high revenue and non-GAAP operating income growth performance goals were established for the threshold, base and maximum targets under our 2022 annual cash incentive program. Actual revenue attainment was 96.7% to target and non-GAAP EPS was 92% to target. Actual cash payouts under the 2022 annual cash incentive program ranged from 80% to 92%  of target, with the cash payouts driven by a corporate performance factor under the program of 80%. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a compensation package more heavily weighted toward long-term equity-based incentive compensation than salary and shorter-term annual cash incentives in order to emphasize the focus on our long-term performance and stockholder value,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">long-term equity-based incentives that were heavily weighted toward performance &#8211; in addition to the value of all the awards being dependent on our stock price, the awards granted in 2022 included PSUs which are subject to performance-based vesting conditions and stock options which have value only if our stock price increases after the date of grant of the awards,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">stock ownership and stock retention guidelines, encouraging executives to maintain a meaningful ownership position in the Company, focus on our long-term performance and discourage unreasonable risk-taking,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a recoupment (or &#8220;claw back&#8221;) policy covering certain compensation elements in the event of an accounting restatement due to material noncompliance with any financial reporting requirements,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a policy not to include tax gross-ups in ongoing compensation arrangements,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no &#8220;single trigger&#8221; provisions in executive and employee change-in-control agreements and arrangements (i.e., payout or vesting is not triggered automatically upon a change-in-control), and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no material perquisites.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Engagement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our 2022 annual meeting of stockholders, our stockholders approved, on a non-binding, advisory basis, the compensation paid to our NEOs described in our 2022 proxy statement. Approximately 96.2% of the votes cast on the matter were voted in favor of this &#8220;say-on-pay&#8221; proposal. The Compensation Committee considered the voting results and high level of stockholder support when establishing our executive compensation programs for fiscal 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme conducts regular outreach to our stockholders to build relationships and solicit feedback on our executive compensation program. Specific feedback from stockholders is discussed and considered by the Compensation Committee as executive </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation decisions are made. The Compensation Committee has taken the following actions in response to feedback from stockholders:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">enhanced disclosure in the Compensation Discussion and Analysis (&#8220;CD&amp;A&#8221;) regarding the annual cash incentive plan design, and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">continued discussions around future long-term incentive (&#8220;LTI&#8221;) plan design, including the introduction of the PSUs as part of the mix of annual LTI awards for our executive officers beginning in 2021. </span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">2022 Business Highlights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme&#8217;s strong financial and operating performance in 2022 was supported by internal corporate developments and significant growth and advancements with our ENHANZE&#174; collaboration partners. The key developments and achievements in 2022 include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strong stockholder return, with the per share price of our common stock up more than 41% during 2022 (from NASDAQ closing price of $40.21 on December 31, 2021 to a closing price of $56.90 on December 30, 2022) and up more than 180% over five years (from NASDAQ closing price of $20.26 on December 29, 2017 to a closing price of $56.90 on December 30, 2022).</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued our commitment to returning value to shareholders by repurchasing a total of $200 million shares at an average price of $44.44 per share.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reported record total revenues of $660.1 million, which increased 49% from $443.3 million in 2021.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased revenues from royalties 77% year-over-year to $360.5 million driven primarily by continued strong sales from partnered products utilizing our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology including the subcutaneous forms of DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (daratumumab) and Roche&#8217;s Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (pertuzumab/trastuzumab/hyaluronidase-zzxf).</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Completed the acquisition of Antares Pharma, Inc. resulting in an expansion of our commercial portfolio of proprietary and partnered products and the potential for future growth through new potential collaboration  agreements.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Entered into a global collaboration and license agreement with Chugai Pharmaceutical Co., Ltd. that gives exclusive access to Halozyme's ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology. Under the terms of the agreement, Chugai made an upfront payment of $25 million to Halozyme and is obligated to make potential future payments of up to $160 million in the aggregate, subject to achievement of specified development, regulatory and sales-based milestones.  Halozyme will also be entitled to receive royalties on sales of commercialized medicines using the ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology. Chugai represents Halozyme's twelfth global collaboration and license partner for the ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Regulatory Submissions</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx announced FDA acceptance of a biologics license application ("BLA") for subcutaneous efgartigimod for the treatment of adults with generalized myasthenia gravis ("MG") with a PDUFA date of June 20, 2023. SC efgartigimod is co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche announced that they submitted data from its Phase III IMscin001 study evaluating a subcutaneous formulation of Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (atezolizumab) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for regulatory approval to health authorities globally, including the FDA.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Chugai Pharmaceutical Co., Ltd. (a Member of the Roche Group) announced the submission of a New Drug Application in Japan for fixed-dose subcutaneous combination of pertuzumab and trastuzumab (same monoclonal antibodies as Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in U.S. and EU).</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Data Announcements</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx announced positive topline results from its ADAPT-SC study evaluating subcutaneous efgartigimod (1000mg efgartigimod-PH20) using ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology for the treatment of generalized myasthenia gravis. The study met its primary endpoint, demonstrating noninferior total IgG reduction at day 29 with subcutaneously administered efgartigimod compared to intravenous administration.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche announced that the Phase III IMscin001 study evaluating a subcutaneous formulation of Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (atezolizumab) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> met its co-primary endpoints. The study showed non-inferior levels of Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the blood (pharmacokinetics), when injected subcutaneously, compared with intravenous infusion, in cancer immunotherapy-na&#239;ve patients with advanced or metastatic non-small cell lung cancer for whom prior platinum therapy has failed. The safety profile of the SC formulation was consistent with IV Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Takeda announced positive topline results from pivotal Phase 3 trial evaluating HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Immunoglobulin infusion 10% (Human) with rHuPH20), for maintenance treatment of chronic inflammatory demyelinating polyradiculoneuropathy ("CIDP")</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Clinical Trial Advancements</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche initiated a Phase 3 study evaluating OCREVUS (ocrelizumab) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in subjects with multiple sclerosis.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Janssen initiated a Phase 3 study of lazertinib and amivantamab with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in patients with epidermal growth factor receptor (EGFR)-mutated advanced or metastatic non-small cell lung cancer (PALOMA-3).</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Bristol Myers Squibb ("BMS") initiated a Phase 3 trial to compare the drug levels of nivolumab with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> administered subcutaneously versus intravenous administration in participants with melanoma following complete resection (CheckMate-6GE).</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx initiated a Phase 2 study evaluating efgartigimod with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in subjects with bullous pemphigoid.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ViiV initiated a Phase 1 single dose escalation study in subjects with HIV to evaluate pharmacokinetics, safety and tolerability of long-acting cabotegravir administered subcutaneously with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ViiV initiated a Phase 1 study to evaluate the safety and pharmacokinetics of N6LS, a broadly neutralizing antibody, administered subcutaneously with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Chugai initiated a Phase 1 study to evaluate the pharmacokinetics, pharmacodynamics, and safety of targeted antibody administered subcutaneously with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Bristol Myers Squibb nominated an undisclosed target resulting in a $5 million milestone payment.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Roche Pharmaceuticals China announced the approval of Herceptin (trastuzumab injection subcutaneous with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in China for the treatment of patients with early-stage and metastatic HER2-positive breast cancer.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Announced the commercial launch of TLANDO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an oral treatment indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone (primary or hypogonadotropic hypogonadism). TLANDO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was approved by the FDA on March 28, 2022.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strengthened our balance sheet by completing the sale of $720 million in aggregate principal amount of 1.00% Convertible Senior Notes due 2028. We used a portion of the net proceeds to repay higher interest rate in-the-money convertible notes and the full amount outstanding on our floating interest rate term loan.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Entered into an amendment to our revolving credit agreement that increased the size of the facility from $350 million to $575 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 CEO Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the total target annual cash compensation for our CEO, Dr. Helen I. Torley, was $1,569,118 ($871,732 in base salary plus $697,386 in target annual cash incentive opportunity). Dr. Torley&#8217;s base salary was increased for 2022 by 5% as a result of the Compensation Committee&#8217;s assessment of her contribution to Halozyme&#8217;s performance during 2021 and its review of base salary paid to other peer group CEOs. (Our executive compensation peer group is discussed below under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Peer Group</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;) Dr. Torley&#8217;s target annual cash incentive opportunity for 2022 (assuming achievement of the corporate goals at 100%) was 80% of her base salary, which was the same as her target annual cash incentive opportunity for 2021. The Compensation Committee believes this target annual cash incentive was appropriate based on her level of experience, the Compensation Committee&#8217;s review of annual cash incentive targets for other peer group CEOs, and the Compensation Committee&#8217;s belief that significant portions of total annual cash compensation should be tied to achievement of specified goals. The annual cash incentive she earned for 2022 was $557,909 which represents 80% of her target annual cash incentive opportunity.  As CEO, Dr. Torley is the only NEO whose annual cash incentive is determined solely based on the performance of the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley also received an LTI award during 2022 that had a grant date fair value approximately $8,250,000, comprising the most significant element of her 2022 compensation opportunity. This award was granted based on the Compensation Committee&#8217;s assessment of her contribution to Halozyme&#8217;s performance during 2021, its review of LTI compensation paid to other peer group CEOs and the desire to link a significant portion of her compensation opportunity to Halozyme&#8217;s long-term performance. The Compensation Committee approved a mix of 25% PSUs (at target), 40% stock options and 35% RSUs for Dr. Torley and each of the other NEOs to emphasize Halozyme&#8217;s long-term stock price performance and to promote retention.  The stock options vest 25% on the one-year anniversary of the date of grant with the remaining 75% vesting monthly over the following three years, while RSUs vest in 25% annual installments over a four-year period following the grant date, subject to continued employment. PSUs granted to the NEOs in </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 vest based on our relative total shareholder return measured against an applicable subset of 92 companies in  the NASDAQ Biotechnology Index over a three-year performance period.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Halozyme&#8217;s Executive Compensation Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal elements of our executive compensation program are base salary, an annual cash incentive opportunity and an annual LTI award opportunity. The LTI awards for 2022 consisted of stock options, RSUs and PSUs.</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.986%"><tr><td style="width:1.0%"></td><td style="width:2.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do Not Do</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay annual bonus based on the achievement of Company financial and strategic goals, and in the case of NEOs other than the CEO, individual performance, and contribution in achieving those goals</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No guaranteed annual bonus payouts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Grant PSUs as significant portion of annual LTI awards for all executive officers </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No severance payments or benefits for executives who voluntarily terminate their employment</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cap the annual bonus plan payout</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No buyback of stock awards or repricing of stock options without shareholder approval</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prohibit executive officer hedging and pledging of Company stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No executive single-trigger change in control benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain an  executive officer recoupment (&#8220;claw back&#8221;) policy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No material perquisites </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain robust stock ownership and retention guidelines for all executive officers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No supplemental executive benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conduct an annual comprehensive compensation program risk assessment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No excise tax gross-ups</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Detailed Discussion and Analysis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This CD&amp;A describes the material elements of 2022 compensation for our NEOs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee makes all decisions relative to the compensation of all executive officers (including the CEO). Except as otherwise noted in this CD&amp;A, the Compensation Committee&#8217;s executive compensation determinations are subjective and the result of the Compensation Committee&#8217;s business judgment. Additional details regarding the role and responsibilities of the Compensation Committee are provided below.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Executive Total Rewards Philosophy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee periodically reviews its total rewards philosophy for executive officers to confirm our programs continue to meet the objectives of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supporting  Halozyme&#8217;s short- and long-term business strategy,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anchoring to market-based principles and being tailored to Halozyme&#8217;s culture, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">aligning the interests of the executive officers with the long-term interests of Halozyme stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material elements of 2022 compensation for our NEOs consisted of  three primary elements, each has a specific purpose as described below:</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.126%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Element</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purpose</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Salary</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Provides a fixed amount of cash compensation based on individual performance, job scope, experience and competitive market for talent</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Cash Incentive</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Motivates and rewards fiscal year contribution to company performance against pre-established goals and objectives </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Incentives (LTI)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Align compensation with the creation of  stockholder value (in the case of stock options) and changes in stock price (in the case of RSUs)  and  relative total shareholder return performance (in the case of PSUs)</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Increases executive stock ownership and align with stockholder interests.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Serves as a key retention device</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our NEOs are eligible to receive severance payments and benefits in connection with a qualifying termination of employment under our executive Change-in-Control Agreements and our severance policy for covered terminations unrelated to a change in control, each as described in more detail below. We also provide our NEOs with the same package of benefits that are provided to substantially all our full-time employees, including Company matching contributions to a 401(k) plan, health insurance, group term life insurance, and disability income insurance. From time to time, we may also provide relocation assistance in connection with the recruitment of an officer or employee with needed skills and experience. No material perquisites or supplemental executive benefits were provided to our NEOs in 2022. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As shown below, the majority of our NEOs&#8217; target total direct compensation for 2022 (base salary, target annual cash incentive, and LTI awards, taken into account at their fair value on the grant date) was variable (target annual cash incentive and LTI awards), with the single largest component (LTI awards) based on Halozyme&#8217;s stock price performance. Ms. Sun has been excluded from the chart since her employment ended in early 2022.  Mr. Snyder is excluded since he was a newly hired executive and therefore did not receive an annual LTI award.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><img src="halo-20230324_g5.jpg" alt="halo-20230324_g5.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:643px"/></div><div style="margin-top:6pt;text-align:center"><img src="halo-20230324_g6.jpg" alt="halo-20230324_g6.jpg" style="height:293px;margin-bottom:5pt;vertical-align:text-bottom;width:642px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salary</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee determines base salaries for NEOs each year based upon the following factors (with no specific weight applied to each factor):</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the scope and complexity of the NEO&#8217;s responsibilities, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a review of external market practices (a more detailed description of the methodology used to assess external market practices is provided below),</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the NEO&#8217;s experience, </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">internal pay equity and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the CEO&#8217;s evaluation of the NEO&#8217;s performance and contribution to the short and long-term success of Halozyme (in the case of the CEO, the evaluation is done in executive session by the Compensation Committee with input from the other independent members of the Board of Directors). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reflected in the table below, 2022 annual base salary levels were increased by 5% for the CEO, 5% for Dr. LaBarre, and 67% for Ms. LaBrosse (reflecting her promotion to her new position as our CFO and was set well below the peer median). The base salary increases for our NEOs, as well as the initial base salary for Mr. Snyder, were approved by the Compensation Committee after taking into account the base salaries paid to peer group executives holding similar positions and other factors described above.  </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.944%"><tr><td style="width:1.0%"></td><td style="width:61.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021  Base Salary</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022  Base Salary</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$830,221</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$871,832</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$291,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$485,500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elaine D. Sun </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$494,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$525,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$494,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$520,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Ms. Sun separated employment on February 2, 2022 and did not receive a salary increase for 2022. </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Cash Incentive</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEOs participate each year in the Employee Bonus Plan (&#8220;EBP&#8221;). The actual cash incentive paid to each NEO with respect to 2022 was determined based on each NEO&#8217;s target annual cash incentive opportunity and based on the performance of Halozyme as measured by the level of achievement of eight metrics, of which two are tied to financial performance and have a combined 60% weighting and six are tied to operational performance and have a combined 40% weighting (&#8220;Corporate Performance&#8221;). As CEO, Dr. Torley is responsible for overall corporate performance, and accordingly, her EBP incentive opportunity is based entirely on the attainment of objective, pre-established corporate performance goals without applying an individual performance adjustment. For the other NEOs, the Committee may modify final payouts based on individual performance during the year relative to the level of achievement of personal goals (&#8220;Individual Performance Factor&#8221;), and the NEO must achieve at least 60% of his/her individual performance objectives in order to be eligible for a cash incentive payment. In all events, an NEO&#8217;s total payout cannot exceed two times the target cash annual incentive opportunity for the NEO.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee sets each NEO&#8217;s target annual cash incentive opportunity as a percentage of the NEO&#8217;s base salary taking into account the same factors as are considered in NEO base salary determinations.  No changes were made to 2022 target annual cash incentive opportunities for the NEOs (as a percentage of base salary), except with respect to the 2022 target annual cash incentive opportunity for Ms. LaBrosse, which was increased in connection with her promotion to CFO and increased responsibilities.   </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.944%"><tr><td style="width:1.0%"></td><td style="width:61.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Executive Officer</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2021 Target Bonus</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(% Salary)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2022 Target Bonus</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(% Salary)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2022 Target Bonus ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Helen I. Torley</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">80%</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">80%</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$697,386</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nicole LaBrosse</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">35%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$218,475</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Elaine D. Sun</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mark Snyder</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$236,250</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Michael J. LaBarre</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">45%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$234,000</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Ms. Sun was not eligible to participate in the 2022 EBP as her employment ended in early 2022. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Corporate goals were established by the Compensation Committee (with input from the full Board of Directors) to tie the compensation of our NEOs to the Company&#8217;s achievement of annual operating objectives that were viewed as long-term drivers of sustainable value creation. The EBP funding incentive zone ranges between 0% and 200% for each of the four metrics. The Board of Directors approved the threshold, target, and maximum goals/level of performance for each metric (other than cybersecurity, which is assessed by the Board of Directors) at the beginning of the year. The threshold target and maximum levels for our revenue and non-GAAP operating measures were adjusted and increased during the year by the Compensation Committee in connection with the completion of our acquisition of Antares Pharma, Inc in May 2022. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 EBP focused on achievement of key financial and strategic objectives that resulted in (i) revenue growth, (ii) increased non-GAAP operating income and (iii) certain other operational goals as identified in the table below. The Compensation Committee is responsible for certifying actual performance relative to these goals following completion of the fiscal year. After reviewing the Company&#8217;s performance results in 2022, the Compensation Committee determined the corporate performance factor under the 2022 EBP was achieved at 80% of the targeted level for the NEOs (see table below). </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.867%"><tr><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate Goal</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weight</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Threshold</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Result</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBP Funding</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue (1)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$639M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$682M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$747M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$660.1M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP operating income (1)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$379M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$422M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$487M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$388.5M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grow ENHANZE potential by supporting partner attainment of &#8220;x&#8221; new study starts (phase 1, 2 or 3)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Number of new co-formulation patent submissions by partner</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Research and development goals</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complete certain portfolio evaluation and business case review by 11/30/2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complete certain portfolio evaluation and business case review by 11/30/2022 and submission of new drug application by 12/31/2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complete certain portfolio evaluation and business case review by 11/30/2022 and submission of new drug application by 11/30/2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At Target</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Enter into &#8220;x&#8221; new licensing agreements</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Develop working prototype </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generate in vivo proof of concept data</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Develop a working prototype for in vivo testing</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establish certain collaboration agreements</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At Target</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cybersecurity goals</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As evaluated by the Board of Directors</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150%</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8%</span></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL CORPORATE PERFORMANCE FACTOR</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The initial threshold, target and maximum levels for revenue ($524M, $555M, and $594M, respectively) and operating income ($344M, $374M, and $414M, respectively) for purposes of the 2022 EBP were set before the completion of the Antares Pharma, Inc. acquisition. As noted above, these levels were increased, to the levels reflected in the table above, in connection with the completion of the Antares Pharma, Inc. acquisition. For purposes of the 2022 EBP, non-GAAP operating income was defined to mean operating income determined in accordance with U.S. Generally Accepted Accounting Principles, but adjusted to exclude the impact of one-time transaction costs and amortization costs related to the Antares Pharma Inc. acquisition.  The threshold, target, and maximum levels established for revenue and Non-GAAP operating income under the 2022 EBP reflect the high growth expectations we had when the goals were established. As illustrated in the chart above, actual revenue was 97% to target and non-GAAP operating income was 92% to target, significantly contributing to the overall 80% corporate performance factor under the 2022 EBP.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee scored the Cybersecurity goal at 150% attainment based on its assessment of, and a recommendation from the Audit Committee as to, employee performance on the identification of phishing attacks, third party assessments of our cybersecurity program, and management&#8217;s efforts to prevent and address cybersecurity threats in an ever-evolving threat landscape.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Individual Performance Factor.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee believes the actual payout to each NEO (other than for Dr. Torley whose payout, as noted above, is based entirely on the attainment of objective, pre-established corporate performance goals) should also reflect the executive&#8217;s:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">performance relative to individual goals and objectives established for the year,</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">contribution toward achieving the Corporate Performance results, and </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">demonstration of living Halozyme&#8217;s Leadership Attributes and Corporate Values during the year.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Ms. LaBrosse&#8217;s accomplishments and other factors, the Compensation Committee supported the CEO&#8217;s recommendation and awarded her an individual performance factor of 115%.  The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ms. LaBrosse successfully led multiple financial transactions supporting execution of the corporate strategy and strengthened the company&#8217;s balance sheet. These activities included accessing bank debt to support the Antares Pharma acquisition, execution of convertible debt raises to secure capital and settle variable rate debt at low fixed interest rates, and continued execution of our share buy-back program. Additionally, Ms LaBrosse led key integration workstreams focused on Financial reporting, IT and Cybersecurity, meeting all goals.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Mr. Snyder&#8217;s accomplishments and other factors, the Compensation Committee supported the CEO&#8217;s recommendation and  awarded him an individual performance factor of 105%.  The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Mr Snyder played a key role in successful accomplishment of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the corporate goals including support of the submission of three co-formulation patent applications and successful negotiation of the Collaboration and Licensing Agreement with Chugai. In addition, Mr Snyder played a key role in the successful completion of the Antares Pharma acquisition, leading multiple aspects of the diligence and negotiation and providing direction to external counsel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Dr. LaBarre&#8217;s accomplishments and other factors, the Compensation Committee supported the CEOs recommendation and awarded him an individual performance factor of 100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Dr. LaBarre played a key role in successful accomplishment of the corporate goals including helping identify the innovations that supported the submission of three co-formulation patent applications and leading the successful development and demonstration of the a large volume Auto-Injector prototype, following the acquisition of Antares Pharma.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates the 2022 cash incentive calculation for each NEO based on the following formula (also reflected in the &#8220;Non-Equity Incentive Plan Compensation&#8221; column of the Summary Compensation Table). </span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><img src="halo-20230324_g7.jpg" alt="halo-20230324_g7.jpg" style="height:97px;margin-bottom:5pt;vertical-align:text-bottom;width:636px"/></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.065%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annualized Base Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Target<br/>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annualized<br/>Target Amount<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Performance Factor</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual Performance Factor</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Final Payout<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697,386</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,475</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">As noted above, Dr. Torley&#8217;s payout is based entirely on the attainment of objective, pre-established corporate performance goals without applying an individual performance factor.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LTI Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All grants of LTI compensation are made under our stockholder-approved equity incentive plan. The Compensation Committee utilized three vehicles to deliver LTI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">awards to NEOs during 2022:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are strongly aligned with stockholder interests because they deliver value to the NEO only if the value of our stock at the time of exercise exceeds the stock price on the day of grant. As a result, the Compensation Committee believes stock options encourage executives to focus on the decisions and behaviors required to support long-term sustainable increases in our stock price.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Time-vesting RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide a counterbalance to the more uncertain value associated with stock options and PSUs while still maintaining alignment with the interests of our long-term stockholders, as the value of RSUs fluctuates (up or down) with changes in </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our stock price. As a result, the Compensation Committee believes time-vesting RSUs encourage executives to make decisions consistent with the long-term interests of our stockholders and help support retention.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and time-vesting RSUs granted to our NEOs in 2022 generally vest over a four-year period subject to continued employment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> help link our equity incentive program to achievement of specific performance goals established by the Compensation Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee believes that the grant of PSUs furthers our executive compensation philosophy to tie achievement of company performance with executive compensation, aligns the interests of executive officers with our stockholders and encourages long-term performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSUs granted to the NEOs in 2022 are eligible to cliff vest after a three-year period provided they are earned based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index (excluding companies that had not be listed or traded on a national securities exchange for at least three consecutive years as of October 31, 2021, those that had gross revenue of less than $100 million dollars for the period of four consecutive calendar quarters ending with the last fiscal quarter for which there were publicly disclosed financial results as of October 31, 2021, and those that cease to be publicly-traded during the applicable performance period). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One-third of the target PSUs are earned based on  three discrete performance periods  each beginning on the grant date of the awards, with one performance period ending December 31, 2022, one performance period ending December 31, 2023, and one performance period ending December 31, 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of these awards, TSR for us and the applicable subset of component companies is based on a 20-trading day average trading price beginning on the PSU grant date and a 20-trading day average trading price ending on the last day of the applicable performance period. Dividend equivalents, if any, will be accrued as additional stock units and delivered with earned shares at vesting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential vesting percentages for the 2022 PSUs are as follows (with the percentage determined by linear interpolation for performance between the 25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentiles):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.785%"><tr><td style="width:1.0%"></td><td style="width:28.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Maximum</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile or Higher</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">150%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Target</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">100%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Threshold</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Below Threshold</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&lt; 25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">0%</span></td></tr></table></div><div style="margin-bottom:1pt"><span><br/></span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PSUs eligible to vest based on performance become vested on the third anniversary of the grant date of the awards following certification of performance results and assuming continued employment (subject to earlier vesting and payment on a pro-rated basis on an involuntary termination).  The three-year cliff vesting schedule serves as additional retention and incentive for stock price performance to support long-term alignment with our stockholders.</span></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Annual LTI Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, the Compensation Committee awarded annual LTI compensation for the NEOs based on the fair value the Committee determined appropriate considering their assessment of annual equity award grants to peer group executives holding similar positions, and taking into account their assessment of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the executive&#8217;s experience, expected contribution to the long-term success of the Company, and skill-set relative to industry peers at biopharmaceutical companies (with no specific weight applied to each factor). The Compensation Committee also determined that the award value for each NEO would be allocated 25% PSUs (at target), 40% stock options and 35% RSUs. Relative to the executive LTI grants in 2021, the weighting of stock options was increased (up from 30% in 2021) and RSUs were decreased (down from 40% in 2021) in order to increase the emphasis on performance-based awards, as the value of stock options depends on increases in our stock price after the grant of the awards.  Ms. Sun did not receive an annual LTI award in 2022 because her employment with the Company ended before the regular grant of annual LTI awards to the executive team in 2022. Accordingly, the Compensation Committee awarded the following LTI values to our NEOs in 2022:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.801%"><tr><td style="width:1.0%"></td><td style="width:42.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.267%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs <br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs <br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,300,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,250,048</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,041</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000,051</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400,043</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Mr. Snyder&#8217;s stock option grant and RSU grant shown above were awarded in connection with his commencement of employment on January 3, 2022, and his PSU award was granted when the PSUs were granted to the executive team generally.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PSU Award Vesting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has determined that, as to the one-third of the PSUs awarded in 2022 that correspond to a performance period ended December 31, 2022, 150% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was 64.8% and this placed us at the 98.8th percentile against the comparison group of companies for that period). These PSUs remain unvested, with vesting subject to continued employment through the third anniversary of the grant date of the awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We awarded PSUs in 2021 to Dr. Torley, Ms. Sun and Dr. LaBarre that are similar to the PSUs awarded in 2022. The Compensation Committee has determined that, as to the one-third of the PSUs awarded in 2021 that correspond to a performance period ended December 31, 2021, 130.04% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was -18.87% and this placed us at the 65.02nd percentile against the comparison group of companies for that period), and that, as to the one-third of the PSUs awarded in 2021 that correspond to a performance period ended December 31, 2022, 150% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was 26.58% and this placed us at the 89.16th percentile against the comparison group of companies for that period). Except for Ms. Sun&#8217;s PSUs which were forfeited in connection with her separation from employment, these PSUs remain unvested, with vesting subject to continued employment through the third anniversary of the grant date of the awards.</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Peer Group</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee annually selects a group of peer companies against which Halozyme benchmarks the competitiveness of executive pay levels and program design (referred to in this CD&amp;A as our &#8220;peer group&#8221; or &#8220;peer companies&#8221;). The peer group companies are identified based upon the Compensation Committee&#8217;s assessment of each company&#8217;s similarity with Halozyme with respect to science/business model, revenue, and market capitalization. The peer group is reviewed annually by the Compensation Committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022 compensation decisions, the Compensation Committee utilized proxy data from the following companies, listed below.  The Compensation Committee&#8217;s objective in selecting this peer group was to include a group of similar-sized public companies in the life sciences sector, with an emphasis on pharmaceutical and biotechnology companies with commercialized products.  Targeted companies generally had revenues and market capitalization between 0.25x to 4.0x Halozyme&#8217;s size at the time of the analysis with Halozyme near the median on both measures.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.537%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#00497f;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 Peer Group</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acadia Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acceleron Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Agios Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alnylam Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amicus Therapeutics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Blueprint Medicines</span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exelixis</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">FibroGen</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Heron Therapeutics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ionis Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ironwood Pharmaceuticals</span></div><div><span><br/></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals<br/>Nektar  Therapeutics<br/>Neurocrine Biosciences<br/>Sarepta Therapeutics<br/>Ultragenyx Pharmaceuticals<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following changes to the peer group were made for 2022: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Amicus Therapeutics, Blueprint Medicines, Exelixis and Ionis Pharmaceuticals were added to the group based on the Compensation Committee&#8217;s assessment of the criteria noted above.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Eagle Pharmaceuticals, Intercept Pharmaceuticals, Momenta Pharmaceuticals, Theravance Biopharma and Travere Therapeutics were removed from the group based on the Compensation Committee&#8217;s assessment of the criteria noted above and, in the case of Momenta Pharmaceuticals, because it was no longer publicly-traded.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Compensation Consultant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee retains F.W. Cook &amp; Co. (&#8220;FW Cook&#8221;) as its independent compensation consultant to provide advice and counsel on matters related to our executive compensation program and FW Cook provides no other services to Halozyme.  In 2022, FW Cook provided recommendations regarding the composition and selection of Halozyme&#8217;s peer group companies to be used with respect to 2022 and 2023 executive compensation decisions, performed a review of compensation levels and practices for similar executive positions at the peer group companies, advised regarding the compensation mix and levels for the NEOs, advised on the design and implementation of our annual LTI awards, reported on executive compensation trends and developments, and advised on the compensation arrangements for our non-employee directors. FW Cook reports directly to the Compensation Committee and regularly attends meetings of the Committee, as requested. The Compensation Committee assessed the independence of FW Cook pursuant to applicable rules and regulations of the SEC and NASDAQ and concluded that the engagement of FW Cook did not raise any conflicts of interest during fiscal 2022 and currently does not raise any conflicts of interest.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Risk Assessment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee, with assistance from its independent compensation consultant and with input from members of management, annually reviews our compensation programs, policies and practices to determine whether they encourage risk-taking that could have a material adverse effect on the Company.  As part of this review, the Company evaluates the primary components of its compensations plans to identify whether those components properly balance compensation opportunities and risk.  Our Compensation Committee considers various factors, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The Company&#8217;s pay philosophy provides an effective balance in cash and equity award mix, short- and long-term performance periods, financial and non-financial performance, formulas and discretion.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The Company&#8217;s compensation programs include an appropriate mix of short- and long-term goals and incentives.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The Compensation Committee has discretion to make positive and negative adjustments to payouts under the Company&#8217;s compensation plans.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Policies are in place to manage or mitigate risk, such as stock ownership guidelines, vesting periods on equity awards, insider-trading prohibitions that also restrict hedging and pledging, recoupment policy and provisions, and independent Compensation Committee oversight.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The Company&#8217;s design and oversight principles also apply to its broad-based employee compensation plans.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this review, the Compensation Committee, based in part on the input from its compensation consultants, concluded that the risks arising from the Company&#8217;s compensation policies and practices, for both our executive officers and our other employees, are not reasonably likely to have a material adverse effect on Halozyme.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Compensation Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Ownership and Retention Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain stock ownership guidelines for our executive officers which stipulate that the CEO is expected to own shares of Halozyme common stock with value equal to no less than six times the CEO&#8217;s current base salary and that all other executive officers are expected to own shares of Halozyme common stock with value equal to no less than two times the officer&#8217;s current base salary.  Certain other officers designated by the Compensation Committee are expected to own shares of Halozyme common stock with value no less than one times the officer&#8217;s current base salary. Each executive officer is expected to comply with the guidelines within five years of appointment as an executive officer, and has three years to comply with any incremental ownership required as a result of a promotion or other increase in applicable ownership multiple. Share ownership that counts for purposes of satisfying the applicable guideline level of ownership includes fully-owned shares (including shares held in trust and by immediate family members), vested but deferred shares, shares held in retirement accounts, and unvested stock units that are subject to time-based vesting only. Stock units subject to unsatisfied performance-based vesting conditions and unexercised stock options are not counted when evaluating compliance. Each executive officer is required to: (i) hold at least 50% of all net shares (after shares withheld or sold to pay tax obligations) of RSUs and PSUs that vest; and (ii) hold at least 50% of the underlying net gain (i.e., not including shares sold to pay the exercise price or to satisfy tax obligations) in shares of the Company&#8217;s common stock as a result of stock option exercises, until the executive officer comes into compliance with the stock ownership guidelines. The Compensation Committee annually reviews progress executive officers are making toward achieving compliance with these guidelines and has determined that all of our NEOs have achieved their specific ownership levels as of March&#160;24, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Deductibility of Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Section 162(m) of the Internal Revenue Code generally disallows a tax deduction to public companies for compensation in excess of $1 million paid to a company&#8217;s chief executive officer and certain current and former executive officers.  As a result, we expect that compensation paid per year to our NEOs and certain former executive officers in excess of $1 million generally will not be deductible, subject to limited exceptions.  The Compensation Committee generally seeks to preserve tax deductions for executive compensation where available but may make compensation decisions based on other factors when it believes doing so is in the best interest of the Company and its stockholders. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into Change in Control Agreements with our executive officers. We believe that the occurrence or potential occurrence of a change in control transaction creates uncertainty regarding the continued employment of our executive officers. This uncertainty results from the fact that many change in control transactions are common in our industry and often result in significant organizational changes, particularly at the senior executive level. We provide additional severance protections under the Change in Control Agreements to help ensure that executives can objectively evaluate change in control transactions that may be in the best interest of stockholders despite the potential negative consequences such transactions may have on them personally and to encourage executives to remain employed with the Company during an important time when their prospects for continued employment following the transaction are often uncertain. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Change in Control Severance Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has approved a Company-wide severance policy, outside of a change in control context, that is also applicable to our executive officers. We believe that such severance protections are only appropriate in the event an executive is involuntarily terminated without cause and that these severance benefits are appropriate in light of severance protections available to executives at our peer group companies, and are an important component of each executive&#8217;s overall compensation as they help us to attract and retain our key executives who could have other job alternatives that may appear to them to be more attractive absent these protections. Despite the establishment of the severance policy, however, the Board of Directors or Compensation Committee retains the right to amend, alter or terminate the severance policy at any time.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Compensation Recoupment (&#8220;Clawback Policy&#8221;)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has approved an incentive compensation recoupment policy which provides for the recovery of compensation received by NEOs in connection with a material restatement in Halozyme&#8217;s financial statement disclosure. The Board of Directors may seek reimbursement of annual cash incentive compensation and all equity compensation awards where the payout or vesting exceeds the amounts that would have been received had the financial results been properly reported. We intend to adopt a clawback policy that is consistent with the requirements of Exchange Act Rule 10D-1 following the release and effectiveness of Nasdaq listing standards in accordance with such rule.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedging and Pledging Restrictions</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Insider Trading Policy prohibits the pledging of Company securities as collateral and entering into transactions to hedge the value of Company securities owned by executives subject to the policy. Under the policy all directors and employees (including officers), or their designees, are prohibited from purchasing financial instruments (including prepaid variable forward contracts, equity swaps, collars and exchange funds) or otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset, any decrease in the market value of Halozyme&#8217;s equity securities that are either (i) granted to the employee or director by Halozyme as part of the compensation of the employee or director or (ii) held, directly or indirectly, by the employee or director.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Report</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the Compensation Committee of the Board of Directors of Halozyme Therapeutics, Inc., have reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with management. Based on such review and discussion, we have recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COMPENSATION COMMITTEE</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span><br/></span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernadette Connaughton (Chair)</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jean-Pierre Bizzari, M.D.</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Connie Matsui</span></div><div style="padding-left:252pt;text-align:justify"><span><br/></span></div><div style="padding-left:252pt;text-align:justify"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_40"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Summary Compensation Table </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning the compensation earned during the fiscal years ended December&#160;31, 2022, 2021 and 2020 by each individual who acted as our principal executive officer, our principal financial officer, and our other most highly compensated executive officers during the fiscal year ended December&#160;31, 2022. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 SUMMARY COMPENSATION TABLE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name and Principal Position</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock <br/>Awards<br/>($)(1)(3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards<br/>($)(2)(3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Equity <br/>Incentive Plan <br/>Compensation<br/>($)(4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All Other <br/>Compensation<br/>($)(5)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,950,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,300,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557,909</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,289</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,696,978</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">830,221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,060,081</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,740,001</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807,619</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,372</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,453,294</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">791,440</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500,018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,500,001</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">712,270</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,147</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,518,876</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467,836</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200,030</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,012</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,997</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,228</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,683,103</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President<br/>Chief Financial Officer</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elaine D. Sun</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,909</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,831</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,740</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Former Senior Vice President<br/>Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,155,062</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,271</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,158,342</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395,833</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,500,269</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,352</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,399</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,359,861</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525,000</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750,044</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250,007</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,450</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,701</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,740,202</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440,041</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,200</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,037</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,123,280</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technical Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">450,010</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,217</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,333</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279,600</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650,009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,163</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,010,197</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This column represents the grant date fair value of stock awards granted to the NEOs in fiscal years 2022, 2021 and 2020, in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 718. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeiture related to service-based vesting conditions. For additional information on the valuation assumptions used by us in calculating these amounts refer to Note 7 of the Notes to Consolidated Financial Statements, filed as part of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC on February&#160;21, 2023. Stock awards granted to executive officers consist of RSUs and PSUs.  A portion of the amounts reported in this column for each NEO for 2022 and 2021 (and, as to Ms. Sun, a portion for 2020) reflect the grant-date fair value of PSUs granted to the executives during that fiscal year.  In accordance with applicable SEC rules, these amounts were determined based on the probable outcome (determined as of the date of grant of the awards) of the performance-based conditions applicable to the awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these purposes, the grant date fair value for the PSU awards granted to each of the NEOs was determined based on a Monte Carlo simulation pricing model (which probability weights multiple potential outcomes) as of such grant date. The significant assumptions used in the Monte Carlo simulation pricing model were as follows:</span></div><div style="margin-top:6pt;padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.245%"><tr><td style="width:1.0%"></td><td style="width:43.810%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.798%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.798%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.798%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.52%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.96%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.5%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.28%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the aggregate grant-date fair value of these performance-based awards granted in fiscal 2022 and 2021 included in the &#8220;Stock Awards&#8221; column for those years and the aggregate grant-date fair value of these awards assuming that the highest level of performance conditions was achieved.  Ms. Sun was the only NEO who received PSUs in 2020.  The aggregate grant-date fair value of Ms. Sun&#8217;s PSUs awarded in fiscal 2020 included in the &#8220;Stock Awards&#8221; column for that year was $500,264, which was also the grant date value of that award assuming that the highest level of performance conditions was achieved.  </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.111%"><tr><td style="width:1.0%"></td><td style="width:19.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.764%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2022)</span></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2021)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Name</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Maximum Performance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Based on Maximum Performance</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">($)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Helen I. Torley</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,062,529</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3,093,794</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1,450,060</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,175,060</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nicole LaBrosse</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">500,013</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">750,020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Elaine D. Sun</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">412,545</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">618,818</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Mark Snyder</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">500,013</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">750,020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Michael J. LaBarre</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">600,008</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">900,012</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">375,007</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">562,510</span></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This column represents the grant date fair value of stock options granted to the NEOs in fiscal years 2022, 2021 and 2020, in accordance with FASB ASC Topic 718.  Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeiture related to service-based vesting conditions. For additional information on the valuation assumptions used by us in calculating these amounts refer to Note 9 of the Notes to Consolidated Financial Statements, filed as part of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 filed with the SEC on February&#160;21, 2023. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts reported in the Summary Compensation Table for stock awards and option awards may not represent the amounts that the NEOs will actually realize from the awards.  Whether, and to what extent, an NEO realizes value will depend on stock price fluctuations and the NEO&#8217;s continued employment.  To see the exact share amounts and the value of awards made to the NEOs in fiscal 2022, see the 2022 Grants of Plan-Based Awards table below. Additional information on all outstanding awards is reflected in the Outstanding Equity Awards at December&#160;31, 2022 table.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Performance-based bonuses are generally paid pursuant to our annual incentive plans and reported as Non-Equity Incentive Plan Compensation. The performance-based bonuses represent amounts earned during each respective fiscal year based on applicable performance levels for such fiscal year, regardless of whether part or all of such amounts were paid in a subsequent fiscal year. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The table below lists the amounts set forth in this column which consist of other compensation including (i) Company contributions to Halozyme Therapeutics, Inc. 401(k) plan, (ii)  payout of accrued paid time off for Ms. Sun in connection with her separation from employment, and (iii) Company payments for group term insurance premiums.</span></div><div style="margin-top:6pt;padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.152%"><tr><td style="width:1.0%"></td><td style="width:25.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">401(k) Plan Company Matching Contributions ($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Payout of Accrued Paid Time Off ($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Other Compensation ($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Total ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$13,725</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$3,564</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$17,289</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$13,725</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$503</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$14,228</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Elaine D. Sun</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$4,178</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">66,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$153</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$70,831</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Mark Snyder</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$13,725</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$2,976</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$16,701</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$13,725</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$2,312</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$16,037</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_43"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Grants of Plan-Based Awards </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain summary information with respect to plan-based awards granted during the fiscal year ended December&#160;31, 2022 to our NEOs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"></td><td style="width:7.510%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.857%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.187%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.404%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.219%"></td><td style="width:0.1%"></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Future Payouts Under <br/>Non-Equity Incentive Plan Awards(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Future Payouts Under<br/>Equity Incentive Plan Awards (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">All Other Stock Awards: Number of Shares or Units(#) (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">All Other Option Awards: Number of Securities Underlying Options(#) (4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Exercise or Base Price of Option Awards<br/>($/Sh)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Grant Date Fair Value of Stock and Option Awards($) (5)</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Threshold<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Threshold<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helen I. <br/>Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">697,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,394,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,887,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,062,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,300,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">439,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,373&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">700,016&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,051&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,152&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,013&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800,012&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">236,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">472,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/03/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1/03/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">234,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">468,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,448&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">840,033&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,521&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,782&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,008&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,777&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">960,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For a description of the elements of the annual incentive plan applicable to our NEOs, refer to &#8220;Compensation Discussion and Analysis - Elements of Executive Compensation for 2022&#8221; in this proxy statement. The actual amount of cash paid to each NEO pursuant to the incentive plan established for 2022 is set forth in the Summary Compensation Table under the heading, &#8220;Non-Equity Incentive Plan Compensation.&#8221; </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The PSU awards to our NEOs were granted in February 16,  2022 and vest based on our relative TSR measured against the applicable subset of component companies in the NASDAQ Biotechnology Index over a three-year performance period, subject to the NEO&#8217;s continued employment through the third anniversary of the grant date.  </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The RSU awards to our NEOs were granted in February 16, 2022 and vest one-fourth on each anniversary of the date of grant.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The option awards to our NEOs were granted in February 16,  2022 and vest one-fourth on the first anniversary of the date of grant and then 1/48 of the shares monthly over the three-year period thereafter.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts represent the grant date fair value of stock awards granted to our NEOs in fiscal year 2022 in accordance with the FASB ASC Topic 718. For information on the assumptions used in the accounting fair value computations, see footnotes (1) through (3) to the Summary Compensation Table above.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_46"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at December&#160;31, 2022 </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the value of all unexercised options and unvested stock awards previously awarded to our NEOs as of December&#160;31, 2022: </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">OUTSTANDING EQUITY AWARDS AT </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Securities <br/>Underlying Unexercised <br/>Options (#) Exercisable</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Securities <br/>Underlying Unexercised <br/>Options (#) Unexercisable (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option <br/>Exercise <br/>Price<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option <br/>Expiration <br/>Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Shares <br/>or Units of Stock <br/>That Have Not Vested (#)(2)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market Value <br/>of Shares <br/>or Units of Stock <br/>That Have Not Vested <br/>($)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: <br/>Number of Unearned Shares, <br/>Units or Other Rights <br/>That Have Not Vested (#)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: <br/>Market or Payout Value of <br/>Unearned Shares, Units or <br/>Other Rights That Have Not Vested <br/>($) (3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/6/2014</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/6/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/6/2015</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/6/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2016</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,559,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,234,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,214,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,781,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,420,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,840,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/1/2015</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/1/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/1/2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">284,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,159,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/3/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/3/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,732,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/4/2015</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/4/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2016</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/2/2018</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7/2/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">577,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,391,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">826,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Each option vests at the rate of one-fourth of the underlying shares on the first anniversary of the date of grant and one-forty-eighth of the shares each month thereafter. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Each RSU was scheduled to vest to  one-fourth of the total number of stock units subject to the award on each of the first four anniversaries of the grant date. Reflects the number of outstanding and unvested RSUs subject to the award. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These values are computed by multiplying the closing trading price of our common stock on NASDAQ on December&#160;31, 2022, the last trading date in fiscal year 2022, of $56.90 by the number of shares or stock units, as applicable, set forth in this table.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2021 PSU awards corresponding to the performance periods ending in 2021 and 2022. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance periods.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2021 PSU awards corresponding to the performance period ending in 2023. Reflects the maximum number of stock units (150% of the target number of stock units) corresponding to this portion of the award that are eligible to vest on the third anniversary of the grant date because, had the performance period ended at the end of 2022, the performance level would have exceeded the target level.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2022 PSU awards corresponding to the performance period ending in 2022. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance period.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2022 PSU awards corresponding to the performance periods ending in 2023 and 2024. Reflects the maximum number of stock units (150% of the target number of stock units) corresponding to this portion of the award that are eligible to vest on the third anniversary of the grant date because, had the performance period ended at the end of 2022, the performance level would have exceeded the target level.</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_49"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Exercises and Stock Awards Vested </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the exercise of stock options and vesting of stock awards by our NEOs during the fiscal year ended December&#160;31, 2022: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.505%"></td><td style="width:0.1%"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPTION EXERCISES AND STOCK AWARDS VESTED DURING FISCAL YEAR 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares Acquired <br/>on Exercise<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value Realized <br/>on Exercise<br/>($)(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares Acquired <br/>on Vesting<br/>(#)(2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value Realized <br/>on Vesting<br/>($)(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,465,334&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,631,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elaine D. Sun</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The value realized on exercise is based on the difference between the closing trading price of Halozyme common stock on the date of exercise and the exercise price of each option.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts in this column represent the number of RSU or PSU shares that vested. The actual number of shares issued was the number of shares vested reduced by the number of shares withheld to satisfy applicable tax withholding obligations.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The value realized on vesting is based on the closing trading price of Halozyme common stock NASDAQ on the vest date. </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_52"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Payments Upon Termination or Change in Control </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section describes the benefits that may be provided to our NEOs (other than Ms. Sun, who separated from employment with the Company during 2022) upon certain terminations of their employment with the Company.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Termination Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our severance policy, if an executive officer&#8217;s employment is terminated by the Company without cause, the executive officer is entitled to receive cash severance equal to one times (in the case of the CEO, one and one-half times) the executive officer&#8217;s then-current annual base salary, plus a pro-rated portion of the executive&#8217;s target annual cash incentive for the year of termination. Cash payments under the severance policy will normally be made in a lump sum payment, and will be conditioned upon the receipt of a release of claims from the executive officer. In addition to cash severance payments, the Company will also pay certain costs for the executive to continue healthcare coverage over the applicable severance period, and the executive&#8217;s vested options will remain exercisable for one year following the termination date (or, if earlier, until the expiration date of the option).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSU awards granted to our NEOs in 2021 and 2022 provide that if the executive&#8217;s employment is terminated by the Company without cause or by the executive for good reason and the executive provides a release of claims, any PSUs credited based on performance during a performance period that has already been completed will fully vest on the executive&#8217;s termination, and PSUs subject to a performance period that has not yet been completed will remain outstanding and eligible to vest based on performance during that period, subject to pro-ration to reflect the executive&#8217;s employment during the performance period.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the executive&#8217;s employment terminates due to the executive&#8217;s death or disability, any PSUs credited based on performance during a performance period that has already been completed will fully vest on the executive&#8217;s termination, and the target number of PSUs for the next performance period scheduled to be completed after the termination date will vest pro-rata based on the executive&#8217;s employment during that performance period. The table below presents the benefits that would be provided to each of the NEOs (other than Ms. Sun, who separated from employment with the Company during 2022) assuming the NEO was terminated by us without cause (prior to a change in control of the Company) on December&#160;31, 2022 and executed a release of claims in a form satisfactory to the Company: </span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:17.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.845%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.942%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lump Sum <br/>Severance <br/>Payment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-<br/>Termination <br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Awards (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,004,984&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,682,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Amounts shown in this column reflect the market value of unvested PSUs that would have accelerated if the NEO was terminated without cause (or resigned for good reason) as described above on December 31, 2022. Values were derived using the closing trading price of our common stock on NASDAQ on December&#160;31, 2022, the last trading date in fiscal year 2022, of $56.90. The number of accelerated PSUs for the 2022 performance period was determined based on our relative TSR through December&#160;31, 2022. We did not include any amount for the PSUs allocated to the 2021-2023, the 2022-2023, or the 2022-2024 performance periods because the number of PSUs that will vest with respect to those periods is not known as it will depend on our future performance (the maximum value of those PSUs at December 31, 2022 was $1,518,264 for Dr. Torley, $317,559 for Ms. LaBrosse, $265,211 for Mr. Snyder, and $427,946 for Mr. LaBarre. These amounts were calculated solely for purposes of this disclosure, and there can be no assurance that the value actually be realized by the executive for these awards (if any) will be equal to the value shown in this column.  </span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the benefits that would be provided to each of the NEOs (other than Ms. Sun, who separated from employment with the Company during 2022) assuming the NEO&#8217;s employment terminated due to death or disability (prior to a change in control of the Company) on December&#160;31, 2022:  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022 Potential Payments Upon Termination Due to Death/Disability Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.502%"><tr><td style="width:1.0%"></td><td style="width:28.138%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Awards (1)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,359,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Amounts shown in this column reflect the spread value of unvested equity awards that would have accelerated if the NEO&#8217;s employment terminated due to death or disability on December&#160;31, 2022. Please see the note to the 2022 Potential Payments Upon Termination Without Cause Prior to Change in Control table above for the calculation of these amounts. The number of accelerated PSUs for the 2022 performance period was determined based on our relative TSR through December&#160;31, 2022, and the number of accelerated PSUs for the 2021-2023 and the 2022-2023 performance periods represents the target number of PSUs allocated to each such period (pro-rated for the executive&#8217;s period of employment). These amounts were calculated solely for purposes of this disclosure, and there can be no assurance that the value actually be realized by the executive for these awards (if any) will be equal to the value shown in this column.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into Change in Control Agreements with each of our executive officers. The Change in Control Agreements provide for cash severance, continued healthcare coverage and accelerated vesting of equity awards if the  executive is terminated without cause, resigns for good reason, or is terminated due to death or disability (as such terms are defined in the Change in Control Agreements), in each case on or within 12 months following a change in control transaction. The cash severance, to be made in a lump sum payment, will equal: a multiple (two times for the CEO and one-and-one-half times for the other executive officers) of the sum of (i) the executive&#8217;s then-current annual base salary; and (ii) the amount of the executive&#8217;s target annual cash incentive opportunity (based on the target percentage of annual base salary) in respect of the year the termination of employment occurs. The Company will also make a cash lump sum payment intended to provide the executive officer sufficient amounts to pay expected heath care premiums under the Company&#8217;s group health plans for 18 months after termination of employment (24 months in the case of the CEO). In addition, the Change in Control Agreement provides that the executive&#8217;s outstanding and unvested equity awards granted by the Company will be fully vested upon the executive&#8217;s termination (with equity awards that are subject to performance-based vesting to accelerate based on the greater of (x) the target performance level for the applicable portion of the award and (y) the actual performance level achieved for the applicable portion of the award through the executive&#8217;s termination date). However, the PSU awards granted to the NEOs in 2021, 2022 and 2023 provide that if a change in control occurs any performance period then in progress will terminate and the number of PSUs to be credited under the award will be determined based on performance through the change in control.  Such credited PSUs will remain subject to time-based vesting through the third anniversary of the grant date, subject to accelerated vesting if the credited PSUs are not assumed by the acquiring company or if within two years after the change in control the executive&#8217;s employment is terminated by the Company without cause, by the executive for good reason, or due to the executive&#8217;s death or disability. An executive officer will not be entitled to severance benefits under our severance policy described above if the executive is entitled to severance benefits under their Change in Control Agreement. The Change in Control Agreements also provide that if an executive officer&#8217;s severance benefits would be subject to the parachute payment taxes of Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended, and a reduction in benefits to avoid such taxes would put the executive in a better after-tax position, then the executive&#8217;s benefits will be reduced to the extent necessary to avoid such taxes.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming a change in control took place on December&#160;31, 2022 and each of the NEOs was terminated without cause, resigned for good reason or was terminated due to death or disability in each case on December&#160;31, 2022, the NEOs (other than Ms. Sun, who separated from employment with the Company during 2022) would have received the following benefits as a result of such terminations:</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022 Potential Payments Upon Change in Control Termination</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:22.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.169%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.177%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity <br/>Awards (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lump Sum <br/>Cash Severance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-<br/>Termination <br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26,006,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,138,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$84,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,229,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,126,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,055,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$72,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,255,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,737,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,141,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,879,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,126,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,131,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8,262,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Amounts shown in this column reflect the value of the unvested equity awards that would have accelerated if the NEO&#8217;s employment terminated in the circumstances described above on December&#160;31, 2022 in connection with a change in control. Please see the note to the 2022 Potential Payments Upon Termination Without Cause Prior to Change in Control table above for the calculation of these amounts.  The number of accelerated PSUs was determined based on our relative TSR through December&#160;31, 2022.  These amounts were calculated solely for purposes of this disclosure and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column. </span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Elaine Sun&#8217;s Separation from Employment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 2, 2022, the Company decided to transition the role of the Chief Financial Officer and informed Ms. Sun of its decision. Ms. Sun&#8217;s separation qualified as a termination of employment without cause pursuant to the Company&#8217;s severance policy (described above) and made her eligible for severance benefits under the severance policy subject to the execution of a general release of claims. Ms. Sun has not satisfied such release condition and, as a result, no severance benefits were paid to Ms. Sun as of the date of this proxy filing.   </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">CEO Pay Ratio </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For 2022, Dr. Torley&#8217;s total compensation was  $9,696,978, as shown in the Summary Compensation Table above. The total compensation for our median employee (excluding the CEO) in 2022 was $195,560. Therefore, Dr. Torley&#8217;s total compensation for 2022 was 50 times that of the median employee&#8217;s total compensation in 2022. The Company believes the pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records, as well as the methodology described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation elements that were considered in the identification of the median employee were annualized base pay, target cash bonus opportunity and target long-term incentive award grant date fair value for 2022 for all employees, excluding the CEO, as of December 31, 2022. The total number of our employees as of December 31, 2022 (excluding the CEO) was 383. We used this population to determine the median employee. The total compensation for the median employee was calculated according to the requirements of the Summary Compensation Table.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_664"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the relationship between our CEO&#8217;s, and our other Named Executive Officers&#8217;, total compensation paid and our financial performance for the years shown in the table (in this discussion, our CEO is also referred to as our principal executive officer or &#8220;PEO&#8221;, and our Named Executive Officers other than our CEO are referred to as our &#8220;Non-PEO NEOs&#8221;): </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:center;text-indent:22.5pt"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:PvpTableTextBlock" id="f-5" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.308%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.998%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.857%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Pay-Versus-Performance Table</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based on:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Summary of Compensation Table for PEO (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation Actually Paid to PEO (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Summary Compensation Table Total for Non-PEO NEOs (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Compensation Actually Paid to Non-PEO NEOs (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Shareholder Return (4)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Peer Group Total Shareholder Return (4)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Income (Millions) (5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue (Millions) (6)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-6">9,696,978</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-7">22,817,187</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-8">2,415,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-9">3,154,512</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-10">320.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-11">113.65</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-12">202.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-13">660.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">7,453,294</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">5,992,078</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">2,398,657</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-17">591,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-18">226.79</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-19">126.45</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-20">402.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-21">443.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">6,518,876</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-23">24,374,731</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">1,812,287</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-25">4,356,681</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-26">240.89</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-27">126.42</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-28">129.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-29">268.0</ix:nonFraction></span></td></tr></table></ix:nonNumeric></div><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-30" continuedAt="i037cffdf1cb743fd84a62f7e82ca9031" escape="true"><ix:nonNumeric contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" name="ecd:PeoName" id="f-31"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:PeoName" id="f-32"><ix:nonNumeric contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" name="ecd:PeoName" id="f-33">Helen I Torley</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> was our CEO for each of the three years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Ms. Stelzer separated employment from Halozyme on March 6, 2020. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#8217;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"><ix:continuation id="i037cffdf1cb743fd84a62f7e82ca9031">See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for each fiscal year covered in the table.  The  average compensation for the Non-PEO NEOs for 2022 was calculated in the Summary Compensation Table above.  The average compensation for the Non-PEO NEOs for each of 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the Securities and Exchange Commission in calendar year 2022 or 2021, respectively.</ix:continuation>     </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-34" continuedAt="if81d8177af59430d9df8ca65517a0e89" escape="true"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:AdjToPeoCompFnTextBlock" id="f-35" continuedAt="i1a9f4a6809a44692b28ac560bbdfbef3" escape="true">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="if81d8177af59430d9df8ca65517a0e89" continuedAt="i5b657caaac2744c48452b534925ed63a"><ix:continuation id="i1a9f4a6809a44692b28ac560bbdfbef3" continuedAt="i839bfd4105464e27a1d561240b8729f0"><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,  </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div></ix:continuation></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i839bfd4105464e27a1d561240b8729f0"><ix:continuation id="i5b657caaac2744c48452b534925ed63a" continuedAt="i097ffb1aee8043a5b21da539a81414e1"><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award in the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards.  For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:57.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.866%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2022 ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2021 ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2020 ($)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" id="f-36">9,696,978</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" id="f-37">7,453,294</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" id="f-38">6,518,876</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic233aab1402747439a99eaeeed8ebeec_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-39">8,250,048</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aa4e90521e74fbda5fc78c806b80fcf_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-40">5,800,082</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27d40edd3894424da8813a26e8d6173b_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-41">5,000,019</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f31ca4805ad4f31bf9686ab3097fe4d_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-42">16,906,354</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i951348a08ad147db83dd0bb1e4382682_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-43">4,269,706</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia04ec946f88c42e5882937b764c87374_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-44">12,349,282</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib406196d7595400897664d81791bb3f0_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-45">4,707,222</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia09b21b978d940d7b4cc0ab07d252950_D20210101-20211231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-46">1,200,168</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b9a40f09ae4019950c233f8e16c789_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-47">8,855,689</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6726fe3095004f08aee055c5fc65a129_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-48">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e8b974a7fb4565bf9cd80e6b9a30fe_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-49">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea6d01c149b4df1a874f34555a8ea73_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-50">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i486c1364dde840db9e11001f598305b4_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-51">243,319</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25825bb1d27d459fa7e4cda106965d40_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-52">1,269,328</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a313ba358404f54813109f614f52c34_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-53">1,650,904</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8189d53cb944b81afe0d84f0854abf5_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-54">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ff6d5bd97145479f89a20ad42fd15a_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-55">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7284bcbaf42cf850afd12ab927c00_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-56">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" id="f-57">22,817,187</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" id="f-58">5,992,078</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" id="f-59">24,374,731</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i097ffb1aee8043a5b21da539a81414e1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for a fiscal year to the average of the Compensation Actually Paid for the Non-PEO NEOs for that fiscal year.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"></td><td style="width:49.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.218%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2022 ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2021 ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2020 ($)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" id="f-60">2,415,581</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" id="f-61">2,398,657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" id="f-62">1,812,287</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7230eccd63144b181cd7473b5e92360_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-63">1,850,034</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87a6bad5804241ee912f12ab5ba61df3_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-64">1,550,057</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3ba339385284259ba286ed4270a14a8_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-65">1,200,080</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f94abe5308e43378c7f5196dcbd8017_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-66">3,501,893</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0218f246c624e68baa4cf97406a96ac_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-67">801,386</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2176be3bb204ee1b5cb0212d4e70bd8_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-68">3,060,449</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb7b7c9fc8e4cc8b741377634d02e07_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-69">390,849</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052e13dd0ce144449177390340355420_D20210101-20211231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-70">226,734</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6eac36125f8409589042ca5c735ab4f_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-71">959,721</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief61f2c54ea74e2f8aae9d1e44bbb344_D20220101-20221231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-72">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i860099e12a694c44b167d75f32a8a497_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-73">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d54128f996942f3b0b87b094ef4a4a0_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" id="f-74">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3f864ec9bf24217b9cfe061a82096f7_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-75">17,998</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3f6d8398a7b458eaacca7ac3fdd0c35_D20210101-20211231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-76">151,721</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae581e574ec480d840feb807df086cd_D20200101-20201231" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-77">199,408</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3f9165ecacd456ca5dac168f8ea3db0_D20220101-20221231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-78">1,285,779</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79a81987b87747ad91a4f6b085db1629_D20210101-20211231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-79">983,392</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34373954fe8e4556ac5d61e920cfeff5_D20200101-20201231" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" id="f-80">475,103</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" id="f-81">3,154,512</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" id="f-82">591,581</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" id="f-83">4,356,681</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-84" continuedAt="if1297e01a0e9493d86f783daf81c95ed" escape="true"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-85" continuedAt="id6561b3b1975469186a2f774a4b4f195" escape="true">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</ix:nonNumeric></ix:nonNumeric></span></div><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><ix:continuation id="if1297e01a0e9493d86f783daf81c95ed"><ix:continuation id="id6561b3b1975469186a2f774a4b4f195"><img src="halo-20230324_g8.jpg" alt="halo-20230324_g8.jpg" style="height:395px;margin-bottom:5pt;vertical-align:text-bottom;width:677px"/></ix:continuation></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-86" continuedAt="i19d12883a10f430fb60a28890cd10c2d" escape="true">This column shows Halozyme&#8217;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our net income for each of those years.</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i19d12883a10f430fb60a28890cd10c2d"><img src="halo-20230324_g9.jpg" alt="halo-20230324_g9.jpg" style="height:393px;margin-bottom:5pt;vertical-align:text-bottom;width:667px"/></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt"><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="f-87" continuedAt="i3c526b40479645d2bf5579643f8c18a7" escape="true">This column shows Halozyme&#8217;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2022 executive compensation program because it is used in determining each of our NEO&#8217;s annual 2022 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our revenue for each of those years.</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i3c526b40479645d2bf5579643f8c18a7"><img src="halo-20230324_g10.jpg" alt="halo-20230324_g10.jpg" style="height:392px;margin-bottom:5pt;vertical-align:text-bottom;width:635px"/></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231" name="ecd:TabularListTableTextBlock" id="f-88" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2022 with Halozyme performance.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"><ix:nonNumeric contextRef="ief15cebdc51a48808cec748bb98ec8c6_D20220101-20221231" name="ecd:MeasureName" id="f-89">Revenue</ix:nonNumeric> (as used in our 2022 EBP)</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Non-GAAP <ix:nonNumeric contextRef="ic7f0a86c0cb84565be52505cbee9db9b_D20220101-20221231" name="ecd:MeasureName" id="f-90">Operating Income</ix:nonNumeric> (as defined in the discussion of our 2022 EBP included in the Compensation Discussion and Analysis above and as used in our 2022 EBP)</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Stock Price (including <ix:nonNumeric contextRef="i476176300b1742fe94ad802bfc6aee95_D20220101-20221231" name="ecd:MeasureName" id="f-91">relative TSR</ix:nonNumeric>, as used in our PSUs awarded in 2021 and 2022 and as described in the Compensation Discussion and Analysis above)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the financial performance measures listed above, we view our <ix:nonNumeric contextRef="i7b2a90f9c80e4bed99a628adfd8e5349_D20220101-20221231" name="ecd:MeasureName" id="f-92">stock price</ix:nonNumeric>, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.</span></div></ix:nonNumeric><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_55"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation of Directors </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning the compensation earned during the fiscal year ended December&#160;31, 2022 by each individual who served as a non-employee director at any time during the fiscal year:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:29.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 DIRECTOR COMPENSATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fees Earned <br/>or Paid in Cash<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards<br/>($)(1)(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,040</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,040</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Daly</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,717</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,757</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,679</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,719</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,458</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,498</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,008</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,048</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,040</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Represents the grant date fair value of restricted stock unit awards granted in fiscal year 2022 in accordance with FASB ASC Topic 718.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The aggregate numbers of shares subject to unvested restricted stock unit awards held by the non-employee directors as of December&#160;31, 2022 are described below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:81.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate&#160;Number&#160;<br/>of&#160;Stock Awards <br/>Outstanding <br/>(#)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Daly</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206</span></td></tr></table></div><div style="padding-left:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation program for our non-employee directors is as follows: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Initial award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - each non-employee director receives an initial restricted stock unit grant having a grant date value of $250,000 (with the number of shares of Company common stock subject to the award equal to $250,000 divided by the closing trading price of the Company&#8217;s common stock on NASDAQ on the date of grant, with any fraction rounded up to the nearest whole share) upon joining the Board; provided that, the grant date value of the award  for a director first elected or appointed between Annual Meetings shall be prorated based on the number of full quarters the individual is scheduled to serve as a non-employee director from the date of election or appointment until the next Annual Meeting of the Stockholders such that the recipient will receive a grant of restricted stock units valued at $187,500 for a period of service exceeding three quarters, a grant of restricted stock units  valued at $125,000 for a period of service exceeding two-quarters (but no more than three quarters), a grant of restricted stock units valued at $62,500 for a period of service exceeding one quarter (but no more than two quarters), and no award for a period of service of one quarter or less. Subject to acceleration in the event of a change of control of the Company, this initial restricted stock unit grant will vest upon the date of the next Annual Meeting following the date of the initial restricted stock unit grant.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(2) Annual award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Immediately following each Annual Meeting, each non-employee director then in office automatically receives an annual restricted stock unit grant having a value of $250,000 (with the number of shares of Company common stock subject to the award equal to $250,000 divided by the closing trading price of the Company&#8217;s common stock on NASDAQ on the date of grant, with any fraction rounded up to the nearest whole share). Subject to acceleration in the event of a change of control of the Company, this annual restricted stock unit grant will vest in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting following the date of the annual restricted stock unit grant. All restricted stock unit awards after our 2021 annual meeting are granted under our 2021 Stock Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, our Board of Directors has approved an annual stock option grant, with a grant date fair value of approximately $150,000 for each of our non-employee directors continuing in office after the Annual Meeting, or who are newly elected or appointed to the Board, in addition to the Annual restricted stock unit grants.  </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-employee directors also receive an annual retainer of $50,000 for service on the Board, provided that our Chair of the Board of Directors receives an annual retainer of $125,000, as well as an additional annual retainer for service on any committee of the Board. Non-employee directors who serve on the Audit Committee receive an annual retainer of $15,000, provided that the Chair of that committee receives an annual retainer of $30,000. Non-employee directors who serve on the Compensation Committee receive an annual retainer of $10,000, provided that the Chair of that committee receives an annual retainer of $20,000. Non-employee directors who serve on the Nominating and Corporate Governance Committee receive an annual retainer of $5,000, provided that the Chair of that committee receives an annual retainer of $10,000. Employee directors (including our CEO) do not receive any compensation for service on the Board of Directors.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain stock ownership guidelines for our non-employee directors which stipulate that each non-employee director is expected to own shares of Halozyme common stock with value equal to no less than five times the non-employee director&#8217;s base annual retainer for service on the Board of Directors. Each non-employee director is expected to comply with the guidelines within five years of election or appointment to the Board of Directors. Share ownership that counts for purposes of satisfying the applicable guideline level of ownership is the same as under our executive stock ownership guidelines, as described in the CD&amp;A above. The same retention requirements apply to a non-employee director whose level of stock ownership does not satisfy the applicable guideline level of ownership as under our executive stock ownership guidelines, as described in the CD&amp;A above.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company adopted the Halozyme Nonqualified Deferred Compensation Plan (the &#8220;Cash Deferral Plan&#8221;) and the Halozyme Therapeutics, Inc. Directors Deferred Equity Compensation Plan (the &#8220;Equity Deferral Plan&#8221;), each to take effect in 2022.  Under the Cash Deferral Plan, a non-employee director may elect to defer payment of all or a portion of the director&#8217;s annual cash compensation, deferrals are credited with earnings or losses based on investment fund elections made by the director, and the deferred amounts (as adjusted for such earnings or losses) will be paid to the director (in a lump sum or annual installments over up to five years, as elected by the director) when the director no longer serves on the Board of Directors or an earlier distribution date elected by the director in accordance with the plan.  Under the Equity Deferral Plan, a non-employee director may elect (1) to convert all or a portion of the director&#8217;s annual cash compensation into Company restricted stock units </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">awarded under our 2021 Stock Plan and/or (2) to defer the payment of the director&#8217;s annual restricted stock unit award from the Company.  If a non-employee director elects to convert all or a portion of the director&#8217;s cash retainers into restricted stock units, the director will be credited with additional restricted stock units on the date the retainers would have otherwise been paid to the director equal to (1) the amount being deferred to the Equity Deferral Plan that would have otherwise been paid to the director on that date, divided by (2) the average closing price for a share of Company common stock over the period of ten consecutive trading days ending with the last trading day prior to the crediting date.  Deferred restricted stock units will be credited with dividend equivalents to preserve the value of the awards if/when the Company were to ever pay a dividend.  A non-employee director&#8217;s deferred restricted stock units will be paid in Company common stock (in a lump sum or annual installments over up to five years as elected by the director) when the director no longer serves on the Board of Directors or, if earlier, upon a change in control of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i0608c1aac05343459aa8f80c42d50fe0_58"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our Code of Conduct and Ethics, our executive officers, directors, and principal stockholders, including their immediate family members and affiliates, are prohibited from entering into transactions which create, or would appear to create, a conflict of interest with us. Our Audit Committee is responsible for reviewing and approving related party transactions. Our Audit Committee shall approve only those agreements that, in light of known circumstances, are in, or are not inconsistent with, our best interests, as our Audit Committee determines in the good faith exercise of its discretion. </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_61"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, as of March&#160;6, 2023, certain information with respect to the beneficial ownership of our common stock by (i) each stockholder known by Halozyme to be the beneficial owner of more than 5% of our common stock, (ii) each director and director-nominee of Halozyme, (iii) each executive officer named in the Summary Compensation Table above, and (iv) all directors and current executive officers of Halozyme as a group:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:35.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beneficial Owner(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares <br/>Beneficially <br/>Owned(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BlackRock, Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,196,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55 East 52nd Street, New York, NY 10055</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vanguard Group Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,303,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 Vanguard Blvd., Malvern, PA 19355</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artisan Partners Limited Partnership</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,140,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875 East Wisconsin Avenue, Suite 800, Milwaukee, WI 53202</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Invesco Ltd</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,036,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1555 Peachtree Street NE, Suite 1800, Atlanta, GA 30309</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,268,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elaine D. Sun</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James M. Daly</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors and current executive officers as a group (11 persons)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,359,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Less than 1%.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Except as otherwise indicated, the persons named in this table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and to the information contained in the footnotes to this table. Unless otherwise noted, the address for each beneficial owner is: c/o Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Under the rules of the Securities and Exchange Commission, a person is deemed to be the beneficial owner of shares that can be acquired by such person within 60 days upon the exercise of options or warrants and vesting of stock awards.</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Calculated on the basis of 135,415,332 shares of common stock outstanding as of March&#160;6, 2023, provided that any additional shares of common stock that a stockholder has the right to acquire within 60 days after March&#160;6, 2023 are deemed to be outstanding for the purpose of calculating that stockholder&#8217;s percentage beneficial ownership. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by BlackRock, Inc. with the SEC on February 10, 2023. BlackRock, Inc. beneficially owned 19,196,061 shares, with sole voting power over 18,972,538 shares and sole dispositive power over 19,196,061 shares and shared voting and dispositive power over 0 shares, which shares are reported by BlackRock, Inc. as a parent holding company of its subsidiaries. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by The Vanguard Group with the SEC on February 9, 2023. The Vanguard Group beneficially owned 13,303,847 shares, with sole voting power over 0 shares, shared voting power over 228,181 shares, sole dispositive power over 12,940,422 shares and shared dispositive power over 363,425 shares, which shares are reported by The Vanguard Group as in its own capacity and on behalf of its subsidiaries.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by Artisan Partners Limited Partnership (and affiliated companies pursuant to a joint filing agreement) with the SEC on February 10, 2023. Artisan beneficially owned 7,140,953 shares, with shared voting power over 6,609,540 shares and shared dispositive power over 7,140,953 shares and sole voting and dispositive power over 0 shares.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on a Schedule 13G filed by Invesco Ltd. on February 10, 2023.  Invesco Ltd. beneficially owned 7,036,951 shares with sole voting power over 6,781,697 shares and sole dispositive power over 7,036,951 shares and shared voting and dispositive power of 0 shares, which shares are reported by Invesco Ltd. as a parent holding company of its subsidiaries.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 1,644,677 shares subject to options that may be exercised within 60 days after March&#160;6, 2023.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 109,666 shares subject to options that may be exercised within 60 days after March 7, 2022.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 357,652 shares subject to options that may be exercised within 60 days after March&#160;6, 2023.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 27,713 shares subject to options that may be exercised within 60 days after March&#160;6, 2023.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_64"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder proposals, including nominations for candidates for membership on our Board of Directors, may be included in our proxy materials for an Annual Meeting so long as they are provided to us on a timely basis and satisfy the other conditions set forth in applicable SEC rules. For a stockholder proposal to be included in our proxy materials for the 2024 Annual Meeting, the proposal must be received at our principal executive offices, addressed to the Secretary, not later than November&#160;25, 2023. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder business that is not intended for inclusion in our proxy materials may be brought before the 2024 Annual Meeting so long as we receive notice of the proposal as specified by our Bylaws, addressed to the Secretary at our principal executive offices, not later than November&#160;25, 2023, in accordance with the specific procedural requirements in our Bylaws. If the Secretary fails to receive notice of the proposal within such timeframe, any such proposal will be considered untimely. Failure to comply with our Bylaw procedures and deadlines may preclude presentation of the proposal at our 2024 Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to satisfying the requirements of our Bylaws, including the earlier notice deadlines set forth above and therein,to comply with universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must also provide notice that sets forth the information required by Rule 14a-19 of the Securities Exchange Act of 1934, as amended, no later than March 6, 2024.</span></div><div id="i0608c1aac05343459aa8f80c42d50fe0_67"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSACTION OF OTHER BUSINESS </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the date of this Proxy Statement, the Board of Directors knows of no other business that will be conducted at the 2023 Annual Meeting other than as described in this Proxy Statement. If any other matter or matters are properly brought before the meeting, or any adjournment or postponement of the meeting, it is the intention of the persons named in the accompanying form of proxy to vote the proxy on such matters in accordance with their best judgment.</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_70"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may satisfy SEC&#8217;s rules regarding delivery of proxy statements and annual reports by delivering a Notice of Internet Availability of Proxy Materials to an address shared by two or more stockholders. This process is known as &#8220;householding.&#8221; This delivery method can result in meaningful cost savings for us. In order to take advantage of this opportunity, we have delivered only one Notice of Internet Availability of Proxy Materials to multiple stockholders who share an address, unless contrary instructions were received prior to the mailing date. Accordingly, for many stockholders who hold their shares through a bank, brokerage firm or other holder of record (i.e., in &#8220;street name&#8221;) and share a single address, only one Notice of Internet Availability of Proxy Materials is being delivered to that address unless contrary instructions from any stockholder at that address were received. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We undertake to deliver promptly upon written or oral request a separate copy of Notice of the Internet Availability of</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proxy Materials, proxy statement and/or annual report, as requested, to a stockholder at a shared address to which a single copy of these documents was delivered. If you hold stock as a record stockholder and prefer to receive separate copies of a proxy statement or annual report either now or in the future, please contact our Secretary at 12390 El Camino Real, San Diego, California 92130, or by telephone at (858) 794-8889. If your stock is held by a brokerage firm or bank and you prefer to receive separate copies of a proxy statement or annual report either now or in the future, please contact your brokerage or bank. The voting instruction sent to a street-name stockholder should provide information on how to request (1) householding of future company materials or (2) separate materials if only one set of documents is being sent to a household. If it does not, a stockholder who would like to make one of these requests should contact us as indicated above.</span></div><div style="margin-top:12pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-top:12pt;padding-left:306pt;text-indent:-45pt"><img src="halo-20230324_g3.jpg" alt="halo-20230324_g3.jpg" style="height:133px;margin-bottom:5pt;vertical-align:text-bottom;width:276px"/></div><div style="margin-top:5.25pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark Snyder</span></div><div style="margin-top:3pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Vice President, General Counsel, </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Corporate Secretary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;24, 2023 </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i0608c1aac05343459aa8f80c42d50fe0_73"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:144pt;padding-right:144pt;text-align:center"><span><br/></span></div><div style="padding-left:72pt;padding-right:72pt;text-align:center"><span><br/></span></div><div style="padding-left:72pt;padding-right:72pt;text-align:center"><span><br/></span></div><div style="padding-left:144pt;padding-right:144pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Annual Report, Notice &amp; Proxy Statement is/are available at www.proxyvote.com </span></div><div style="margin-top:5pt;padding-right:144pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.012%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt dashed #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXY SOLICITED BY THE BOARD OF DIRECTORS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR THE ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TO BE HELD ON MAY&#160;5, 2023</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">www.virtualshareholdermeeting.com/HALO2023 </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned hereby appoints Helen I. Torley and Mark Snyder, and each of them, as attorneys and proxies of the undersigned, with full power of substitution, to vote all of the shares of stock of Halozyme Therapeutics, Inc. (the &#8220;Company&#8221;) which the undersigned may be entitled to vote at the Annual Meeting of Stockholders of the Company to be held online on Thursday, May&#160;5, 2023, at 8:00 a.m. Pacific Time and at any and all adjournments or postponements thereof, with all powers that the undersigned would possess if personally present, upon and in respect of the following matters and in accordance with the following instructions, with discretionary authority as to any and all other matters that may properly come before the meeting. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The shares represented by this proxy card will be voted as directed or, if this card contains no specific voting instructions, these shares will be voted in accordance with the recommendations of the Board of Directors. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">YOUR VOTE IS IMPORTANT. You are urged to complete, sign, date and promptly return the accompanying proxy in the enclosed envelope, which is postage prepaid if mailed in the United States. </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Continued and to be signed on reverse side.) </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                   </span></div><div style="text-align:center"><img src="halo-20230324_g11.jpg" alt="halo-20230324_g11.jpg" style="height:750px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20230324_g12.jpg" alt="halo-20230324_g12.jpg" style="height:900px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>halo-20230324.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d427a237-d92d-477a-97f4-29c1176891df,g:b34a9be0-a49e-4e04-951f-b4dd4f76c1d4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:halo="http://www.halozyme.com/20230324" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.halozyme.com/20230324">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2022q4" schemaLocation="https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2022q4" schemaLocation="https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20230324_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20230324_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20230324_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" abstract="true" name="EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" abstract="true" name="EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" abstract="true" name="EquityAwardsOptionsAndStockOutstandingUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockReportedValueMember" abstract="true" name="EquityAwardsOptionsAndStockReportedValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockVestedMember" abstract="true" name="EquityAwardsOptionsAndStockVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" abstract="true" name="EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>halo-20230324_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d427a237-d92d-477a-97f4-29c1176891df,g:b34a9be0-a49e-4e04-951f-b4dd4f76c1d4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember_21177624-bdbe-464e-98ba-5018c1aac619" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockReportedValueMember_21177624-bdbe-464e-98ba-5018c1aac619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_9ef18072-75c6-4b59-a333-f73e689f7542" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_9ef18072-75c6-4b59-a333-f73e689f7542" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_2aaafd8d-717d-41f8-bff3-f09bcfa9f6e3" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_2aaafd8d-717d-41f8-bff3-f09bcfa9f6e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember_81745c4d-8692-4706-b180-92cea7d0f206" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockVestedMember_81745c4d-8692-4706-b180-92cea7d0f206" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_fb031558-0a98-4f02-8a60-e956c0196da0" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_fb031558-0a98-4f02-8a60-e956c0196da0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_37bb90bf-f7fb-4b5b-a32e-ec86aa88d91a" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_37bb90bf-f7fb-4b5b-a32e-ec86aa88d91a" xlink:type="arc" order="6"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>halo-20230324_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d427a237-d92d-477a-97f4-29c1176891df,g:b34a9be0-a49e-4e04-951f-b4dd4f76c1d4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_halo_EquityAwardsOptionsAndStockVestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockReportedValueMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Reported Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Outstanding, Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>halo-20230324_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d427a237-d92d-477a-97f4-29c1176891df,g:b34a9be0-a49e-4e04-951f-b4dd4f76c1d4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:href="halo-20230324.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>halo-20230324_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X2!417AI9@  34T *@    @ ! $2  ,
M   !  $   $R  (    4   (2H=I  0    !   (7NH<  <   @,    /@
M$'X<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 #(P,38Z,#,Z
M,#,@,#DZ,S(Z,#0   :0 P "    %   $$:0!  "    %   $#*2D0 "
M S P  "2D@ "     S P  "D(  "    (0  $%KJ'  '   'A@  "*P
M'.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                ,C Q-CHP,SHP
M,R P.3HS,3HR-  R,#$V.C S.C S(# Y.C,Q.C(T #%!,$(U-#1$,3DX,30S
M,T-!0C0R,D0Q1C@Q-S=$1#4X       & 0,  P    $ !@   1H !0    $
M !#, 1L !0    $  !#4 2@  P    $  @   @$ !     $  !#< @( !
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M>2O^% %F&"*WB$4,:QQKT51@#\*DH ** "B@ HH ** "B@ HH ** "B@ HH
M*J:CJ-II5C->WTRPV\2[F=C_ )R?:@#Q+Q1\6-4U*5[?1BUC:9P)!_K7]\_P
M_AS[UY_<7=S=3-+<W$LLC'+/(Y8G\30!UG@/QI>^']9MX)KEWTV9PDL3L2J9
M_B'IC]:^BQR,T <SXS\1_P!A:8(X&'VRXR(_]D=VKQUV9W+NQ9F.22<DF@#J
M/"'A2379_M-R"EA&W)Z&0^@_J:]<M[>*V@2&"-8XT&U548 % $M% !10 44
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MRZ1:W,BC"SK,J@^Y&>?TK-U3PMKVJ&#4+R6.:]\U?W$;!8X8^2<9ZG./_KT
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MX'T'^R-'$\RXNKK#OZJO8?Y]:ZG% "T4 %% !10 44 %% !10 44 %% !10
M44 %% !10 44 %% %>2TCDO8;IMV^%'11GCYL9/U^7]37/:G9_V]XHM;-QFS
MT]1//Z-(?NJ?P&?H: .H I: "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH
M ** "B@ HH 0U7M+1+7SBO+32&1V/<G_  &!^% %FB@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"N2%&3Z\#UH#RL1\N03QQBA@6=."5/;KBO./B5\3_!'P@\(:SXZ^(OB
M?0_!OA'P]:?VAK7B/Q'J\>CZ5IL2MC=--(0.7\M.OSF0 9)H ]%P^_<6R,<?
M+C'XTCW$*@YECC?J5=@I/YU_)%^VA_P<K:9I-SJ?@S]B[P'#XCN;6::S/QA^
M)-K-;Z#-@D>=I7A])(KJ3(*F*6_DAP1^\M)17\\GQG_X*;_MX?'N[N9_B'^T
MS\4I[6Z^6;1/"OB*7X?>&%'_ #S-AIOV:U/_ &VCH _T\C?VA956XMF)ZD7*
M<?K4X8N#R'0]",;?TK_)>T[XP_%;3-176-.^)'CRPUFWF\^'4[/Q=J,%]!)_
MST\V.7K7[5_\$]/^"Z?[1_[._C+0O"?[17C+Q)\=?@;J6HP:=J\OBV^DUGXB
M^"K>:0K-?V.KR9NKGR=Q/V6\DF\WR1''):_ZR@#^[3XE?#WPK\5/ _B;X>>-
M-+@UCPUXKTF71M6LKE<F2&8-_JY.JR1_ZR.12)(I(T<$$ U_)-^U7_P3#_:#
M^ /B#5-3\&>&==^*OPODN9)=&\1^%;#^U->TVW_Y8PZKI\?[U)(>OG01_9<<
M_NO]57]>'@SQAX;\?^%_#WC3P=JUCKWA;Q5HMMXB\/Z]ITWGV.K6=Y#%<6MQ
M#)W22*2-@?0UU9C\Q"LBI*.F" P_6@#^ #1?@W\5?$6K'P_X<^%WQ"UC7UE\
MM]*TGP=J%[>"3WBCB_6OWO\ ^"<W_!+SQ#X'\3Z#^T!^T=IMOI^KZ!*FJ^!/
MAM*8[^73KD*WDZIJF/W,<L7$L-M%^\BE\MY#&T8B'] HM+57\U+2WC=^"XB5
MZ_(G_@I_^WL/V=O"S?![X7:C&WQF\;Z3(T]_:MM?P#ILWF1&^4C_ )?)=LPM
M1_ 8C(>D:R@&?^W[_P %0?#_ .SZNI?";X+2:=XI^,FS[)JNIR$7OAWX=@Y_
MUP'$]YZ6H_=Q]93P(I?Y<_''C_Q=\1O%&J^,_'6OZQXH\5ZW<_:-3UK5KG[=
M=W0'0*!P(@./)_Y8US=Y>7E_=3W=[/<W5W<RR7=U=7,WGSRR3?ZZ6::HP1$G
M[T;B> V: (V/\/!S^8KJ/!7@?Q;\1?$VC^#/!'A_5/$WBG7KG[%I&CZ5;27E
MY<OU),/T]?\ 5>376_!KX-^._CUX^T7X;?#;1+G6_%6N3?NTV^38Z9;_ /+2
M^NI?^6=M%TEE'_HVO[!_V,?V%/AC^R5X-BATZWA\1?$O6;6)O%WQ U"V07]T
MW[MI+.QQ@V]F)%R(1]\@&3S#@@ ^!OV/?^".OA3PM%IGC;]J7[/XQ\3>5'=6
M_P -[*XQX2T:3;]V^N$_X_)0?)!BC\NV!5AMN1AJ_<;P]X:T7PEI6GZ!X9T7
M2M T/3+9;33]*T:QBTW3[&-?^6<5O$ B(/05T;(I(QP5.1Z$TT+]X,FW=W#9
M!H L8!QD9^HI:0=!]*6@!,#T'Y4N,=!C\*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ H-&:KW-Q%:6\MQ,RQQQ1M(Q;@# S0!\W_ +4'[37PJ_9$^#GBOXV_&+Q#
M%HOA/PM;?);V\/VG6/$-]/N^R:;I\.<RW,\GR@  *,R2-'%')(/\[W_@H3_P
M4M^./_!0+X@3ZOXPO)O"OPJT749)?AS\(=&O9?[#\-1C/E75XW_+[?&//FW4
MO&2?*BAC_=5[M_P64_X*%:K^V[^T9?\ A_P;K=Q)\ ?A+JEUX9^&NEV<C?V=
MXGN89C#J'B*7_GK+=2<0_P#/.U@BP!)+-YGWM_P2M_X(*WGQHT3P[^T!^V+;
M:OX:^'6IK%J_@KX.0/-I?B;QM:YS'=:O= B6QLIE_P!3%#_I4T4WF^=:_N_,
M /YQ_AG\%/B_\9M8DT#X2_##Q_\ $O6X(O.DTOP-X1U#Q5>P1_\ /6:.VBD\
MN+WKU_XH?L+_ +8?P7\.OXN^*7[.'Q@\$^%;>'[1=^(]7\%7T>AZ6O\ T^70
MC\JV'O+BO].?X4_!CX6?!#POI_@KX3> /"_P]\):9%LL]!\*Z1%I%A%]T&3R
MXT^>0A1F1_WDA!)SUKNM8T33=:L;W3]2TNRU&TU"UELKRUO8(I[6YCFC:)XY
M8SPZ2!FR".>AXXH _P C%@ZL48$,#@JP^84?/E<C!QD&OTP_X*Y_LP^'_P!E
M#]NGXM?#?P7I\.D^!-4FM/'O@K2+:#9;Z79ZQ:Q7<ME"N>(K:Y^U6T([0Q1"
MOS0R6!P,=LT ?WM?\&Y7[05_\5?V*M3^&FNWMQ>ZK\!O'UQX3TQ[F?[3.VBZ
MG'%JVG!I>F8I9]4@6(<QQ6<0K^A%7^1B!@[<FOY"O^#5F[NO+_;8L))G:S@?
MX?7$%N?^6,LW_":"8_B(XO\ OW7]>BE6$B#C:O/.1SS0!XG^T-\:?#/[/OP?
M\=?%?Q4R_P!F^$]&:]AL1+Y,^KWDG[FQL8?26YN9(85_VIA7\,'Q3^)GBSXP
M?$7Q9\1_&U_+J/B?QCK,FK:I<%BT.Z3B".$_\LXX8O)BBB_Y910Q1U^T'_!:
MK]I0^*_&WA?]G+PWJ,;Z/X"5?%?Q#AM[C=Y^K7D?_$MLY>./L]K))-@'&-07
MH8Z_",L) '5<$<'C% !Q@Q\F3KUQ78?#KX=^,?BKXR\/?#OP+HEUXA\7^)]5
MCTO2-)M4Q+(TW_HN*&+SIIIO]3#%#++7&E?^6A)5_P Z_;G_ ()C?&+]AO\
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MRE_X+.?M$7O[.G_!/WXVZ[HMX]AXJ\;Z;;_"SPM<V\IM[F"XUZ;['=2PR_\
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M._X?5_L??] KXS?^$3I__P LJ /UVK^7S]K;_E,Q\*_^RR_"?_T;X;K]#?\
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M /@ES^Q1X]T:YTZ/X0P>"+]X/*M?$?@+6K[0M5TX_P#/2*$RR6LA_P"NT,E
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MTYO.L))._E2GS;6;J?)O)L?/BONKJ@ ZM\H[4 E2JC)4YYQTH _B _X)\?\
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MQ_X+?_%$_"[_ ()K_M WMM(%U3QC8Z;\.=-B,OD/<?VSJEG97@7'I9-J$O\
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MU\.O%'AOX4Z/J]O,)X=2_LW6OMFH2Q8XDC^VZAJ$44HXEBABD&17]'O[<_\
MR9U^TM_V1O7/_2&2@#\OO^"']^=,^"/[1&JM$9/L'C*SOO('#2^3H\TWEU\M
M_P#!&[PQ;?%']K3XG_&'QG)_;'B?POX2U#Q18W%P?/G&L:]J'DWFH?\ 73RI
MM1B_[?*^K/\ @AG;0WOP>^/]E<()K>[\>6%O<J?^6JS:9+YGY[J^/O\ @G;X
MEE_8X_;\\=? ;XDSG2+?Q9=7GPA&H:A^X@_M"&^AN_#UUYN.8M1\KRH1_P!1
M>&@#^J:BBB@#X _X*9?#71OB7^QA\9X]0@MGU#P-H\?Q)\.W\D>Z?3+S1Y/.
MEDA]#-:M?VOTO)*^5O\ @B!XRO=9_9M^(/A"[EGG3P7\6[B33#+_ *FSMM2T
MVRF,,/M]IAO)?^WNO7O^"MGQ[TCX2?LI>)? R7@'C3XU_P#%$>'K"*7$PT_S
M89=;O91_SR%MFUSQ^]U*'K7)_P#!';X;77PU_9$N_''B41Z6GQ,\9ZAX[MKG
M49H]/@ATBSM8--ADF_YYQ^98:A-F7_EE-')Q0!]=_MG_ +3^B?LH? WQ#\2+
MW[/=>*KO_BG/AWX?N.!KNL3Q3&U\S!_X]X1')=3'_GG"8Q^\DC!_('_@DS^R
M_K?Q7\?^(_VVOC*MSKD\?B6_E^'UWJZ_:)_$WB"::;^UO$$W_/3[+)+-#$<<
M74TW26VKP+XN^+?%W_!53]N#0_AQX#O=1M?@YX/GN-,T*_6/,&@>'[2:'^VO
M$TD/_/349?)$(E_Z<(I:_I^\!>"/#?PW\&^%_ 7A#3(=$\+^#]'@T'0]-ME\
MM8+>WC\J'=@G?(>LDC<R2$R$Y- '<5_-+_P5N^%GB#X!_M(_"S]K[X:J=+N/
M$^J6=UJ-_##_ *%IOBOPYY,UG--_U^6,,7[K_EK_ &;=?\]*_I:KY/\ VS_@
M!;_M,?LY?$7X7I;1/XCN-+_X2'P)<2DJ;/7-._?:?^\Z1^<1):2G_GC>2T >
MK_!/XJ^'OC?\*/ 'Q:\*N/[$\=^&;?7H+;S?-FTR>4;;RQF_Z;6EQ'-:R_\
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M_CVN8C)Q>#RO]=*89H_,DBB_JTIA&[Y& 93ZB@#\$/!__!=3P)-HB?\ "=_
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MXGPU^SM^S]X,O8]2\'_ SX.^$M2BD\Z+4?#7PPT70KV.2/\ Y:>=;VT;?RH
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M/MY+.WU[4KN41B:.%^0D5K#9VP'I:COT^NZ** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H)QS10>>/6@"N6RN57YL<'
M-?GAXP^'$G[1O[:?AB_U^W,_PQ_9 TV/5;>WD_X\]<\<Z]'#>0QRC'[S^RM/
MCTN\YZ2ZK;8Z2"OT,9MA"[CAC@\9"YY%5DM;>-IIH(HXY)Y?,G=8\-.W][_Z
M] &DJJ%4 # &!Q3J!GO10 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 )@>@_*EHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>halo-20230324_g10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g10.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #,S(
M )*2  (    #,S(  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" &( GL# 2(  A$! Q$!_\0
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MH **R-<\3:?H'DI=F66><XBMX$WR/]!^E/T77X-::XCCM;RTFM]OF0W</EL
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M]:Z^@3"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC :1@.@.W)_.LF3Q\MS(8M#TJ[OGZ9VX'Z9/\JM3A37*V;1K4J"Y)2ZOS?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445'-<
M0VR;[B6.)?[SL%'ZT!>VY)16%=^,]!L\AK])6':$%\_B./UK,/CTW3%=%T6\
MO#TR1@?IFLG6IKJ<TL50B[.7W:_D=A17'?:?&^H_ZFUM=-0]&?!(_//\J/\
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MUJ !5 4  = ***V45'9'3&$8*T58****904444 %%%% !1110 4444 %%%%
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MXEC&[\^M7:*N-.$=D;0H4J?PQ2"BBBM#8**** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO55-.USFQ6(6&HNJU>W^=CTBBOF__A*-?_Z#FI?^!<G^-'_"4:__ -!S4O\
MP+D_QKUO[&J?S(\7^WJ7\C/I"BOF_P#X2C7_ /H.:E_X%R?XT?\ "4:__P!!
MS4O_  +D_P :/[&J?S(/[>I?R,^D**^;_P#A*-?_ .@YJ7_@7)_C1_PE&O\
M_0<U+_P+D_QH_L:I_,@_MZE_(SZ0HKYO_P"$HU__ *#FI?\ @7)_C1_PE&O_
M /0<U+_P+D_QH_L:I_,@_MZE_(SZ0HKYO_X2C7_^@YJ7_@7)_C1_PE&O_P#0
M<U+_ ,"Y/\:/[&J?S(/[>I?R,^D**S?#DLD_A;2I9W:222RA9W<Y9B4!))[F
MM*O$E'EDT?0PES14NX4445)04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%07E_9Z=")=0NH+6-FVAYY BD]<9/?@_E5+_A*- _Z#FF_^!<?^-6H
M3DKI$2J0B[2:14\66.M7-G%<^&[Z6WO+?.(5"E9@Q4'=NXX )&??UK*E^'TC
M>'KO3TUN9;F^N?M%W=&'/G<'Y=H88&3GK70?\)1H'_0<TW_P+C_QH_X2C0/^
M@YIO_@7'_C73"IB(148JUO(XYTL-4FY3E>_GI\M>IC0>$]:CT.XTM_$W[B2
M0PB*P2+R?F!)&TY.0".O?-)HO@_5]&LC8Q>)/]#\J1%BBL$C9692 ^\'.02#
M[XK:_P"$HT#_ *#FF_\ @7'_ (T?\)1H'_0<TW_P+C_QINKB&FK;_P!U?Y"5
M'"II\VJT^)[?>8D_@F]<Z9=0>(;B/4[")HC>20B7S023RK'KR1U-1K\/572X
M[=M4DDN/[274)[AH1^\8 C:%!XSGKS6__P )1H'_ $'--_\  N/_ !H_X2C0
M/^@YIO\ X%Q_XT_;8JW7[O\ @"]A@V[NWW_\'\=S.M/!5M:>-Y_$2W!)D#%+
M?9PCL &;=GG(SQCO5WPMH'_"-:%'IHN?M.QV;S/+V9R<],G^=2?\)1H'_0<T
MW_P+C_QH_P"$HT#_ *#FF_\ @7'_ (UG.6(G'EE>VG3MM^9I".%IRYHM)Z]>
M]K_DC4HK+_X2C0/^@YIO_@7'_C5^VNK>]MUN+.>.XA?.V2)PRM@X."..HK"4
M)15VCJC4A)VBTR6BBBH+"BBB@ HHHH **** "BBB@ HHHH **** "O+?C1_S
M!?\ MO\ ^TZ]2KRWXT?\P7_MO_[3KT,M_P![A\_R9Y>;?[E/Y?FCRVBBBOL3
MX,**** "BBB@ HHHH **** /I#PO_P BAH__ %XP?^BUK4K+\+_\BAH__7C!
M_P"BUK4KX*K_ !)>K/TNC_"CZ(****S-0HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH X+XP?\BA:_]?R?^BY*\8KV?XP?\BA:_P#7\G_HN2O&*^MR
MK_=EZL^(SK_>WZ(****]0\8**** "BBB@ HHHH *][^&O_)/=,_[:_\ HUZ\
M$KWOX:_\D]TS_MK_ .C7KQ\X_@+U_1GO9%_O,O\ "_S1U-%%%?+'V04444 %
M%%% !1110 4444 %%%% !1110 5Y;\:/^8+_ -M__:=>I5Y;\:/^8+_VW_\
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MI"0?E/:NQKU,'BXXNFYQ5M;%Q=T%%%%=HPHHHH \8_X7!K__ #YZ;_WZD_\
MBZ/^%P:__P ^>F_]^I/_ (NN"HK[7ZCAOY$?GW]HXO\ Y^,[W_A<&O\ _/GI
MO_?J3_XNC_A<&O\ _/GIO_?J3_XNN"HH^HX;^1!_:.+_ .?C.]_X7!K_ /SY
MZ;_WZD_^+H_X7!K_ /SYZ;_WZD_^+K@J*/J.&_D0?VCB_P#GXSO?^%P:_P#\
M^>F_]^I/_BZ/^%P:_P#\^>F_]^I/_BZX*BCZCAOY$']HXO\ Y^,[W_A<&O\
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MF?,_V%B?YH_>_P#(\'HKWC_A67A7_H'/_P"!$G_Q5'_"LO"O_0.?_P ")/\
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M_P">K_D/\*-C?\]7_(?X5Z10^BF;&_YZO^0_PHV-_P ]7_(?X4 ?+U%>\?\
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MX5EX5_Z!S_\ @1)_\51_;%#L_P /\P_L+$_S1^]_Y'"?!_\ Y&^Z_P"O%_\
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M'[W_ )'M^S9Q5%=K_P (UIO_ #R?_OLT?\(UIO\ SR?_ +[-']AXG^:/WO\
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M5$UW.PY3!.652,Y/&0 .APWPT+)]3TEM+*?:18N=3V?>+_)_K>^[?NZ\]>U
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MN)]RD)G./E4NJY[ XYJKITFFN^C03S06^IPF*6:XNI LJQ\^7$NXY.Y2 0.
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MOL7VRW^UXS]G\U?,Z9^[G/3FLY[+4[35KVYTT6LL=Z$9A<2,AB=5VY "G<,
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M-] 3DUG:KH4VK:JDLMX]O:QVS1*L(0LS.</G>I&-H ]>3T[P:'I6KZ3,?/\
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MD=  15NQT"6'5+6]D@BA:-Y6D_TR6Y9RR*JMND4'. 1CTQ0&AM_;;7!/VF'
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MGJ ,<^_M0&AN4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>halo-20230324_g11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g11.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #-38
M )*2  (    #-38  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         #(P,C,Z,#,Z,3 @,34Z,S Z,#D ,C R,SHP
M,SHQ," Q-3HS,#HP.0   $< 90!T &$ <P!E '< ( !9 &4 <P!E &< 80!T
M    _^$+(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T
M(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G/SX-
M"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z
M9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B+SX\<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M
M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(^/'AM<#I#<F5A=&5$871E/C(P,C,M,#,M,3!4,34Z
M,S Z,#DN-34W/"]X;7 Z0W)E871E1&%T93X\+W)D9CI$97-C<FEP=&EO;CX\
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D
M+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R
M;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^/&1C.F-R96%T;W(^/')D9CI397$@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS
M>6YT87@M;G,C(CX\<F1F.FQI/D=E=&%S97<@665S96=A=#PO<F1F.FQI/CPO
M<F1F.E-E<3X-"@D)"3PO9&,Z8W)E871O<CX\+W)D9CI$97-C<FEP=&EO;CX\
M+W)D9CI21$8^/"]X.GAM<&UE=&$^#0H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(#P_>'!A8VME="!E;F0])W<G/S[_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" 2J Y<# 2(  A$! Q$!_\0
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M\31_P@OA+_H5M%_\%\7_ ,36]10!@_\ ""^$O^A6T7_P7Q?_ !-'_""^$O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ7_I;-0 W_A!?"7_ $*VB_\ @OB_^)H_X07PE_T*VB_^"^+_ .)K>HH P?\
MA!?"7_0K:+_X+XO_ (FC_A!?"7_0K:+_ ."^+_XFMZB@#!_X07PE_P!"MHO_
M (+XO_B:/^$%\)?]"MHO_@OB_P#B:WJ* ,'_ (07PE_T*VB_^"^+_P")H_X0
M7PE_T*VB_P#@OB_^)K>HH P?^$%\)?\ 0K:+_P""^+_XFC_A!?"7_0K:+_X+
MXO\ XFMZB@#!_P"$%\)?]"MHO_@OB_\ B:/^$%\)?]"MHO\ X+XO_B:WJ* ,
M'_A!?"7_ $*VB_\ @OB_^)H_X07PE_T*VB_^"^+_ .)K>HH P?\ A!?"7_0K
M:+_X+XO_ (FC_A!?"7_0K:+_ ."^+_XFMZB@#!_X07PE_P!"MHO_ (+XO_B:
M/^$%\)?]"MHO_@OB_P#B:WJ* ,'_ (07PE_T*VB_^"^+_P")H_X07PE_T*VB
M_P#@OB_^)K>HH P?^$%\)?\ 0K:+_P""^+_XFC_A!?"7_0K:+_X+XO\ XFMZ
MB@#!_P"$%\)?]"MHO_@OB_\ B:/^$%\)?]"MHO\ X+XO_B:WJ* ,'_A!?"7_
M $*VB_\ @OB_^)H_X07PE_T*VB_^"^+_ .)K>HH P?\ A!?"7_0K:+_X+XO_
M (FC_A!?"7_0K:+_ ."^+_XFMZB@#!_X07PE_P!"MHO_ (+XO_B:/^$%\)?]
M"MHO_@OB_P#B:WJ* ,'_ (07PE_T*VB_^"^+_P")H_X07PE_T*VB_P#@OB_^
M)K>HH P?^$%\)?\ 0K:+_P""^+_XFC_A!?"7_0K:+_X+XO\ XFMZB@#!_P"$
M%\)?]"MHO_@OB_\ B:/^$%\)?]"MHO\ X+XO_B:WJ* ,'_A!?"7_ $*VB_\
M@OB_^)H_X07PE_T*VB_^"^+_ .)K>HH P?\ A!?"7_0K:+_X+XO_ (FC_A!?
M"7_0K:+_ ."^+_XFMZB@#%\#V-IIMWXGM-.M8;2VCU9=D,$81%S9VQ.%' Y)
M/XUU=<WX4_Y"_BK_ +"R?^D5K724 %%%% !1110 4444 <[XY_Y%R'_L*Z;_
M .EL%:-97Q GAM?":W%S*D,,6I:>\DDC!511>PDDD\  <YJM_P )UX2_Z&G1
M?_!A%_\ %4 ;U%8/_"=>$O\ H:=%_P#!A%_\51_PG7A+_H:=%_\ !A%_\50!
MO45@_P#"=>$O^AIT7_P81?\ Q5'_  G7A+_H:=%_\&$7_P 50!O45@_\)UX2
M_P"AIT7_ ,&$7_Q5'_"=>$O^AIT7_P &$7_Q5 &]16#_ ,)UX2_Z&G1?_!A%
M_P#%4?\ "=>$O^AIT7_P81?_ !5 &]16#_PG7A+_ *&G1?\ P81?_%4?\)UX
M2_Z&G1?_  81?_%4 ;U%8/\ PG7A+_H:=%_\&$7_ ,51_P )UX2_Z&G1?_!A
M%_\ %4 ;U%8/_"=>$O\ H:=%_P#!A%_\51_PG7A+_H:=%_\ !A%_\50!O45@
M_P#"=>$O^AIT7_P81?\ Q5'_  G7A+_H:=%_\&$7_P 50!O45@_\)UX2_P"A
MIT7_ ,&$7_Q5'_"=>$O^AIT7_P &$7_Q5 &]16#_ ,)UX2_Z&G1?_!A%_P#%
M4?\ "=>$O^AIT7_P81?_ !5 &]16#_PG7A+_ *&G1?\ P81?_%4?\)UX2_Z&
MG1?_  81?_%4 ;U%8/\ PG7A+_H:=%_\&$7_ ,51_P )UX2_Z&G1?_!A%_\
M%4 ;U%8/_"=>$O\ H:=%_P#!A%_\51_PG7A+_H:=%_\ !A%_\50!O45@_P#"
M=>$O^AIT7_P81?\ Q5'_  G7A+_H:=%_\&$7_P 50!O45@_\)UX2_P"AIT7_
M ,&$7_Q5'_"=>$O^AIT7_P &$7_Q5 &]16#_ ,)UX2_Z&G1?_!A%_P#%4?\
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M>!O^1<F_["NI?^EL]=%7.^!O^1<F_P"PKJ7_ *6SUT5 !1110 4444 %%%%
M!1110 4444 %<EX2_P"01=_]A;4O_2V:NMKDO"7_ ""+O_L+:E_Z6S4 ;E%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F>%/^0OXJ_["R?\
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M_P!^=I/;&,_/7DFO>#]?\6_ /X>IX;TN?4&MA=&40X^0&3C.3[&@#>\0:_\
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M<EX2_P"01=_]A;4O_2V:@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^$NN^*-<GEF\1WNM7$+6B21B_P!"BLX=S$',<J,3(,>PR#FN@^+'_))_$/\
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MM8I:P&-Y9XE\V8DYYVDC [<GJ: /2_$WQS^'6H>$]7L[3Q$)+BXL9HHD^Q7
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MI]-O[(KJ=I-9_NK>2*$R+'&A^4H&C &0< #%>WQ11P0I#!&L<4:A41%PJ@<
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M<B"ZL)X\-B'<&_=32[&#$C&\G@'C.  2>--"UF[\36^HZ-;WTJ?8U@G-G?\
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M);IX]XE,J,RKCM&W09*Y&&O\6=>?3UN8K"QMT67['--.%6..YCB#2H6DFC4
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M^1C\5_\ 85C_ /2*UK9K&T;_ )&/Q7_V%8__ $BM:V:!!1110 4444 %%%%
M&=X&_P"1<F_["NI?^EL]=%7.^!O^1<F_["NI?^EL]=%0 4444 %%%% !1110
M 4444 %%%% !7)>$O^01=_\ 86U+_P!+9JZVN2\)?\@B[_["VI?^ELU &Y11
M10!B^*-"F\0::EI!=PVX$FZ1+BT6YBF7!&UD)&>N001@@=:Y+3OA(VF7=O>V
M_B6\>[@#1AIH$9=GD/#&,<-E58'[V"0< 9X]'HH Y7PGX$M/"6J7]Y:7#2K=
M06T"1%-HA$2;3CG^(_,?>H]=\$3Z[XBGOI=7\JRN+:*VFM!;99DC<R;=^[@,
MQ^;"Y(&,BNNHH X2X^'M_>^%[S2K[7+:>6\U0:C+*VG'RW^8-Y;1^;RN5 ^]
MT&/>F/\ #)C';I;:LNGJ+=;>X73K4VX=5F:4&/;)^[)+D'.X'TKOJ* .(3P5
M?Z5YMUIVHB[EM#=2Z5;20!5AFN&)9I&W?/C<P!XPI/!-=LH(0!CN8#DXQDTM
M% '%7?@/49EU&UM/$TUGI]_--*T$5L-X,S9ER^[G@L%X&W.?FQ6IX/\ ":>$
M+.]M(+Z6\@N+GSX_.C56C'EHFWY0 ?N=@/IW/0T4 174+7%G-#')Y3R1LBOL
M#;21C.#P<>AKSQ/A5=VNDFRL/$*PK/*KWJO9N\<Z(H6.$#S@RQCG*[CG..!Q
M7I%% &/'H&WQ!#JC7"@P:>;**..(*(\L&9UY(&=J@#'&.IKGE^'MX"]V=>4Z
MJUY#=?:A8JL;-$CH"\08!G(D)+9&2%XP,5W-% %#1-)AT+1;73;9WD2W3;YD
MARTAZLQ]R22?K5^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** ,SPI_R%_%7_ &%D_P#2*UKI*YOPI_R%_%7_ &%D_P#2
M*UKI* "BBB@ HHHH **** *&M:O!H6E2:A=QRO!$R"0Q $H&8+N.2/E&<GV!
MZUS]M\2-,NY\0:?J36JW"6[WGE)Y2.\ACCS\^[#L!@A3PRYQFMGQ5!%=^$]3
MMKF^M=/@GMWBENKM T<2,,,2"RCH3U.,XZ]*YZRL?A]%<:/]FU+39)HXH([)
M5U,;;CRB5B;RP^V5E8-AB"00<<B@#>T'Q19>(64645PF[3[74!YJJ/W=P'*#
M@GYAY9R.G3!-8R_$O39-2GTV#3KZXU"*1(TM;>2VE:8L)&&TK*57"Q.Q#E2
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MOL"(,/NECCDV.!@'+;E]#B@#'/Q7M;![C^U[2585:*.WF!AA$[L'8_ZR;:@
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MCB;]Y]X']WOXJ"#XL:7#<6]IK5M-8W<\\B!&EA^1!<O C8\S<V60@A Q&"2
MN"=JX\!>'[LQF\@O+AHTV!YM2N79EW;@&)D)8!N1NS@],5-%X,T2WOQ>VT-S
M!<>8\A>&^G3<6<R$$!P"N]F;8?E!9L#DY *6C?\ (Q^*_P#L*Q_^D5K6S6-H
MW_(Q^*_^PK'_ .D5K6K.LS0,+62..7C:TD9=1SW (SQ[T 245G>3K/\ S_V'
M_@"__P =H\G6?^?^P_\  %__ ([0!HT5G>3K/_/_ &'_ ( O_P#':NP+,L"B
MZDCDEYW-'&44\]@2<<>] $E%%% &=X&_Y%R;_L*ZE_Z6SUT5<[X&_P"1<F_[
M"NI?^EL]=%0 4444 %%%% !1110 4444 %%%% !7)>$O^01=_P#86U+_ -+9
MJZVO/- \-6.H6E]<SSZHDDFK:CD0:M=0H,7DPX1) HZ=ASUZT =E16#_ ,(=
MIG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;
MW_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\
M_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#C
MM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=
MIG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;
MW_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\
M_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#C
MM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=
MIG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;
MW_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\
M_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#C
MM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=
MIG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;
MW_X[1_PAVF?\_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\
M_.M?^#V]_P#CM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#C
MM &]16#_ ,(=IG_/SK7_ (/;W_X[1_PAVF?\_.M?^#V]_P#CM %OPI_R%_%7
M_863_P!(K6NDKSC0?"]B^L>)$-UK"K%J2(NS6KQ21]DMV^8B7+')/)R<8'0
M#:_X1*P_Y_-<_P#!]>__ !Z@#K:*Y+_A$K#_ )_-<_\ !]>__'J/^$2L/^?S
M7/\ P?7O_P >H ZVBN2_X1*P_P"?S7/_  ?7O_QZC_A$K#_G\US_ ,'U[_\
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M444 %%%% !1110!RNC?\C'XK_P"PK'_Z16M;-8VC?\C'XK_["L?_ *16M;-
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MR+,^<8* ,<YSP.OM5RSUO2M1NYK73]3L[JXMR1-#!<*[QD'!W*#D<^M<C;>
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MWP-_R+DW_85U+_TMGKHJ "BBB@ HHHH **** "BBB@ HHHH *Y+PE_R"+O\
M["VI?^ELU=;7)>$O^01=_P#86U+_ -+9J -RBBB@#%\8_8?^$,U7^U&A6V^S
M,6,S!5#?P\G_ &MN/?%<C!JW]G?"3P[)X5O+>)YIK*V>6)5E57D=5ER#D;MS
M-GOFNZUJ\ET_1+N\M[5;MX(S)Y+R; X')^;!QQD]*S;7Q19P^#['7-<CCTN"
MZ$;+&&,H7S#\G(4<G(/3@F@##CUK7SX;\2B"Z^U7^A7Q2.4PH&N8T2.1E*@
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M:V317$5KK+0)$L<EG<:LDTKS&"59)@S28\O>8B%W C:6"CI7J5% &&MMK/\
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M.)&()4D'@' X)50>* .XHIL:LL:J[EV  +$ ;CZ\4Z@ HHHH **** "BBB@
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MDM[:2X18E(D8+N.'))&<CL!@=JU=%U_4)M6N=-U3[%-+'8Q7R3608(%<L-C
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M?YF-^>.=VU<^N!GI45MX=T2SM7MK31]/@MY(S$\45JBJR$Y*D 8()).*TJ*
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M;!;X6YO9#'YC2LI&W.-N /EZ5SUIJNJO\4I[?[;>I"=9:!'EN_\ 1C&MNKM
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M1110 4444 %%%% !1110 4444 <KHW_(Q^*_^PK'_P"D5K6S6-HW_(Q^*_\
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MKJ7_ *6SUT5<[X&_Y%R;_L*ZE_Z6SUT5 !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD4?\)7?_ /0G:Y_W]LO_ )(H Z2BN;_X2N__ .A.US_O[9?_ "11_P )7?\
M_0G:Y_W]LO\ Y(H Z2BN;_X2N_\ ^A.US_O[9?\ R11_PE=__P!"=KG_ ']L
MO_DB@#I**YO_ (2N_P#^A.US_O[9?_)%'_"5W_\ T)VN?]_;+_Y(H Z2BN;_
M .$KO_\ H3M<_P"_ME_\D4?\)7?_ /0G:Y_W]LO_ )(H Z2BN;_X2N__ .A.
MUS_O[9?_ "11_P )7?\ _0G:Y_W]LO\ Y(H Z2BN;_X2N_\ ^A.US_O[9?\
MR11_PE=__P!"=KG_ ']LO_DB@#I**YO_ (2N_P#^A.US_O[9?_)%'_"5W_\
MT)VN?]_;+_Y(H Z2BN;_ .$KO_\ H3M<_P"_ME_\D4?\)7?_ /0G:Y_W]LO_
M )(H Z2BN;_X2N__ .A.US_O[9?_ "11_P )7?\ _0G:Y_W]LO\ Y(H Z2BN
M;_X2N_\ ^A.US_O[9?\ R11_PE=__P!"=KG_ ']LO_DB@#I**YO_ (2N_P#^
MA.US_O[9?_)%'_"5W_\ T)VN?]_;+_Y(H Z2BN;_ .$KO_\ H3M<_P"_ME_\
MD4?\)7?_ /0G:Y_W]LO_ )(H Z2BN;_X2N__ .A.US_O[9?_ "11_P )7?\
M_0G:Y_W]LO\ Y(H Z2BN;_X2N_\ ^A.US_O[9?\ R11_PE=__P!"=KG_ ']L
MO_DB@#I**YO_ (2N_P#^A.US_O[9?_)%'_"5W_\ T)VN?]_;+_Y(H Z2BN;_
M .$KO_\ H3M<_P"_ME_\D4?\)7?_ /0G:Y_W]LO_ )(H Z2BN;_X2N__ .A.
MUS_O[9?_ "11_P )7?\ _0G:Y_W]LO\ Y(H Z2BN;_X2N_\ ^A.US_O[9?\
MR11_PE=__P!"=KG_ ']LO_DB@#I**YO_ (2N_P#^A.US_O[9?_)%'_"5W_\
MT)VN?]_;+_Y(H Z2BN;_ .$KO_\ H3M<_P"_ME_\D4?\)7?_ /0G:Y_W]LO_
M )(H Z2BN;_X2N__ .A.US_O[9?_ "11_P )7?\ _0G:Y_W]LO\ Y(H Z2BN
M;_X2N_\ ^A.US_O[9?\ R11_PE=__P!"=KG_ ']LO_DB@#I**YO_ (2N_P#^
MA.US_O[9?_)%'_"5W_\ T)VN?]_;+_Y(H Z2BN4N/'$]K/:PW'A+7$DO)3#
M/,LSO<(SD<7''RHQY]/7%3_\)7?_ /0G:Y_W]LO_ )(H Z2BN;_X2N__ .A.
MUS_O[9?_ "11_P )7?\ _0G:Y_W]LO\ Y(H Z2BN;_X2N_\ ^A.US_O[9?\
MR11_PE=__P!"=KG_ ']LO_DB@#I**YO_ (2N_P#^A.US_O[9?_)%'_"5W_\
MT)VN?]_;+_Y(H Z2BN;_ .$KO_\ H3M<_P"_ME_\D4?\)7?_ /0G:Y_W]LO_
M )(H Z2BN;_X2N__ .A.US_O[9?_ "11_P )7?\ _0G:Y_W]LO\ Y(H Z2BN
M;_X2N_\ ^A.US_O[9?\ R11_PE=__P!"=KG_ ']LO_DB@#I**YO_ (2N_P#^
MA.US_O[9?_)%'_"5W_\ T)VN?]_;+_Y(H Z2BN;_ .$KO_\ H3M<_P"_ME_\
MD4?\)7?_ /0G:Y_W]LO_ )(H Z2BN;_X2N__ .A.US_O[9?_ "11_P )7?\
M_0G:Y_W]LO\ Y(H Z2BN;_X2N_\ ^A.US_O[9?\ R11_PE=__P!"=KG_ ']L
MO_DB@#I**YO_ (2N_P#^A.US_O[9?_)%'_"5W_\ T)VN?]_;+_Y(H Z2BN;_
M .$KO_\ H3M<_P"_ME_\D4?\)7?_ /0G:Y_W]LO_ )(H Z2BN;_X2N__ .A.
MUS_O[9?_ "11_P )7?\ _0G:Y_W]LO\ Y(H Z2BN;_X2N_\ ^A.US_O[9?\
MR11_PE=__P!"=KG_ ']LO_DB@#I**YO_ (2N_P#^A.US_O[9?_)%'_"5W_\
MT)VN?]_;+_Y(H Z2BN;_ .$KO_\ H3M<_P"_ME_\D4?\)7?_ /0G:Y_W]LO_
M )(H Z2BN;_X2N__ .A.US_O[9?_ "11_P )7?\ _0G:Y_W]LO\ Y(H Z2BN
M;_X2N_\ ^A.US_O[9?\ R11_PE=__P!"=KG_ ']LO_DB@#I**YO_ (2N_P#^
MA.US_O[9?_)%'_"5W_\ T)VN?]_;+_Y(H Z2BN;_ .$KO_\ H3M<_P"_ME_\
MD4?\)7?_ /0G:Y_W]LO_ )(H Z2BN;_X2N__ .A.US_O[9?_ "11_P )7?\
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M*SO)UG_G_L/_  !?_P".T>3K/_/_ &'_ ( O_P#': -&BL[R=9_Y_P"P_P#
M%_\ X[1Y.L_\_P#8?^ +_P#QV@#1HK.\G6?^?^P_\ 7_ /CM'DZS_P _]A_X
M O\ _': -&BL[R=9_P"?^P_\ 7_^.T>3K/\ S_V'_@"__P =H T:*SO)UG_G
M_L/_  !?_P".T>3K/_/_ &'_ ( O_P#': -&BL[R=9_Y_P"P_P# %_\ X[4;
M3:G:W]DEU<6DT5S,8F$=LT;#]V[Y!,C=T].] &K1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!G>!O^1<F_P"PKJ7_ *6SUT5<[X&_
MY%R;_L*ZE_Z6SUT5 !1110 4444 %%%% !7-^*_^0OX5_P"PL_\ Z175=)7-
M^*_^0OX5_P"PL_\ Z175 &G1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &#XA_Y#GA;_L*O
M_P"D5S6]6#XA_P"0YX6_["K_ /I%<UO4 <I)=:OKNOZC9Z7J*Z=!IQ5<B$.T
MKD'KGH.#3;W4M=,NDZ+YL%KJ-VKM/<HN\(JYY /&2!_GM<O_  U=/JD]]HNJ
MOILETH6X41"0/C@$9Z'_ #Q4<W@]4L-/73;Z2VO-/R8KEE#[MWW@1Z?RI@4)
M=8U?1YM4TR]O%NI8K%KJVNO*"L,<8*].O\O>JECXQO[JTTJ"67RKYK^&*Y!1
M?WL3\@@8XR".G]:V8_"D\L6HS:EJ'VF_O;<V_F^7M6)?0*/PIL_@N*6ZT6Y2
MX"3::L2R,(_]<(\8[\'CWZ^U BE*?$<?BJ'1QXB)$MN9_-^Q1\<D8Q^'7-5-
M4\1WMMXAU*TG\0?V?';A/)7[$LOF':"1TXY]?6NKET8R>*X=8\\ 16Q@\K;U
MY)SG/O5;_A%X9M0UB:\D$T.I*B^7LP8]HQG/KW% S(77-;O[;1=.1EL;^_1W
MFG:+)1%S@A3W(&?\\++K&KZ/-JFF7MXMU+%8M=6UUY05ACC!7IU_E[U</A.[
M.GV &JE=0TXD6]V(L_(?X64GGCCZ4Z/PI/+%J,VI:A]IO[VW-OYOE[5B7T"C
M\*!&OH5S+>Z!8W-RV^66!'=L 9)')P*YOQ7XIU#2]4%M9PO''%$\COE") 5
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MJ"7?V_4A=R1LH\HV_E-%UZC SG^E=+6-HFARZ=>7=_?W0NKV\*^8ZIL50HP
M!6S2 **** "BBB@ HHHH **** ,[P-_R+DW_ &%=2_\ 2V>NBKG? W_(N3?]
MA74O_2V>NBH **** "BBB@ HHHH *YOQ7_R%_"O_ &%G_P#2*ZKI*YOQ7_R%
M_"O_ &%G_P#2*ZH TZ*** "J]]#<7%E)%977V2=L;9O+#[>>?E/!XX_&K%%
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M/$6H0:]J\ UU=/CM54V\+6RR>:=N=N<9'/UZU/J_B;5QH.DK98@U.\C::0;
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M:L6_AK6=/N+MM,UN."*YG:8HUJ&P2?4FI#X)L[W4+Z\UIOMDMR^8R-R>4H&
M.#R<8_*@!_BC5KV#P_;WFC,PBF=#)<1QB1HXB,[@O0_Y^M9%IK^K2>'=4ETZ
M_CU62 IY$@BVRHI^\63';MU[]:U5\+W::!96<6JM'=6,FZ&X5.",_=9<\C_"
MH$\&3RI>SWNJ.;^ZVD3P1B,1E>G Z^_3^M AGA'6;F_U*6!]734(1#OVRP^5
M-&^<$;>A'XGM4WC/6K_3UM;/1I EY/OD)VJV$123P1CG^E6-+\.WD.N?VMJ^
MH+=W"Q&)!'"(P!ZG'4TM[X2M=6U^:_U=OM,)B6.&#YE\O').0>><_G0,TM&U
M%=6T6UOEQ^^C!8#LW1A^!!J]63X>T5M!M9[5;CS;=IFDA7;@QJ?X<YYK6I %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@^(?\ D.>%O^PJ_P#Z
M17-;U8/B'_D.>%O^PJ__ *17-;U !1110 4444 %%%% !1110 4444 %%%%
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M]3U2:\2Z55?[$98EBR%SESCL?0GM6;H_BK5I++4I3<"^^SV*S@R1*C)(<9
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MUT5<[X&_Y%R;_L*ZE_Z6SUT5 !1110 4444 %%%% !7-^*_^0OX5_P"PL_\
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M\PB0*_.TL/\ /6LR_P#$FJ3V>G6T5Y<Q36:L+IDF8%CYFT;B#SP!U]37=?\
M"&Z>VC36)FN&-Q(LLURSAI)&!SR2*CF\#Z=-+?2&6=6O9A*Y!'RD,6P..A)H
M$<[K%].WB;686OM85HPGV6*Q=BH8IT(';./UJ7Q#J^J1:+I&GS7K66H2PM/<
M2>9Y9 4':"1T)_F*[*ST>&RUB^U&.21I+W9O5L;5VC'%0OX;L)]:GU*]C%W)
M+&L:QSJK)&!Z C_.30,YG6=:O]1\(Z)<Z7<R17=S<I$WEOMW/@@@^Q8=#4VA
M:Y)XA\3NC33Q1MI96:!9&41R[P&(]#SP>O-:T/@^R@$:13SK%%?"]CC!7:C#
M^$<?=Z5:M?#MG9>(KG6+<NLUS&4>/C9R02?7)*_SH YBV;7+G5D\,3W<ZBTE
M,TUZDI$DL'&T9SG)SC\O2M/QW/?P6.GQZ5/+#<37BQJ8W*[B0< ^HSCK6U%H
M\,6OS:LLDAFFA$)0XV@ @Y]>U+J>DPZH]FTSNAM+A;A-F.67H#[4 <WX<\02
MZWXN!,DB(--_>VQ8[4E$@!.WU]^N#6;9^*9Y/&PNFO\ =87%RUJMMYO"K@!7
MV] ">_UKJU\+VD>KWVHV\DL,U[ T+A",*6QEAQUR,U _@G2&T1-/6+8R8(NE
M5?.R#G.['^10(YB[\17NE>.-0EFN9GLHRT?E-(2BL8R5PO3JO\ZHV6JZJ/!^
MLRS:A=F>-[<HYG8L@8YX.>,BNRO?!-C?B[\^XN"UU+'*[ KD,BD<<=]QJ2?P
M=8S6NH0>=,B7SQLP4CY-G0#B@"CX965M35I!XB $1.=0ES">G;UYXJQK-W<Q
M>-M'@BGD2&2&<O&KD*Q",1D=\8J[IN@2:?=K,VL:A=*JD"*>4%#QZ8JQ>:+!
M>:Q::C))(LMJCHJJ1M(8$'/'O0,\WB\3:G!X3GMKR[N1-<!9K2Y\UM[ 2;67
M=U[']?:NNU+[1K7C(Z,U[<6=I!:^>PMGV-*Q('7TY_2K$_@K3KCP_:Z5))-L
MM69HY@1O&XDD=,8Y].PJWK/A^UU.:.[>XN+*YA7:MS;2[&V^A/IS0!)H,$UK
M9RV\^I#4?*F95D)RZ#^ZQSRPJSJ&JV6E1H^H7*0*YPI?N:HVGANVL;.WM[&Y
MNH5BN!<2.LOS7#=PY[@\9%:LUO#<*!/%'* <@.H./SI 8OBW5IM.\+R7>GN!
M)(55)?[H;^+\JCL=%FTC5[9DUZ>9)E82P7DF\S$#J@[8_&MF]L+;4;"2RNX@
M\$B[2O3Z8],5E:7X6LK#4%NS>7=]- ICA^TS;Q",8P!VXH B\(75Q=?VO]IG
MDF\O4)$3S'+;5XX&>@]JP_&VO7<&N);:=??9C8Q">1?-V^:Q880COQSCW-;2
M^#5BN+B6TUG4K47$K2ND,H4;B?I5N'PKIJW-[/=Q"]ENWW,URBL4'8+QQ_\
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MHH P?$/_ "'/"W_85?\ ](KFMZL'Q#_R'/"W_85?_P!(KFMZ@ HHHH ****
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M!.?,4_3C'H.M=SK=I87>DS?VM&9+:$&9@'*_=!/4$51TK2O#MKK,TFF&!KQ
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M%QC! Z# JMI<6@B&X_L<6)C/$_D%2,>C8[=?:@#E/!;N?%#;((((ETQ!(()
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M.\>I((&?2M_3;+0I;2;^RH+)X)ALE\@*5;V./K4][%IL-A'%?I;I:QE5190
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M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#!\0_\ASPM_P!A5_\
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M[P-_R+DW_85U+_TMGKHJYWP-_P BY-_V%=2_]+9ZZ*@ HHHH **** "BBB@
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M>R:YL=116,_EDF.4#G<1T!/KZCT-=G12 **** "BBB@ HHHH **** "BBB@
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MGQ;_ -![1?\ P2R__)5']D^+?^@]HO\ X)9?_DJNFHH YG^R?%O_ $'M%_\
M!++_ /)5']D^+?\ H/:+_P""67_Y*KIJ* .9_LGQ;_T'M%_\$LO_ ,E4?V3X
MM_Z#VB_^"67_ .2JZ:B@#F?[)\6_]![1?_!++_\ )5']D^+?^@]HO_@EE_\
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M7$B8,14@^;_='UH$>S45X)X,73M2^(#W^L?V''=M=V;QKK,Y34=_V>$KY:Y
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MV=7_ .A-UK_O_9?_ "11_;.K_P#0FZU_W_LO_DBNJHH Y7^V=7_Z$W6O^_\
M9?\ R11_;.K_ /0FZU_W_LO_ )(KJJ* .5_MG5_^A-UK_O\ V7_R11_;.K_]
M";K7_?\ LO\ Y(KJJ* .5_MG5_\ H3=:_P"_]E_\D4?VSJ__ $)NM?\ ?^R_
M^2*ZJB@#E?[9U?\ Z$W6O^_]E_\ )%']LZO_ -";K7_?^R_^2*ZJB@#E?[9U
M?_H3=:_[_P!E_P#)%']LZO\ ]";K7_?^R_\ DBNJHH Y7^V=7_Z$W6O^_P#9
M?_)%']LZO_T)NM?]_P"R_P#DBNJHH Y7^V=7_P"A-UK_ +_V7_R11_;.K_\
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MG>^L+&&^7=Y,,-Z\D3\?+ND,2E<G(.$; YYZ5G_;/&/_ $ M#_\ !U-_\BT
M=!2%5)!(!*]"1TK$M[OQ4US$MUHVCQP%P)'CU>5V5<\D*;8 G';(SZBK&IW&
MO17*KH^FZ==0; 6>ZU"2!@V3P%6%P1C'.>YXXY -2BN?^V>,?^@%H?\ X.IO
M_D6M"TFUA]-G>^L+&&^7=Y,,-Z\D3\?+ND,2E<G(.$; YYZ4 :%%<_\ ;/&/
M_0"T/_P=3?\ R+4EO=^*FN8ENM&T>. N!(\>KRNRKGDA3; $X[9&?44 ;E%9
M>IW&O17*KH^FZ==0; 6>ZU"2!@V3P%6%P1C'.>YXXYI_;/&/_0"T/_P=3?\
MR+0!T%%9^ES:Q-YO]M6%C:8QY7V2]>XW=<YW11[<<8QG.3TQSG_;/&/_ $ M
M#_\ !U-_\BT =!2%58@L 2IR"1T/3^M8'VSQC_T M#_\'4W_ ,BUH:I-K$/E
M?V+86-WG/F_:[U[?;TQC;%)NSSG.,8'7/ !H4A5202 2O0D=*P/MGC'_ * 6
MA_\ @ZF_^1:T-+FUB;S?[:L+&TQCROLEZ]QNZYSNBCVXXQC.<GICD T*1E5U
M*N RGJ",YK ^V>,?^@%H?_@ZF_\ D6C[9XQ_Z 6A_P#@ZF_^1: .@I-JABP
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M9>F7&O2W++K&FZ=:P;"5>UU"2=BV1P5:% !C/.>PXYXKW%WXJ6YE6UT;1Y(
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M2B^N?$D=[(NF:3I5Q:C&R2XU22%VX&<H+=P.<C[Q]>.E &Q17/\ VSQC_P!
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M_5/[2_M*/2G\K[#!JUXES<JP!\PEU=@%)VX!8].U<7KMA=Z5>>.Y+7Q#K_\
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MZ5 D@6Y8(ZAN 9_)WD!><;.O'O6:\7B.22Y=_"OAMGO(Q%<L=5D)G0 @*_\
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M0,#GI6)\28;FVUSPIKZ65S>V.DWLCW<5K$9757CVJ^P<D*1VZ9KA/%-AK7Q
MN+73-&\%'3+%FN]2E2Y/V<7+./*BG<A,++DLVPY. .<4#/6?$?CGP[X2FMX?
M$&H_9)+E6>(>3))N"XR?D4XZCK5.[^*/@NPNK:"[UZ"-KJ%)XFV.4*-]UBX7
M:!P>I&.]>6WMAXP\2V_@]].CO=,UBUTB\MIII;<C]Y'A-K%A@>8%Z_[6:IV
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M\7_?8H^UV_\ SWB_[[%<5]F\0_\ 0"TK_P 'DO\ \B4?9O$/_0"TK_P>2_\
MR)0!VOVNW_Y[Q?\ ?8H^UV__ #WB_P"^Q7%?9O$/_0"TK_P>2_\ R)1]F\0_
M] +2O_!Y+_\ (E ':_:[?_GO%_WV*/M=O_SWB_[[%<5]F\0_] +2O_!Y+_\
M(E'V;Q#_ - +2O\ P>2__(E ':_:[?\ Y[Q?]]BC[7;_ //>+_OL5Q7V;Q#_
M - +2O\ P>2__(E'V;Q#_P! +2O_  >2_P#R)0!VOVNW_P">\7_?8H^UV_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\B__ -OEI_Z4QUMUB>+O^1?_ .WRT_\ 2F.@#>T7_D$0_P# O_0C5ZJ.B_\
M((A_X%_Z$:O4 %%%% !1110!D6G_ ",UU_US_P#B:UZR+3_D9KK_ *Y__$UK
MT %8%]XWT'3?$,>AWES<)J$I 2);&=PV<='5"N/F7)S@9YQ6_7/:GI=Y<_$#
MP_J4,6ZTL[6]CGDW ;&D\G8,9R<[&Z>G/:@#6TO5+/6M*MM2TR;S[2ZC$D,F
MTKN4]#@@$?B*MUX3%\-/%.GZ%9V^FZ9"J&RLFU*SDE21+N9'FWJR^8H8@-$>
M6"D+C/&*]7\#Z;J.D>"].L=98->0HP< Y" N2J=6^ZI5>IZ=: )-%\8Z#XAU
M"XL=(OO/N;;<9(VADCX5]C%=R@, PP2N1FMNO$+/X?\ BP?VA]HTZ5X%9P+:
M>]BQ=1-?"=X82AS&KQ@[MYR6P.!FG7?@7Q8QT;R-'"BSE\^V\N[1GT]?MAD\
MG<S]%BP 4&3RI.T $&>VU4T_5+/58II+";S5@N)+:0[2NV2-BKKR!T((ST/:
MO.)_AY<-H>L7(TL3:G<:Q+*T+7.#=V/VL2^3G=M4,@X!QC)!QDUT_P .]%N]
M"\-SVU]8C3VDU"YGCMA*LGEQO(60;@2#@$4".KK/T77-/\0V!O=(F:>VWE!*
M8G0,1U*[@-P_VAD'L:\_TKP/JG_"8M+J-@\2-/>-?ZM'?E6U&"7=Y405&WIL
MRGH%V?*>:ZCX<>'YO#/@'3-.O(I(;Q8@US&\YEVR8 (!W$ <#A>/2@"_:>+M
M#O?$=QH-M?!M2MB1) T3KR "0&("L0&4D G&:T;"_M]2M!<V;L\1=TRR,ARC
M%&X8 ]5//?J.*\^M/".JW/Q NGU+3$71QJ=U?>?),C+<I-:);^5L!)_O$[@!
MP.M0V'P_N9-&\+:3JFEH=/LM1U![RV$JA%A<SM%PK<@EH^!G'<<&@#T^J]Y?
MVNGQ1R7LRPI)-' A;^)W8*BCW+$"O+-0\"^+&\?7MSI,L=I:M&Z6FH;LM'%]
ME,20D^9NP),-C8>1NW9XILG@.^NO""Q+X7DTZ2UU&TN18V^K'?=",IYS APB
MLP!P<@Y^8X:@#UVBO+G\(:U/XVBOSI+*[7MM<QZI)? M:6JQHLEH5W$DDAQQ
ME6WY)S5*3X:W4/PKTZRATB1M:=H'U*-+F-FD**X^82$QR@;L;=R]!AOE H ]
M>HK,\-6UY9^%=+MM32..\AM8XYDB<LJL% (!))/U)->:W?PZU2/P2C6.F0OK
M,FIR27\,T@D%Y:^?*40@R*K  Q,%++TP>X(!Z[17D>E>"_$EI>:.VL:4FK/#
M! L-P;XPC2BD\CL,!BS9C9%^4MG9M/%<]KOPU\87?AN_M;+2RMVT:)<R"_0_
MVI.)P_VCEAMPN?O8/S8Q@4#/?:*^<=1^%'C.:_#0:4YBB@N8X2+V,;<R73Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7VC[H<(K8'!ZCC%>K44 >52S2^%9?'3>'HX["--5L@\L<&];6.2&'SIMG\1
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M ))WX<_[!5K_ .BEK>H **** "BBB@ HHHH \(_:7_YEG_MZ_P#:->L^!?\
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M $&]%_\ !-+_ /)5._X2VP_Y\]<_\$-[_P#&:/\ A+;#_GSUS_P0WO\ \9H
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M_P );8?\^>N?^"&]_P#C-9VNZY!JNFK:6=EJ_FM=6[9ET>ZB0!9T9B7>,*
MI/)H SYS:V][*;"^U*.:7!O$M+)9U4]!R>AV_6NZ\,Q6,/ANR3296FM G[N1
M^K<G.??.:\WU"1)-4G6VEATYH]OGM+?/!]I/4$*/0<9KT3PG+!-X4T^2TM3:
M0F+Y82Q.WD]SUSUS[TP-BBBBD 4444 9%I_R,UU_US_^)K7K(M/^1FNO^N?_
M ,36O0 4444 %%%% '(Z!\3/#WB&"UGM99+>&XLIKUI;K9&L"12+&PD.[Y6R
MX/ICG/3.S)XI\/Q&(2Z[IJ&:-98@UY&/,1C@,O/()! (XR*\LT_X)ZGIDEM-
M:WE@6CT^!9K:1G:&6[CGAD.1M_U;K H)ZY&<&JVL?!+7M2O([A+K25+6MPLD
M>YU2*65KI]L8V'Y%,Z8/!^4G'04#/5[3Q=HMY_:3I?VZ6VFSI;S737$?DEV"
MD ,&..6"X.#NXQ5M=>TA[:TN$U6Q:"]?R[647"%9VSC:ASACQT&:Y35_ MY?
MQ>)HH7LUCUC4;&YB1B<*D/D>8&&WJ?*? &0<C)&3C UCX3:Q?[19ZG;6J->7
MS,B=(X+BX652N8VPX" $#;SC#8!R"/3O[6T[[1<V_P!OM?.LT$ES'YR[H%QG
M<XSE1CG)I]AJ-EJEHMUIEY!>6[YVS6\JR(V/1@2*\W;X7ZI)KWB&YGO[6>TU
M"&\6VBF!P3<,K%9 BJVU=H /F,> 0%Y!ZKP'X>U#PUX?EL]5N(III+EYE\MS
M)L4@?*9"JF0Y!.YAGG'.* .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "L3Q-XJLO"MO:27MO>7+WD
MXMX(;* RR.^TM@*/936W7*>.?"!\7MH<$HC:SL]0%Q=HTKQLT?ENN%*\YRP[
MCZT ;L&M:?,S1FZABN(X%GFMI9%66!",Y=<Y7\:LVUU;WL FLYXKB(D@21.&
M4D'!&1Z$$?A7D]S\*M8?4-12W;3TMV_M"2"\,C?:)_M,+1I#)\O"H2.<G@#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.%1:N&G+",*H+87>7<_+D87:3P<UTVAZU:^(-)CO[(2(C,\;1RKM>-T8JR,
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MG"Y)SU[4 >@T5SO@C5[[5]#N/[6>.:\L;^YL9)HTV"8Q2% ^W^'( X]:Z*@
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M7/RYV9).W)S6G=^$=/O/[3\V2X']I7EO>3;7'#P>5L"\< ^2N>IY/(XQNT4
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M=V'VKMDW8VE0-O![/PII5WHGA>ST_49X[BYA5M\D2A5.6+8X R0" 6P"Q&2
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M*+:R0@NL42'^(8VQL1A021EQU/A'POJ%E8^#+B\"0-I6CRVUS Q.\22"$@#
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M"(.O+$C)QSTKMJY31?#%_IGB2XN)/[.DLC=7-U'<&,M=,T[ E"2,(J],@G<
MHP,<]70(Y6[^'NEW?B=]=-W?PW+NTA6&8( [0& L&V[P=AXPWRD9&,G.AX9\
M+V/A:SN(+!YI6N9O/FEFV[G?:%SA%51PHZ 9ZG))-;5% !1110 5PNI74_AG
MXD7NKW&E:G?6.H:=!#')IUHUP4DC>0LK*N2,AP0<8/-=U10!Q&C7,_B'XD#7
M(=+U*QL;329+,MJ-JUNTDCS(X"JW) "')QCD5V]%% !1110!Q?BHW&D^.=%\
M0C3KZ_LH;2YM)A86YGDC9S&RDHOS%3L89 ..,]:K?VC-XL\<^';BRT?5[2WT
MF2XGN9M0L7MEP\+1JJ[\%B2^>.@!S7>T4 %%%% !7*^/[6ZETS3+RSM)[S^S
M=5M[V6"W3?(T:$AMJ_Q$!LX')Q7544 ><^)]?D\8:,NAZ5H&OQW%S=VS>;>:
M9)!%&L<Z2,S.X  VH?<G%>C444 %5M1_Y!MQ_P!<S5FJVH_\@VX_ZYF@"+1?
M^01#_P "_P#0C5ZJ.B_\@B'_ (%_Z$:O4 %%%% !1110!D6G_(S77_7/_P")
MK7K(M/\ D9KK_KG_ /$UKT %%%<YKOB.\TGQ5H>G)8!K#4'F$]XSCY"D$D@1
M5!SG]WDD\8XY)X .CHKG/!VJZYK>EV^IZM#8QV=_:QW5J+8N'B#C<$<'(8A2
MIW#')(V]ZZ.@ HKR7P?\8-2UR=/[5T*2&&+2GNYC;1,6EF$L2@1Y;&S9,C$L
M>,\D $UTEC\1/[7U[1;72='NI[+48[DR3EX<Q/#(B,/]9@A2Q+$9R"NS=S@
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M>HZA?S7<4,+->R*Y1(M^Q1M5?[YY.2>IYR3O44 %%%% !1110 4444 %%%%
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M.MT9RWDQ^5&NP9Z#<C-@<?-6A10!@WOA47?BN'7DU?4+>>&(0K#&(&B";LL
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M:\+2,J+M64QEOG(48#D$^]9>OS^"]/\ A^$AM&U?1]$=08])NP\MD54_-O\
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M=%D='V;%RGW@6& I/.171Z=\+/$T6J7-W>SZ=F::W9O)D*J_EWBS%@@C 7*
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MLC.6'E&SR5RGI;2X_P!Y>F3@ [FYC\#KX;ATRXU#3H=-TN588B-1\LVLJ*<
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MMQ^[]._X4 ;E%<'8?$Y-2MX;^WTEQI8:SBNKA[@!X);D(4 CQ\ZCS4R<C[W
M.#A-$^*=C=6 N_$MO%H,,EI;WD+O=>:KQS&15!.T8;,3<<\8Y[  [VBN'O\
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MZ=,]>:Y^YNOAQI-MHIEO-/DBEU,W%I<F_$O^DA#NF>5G);  4EB>2@ZXJ,>
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JMJ/_(-N/\
MKF:LU6U'_D&W'_7,T 1:+_R"(?\ @7_H1J]5'1?^01#_ ,"_]"-7J "BBB@
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M!9PN\*HSD$#!-=I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 56U'_D&W'_ %S-6:K:C_R#;C_K
MF: (M%_Y!$/_  +_ -"-7JHZ+_R"(?\ @7_H1J]0 4444 %%%% &1:?\C-=?
M]<__ (FM>LBT_P"1FNO^N?\ \36O0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;<?]<S0!%HO_ ""(?^!?^A&KU4=%_P"01#_P+_T(U>H **** "BBB@#(M/\
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MC:?;M-N+;"EI8V5=XR Q'!_ U4\,:9-HOA'2-+NFC>>QL8;>1HR2I9(PI()
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M-Q/G1!1@OANAQ]Q>>*Y:/X::YK\=W'(MG8P6NLW]U!+<QOYUX6E.U91M ,3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYU&]%G'')<>2JDQR/N+;6X_=^G?\* -RBN#L/B<FI6\-_;Z2XTL-9Q75P]P
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M(H?+*1DQ;MI))!WK@$Y4YIMMX$U^RM=(^SC0_M&AO MLP1T:[2..:,M+(%W
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MNK\5:--KN@FTM9(UF2>&X19LF*4Q2K($<#G:VW!^O?I0!D7&A>!+J33[F9[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2))=R:N9?M(/6(+_ ,M"W0;L8ZCD4 =9:?\ (S77_7/_ .)K7K(M/^1FNO\
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M=0V]I_:#/,0$+Z7=(ISW+-&% ]R<4 3VG_(S77_7/_XFM>LBT_Y&:Z_ZY_\
MQ-:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5M1_P"0;<?]
M<S5FJVH_\@VX_P"N9H BT7_D$0_\"_\ 0C5ZJ.B_\@B'_@7_ *$:O4 %%%%
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MTDD1'E;;&K, 7."<#U. 3] : 'T44QYHHGC221$>5ML:LP!<X)P/4X!/T!H
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ML.I.W/O/%ME%X?\ #6H:]H<&JW]YI,5U83SHFZ2[;RAY2G9\C,90<@= W'%
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MJ3*"'!!PJC^(J2 01P5OX>\9SZ+>V&H:;='3[/0KV+38A Q8/N2$1],Y8(7
M[AOQKH_$$/C'3H+FRTP:W=64&HW"P2BZG\XC[/"83O5'9T\QIN#\F0 Q %=%
MXB\<ZE'X=\176DV(MX+&*[BMM0:=&;SX.&S"PZ;@P!&[.TD@#&>E\-:[/KD-
M^M[8BQN]/NS:3PK-YJ[MB."&P,C;(O;KGZT#.,\*V?BB'4='O]8EU9KFYU:^
MCU"*6:1H(X LQCPA.U5W*FU@.<@ X(%;GQ*75CX?MSHCWZR+<YD6R24EUV-@
M,8F$BC=MP5##(&X%<U.?&<I\=3^&AIJQ2"-FMY;BX,?V@B,/E04PR<E<JS,"
MK90 9K+T_P <ZD/#]@6T]=0U:[EU!VA-RL:)%;3LC8?8,D HJY49SDD<F@1'
M>P:U;:I'K$*7-M=MX4N3(UY<EX(+H>04#'B-3D,25"@[2>U<CI;ZKKGB@V.F
M:CXH.FJEL]P9;J971C:W3$[LY"M((^>A.W;QMKLO#_Q*EU^6P,NABWL+^XCL
MQ-]K$C":2T%SM*;!E0I*YSUQQR<:VIW47A!],T[PQX?LFEU6Z>-88G6TC#+$
M\C,2J')PA[4#,;1;/66U;1-2O8]0^U3^%7%XTK2;4NO]'.W83M1SA^  3@YS
MBN5CDU_1M/T^/7K_ ,0)IMS;V$MZQN)/M9F:WN&E2(D[N)$B+HO( )(QN-=7
M8_%O3-1U[3["UMT\N]6W7,ETBSI)-%YB#R>K* 5#.#P6& 1DU%?^-'U+P!!K
M>L>$+>YTV\:%XHKB?SXU5@Q\R4")M@! &=K??7D<X .C^']S<WGPZT"YOYI9
M[B:PB>265BS.2H.23R2?6O/+&;QC<6/B$2IK]HDD=O+$LD<\SH_GMYJ@Y1L;
M-H;R-O'* GKUT'Q"0^7);:2O]E0M9P7-PETA\B2X5"BHB@B15\V/+!N_ ;!J
MA9_%6:XTA;JYT2&TFFMK:ZMXY-0!1HYF=068)N!!C;Y55R00<=0 #JO!CW[^
M#]/.L0W$-YL(=+F0O)@,0I)(#<K@X8;AG#9()KRFXL/%7B"SURRN;371%=:-
M=.MO<27 _P!*61?+0L=J$[2PQ&!&P_O8KM['Q9>:W>^$-2LYIK2TU2ZNK2ZL
M"J,A,4<_S;B@?.^(8Y''44Z/Q3>:#<^(CJL\VI66G:M;6_G2B-&MH9HHF+'8
M@#*K2=QG;U/% %2YT^V?Q9X3UFWM?$3620W$!,DEX9(G,D1C\U&;<%.U\EQ@
M@+NR N,4-XQ71-0-L-=_M-=(N6O_ #A(4^VAU\K[*.A&-_$?R[=N?FS7I?AS
M6?\ A(?#]MJJVYMX[K<\*,VXM'N(1^@^\H#8[9QSUK-^(.O2^'/!=Y>6ES#:
MWDC);VTTQ4)')(X0,=W&%R6.>,*:!'+>+]#UVP8Q^'[_ ,0SI:Z1=W4+)=RR
M&2Z#P^6C'^/C>0ASGGC&15.>+QM>^+-;MQ+?V$++>;+LW,@@2-0#;%5*"-3D
M#.UR2"^X 8K:L?%-_JVD>!=9MM0=$U6Y6UO;94B:.1O(F9SG:6!$D7&U@,=J
MV+%YK[QEXDT759_[1TU;6TFCMKF&,JGFF8.G"C<O[M?O;C[T#*'@KQ!>2^&M
M-U;7UN3<>)+YF@A7YEM4,;&->3\J[(L\?Q/[DUTGB5M27PMJAT(;M2%I+]E'
M'^LVG;C/&<XZUS'B_P 1WOASQ):?9-.AO;"RTB[U"6 LL9B$1C'F(VTG<$=U
M"C ._D@<U;L?&_\ :VKQV4=G);6=]<7%C:7RRJ9#/"K%\QE2% V/@DMDKR!D
M9!'GML_C9FB80>)(K&.Y#3J)YY9#:?N?,56D1':3?N*X4,%\P*<;:V_$,OCW
M_A/KT:%;W>,L+-VFD^R^3]E.-R;/+W>=SN+[^@V[>:FNO'6L:=\.7:(MJ&M/
M%JKI=2^7'Y<=K*Z>:0$VLRCR_E"@-STK3;XH6L'B9-%DAAD<%8'D^UH)3,8/
M-XAQN\O&%W] QQCC- S+BN-8L;73KNRA\52V<-TPNDO \LSLUI(O$>-Y03%.
M3E0W*X4 U6TW3-:L[ZWU'R-8;6[SPG;QP3327#QB^6.7<LP)V+RR'#@#<21\
MQ)K>G^(>HVW@^T\0W'ASR[:]\MX#]L+HL3QEP\K)&3'T"]",L,D#)'2ZCKR6
M/@NZ\0QPB9(-/>^6)95(<+&7VAUR.<8R,COS0!P$,7B&YLY(-.?Q'%823Z;'
M))>M*MTLC38NRA;Y@@0@D_=!R5X%>@V]Q!I%YI^A;[RXDGAFDCGG?S#B,ID.
MY.2?W@QUZ'GUY#0OBJ^K:Y;Z7=:$;2::\%L&6[$BC_CY!;[HZ-:L,=PV>V#)
M;?$87M]X>?\ L..%M7LXY(;BXN-@5I3S$C[-K8*)N&58Y7:K'B@1L>/Y+]/#
M\*Z9%?.TEW&DK632AHX^26;R@9"O !"8;D<@9KSJV@\67Z>'UU^WUR7R=0M&
M@41R;%":A(9&N <GB(0E68GCD$G<:]'\!ZQK&N:!)=Z[#:QO]KN8HVMYB^X)
M/(F""BXV[0 >=P&3@G%-U[QD="\5Z9I$NG[H;\HHNY9O+7<S[=JDKM9AP2I9
M201M#'B@#@?A_8>+KA[BW\32^(3;SZ9*I%U/.A$@2U9=K9#*VZ2<<')P1_#@
M69=-\3'PU'+ ^N07.G^$;)[:""26,&]'F;PR#[[@!05.>HR.F.G3QAJ%B_B+
M^T;5)KBTU2VL;.TAG!1FFCA\L>844@%I,L2#MR0,X%9@^*M_LU)W\-(JZ1 \
M]_\ \3'/EA)Y86"?N_G.821T'/48&09+>:;JMCIOCB/33JL1DO8)+.5#+/(Z
M^3!OV$N'*YWJ=C9 R%Y %9SZ=J%SI/@_5==L]<9K"]N!<K!<7+S"-DF6-]J;
M9,$F,98;PIPY/S9]5KF?%MUJ%KJGAE-/U&:SCN]4%M<QQQQ,)4\F23!WHQ',
M0&5(X9N^" 1EFQUCS/%NJ-)K4EQ;S31Z;:17)C22,VT9!C5@5SYC/AL'!&.<
M8KD=.T[5I_[-U'Q!;^(9X-.UR8+Y;7HE%L]I\C*N[S"/-8@L>0"0<+D5W/A[
M4?$&I>/O$$6HO#%IFFNEO#;P3!@6:..0,V8@Q)5_[X /R[6^]4OCGQLO@NTA
MG-G'=ATDE=6N1&P2, G:H5F8\^@4?Q,N1D&<GK!\7"\UHV0UK[:$U$MLW_9_
M(\I_LGD8^7S=_E_=^;._=QBNWMFC\*Z#;-=S:C>&XN8(F:>4S.DDSI&.6/"[
MF!([9.!T%7M6UNVTCPU=:W<AS;6ULURRJ/F*A<X'N:YN]\7ZE$T%A>^&(6U5
MO,N%MCJ"-&(X51S()-N0P,B@ J/FYSM^:@1T^M_;_P#A']0_L;;_ &C]ED^R
M;L8\W:=F<\8W8KS>SM?$-]<65M#+XDATB74+=99+F66.X'^C3FXRQ^98]XA
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MR,ZLREB7#$_,"P/7!' %Z7P1<W/C"#7KK468B:"YN+=))426>*,(&"[MBJ<
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M6&8%4569@<<+GG&*GU.;X>1?V5;:I!/ VG6D,EM');7<;06Z/B,R\ A \?\
MRTX!Y/WN;X\-,W@2_P##,TBM%>_:]TZMM9?/E>3I@_=WX]\=LU3U#PIJ6L6N
MK?VIJ%N]UJFDKILDL,)14VO*P<*2>TH&,_PYSSP :^J>)O"6H0ZII6J7L4D=
MI&S7D;(X551AN(8#DHQ7.TDJ<9P:P+J#X;7>EVL%Y%*T$QF4%UNUD<,R>:TS
M??*%FC)>0[<[3G.*HW/PO>YGU4G5)/)O(;N.WB>61Q;&Y;<YPS%3@YP%5"<_
M,6/-;WC'PQ<>+);!UN([%K1F*R(NZ5,E3NCD #1M\N,Y*G/*G P 9UE<>"=>
MOM>CO=+E6^#WEK<VZI<2F:-)/*D>(*,%F 0MY8+<KN)X-:VF>+?#FGZ/9:K.
M#8S>(XSJ310I-<;RL<:NWRKP%79DX48!..IJ/2_#,VFZY;ZEYR2&&;49?+Y&
M?M<R2XSC^'9CWSGCI6-+X1UVU7PO8:/>0P1Z5I=S937KQA]P<0@?(2""0C$$
M$@$#.1P0#K;JP\,Z9-/XQN$C3RXC<O>*[N@78%,H0$KN* #<!N(XSBN/\1IX
M4U?0;6'2M6>PA@N;G,*Z?<32EI1YDIV+ME48DWYSL(;Y@RX%=-J.A?:_ $OA
M6U"V]NU@+&.4R%RBA-@)&!G@>U8>O>!;S6M5OKM-1CABO;CSI+61&>,_Z/'"
M"0"N67RRRDY W$%3UH =H&H_#FPEL-#T_48I+FS>*ZC9S* 9%M BR%CA.8!T
MSC@G&:U;JUT#XEKI]S;7S3VFF7322Q*LD+N6A95&<JZC$@<,."!QP<UQEE\&
M_LTTAGU7S8I8H(G1(RA*QVDEL<')P3YF[IQC'/6NO\&^&[GPHEZTUT=0N+MH
M]TDD\APJ+M4#>7;U)^;'/  XH HKJ'@RT\;WMK>V0L;S1Y(8H&7S3#)BV5XS
MM4>6'"LR*#EB%.WTK:L[#PGKFC6NA:>!-9Z?!;W%ND$LJ&%'5A$RR A@2H;^
M+.#SUYRKKPM?S^)KW49+R-]/NKZWU!]/6/#F6"-%0"4]B8U8C;V R!G+_AYH
M-QX6T2Z66S6*:]NWG\IYPS01_=BBRH(.U%4<<9SB@"Q>:?X'TGQ)IEM<V\=M
M?J(%M8HUE\H%24@+A?W>X$$(7YR"%-8>KW7P_L="L;JUL;B\6.WL!:"S^U"2
M.W:61('#+\RX+3<\,<[3DLH.EXD\)7GB'Q-8:J;]8H[*6WF6V<-(JM%+YF4Z
M!=W1C@GA<$ $'+M/AW?6VFW%H^K12 6MI:V;>1CR%MIS-'N&?G.XX/W<\].P
M!HV.I^$='\066@_8I+"/3Q%>Z=)*)_EDNS*C!@P_=\L1B0CF3& 12:]J7A+5
M=!\106NKQ60U HNHW36TDOF*VVWW1@X!^Z$#IE0W/)J:]\+7NHR7L]Y>0F>]
M33A*T<950UK.920.<!]V,9^7U-9T?P]G6VAMY=062&RCAM[!=F## ES%.5<_
MQL?)1=WRX Z$YR ;DFK:$EQX3@M+.9U>Y:&P=X9X5M]L$J'JF-VU678^#@DC
M[M27WB7PK?7S1:H]Q%-HO_$Q(NK.X@$6-T8D&Y5#\LP YR>0"1Q:UBRGU:[T
MB<B.+^S;X7FW>3YG[J2/;TX_UF<\]/>N:?P9JUW8ZY::GJEK,-7F%P;F&"2*
MXC=)%:(>8)""B! H4!?7().0!=7\4^"-"\.#4[*/[4]M/<:I;6B"96%Q\Z.7
M&#Y66D9<.  6Z9Q79W8TK0WO]>O"EJ7AC6ZN'8X*1EM@Q[&1N@R<XYXKSE_A
MA?)I>H6]GK2Q7&K0/!J,\T;S^:K.6&S>Q92-Q&6=R0>><$=QXALI?$&AS:<X
M6W+M')',DF3')&ZR(V"N#AE4X[]* .<\6>*/#UQ:V]S;Z7<:S=:CYVB^68;J
M+8DBAY8Y-D;,C813MV;\<@8R0^SN=%M?B=<6FG>'YEN+2V\^[O"ER4B9U;_5
M1B,H681X+Y0OT!<@BIK;PM>"\@O[^\BN+\:L-3N)40QI(1;M L:KSL4*0<DL
M>#Z\;-K93VOBC4M8 C8WUO;P&+>1L\HRG.<<Y\WICC'O0!S4LW@;4_ ]I+KM
MG]FT^:[O1#"IN#)GSI/.8[0)%4X9G! 5<X/ %:4I\"_\)<JR-&VJF,2!5:4Q
MG]R<' _=F3RLX_CV].*JCPC?VUI9?V7J*6M]9RWI2Z,>\>7=2F1UVG^(';AL
M]5R002*JS_#^2?Q5_:S:C.T!F6Y:V>XD;=,L'DASSLZ $_)NSP& XH W--M_
M"/B[P[:Z?IJ/<:=IJQI;%?/A,:A"BE)#M8@ID9!((R#FN@FTFQGT.31Y+9!I
M\EL;5K=,JOE%=NP8Q@;>.*Q;"QU'2_".F:+87,<4MA!;0?:L;MZQ; WR$8&]
M5(ZG&[/:MG[;<?\ /O'_ -_3_P#$T 8\GP]\,2&0G3,-(_F%TN)58-OD?((;
M(^::3ICAB.G%3P^"/#MO-820Z:JMI\<<=N/-?:%C),>X;L.5))4MD@G(K1^V
MW'_/O'_W]/\ \31]MN/^?>/_ +^G_P")H 9INAZ?H\]W+IT+0F[D,LJ^:[)N
M)))5"2J9+,3M R3DU%J'AG2-4U6#4;^S$MU %"/YC $*V]0R@[7"M\PW X/(
MYJQ]MN/^?>/_ +^G_P")H^VW'_/O'_W]/_Q- &=K?A2UU72M5MK9EM)]4DCF
MGG*&0,\80*2I(Q\L:CY2I&,@AN:S]!^'&C:1X?N--ND-\UY ]O>3.SJ9D:22
M3;C<2 #*V#G/J370_;;C_GWC_P"_I_\ B:/MMQ_S[Q_]_3_\30!);:?:VEW>
M7-O%LFO9%EN&W$[V"*@.">/E11QCI5?5-!L-9NK&XU!)FDT^;S[8QW,L01\8
MW$(P#<9'S9X+#H3F3[;<?\^\?_?T_P#Q-'VVX_Y]X_\ OZ?_ (F@"2VTZUL[
MR\NK:+9-?2++</N)WLJ*@//3Y44<>E4-=\*:+XEV?VU9_:#&CQ@B5XR4;&Y#
MM(W*< X.1D ]15O[;<?\^\?_ ']/_P 31]MN/^?>/_OZ?_B: )GLK>73VL98
MEDMFB,+1/\P9",%3GJ,<<UAGP#X::Q%H=./EB0R;_M$OF$E0A!DW;R"H"[2<
M;0!C Q6M]MN/^?>/_OZ?_B:/MMQ_S[Q_]_3_ /$T 4-0\*6%QH&MZ;8(MB=8
MMF@ED12P4F$0J0N<85%48&!Q^-5(_AWX:2P2V:P9BIW&87,HE/R;,>8&W!=O
MR[,[<<8Q6U]MN/\ GWC_ ._I_P#B:/MMQ_S[Q_\ ?T__ !- #;/0]-L)I9;.
MSCA:6WBM7"YVF*+<$3;T  =N@[_2LNW\ ^&K6SO+6#3BL-['%',IN)3E8B6C
M );*["?EVXQP!@ 8UOMMQ_S[Q_\ ?T__ !-'VVX_Y]X_^_I_^)H ;%HMA#<6
M-PL+--80/;V\DDKNRH^W<"23N)\M>3D\=>35&Q\%>'M-FCELM-2)XK@7,9$C
MG8ZHZ+C)X4+(X"?=&XX K0^VW'_/O'_W]/\ \31]MN/^?>/_ +^G_P")H DT
M_3K72K/[+81>3#YDDNP,3\SN78\^K,3^-9,?@?P[#Y_EZ:H$SH[#S7(79()5
M"#=\B[P&VKA2>HK2^VW'_/O'_P!_3_\ $T?;;C_GWC_[^G_XF@"[15+[;<?\
M^\?_ ']/_P 31]MN/^?>/_OZ?_B: +M%4OMMQ_S[Q_\ ?T__ !-'VVX_Y]X_
M^_I_^)H NT52^VW'_/O'_P!_3_\ $T?;;C_GWC_[^G_XF@"[15+[;<?\^\?_
M ']/_P 31]MN/^?>/_OZ?_B: +M%4OMMQ_S[Q_\ ?T__ !-'VVX_Y]X_^_I_
M^)H NT52^VW'_/O'_P!_3_\ $T?;;C_GWC_[^G_XF@"[15+[;<?\^\?_ ']/
M_P 31]MN/^?>/_OZ?_B: +M%4OMMQ_S[Q_\ ?T__ !-'VVX_Y]X_^_I_^)H
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M<-:_[\V7_P CT?\ "/:G_P!#AK7_ 'YLO_D>@#>HK!_X1[4_^APUK_OS9?\
MR/1_PCVI_P#0X:U_WYLO_D>@#>HK!_X1[4_^APUK_OS9?_(]'_"/:G_T.&M?
M]^;+_P"1Z -ZBN:M4U'3/&=E8W&N7NI6UUI]S,R74< VO');A2#'$AZ2MUSV
MKI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **R?%=[<:;X,U
MJ^LI/*N;73YYH7V@[76-BIP>#R!UJO\ \(]J?_0X:U_WYLO_ )'H WJ*P?\
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M^;+_ .1Z -ZBL'_A'M3_ .APUK_OS9?_ "/1_P (]J?_ $.&M?\ ?FR_^1Z
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M;U8/B'_D.>%O^PJ__I%<T ;U%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6#XA_Y#GA;_ +"K_P#I%<UO5@^(
M?^0YX6_["K_^D5S0!O4444 %%%% !1110!@W?_)1-(_[!5]_Z-M*WJP;O_DH
MFD?]@J^_]&VE;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8/
MCK_DG?B/_L%77_HIJWJP?'7_ "3OQ'_V"KK_ -%-6]0 4444 %%%% !1110
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M-/\ &CR=9_YYC\T_QH OT50\G6?^>8_-/\:/)UG_ )YC\T_QH OT50\G6?\
MGF/S3_&CR=9_YYC\T_QH OT50\G6?^>8_-/\:/)UG_GF/S3_ !H OT50\G6?
M^>8_-/\ &CR=9_YYC\T_QH OT50\G6?^>8_-/\:/)UG_ )YC\T_QH OT50\G
M6?\ GF/S3_&CR=9_YYC\T_QH OU!>?\ 'E+_ +IJOY.L_P#/,?FG^-,FLM6G
M39)'\OH&49_6@#5T7_D$0_\  O\ T(U>J."%;>!(H_NH,"I* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>halo-20230324_g12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g12.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #.34
M )*2  (    #.34  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" 2I XH# 2(  A$! Q$!_\0
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M^2G:]_V!]._]'7M;-8VC?\E.U[_L#Z=_Z.O: .LHHHH **** "BBB@ HHHH
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M#_R*\'_88TO_ -+[>NGKF/B#_P BO!_V&-+_ /2^WH U**** "BBB@ HHHH
M*PM=_P"1H\'?]AB3_P!(+NMVL+7?^1H\'?\ 88D_](+N@"?QC_R&_!__ &&I
M/_2"[K6K)\8_\AOP?_V&I/\ T@NZUJ "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "L;1O^2G:]_V!]._]'7M;-8VC?\E.U[_L#Z=_
MZ.O: .LHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8^(/_ "*\'_88TO\
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M=XW_ .@#X?\ _![/_P#(E&[QO_T ?#__ (/9_P#Y$KKJ* .1W>-_^@#X?_\
M![/_ /(E&[QO_P! 'P__ .#V?_Y$KKJ* .1W>-_^@#X?_P#![/\ _(E&[QO_
M - 'P_\ ^#V?_P"1*ZZB@#D=WC?_ * /A_\ \'L__P B4;O&_P#T ?#_ /X/
M9_\ Y$KKJ* .1W>-_P#H ^'_ /P>S_\ R)1N\;_] 'P__P"#V?\ ^1*ZZB@#
MD=WC?_H ^'__  >S_P#R)1N\;_\ 0!\/_P#@]G_^1*ZZB@#D=WC?_H ^'_\
MP>S_ /R)1N\;_P#0!\/_ /@]G_\ D2NNHH Y'=XW_P"@#X?_ /![/_\ (E&[
MQO\ ] 'P_P#^#V?_ .1*ZZB@#D=WC?\ Z /A_P#\'L__ ,B4;O&__0!\/_\
M@]G_ /D2NNHH Y'=XW_Z /A__P 'L_\ \B4;O&__ $ ?#_\ X/9__D2NNHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KF/B#_ ,BO!_V&-+_]+[>NGKF/B#_R*\'_ &&-+_\ 2^WH U**** "BBB@
M HHHH *PM=_Y&CP=_P!AB3_T@NZW:PM=_P"1H\'?]AB3_P!(+N@#L**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "N8^(/_(KP?]AC2_\ TOMZZ>N8^(/_
M "*\'_88TO\ ]+[>@#4HHHH **** "BBB@ K"UW_ )&CP=_V&)/_ $@NZW:P
MM=_Y&CP=_P!AB3_T@NZ .PHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MYCX@_P#(KP?]AC2__2^WKIZYCX@_\BO!_P!AC2__ $OMZ -2BBB@ HHHH **
M** "L+7?^1H\'?\ 88D_](+NMVL+7?\ D:/!W_88D_\ 2"[H ["BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KF/B#_R*\'_88TO_ -+[>NGKF/B#_P B
MO!_V&-+_ /2^WH U**** "BBB@ HHHH *PM=_P"1H\'?]AB3_P!(+NMVL+7?
M^1H\'?\ 88D_](+N@#L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8^
M(/\ R*\'_88TO_TOMZZ>N8^(/_(KP?\ 88TO_P!+[>@#4HHHH **** "BBB@
M K"UW_D:/!W_ &&)/_2"[K=K"UW_ )&CP=_V&)/_ $@NZ .PHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *YCX@_\BO!_V&-+_P#2^WKIZYCX@_\ (KP?
M]AC2_P#TOMZ -2BBB@ HHHH **** "L+7?\ D:/!W_88D_\ 2"[K=K"UW_D:
M/!W_ &&)/_2"[H ["BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF/B#_
M ,BO!_V&-+_]+[>NGKF/B#_R*\'_ &&-+_\ 2^WH U**** "BBB@ HHHH *P
MM=_Y&CP=_P!AB3_T@NZW:PM=_P"1H\'?]AB3_P!(+N@#L**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "N8^(/_(KP?]AC2_\ TOMZZ>N8^(/_ "*\'_88
MTO\ ]+[>@#4HHHH **** "BBB@ K"UW_ )&CP=_V&)/_ $@NZW:PM=_Y&CP=
M_P!AB3_T@NZ .PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YCX@_P#(
MKP?]AC2__2^WKIZYCX@_\BO!_P!AC2__ $OMZ -2BBB@ HHHH **** "L+7?
M^1H\'?\ 88D_](+NMVL+7?\ D:/!W_88D_\ 2"[H ["BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KF/B#_R*\'_88TO_ -+[>NGKF/B#_P BO!_V&-+_
M /2^WH U**** "BBB@ HHHH *PM=_P"1H\'?]AB3_P!(+NMVL+7?^1H\'?\
M88D_](+N@#L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8^(/\ R*\'
M_88TO_TOMZZ>N8^(/_(KP?\ 88TO_P!+[>@#4HHHH **** "BBB@ K"UW_D:
M/!W_ &&)/_2"[K=K"UW_ )&CP=_V&)/_ $@NZ .PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *YCX@_\BO!_V&-+_P#2^WKIZYCX@_\ (KP?]AC2_P#T
MOMZ -2BBB@ HHHH **** "L+7?\ D:/!W_88D_\ 2"[K=K"UW_D:/!W_ &&)
M/_2"[H ["BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF/B#_ ,BO!_V&
M-+_]+[>NGKF/B#_R*\'_ &&-+_\ 2^WH U**** "BBB@ HHHH *PM=_Y&CP=
M_P!AB3_T@NZW:PM=_P"1H\'?]AB3_P!(+N@#L**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "N8^(/_(KP?]AC2_\ TOMZZ>N8^(/_ "*\'_88TO\ ]+[>
M@#4HHHH **** "BBB@ K"UW_ )&CP=_V&)/_ $@NZW:PM=_Y&CP=_P!AB3_T
M@NZ .PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YCX@_P#(KP?]AC2_
M_2^WKIZYCX@_\BO!_P!AC2__ $OMZ -2BBB@ HHHH **** "L+7?^1H\'?\
M88D_](+NMVL+7?\ D:/!W_88D_\ 2"[H ["BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KF/B#_R*\'_88TO_ -+[>NGKF/B#_P BO!_V&-+_ /2^WH U
M**** "BBB@ HHHH *PM=_P"1H\'?]AB3_P!(+NMVL+7?^1H\'?\ 88D_](+N
M@#L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8^(/\ R*\'_88TO_TO
MMZZ>N8^(/_(KP?\ 88TO_P!+[>@#4HHHH **** "BBB@ K"UW_D:/!W_ &&)
M/_2"[K=K"UW_ )&CP=_V&)/_ $@NZ .PHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *YCX@_\BO!_V&-+_P#2^WKIZYCX@_\ (KP?]AC2_P#TOMZ -2BB
MB@ HHHH **** "L+7?\ D:/!W_88D_\ 2"[K=K"UW_D:/!W_ &&)/_2"[H [
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2+[6M<TRX@TRY>Y6&TTJ2!I&:"6$ NUPX  E)^[V% '6T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8 E&_=QK&1C! V\9P<FHS\*;Z_TG6E\2^*YM8UC4[ Z='J$EDD2VT).<+$A
M))Y)SS@5U6L^&?[7^']UX9^U^3]HL#9?:?*W;?DV[MN1GUQG\:4O@:6__#_\
M"_GY%1^-7V_X;_@_(\D^'?Q&UW5_%6E6T'C3_A,8+B%WU*V_L+['_9V(RP/F
MA0&^8;?>NGTGXQWM_P"$5\077@^YMX+N2.VTR..]CD>_N&=DV*, HHVYW-CO
MQQSZ)INF_P!G^'[73/-\S[/;);^9MQNVJ%SC/'3IFN/M_A;%#\,]-\*MJ\RW
M.ES"YM-3@A"/%,'9U<(20<;B"">1Z54FKNWE^>OX;7)C>ROO_P #_/>Q'#\3
M=2&CZL^H^$KBRUG1A'/?:6;Q)"+9R?WL<B@B3 5CMP.1C-/3XH&73HM9BT<M
MH$^K1Z?#J!N<&2-CM^T;-GW/,PHYY'/M4<7PQU&32=234_%MQ>ZMK!BBU'4_
MLB1,]LA/[F)%($>02-W/4G'I4UGP9'X7^&_B+0[66^O]-OBQTG3[2QDFELI2
M-RJ&7/R^8 P+!0O<TFTM7_6U_OZ?/R&E?1?U_P ,]?2WF=AX;\3_ /"1ZAK<
M<%IY=II=Z;*.Y\W=]H=5!<@8&T*QV]3G!Z5Y9H_Q.\2VR>-/[8O$NWA%PVB#
MR%4JT=PT C^51N^9HNN3S7IOP_T&?PWX%TW3[XEK[RS->.3DO/(2\A)[_,QK
MF#\&K62^TFYGU5G;3M9N-3(%OM\Y99!)Y)^?H&53GG..E'*E/E>UK/\ #5?F
M)2O&Z76_RUT_)&?X<\>^+[3X81:E>Z6OB?5([ZYM[F9[RVT^-%BD9<DM@=!P
M IZ')%)!\6M<UOQ)X-_L#0%?1];@EEN&>[C#J4;;( ?2/[WJ^0!C!J\WPAO(
M?[/DTOQ;<6%S9WEW.TL=E'('CN)-[*$<L%<= _/TJ;3_ (3W&E0^%5T_Q))%
M)X>DG!D:R5_M<$S[GC8%OE8CC>/<@#LT[N[_ *T_*]O,'IHO/\_S_ J^'OCC
MIFO^*UTM+&**SNGDCL+L:E#)),R GY[=3YD0.TX+#GCIFJL'Q9UC6/"%GKS>
M&[K1["ZO[:W@N(]0A<SEYC&X"M$Q"C R2JDYX(QFKOAGX+6OAGQ,;^VU*UET
M^(NUK:/HMKY\1;/6ZV^8P&3CD'H,U?A^%WD_#?1O"?\ ;&?[+O8KO[5]E_UN
MR8R;=F_C.<9R?7%$;:7\OSU_ <NMO/\ +03Q%\3+WPSXRL],U+PR8])N[J.T
MCU,ZG!O9WX!%N"7*Y[G'&3CUYZ'XMZEH?A6[O=2MEUB[D\17>G6JS7,-C#''
M&25#S, JX4'!/)-:=Y\'[NYUN[NH_%UTEC/JT6K)8O9QN!*KAB&DR'9<#"C(
M"\=<5?7X;ZK9>&;[3-$\6&PFO-4GOVF.F0SH1*V[RVCDSG'9@5^G:I7PZ[__
M +/_  ?D-_%IM_P)?\#0Z?2M8U'4?":ZG+HQM;]H6<:>;N*0,X!PHE0E2"1P
MWOR!7EG@SXH^*7\,OJ>NZ3=:GJ>JZ@]IH^G17%ND<K(7+A2J QJ@7!:1FSC(
MKTCP+X/C\$>%DTB.[-XQE>:6;R5A5G<Y;9&ORHOHHX%<]#\)VMO!NGZ79:_-
M:ZII=[->V.JQ6RYB>1G)!B8D,N'(()Y]J;MS/Y?GK:XE\/G_ ,!_\ JW?QBN
M+33( _A.Z&N?VK'I5UI#7<8>*21"ZLLF"KJ1C!^4=>F*V_&GBGQ#H'PGNO$-
MMHL<6L0VPEELY+E76U)^\2PP'V]<#KCBLV+X3MMT^YO=?FO=5BUF'5KZ_FME
M!NWC0H$"*0(UP>,9Q[UV'BG08_%'A34M$FG:W2_MV@,J+DID=<=Z4OA=M_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV#YO]G:?_:W_ #Z_;W\C[V/]=Y.[[O/^KZ\=/FK-^W>-_P#H7O#_ /X/I_\
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M<^(X[6T;3-*TNXN'3-U'<:G)"D38'",('+C.[DA.@XYP*7V[QO\ ]"]X?_\
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ME%9ND3ZY-YW]O:=I]EC;Y7V*_>YW]<[MT,>W'&,9SD],<YOV[QO_ -"]X?\
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MBOWN=_7.[=#'MQQC&<Y/3'.;]N\;_P#0O>'_ /P?3_\ R'0!TE%<W]N\;_\
M0O>'_P#P?3__ "'6EJ\^N0^3_8.G:?>YW>;]MOWMMG3&W;#)NSSG.,8'7/ !
MI45S?V[QO_T+WA__ ,'T_P#\AUI:1/KDWG?V]IVGV6-OE?8K][G?USNW0Q[<
M<8QG.3TQR :5%<W]N\;_ /0O>'__  ?3_P#R'1]N\;_]"]X?_P#!]/\ _(=
M'24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?1O_  81?_%5YO\ \,N^ _\ GXUG_P "D_\ C='_  R[X#_Y^-9_\"D_^-T
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M?1O_  81?_%5YO\ \,N^ _\ GXUG_P "D_\ C='_  R[X#_Y^-9_\"D_^-T
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M?1O_  81?_%5YO\ \,N^ _\ GXUG_P "D_\ C='_  R[X#_Y^-9_\"D_^-T
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M?1O_  81?_%5YO\ \,N^ _\ GXUG_P "D_\ C='_  R[X#_Y^-9_\"D_^-T
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M?1O_  81?_%5YO\ \,N^ _\ GXUG_P "D_\ C='_  R[X#_Y^-9_\"D_^-T
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M?1O_  81?_%5YO\ \,N^ _\ GXUG_P "D_\ C='_  R[X#_Y^-9_\"D_^-T
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M_P#\>H_X0S3?^?[Q!_X45_\ _'JZ"B@#G_\ A#--_P"?[Q!_X45__P#'J/\
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MUY_,2N%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\(_:O\ ^1#T7_L)_P#M)Z]WKPC]J_\ Y$/1?^PG
M_P"TGH ]WHHHH *JZG_R"+S_ *X/_P"@FK55=3_Y!%Y_UP?_ -!- 'B'[,'_
M "3'4?\ L,2_^B8:]FKQG]F#_DF.H_\ 88E_]$PU[-0 4444 %%%% !1110
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M?S9$1"VPISA8QC)XRWMAFF_#:VT6]M[G1=?UBQ,%LMH(X_LSJT*R/(J'?"Q
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M*MNL1O\ DJ>B_P#8%U'_ -'V5 '74444 %%%% !1110 4444 %%%% !1110
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M"PBABCL;B*&&-X5BAU"XC0QLY=HV59 &3<3\A!7'&,<4WKM_6C_6S$OZ^_\
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MRT: S>4UEJ=S;E!*X>108Y%PI8 [>@[ 5=?P;H<FJQZB]I(UPC(YW7,I21T
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M?_T$T >(?LP?\DQU'_L,2_\ HF&O9J\9_9@_Y)CJ/_88E_\ 1,->S4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6(W_)4]%_[
MNH_^C[*MNL1O^2IZ+_V!=1_]'V5 '74444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5X1^U?_P B'HO_ &$__:3U[O7A'[5__(AZ+_V$_P#VD] '
MN]%%% !574_^01>?]<'_ /035JJNI_\ ((O/^N#_ /H)H \!_9NT_P 07?PX
MOWT75M,LX!JT@:.[TV2X8MY,.2&6>, 8QQ@]#SS@>N?V-XT_Z&/0?_!%-_\
M)=>??LJ?\DLU+_L-2_\ HB"O;: .3_L;QI_T,>@_^"*;_P"2Z/[&\:?]#'H/
M_@BF_P#DNNLHH Y/^QO&G_0QZ#_X(IO_ )+H_L;QI_T,>@_^"*;_ .2ZZRB@
M#D_[&\:?]#'H/_@BF_\ DNC^QO&G_0QZ#_X(IO\ Y+KK** .3_L;QI_T,>@_
M^"*;_P"2Z/[&\:?]#'H/_@BF_P#DNNLHH Y/^QO&G_0QZ#_X(IO_ )+H_L;Q
MI_T,>@_^"*;_ .2ZZRB@#D_[&\:?]#'H/_@BF_\ DNC^QO&G_0QZ#_X(IO\
MY+KK** .3_L;QI_T,>@_^"*;_P"2Z/[&\:?]#'H/_@BF_P#DNNLHH Y/^QO&
MG_0QZ#_X(IO_ )+H_L;QI_T,>@_^"*;_ .2ZZRB@#D_[&\:?]#'H/_@BF_\
MDNC^QO&G_0QZ#_X(IO\ Y+KK** .3_L;QI_T,>@_^"*;_P"2Z/[&\:?]#'H/
M_@BF_P#DNNLHH Y/^QO&G_0QZ#_X(IO_ )+J32O#>M1>*H-9US6+"\^S64]I
M%#9Z<]O_ *UX7+,S329QY(   ZFNHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\(_:O\ ^1#T7_L)_P#M)Z]WKPC]J_\ Y$/1?^PG_P"T
MGH ]WHHHH *JZG_R"+S_ *X/_P"@FK55=3_Y!%Y_UP?_ -!- 'CG[*G_ "2S
M4O\ L-2_^B(*]MKQ+]E3_DEFI?\ 8:E_]$05[;0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 55U%+Z2PD72KBWMKKC9+<V[3(.><
MHKH3Q_M#^E6J#R*3V \UT+QOXDO/">F:A?2:3+?:W>FQL88K.6*.!E:0,\A,
MKEQMC)"C;SQGG(Z;0];U%O$5_P"']<-K->V=O%=+=6D+11RQR%E V,[E6!0C
M[QSP>.@+7P-IEIX5MM"BFN_)M)S<6]QY@$T4F\N&#  9!8C!&"."#S5W1O#D
M.D7%S=R7=UJ.H7859[V[V>8ZKG:N$5551D\!1U).2<U3Z_U_6O\ 78_K\?\
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M=O+@D!02$*[,]\]JDTWQ1XEU"\US2H)-'N+W2_),E[#;S&"%GW&2+8&+2R(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7A'[5__(AZ+_V$_P#VD]>[UX1^U?\ \B'HO_83_P#:
M3T >[T444 %5=3_Y!%Y_UP?_ -!-6JJZG_R"+S_K@_\ Z": /'/V5/\ DEFI
M?]AJ7_T1!7MM>)?LJ?\ )+-2_P"PU+_Z(@KVV@ HHHH **** "BBN-\0VNL?
M\)AI4%EXJU2QMM1>4/!##:,L6R/<-A>!FY(YR3UXQ0!V5%>;:?\ $/4M)T7[
M1XBL6NX3]L,%U#*&FG,,Q0*T2Q@+D%0"I)..0*Z+PWXMNM:TN_N+_1;G3I;(
M;MLD4Z1S#:3\C30Q,>F#\G!]:'9)OL):V.GHKB;KXA316^F-:Z.)YM1M;.=(
MVNM@4W$@3:3L/"YSG'/I56]\>:Q/IE];Z9HL*ZK9P73W0-[F.#RB5#1L8_WI
M)Y 94'!R1QD>E_G^&X1:E:WE^.QZ!17FUA\5+B?.S0+V[M88I%DO4@G ,L<9
M+%CY'E*A92NX2$@D?+Z79/B%J=G?:=%J?AZ&U@O(XI6N#?ML59'VJ%=HEC9Q
MD%D+J>1MWT[:V"^ESO**\^M/B#?OI0N;72#>P6R1&\FGO5CD5I7*J%58@KX'
M)/R]L!CFGO\ $R>TM&OM2T/RK)UNOL[6]T9I96@DV$&,(,;N",%CVQZKI<?6
MQWU%<)I_Q U74?*M(O#$L.J33%(X[IKBV@= FYG$DUNCDCI@1]2.<<TA\2:X
M/ASH>J1D/J=W>VT4J-L4.'F"LA.T@<<9 SW%'6WI^(KJS?:_X'>45YQ<_%6[
MM[AK*+PS<7>HVI?[;!:?:+A4"N4_=O%;MN)VG&\1CU(JQ??$F]M(I)8_#S2)
M)?/8VBB69Y))$!9B\<4#NBA5[!CG@@#YJ-U<;TW._HKS:+XB:M]KU'4)='N(
M["RTJ&\N+*ZS;R08EG61E#QAW)6,%0P4$#^$G!Z32_&"ZIK$&F)9[+HM<?:D
M\W/V=8BH5NG.\.A XX8^E5RO8'IO_74Z6BN$U7XE-I>OO8MI236VZ>*.>*Z9
MF,D432$,!&40'81S)OS_  <'#'^(&M1ZEI^ER>&;==1U+8]K'_:?[KRVCD;+
MOY658&/!4*P^8$%NE2M=AM-;_P!6.^HKS]?B=//;7T]KH6]-'A:75P]X%,&U
MY$98OD/FD&)SSL&,<Y.!"OQ(OHK._FMM)^W0V"75U<2W%ZL;+#%<21D(%BP3
MA,J#CT+9^8OE86=K_(]&HKS=_B%KNGI?RW6BP74*ZE-##*+ITCBB1%8"1A"0
MK'/&[Y2<@N,#.YXC\2WMD_AFXTBUGOH]1NBLEK:- SS(;>1P SN$X*J<AAG'
M!.<$2NK^GXDW_7\#K**\Q/Q,U2SU/5+6;0[V6\:_,=K831LS6\26\+MN-I'.
M3EI,@X;[V"1TJ1_B9?6UQ.1I%[-/=/ +73YK:97M@8 \@D$4,D@P?]@\D=!2
M>BOZ?B4TT['I5%<$GQ&OI=TJ^&Y(;:WBMI+O[7.T$T0F=DPL31Y)!7/S%<@Y
MXZ5OWNI7<7C[2=-CEQ:7%A=32Q[1\SH\(4YQD8#MT/>G9WM_6BN)6EL;U%<O
M\06U*T\'ZAJ>D:S=Z9<:?:RSJ+>.!UE(7(#B6-^./X<=:S[KQ1?^&A>VVVXU
M^/2K1;[4;V]GB@E2)]V%C2*(*Y 1C@[.WS$T)7 [BBO-K[XCW\+6^JRV*VVC
M17=[$XBF\Z:Z%NDW\!C&S+1J1AB>QXZZ&E?$6XN60ZQH%SI<'GI%)=3)<1Q*
M'5BA!G@B+'<H4@# +KR<T6L*^K1W-%<S/XNEC\&V6MI81++?;?(MKBZ\L8?)
M4LVTM]T9(56(YX.,US\7Q3N[G29;^T\/*R6EG-=WJRWC1&-8I7C=4#1;F/R$
M@,$ST.TT6=[%)-JZ/1J*X5_&&JZAXBT9=.M$M]'GU:6RDN#,&DF\N&4LIC*?
M(N]!A@Q)V] #S0O_ !OJNB^-_$T%[()].CMU73(=B@K<K$C^7G&6+F48R3]T
MTK,+?U\['I-%>5:;\2=7T;PG9/KL$.KWL*.=1N$E\MR!/)'E(HXV[(3E_+7
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MJA0%RQ88VY.?EP3G&A<^/] M].^U">X=R746_P!BG$RL@!;?'LWQ@!ERSJ
MP)/(I/1<P):\JZ/\=R'PUX"L="A9[N0WU_(9O,N-TBC$H0. &D=N?*3EF9L@
MG/-6XO _AZ&[M[B*Q93;K&$C%S+Y3&-0J,T>[8[*  &8%A@<\4R]\7Q6'P_B
M\4W%G,R26L5Q]FA5I6!D"X7Y5).-W7%6+;QAHEUJR:;#=R?:78HN^VE1#(%W
M&/S&4+Y@ )*9W#!R.*I\U^7JOT)335UL_P!2K'X#T>RF\_2%N+&XRBB1+N9@
MD0E60Q(I?"(=F-H 49/&"0=/5/#VE:U=V-UJEFMQ-8.SVSLQ'EEE*-T/.02,
M'(_*I;O5[&QN##>7 B<6\ES\RG'EIC>V<8XW#CKS6-<_$'P_ )PMS-+)%&[A
M4M)MLC*A<Q*^S:9 H),8.X8.1Q4-Z:[%ZW]21? 7AM-)@TV/3?+M+>U^R0HD
M\BF./>KX#!L@[D5MV=P(ZU=M?#6DV7V4V]J5-I<2W,):9V*R2[O,8DDYSO;K
MGKQ6=8^/M$N[?3VEDN+>6]CB?:]I-M@:0#:LC[-L9)( WE=V1C.16QJVLV.B
M6J3ZC)(JR.(XTA@>:21B"=JH@+,< G !X!-6[K<E6:T]?Z^12OO!^B:A+++<
MVD@EENA=M+%<RQ.)1&(]P9&!7Y %(! (SD')IMEX*\/Z?<6LUGIXB>T*& B5
MR$V+(J\%L<"60<_WO88BTKQKINM>(O[*TY+B4&R6\6X-O(J$%V0H25 5@5.0
M2#G(QD'%#6OB-9:+XJ;19[&[=HVM]\RP2E<2[_N[4.XC8,*#EB2!RII:JW]>
M0WK=]OZ_4NW/@C3;_P 576M:EON?.C@1;?>Z1CRBY&]0VV098$!E(!&:DC\"
M^'(_M0&G;DNH9+=XI)Y'C2.3[Z1H6*Q*W<(%S@>E-?Q[X=2SANC>RM%,&8E+
M.9C"JL59I5"9B 8$$R!0"#GI6Y<7<%K8RWDTBK;Q1F5WSP% R3^5)Z+4%>^A
MAP^ ?#-O#/'#I4:+<6T%K(1(^?+A_P!4 <Y4KV88;(!SD"K6F^%-'TFZBNK*
MV<7,2R*)Y;B261O,*;RS.Q+D^6G+$D!0!Q5&Q\<6$GAZ+4]6AFTUWN/LK6I1
MII%E/*IB,$DLN"!CN*;_ ,+'\+DH!J$IW(KOBRG_ '*EV3,OR?NL,C*=^W:1
MSBJ]ZXM+>7]+_@&AJ/A/1M5U1-0OK1GN%"AML\B)*%.5$B*P63:>1O!QVJ;_
M (1[2O['N=+-HK65U)))-$S,0S2.7<Y)R,L2>.G;%0MXLT1($GDOU2)YIX0[
MHRC?#N\T$D<!=C<G@XXS5!/'>FW5_IUKIJ33/=W@M9%N();9X089)5?9(@9E
M/ED ]#S@\8I6;T*U_KR_R'-\/O#CQ1I):7#LCLYF>_N&FD+*%8/*7WNI55!5
MB1@ 8X%+#\/O"\%QYT>DIN.P,&E=E?9&(TW*6(;:JC&0<')'))I/$?C!?#OB
M30-,FLC+#J\KQ/<B3:+;&T*2N.0S.J]1C/>J-C\2=/N-8URTN[:6"#2[E+:"
M6)7N'O6(;=LB1"QVM&XP-WW2> *-U?\ K3_AQ/2U_P"OZL:$/@'P[!&$CLY\
MK)')'(U].TD93.Q4<ON1!N8;%(7#$8P32-\/_#9MU@6RFC1(884\J]GC*K"<
MQD%7!#+V<?-CC.*?+XZ\.Q1P2-?2,DR>86CM97$*[BN92%/DC<K#,FWE2.QK
M,L/B?HUU ;F[\RQMU>:,^?!.)"4N%@!"^7RI9UYSD$XQPV#5NW]:!?3^OD:2
M^ ?#:I$B6#JL7F;0MU*-V^02MNPWS?.-WS9P>F*5O ?AQY+IGT]F%TKJ\9N9
M3&@<Y?RTW;8]QY)0+GO36\?>'4M([AKN<!Y'C,7V&?SHRF-Y>+9OC"@@EF
M# D\BM8ZSIXT,:R]TB:>T N!</E1Y9&0W/(X/3K1JM1:/YD$NA0?VHE_:R26
MTK3K-<[)'Q<;8VC56&[&!D'&"/E'&>1J5R%W\1=.%UI-MI<%S=S:CJ"631RV
MMQ UOE2Q=U:+<ORC(# !NN0H9AU](KL%%%% @HHHH *\(_:O_P"1#T7_ +"?
M_M)Z]WKPC]J__D0]%_["?_M)Z /=Z*** "JNI_\ ((O/^N#_ /H)JU574_\
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MF4K_ *P?O%9VP_3! *'&:[FH!?6S:BU@)5-TD0F:+N$)(!_$@_E2Z6'Y^G_
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M7(STW ?A6L3@9/2LG1/$NF^(E=]*^UO&@#"6:QGACD!Z%'D15<<=5)_6ENK
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MVV/^OU_4****0!1110 5X1^U?_R(>B_]A/\ ]I/7N]>$?M7_ /(AZ+_V$_\
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ME:U>WTB?[3&!HSB:4K(,ME!L:(@Q[FPFT@ 5[#15N;;N*UK>2M^O]=#QK5/
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M8088LR_>/&,Y/ %9(\&WTES'>V_A41Z!OA:Y\.>= ?MK*DH:;;O\ILL\9P[
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MK&ZCY0  =JD@<PZW\.-3EUR]$&F73Z)]ID:PLM.:Q"P,T<7[[;<*RH-XD^9
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M&T^XM'E,[6\MJC1M(3DN5(QN)).>N34TNCZ9/;7%O-IUI)!<J$GB>!2LJ@8
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M(QQA)_AKH]U/,UW=:A/!.Q=[>6<,I8V_D,V\KYA)3&26ZJ#QSEJVM^WXZ?\
M!)EY!)\1+:&XBLYM#UB/4YI4CCT]DA\U@Z2.C9\W9M(B<<MD$<@4R#XFZ3<Z
ME8V,%EJ#SW2!W0)'NM\RF+YDW[FPZD$QAPO4D @U;M? EG#JMKJ=WJ6HZA?V
MTR2+<W3Q[F5(Y$6,A$4;0)G/ !).235>7X<:9,((WU#43:QRF5[5I(VCE8S&
M4'YD)0AFZQE"0!DG H]VZ!WZ=OQ.AU?58-%L/MEVDC0B6.-C& =F]PNXY(^4
M%@2>PS7(R?%32KFW0Z9'=F5M0-F=UNKXV3QQ,Q'F+A6,J[6S_%G:<8KII='D
MU/PS=Z5KERTWVM9HY)8B%94=FVX( Y52!G'49K!M/A9H-D[/#+>[VCLT+-*I
M_P"/9E93]WJQC3>>^T=*4;<VNW]?U\ROZ_K^NAF6'Q1O#%]KU7P_>1VB64EU
M,(!$SPHDSH9&/FX*A5Z#+$@X!%==K/B2+2?LL4-G=:A=7:L\5O:JF[8H!9SO
M91M&5[Y.0 ":S8_A[IL=CJ-HU[?R0WUI+9D,\>88I'9R$(0="YP6W>^:TM6\
M-PZJ;21+V\L+FS5DBN;1D#[& #H=RL"#M';(P""#4OX//_A_^ "M?^NR_6_X
M'&Z+\7(9-%M+C5K6:XO;KRPMO90I%@FVCF?:99OGQYG &'/0*VTL>FNO'%E;
M7UQ NG:G<16D6^YN8;<&.!C%YH1P2&#%>^W:"0"036=!\+M,M-)-A9ZMJT,;
M%?,/F12>:HA2':R/&R-E8U.2NX$G!&<5;;X>Z<K.EI?ZG9VDL"PS6EO< 1S;
M8O*5F)4L2$P,;MIP,@XJZC3;Y?Z_K\_(?NW\C-N/C!X?L;RWM=3@N;"694D*
M74ULCQHY_=N4\[>P;KA S ?>"TS3?B:9$\S5].N;1F>XCAM4B21[ADN5@0*R
MRD DL%(( SD[@H!.\_@Z 7T5Q::KJ=BHBBBN(K:5%6Z$?";SM+ XXRA7(X.1
M5%_AKI3R2.U[J&2\LD&)$'V5WF6?<A"9XD7<-V[J0<CBCW;^6OW?YF?O<OGI
M_P $23XCVB7'V--#U>74$69I[%$A\R#RA&S;B90GW948%6((Z'/%/E^(^D0Z
MCI]NUO>"'4#$L%VPC1&:1=R*%9Q(V01DJC <Y(P<6++P+86>HMJ#WE]=7TD4
M\<]Q.Z;IS*(PS,%0*"!"@ 4  9XJA%\+]+@EB,&IZG'#');R^0&AVM) J*K%
MO+W<B-05W;>X /-+33Y?\'_@%/;3S_X'_!)K+XCZ?>:7)J$FF:G:0_8TO+83
MI%NO(V.T>6%D/.XJ,-MY9>QS5[Q3XQM/"5LD]_9W<T11I)'B,2+"BXR6:1T7
M/(^4$L>P-9ESX"22[\*VD6PZ7X> 82R3$SS%5 2,J%"E=RHY.>J+A>XTO$7@
MVT\1WD=S/?7MHZV\EJ_V8Q_O(WZ@ET8J>.JE3[T2M]GS_P"!_P '\!Z7_K^O
MZL,E\<6'V&6XM;:ZN"MV+-$55!DD,0E&-S# ((&3CG\ZY_0OB?=7:1SZOH=U
M#;/965P\D"HPMS.6&YSYG*$A<!06 /(';9@^'EA!>1RKJ6IM#'-'<?93+'Y;
M2I$(MYPF[)4#(SC/( -+8_#W3;'2IK 7M_/%-#;P;I7CW+' Q:-1A .,XR02
M0!WR2]+/Y?\ !_$S][3^OZT_$AN?B7I=I"UQ-IVIBT=F2TN1$A2]96VL(QOW
M<<GYPN0"5S5";XCWT&MBT_X1[4)E6XDCG@5(!-;A+9)MN?M!5S\^<CMQ@D9.
MC)\-]+FQ'-?ZC):0R&2TM&D3R[1BVYMGR;CGD?.6P"0N*N3^#[8:Q)K%I<7*
MWQNS>!/,01NWD+"8SE&(0JHR1\P/(/:IV1HNI?T_Q!9ZI=7,5B))4MX(IFF5
M0482*651@Y+;0"1CHR^M<TWQ7T6*.\-Q9WMO-;>21!*]NKR"5MJ'_6[8\GM*
M4([BM'P=X03P]X5GTVZV>=>RRS7(AD9D3?P(T8@':B!4!P.%' Z54M?AK:6D
M6(M=U@2"W2VCD#PKL16W*-JQ!&[@[E8,#\V>*;^+R_JY.MBWK/B^6S\$1Z_I
MVE74TDDL,8M)55)%WRK&<Y8*<9X(8@\$'!S4EAXWLK_5(;5;*^AAN9Y+:VO9
M400SS1AM\:X8MD;'Y*A3M.":<G@K3XO![>'HI[F.%I/.-PA02B7S/-\P#;L!
MW\X"[>V,<4W3_!%EI^IPW2WU]/#;3R7-M9RNAA@FD#!Y%P@;)WOP6*C<< 4]
M+CZ>9'J/CW3M+\1)I%Y:7D;2.8X[@^4J2.$W[54N)&X_B"%<\;JBT_XB6%]]
MF,NF:E9)=);R0O<QQ@-',=J2?*YP-V%(.#DCC'-+=_#VPN]7FOFU+48UFNA>
M&VC:(1B7;M)SY>\@CL6('8"H]9\$;_#DMEHQ$ERVEII4;7DY1(XU/$N43)=?
MO#& 2!RO6I6VO]:?YZ>@/?3;_@_Y:^IK#Q/:OX?N-7AMKN:"&9X52.,%Y2DA
MCRHSC:6!^8D#')P.:PH/BCIMY&@L-)U.\N#]H\RWMS;NT1@*>8"XE\LX$BGY
M6/<=>*V)_!]C<>#;;PX9KB*WMDA$<\94R!HBK*_S!E)W*"=P(/<54TSX?Z?I
MFH27HO\ 4+F>5)U=IWCP?-6)7.%0 ?ZE< <#)XQ@!Z7?X?I_P1JSM<IWGQ$C
MFELAH-A<W-O/>6EO+?/&H@3SBC;/OA]^QP<[2H) )SQ6EX@\;V'AO4X+34+6
M[V2M&K7*^6L:&1MJCYW5G.>T:N1W JK!\.M/M7M!:ZEJ<-M;R6\S6BR1^7-+
M"%5)'RF[.$4$ A3C.,\U-K?@.RUS59[V74=0MC<I$DT5N8@KF-MR'+1EA@]@
MP![@TWR]._X:?\$S7-U[?CK_ , K>$/%U]K^KWUK?16T<=O;B56B5@<_:;B+
MG)/&V%3]2?8"IJOQ.BM]#FO=-T;4)3)"9M/DE6-8[U RJS(?,R -P.'V$CD
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M %%%% !1110 4444 %%%% !1110 5X1^U?\ \B'HO_83_P#:3U[O7A'[5_\
MR(>B_P#83_\ :3T >[T444 %5=3_ .01>?\ 7!__ $$U:JKJ?_((O/\ K@__
M *": /'/V5/^26:E_P!AJ7_T1!7MM>)?LJ?\DLU+_L-2_P#HB"O;: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\(_:O_ .1#T7_L)_\ M)Z]
MWKPC]J__ )$/1?\ L)_^TGH ]WHHHH *JZG_ ,@B\_ZX/_Z":M55U/\ Y!%Y
M_P!<'_\ 030!XY^RI_R2S4O^PU+_ .B(*]MKQ+]E3_DEFI?]AJ7_ -$05[;0
M 4444 %%%% !117GGB;3A_PLJTV7^K1)-I5Y=O##JUS'$98FA"'RUD"@ ,W
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M*2.B/"?-PB-M#<[^X!.0:Q4^*.H:;8^(]0AU_3M4N6O(TLC' TMI*1:J[11
MW $9)S_&Q)!PK$XI=+_UO8JSOR_UM<]SHKRN#XF>()+QKA;&RN;)YI8(+2&-
MQ.S+8BZ!WERIR25QM[@Y['/OOBWK]MI]DUC_ &'J37$K*;R',-ON$:,("TTR
M(LA9F7*R.1M/R9RHIQ:=GY?B3%J2NOZL>R45P_Q&\9:UX0T"RU#2M,CNY;MC
M;B!D,A6X=?W(^5A\I<;3]1@UQ%]\1?$&M:"=6LS'I2W&FSW-O*R2YCBCN($9
MF3S N>9#NQD#&".<I*[M_7<&[)/N>WT5YIX0\2:XWBV2SO+ZSU#3;_4;Q('1
M'WQ^6B,"KF1E\LY.% XX^8UEZWKOB<_$*XTVQUVV@>/78$MK:6!R%@:R=R75
M95,B%@?3YESGC 7;S5_R_P QQ]Z]NE_P/7Z*\JT/XH:[J_B?0; Z9910:A:6
M\\H:6-'?S%8N\6^968(0/E6-SUR1@9]5IM-!UL%%%%( HHHH *\(_:O_ .1#
MT7_L)_\ M)Z]WKPC]J__ )$/1?\ L)_^TGH ]WHHHH *JZG_ ,@B\_ZX/_Z"
M:M55U/\ Y!%Y_P!<'_\ 030!XY^RI_R2S4O^PU+_ .B(*]MKQ+]E3_DEFI?]
MAJ7_ -$05[;0 4444 %%%% !117%Z[\4-)\/:CJ5K?6%_LTUX8I;H- D+22@
M%$#/*N#@DDL HP<D<95P.THKCK'XFZ-JDMF-+M=0O8;B".XFGMH5D2T1V95,
MN&SC<C E0P&,D@<U6/Q8TC[''-'IFJ2/<&!K.!4A#W<<[[(Y4S( %+#^,JP[
M@55F'2YW5%>?Q_&'2)K=7CT?6#++Y(@@,<(><R2F(;<RX&)%*G<1ZC(YH7XR
M>'QI=Q?75GJ-G'##',BW*Q(9@\IBPI\S:N) 5)<J!C.<<T@/0**X2V^+NA7I
MM6L[34+BWG2%I+F)8FCM_-F:!0Q$G/[Q2/D##D$9'-0#XH&X\31P6>ES-I)L
M;JX$TAAC>Y:&:./,;-*%"Y9O]9M/ QQU=G>WK^&H?\#\3M]5TJSUO2;C3=4A
M\^TN4V2Q[BNY?3*D$?@:M@!5 '0<"O-S\68KY8[G2K"<:=+IWVO[8Z1R[&^T
M>24*+,,\@C*DCD$$@<Z5W\5-%L_M+R6>H-#&95@F2.,K>-%((Y5C&_.58X^8
M+GG&:-?Z\M!73_KOJ=M17#S?%32;:6RANM.U"WGNKJ6T,=PUO$(9(R RM(\H
M0GY@0J,S$9P.*UO$?C73_#-PL-U;W=RRV[7<YME0BVMU(#2ON894$]%W,><
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MD\G)KB(_'>LZ;';IX@DL97N[2TO(9K&Q=0BRS)$T;1M,><N,/N'<[3C!=/\
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MU4@UM44 8-SX)T&\O+2ZO+.2XFM41$::ZE?S AW)Y@+8E*L207W$'D<U%;^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAO/>ZJ+^2]#E8WL[9S=!"P&\QR6T>6&23B#D#A2:P]%USQO+]E&KC5(I5<K
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MHI#"BBB@ KPC]J__ )$/1?\ L)_^TGKW>O"/VK_^1#T7_L)_^TGH ]WHHHH
M*JZG_P @B\_ZX/\ ^@FK55=3_P"01>?]<'_]!- 'CG[*G_)+-2_[#4O_ *(@
MKVVO$OV5/^26:E_V&I?_ $1!7MM !1110 4444 %<9K6J:G:^)6FCU61-/MY
MX(7AMEMY8HR^,BX5L3*6+*%*'C<"5(S79U0GT+2;K58=3NM+LIM0MQB&[DMT
M:6/_ '7(R/P-'4.AP\?Q(U.TTK19-1TVQGN+]HHIQ;7<K&!Y7*Q$@0;0IQD[
MF7H0-QQDT7XF:G=KIEK<^'I[NZFLX9;F2Q2>15>1-RX80^6%/&=[KMSP& S7
M8CPIX=6Z2Y&@Z6)XR2DHLX]RDOOR#C(^?YOKSUI1X7\/K-!,NA::);966!Q9
MQ[H@V2P4X^4')SCKDT^@/R*WA+Q'+XDTR6:\LUL+R"7RY[/=*6A. 0&\R*,Y
MP0>%(/8D<UO50T_0='TB*.+2M*L;&.)F:-+:V2,(6^\0% P3W]:OT.P!1112
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KPC]J_\ Y$/1?^PG_P"TGKW>O"/VK_\ D0]%_P"PG_[2>@#W
M>BBB@ JKJ?\ R"+S_K@__H)JU574_P#D$7G_ %P?_P!!- 'CG[*G_)+-2_[#
M4O\ Z(@KVVO$OV5/^26:E_V&I?\ T1!7MM !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %>$?M7_P#(AZ+_ -A/_P!I/7N]>$?M7_\ (AZ+_P!A
M/_VD] 'N]%%% $<MQ##)&DLJHTI*QAC@L0"3C\ 3^%9CZSIVK:3?C3;R*Y,=
MNQ;RVSP5.#[@X.#T.*DUW2X=2LU,UTUFT#%TN%*_)E2I!W @@JQ!^O&#@UCV
M.F"RT^X8ZC-JODZ<;>.YQ$(T51]W"<EC@$D\<#&.<BW!['GO[*G_ "2S4O\
ML-2_^B(*]MKQ+]E3_DEFI?\ 8:E_]$05[;0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPC]J_P#Y$/1?^PG_ .TG
MKW>O"/VK_P#D0]%_["?_ +2>@#W>BBB@#/UAM56WA.BM:+(95$IND+!4/!(
M9<D''?IGO51_[22QOX]5O;"=OLKE$MK=HF P>3ND;(_*D\3Z!)K]O:Q(]F4A
MF,CPWML9XI1L90"H9>A;(/J*S]&\.77A[P]>17<UE<N;0J]S#:NDT[!,;I':
M1BQ_E0@9Y]^RI_R2S4O^PU+_ .B(*]MKQ+]E3_DEFI?]AJ7_ -$05[;0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A'[5_\ R(>B_P#83_\
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MVU>UTNXCN66)[JSDN5D+1NNT*CJ<X)(.>W2LW08])%OJ*:+A&LM/^R706S:
M3R! WF'/7ACUYY-$=7_7]?\ #@]%_7]?\,<9^RI_R2S4O^PU+_Z(@KVVO$OV
M5/\ DEFI?]AJ7_T1!7MM !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>$?M7_\B'HO_83_ /:3U[O7A'[5_P#R(>B_]A/_ -I/0![O1110!C^)
M[E[;2?\ D#_VM!(X6>+(PB?WR,$D XZ GOVKGO"TTDNE>)-L8-MYK-'-]M^T
M[LV\?&[ ) &.22:W/$^IZGI,-I=Z9I]Q?Q+*PN8;=H5;;Y;;3F5T& ^W.#FL
MS2+2\M-,NW><W$5Y8-<7+E80%N2,, 8P,\>N?NCFB.[_ *\_T%+9?U_6YP7[
M*G_)+-2_[#4O_HB"O;:\2_94_P"26:E_V&I?_1$%>VT#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A'[5_\
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M_P"B(*]MKQ+]E3_DEFI?]AJ7_P!$05[;0 4444 %%%% !1110 4444 %%%%
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M=KD$QAA'G)QS7)>&OB%XTL_ACX:-S%IVK:]XCNFATV66214"8+%YSW(.?E3
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M52B[I=[?B["NM?G^"N?15%<Q\0?%S^"O"K:E;68O;J2>*VMH&?8KR2-M&6[
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M/'O4&@3-I'Q^\2:+"6^RZIIT.K;.-JR@^4Y'IN &?I3Y7S<O];7_ ""Z:O\
MUO;\STBBBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUOZ[_F%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:._Y_M*_[YM__B: />:*\&^R_M'?\_VE?]\V_P#\31]E_:._Y_M*_P"^;?\
M^)H ]YHKP;[+^T=_S_:5_P!\V_\ \31]E_:._P"?[2O^^;?_ .)H ]YHKP;[
M+^T=_P _VE?]\V__ ,31]E_:._Y_M*_[YM__ (F@#WFBO!OLO[1W_/\ :5_W
MS;__ !-'V7]H[_G^TK_OFW_^)H ]YHKP;[+^T=_S_:5_WS;_ /Q-'V7]H[_G
M^TK_ +YM_P#XF@#WFBO!OLO[1W_/]I7_ 'S;_P#Q-'V7]H[_ )_M*_[YM_\
MXF@#WFBO!OLO[1W_ #_:5_WS;_\ Q-'V7]H[_G^TK_OFW_\ B: />:*\&^R_
MM'?\_P!I7_?-O_\ $T?9?VCO^?[2O^^;?_XF@#WFBO!OLO[1W_/]I7_?-O\
M_$T?9?VCO^?[2O\ OFW_ /B: />:*\&^R_M'?\_VE?\ ?-O_ /$T?9?VCO\
MG^TK_OFW_P#B: />:*\&^R_M'?\ /]I7_?-O_P#$T?9?VCO^?[2O^^;?_P")
MH ]YHKP;[+^T=_S_ &E?]\V__P 31]E_:._Y_M*_[YM__B: />:*\&^R_M'?
M\_VE?]\V_P#\31]E_:._Y_M*_P"^;?\ ^)H ]YHKP;[+^T=_S_:5_P!\V_\
M\31]E_:._P"?[2O^^;?_ .)H ]YHKP;[+^T=_P _VE?]\V__ ,31]E_:._Y_
MM*_[YM__ (F@#WFBO!OLO[1W_/\ :5_WS;__ !-'V7]H[_G^TK_OFW_^)H ]
MYHKP;[+^T=_S_:5_WS;_ /Q-'V7]H[_G^TK_ +YM_P#XF@#WFBO!OLO[1W_/
M]I7_ 'S;_P#Q-'V7]H[_ )_M*_[YM_\ XF@#WFBO!OLO[1W_ #_:5_WS;_\
MQ-'V7]H[_G^TK_OFW_\ B: />:*\&^R_M'?\_P!I7_?-O_\ $T?9?VCO^?[2
MO^^;?_XF@#WFBO!OLO[1W_/]I7_?-O\ _$T?9?VCO^?[2O\ OFW_ /B: />:
M*\&^R_M'?\_VE?\ ?-O_ /$T?9?VCO\ G^TK_OFW_P#B: />:*\&^R_M'?\
M/]I7_?-O_P#$T?9?VCO^?[2O^^;?_P")H ]YHKP;[+^T=_S_ &E?]\V__P 3
M1]E_:._Y_M*_[YM__B: />:*\&^R_M'?\_VE?]\V_P#\31]E_:._Y_M*_P"^
M;?\ ^)H ]YHKP;[+^T=_S_:5_P!\V_\ \31]E_:._P"?[2O^^;?_ .)H ]YH
MKP;[+^T=_P _VE?]\V__ ,31]E_:._Y_M*_[YM__ (F@#WFBO!OLO[1W_/\
M:5_WS;__ !-'V7]H[_G^TK_OFW_^)H ]YHKP;[+^T=_S_:5_WS;_ /Q-'V7]
MH[_G^TK_ +YM_P#XF@#WFBO!OLO[1W_/]I7_ 'S;_P#Q-'V7]H[_ )_M*_[Y
MM_\ XF@#WFBO!OLO[1W_ #_:5_WS;_\ Q-'V7]H[_G^TK_OFW_\ B: />:*\
M&^R_M'?\_P!I7_?-O_\ $T?9?VCO^?[2O^^;?_XF@#WFBO!OLO[1W_/]I7_?
M-O\ _$T?9?VCO^?[2O\ OFW_ /B: />:*\&^R_M'?\_VE?\ ?-O_ /$T?9?V
MCO\ G^TK_OFW_P#B: />:*\&^R_M'?\ /]I7_?-O_P#$T?9?VCO^?[2O^^;?
M_P")H ]YHKP;[+^T=_S_ &E?]\V__P 31]E_:._Y_M*_[YM__B: />:*\&^R
M_M'?\_VE?]\V_P#\31]E_:._Y_M*_P"^;?\ ^)H ]YKP;]J]U'@;1$)&XZB2
M!Z@1MG^8H^R_M'?\_P!I7_?-O_\ $U%I_P (_'WC?QC8:O\ %W5[>6QTU@T5
ME;LI\S!!V[5 502!N/+$#'H0 >_4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>halo-20230324_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X2$*17AI9@  34T *@    @ ! $2  ,
M   !  $   $R  (    4   (2H=I  0    !   (7NH<  <   @,    /@
M$'X<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 #(P,34Z,#,Z
M,3D@,#@Z,#8Z,#(   *D(  "    (0  $%KJ'  '   'W@  "'P     '.H
M   (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                         #E&1#(V1C8V140X0C0V
M-40Y.$(X-35#,#!!-#<S,4(Q       & 0,  P    $ !@   1H !0    $
M !#, 1L !0    $  !#4 2@  P    $  @   @$ !     $  !#< @( !
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MH:";5;U?)V1CY8$/!+8Z<4 =7X?TF/0M LM,C.Y;>()N]3W/YUI4 %% !10
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M)I=[!#); )*DRDY7G.,>H)':NW'3F@!:* "D//6@!$547:BA5'0 8%.H **
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M@2&",855'Z_6O.48^-?BJ'7Y]*T-< ]5>7_]?_H- 'J(HH ** "B@ HH **
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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MHHH **** "BBB@ HHHH **** "BBB@ HHIC]!\K-ST4[?ZB@!]%>8>*OC/\
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M9O=75TR [3J.J2P_,EBJG^I_X<?"[X9_!_PY#X3^%7@#P1\-?"MIM2#P_P"
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(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>halo-20230324_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "& 18# 2(  A$! Q$!_\0
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M8UB36M,$EQ#]GO(G:"YB!R%D7AL'T[CV(IM6 UZ***D HHHH **** "BBB@
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MQ%K4GE6>FR!HK>$98B7[.O5O+PVU]^'8>E9EG\*_$?C3Q<WA6Z^)FIZ_I6C
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MZMINA6.@V]N;>UO(Y91,_P J!!\A(ZLH)R0.3CWKGOB7;M!X?T7X?:62+WQ
M?LLUQLY2V0+Y\A'NGRX/8D=J]BKA/!]JOB#QEK_B65/D@?\ LFQR/^649S(P
M[$,YX/HHJE(#S::YM]>\8V>I6R(UAHK?V7X7TE=Q668+L>[=?[B!75,\?NV;
M*X)I/@[8ZA>>)/&<"0213+K%Q;76J,P8F.-@,KE?]9*<Y[ )GK@'V/1_A[X>
MT#4/MVGZ7#;WFPQB;+,P4L6(!).,DDG'7O6U!8P6V_R8DB\QB[[% W,>K''4
MGUJN?2P'S?\ ##Q?=6]YX] +AX=2N[V\OXSLCL].A9U@@#-G=(0D@/H-QSP*
MZWX87VI>(O!^GZ;#=2_;]03^UM6U$ @A9W+)&N[/S&/ ]@H]>.^\3> [:]\*
M:YI6CVUGILNJ^8T[1PK&LLCG]X[[1DLW.6Y/-2?#KP0G@/PS;:<9Q=W> 9[E
M4V!VQ@!5_A10 JKV %)SN!S'@O3(-'^,'B6U0+&JZ59K;)OR1&I<-@'GKMR>
MY-;7BJ3_ (17Q-I_B)#BVNFCTZ_3< -K,?+DP<9*LQSU.#P.M6/$O@>YU+Q)
M::_H^J_V/JL5NUI)(UL)TFA+!MI4D8P1G.:MP^!["5Q<:F7UG4-C)]JO,$H&
M!#!% VH,''RC..I-3?J!T=%8BW\VA,EO>I)-9D[8KQ%+;?19!R1[-T/&3GJV
M^\86<.(K-9-4O&^Y;V@W$^Y)(4 =R34@5OB%J4UGX=FL[)/.U/4O]"M(LX^=
M^"Y] H)8GV]ZV-#TJ/0]'L=/BYCM8$A4^H50/Z5F:7HEU=:P-9U;R_M<:-%;
M6\1)2W5OO')^\S8 +8' Q70T %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 4-<O);'39FMEWWCCR[=/[TC<+^&>3[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I"<444 ,\T>E-\_P#V?UHHH E!R,TM%% !1110
/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>halo-20230324_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #,3@
M )*2  (    #,3@  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         #(P,C,Z,#,Z,#8@,38Z,S0Z-3, ,C R,SHP
M,SHP-B Q-CHS-#HU,P   $< 90!T &$ <P!E '< ( !9 &4 <P!E &< 80!T
M    _^$+(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T
M(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G/SX-
M"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z
M9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B+SX\<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M
M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(^/'AM<#I#<F5A=&5$871E/C(P,C,M,#,M,#94,38Z
M,S0Z-3,N,3<Y/"]X;7 Z0W)E871E1&%T93X\+W)D9CI$97-C<FEP=&EO;CX\
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D
M+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R
M;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^/&1C.F-R96%T;W(^/')D9CI397$@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS
M>6YT87@M;G,C(CX\<F1F.FQI/D=E=&%S97<@665S96=A=#PO<F1F.FQI/CPO
M<F1F.E-E<3X-"@D)"3PO9&,Z8W)E871O<CX\+W)D9CI$97-C<FEP=&EO;CX\
M+W)D9CI21$8^/"]X.GAM<&UE=&$^#0H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(#P_>'!A8VME="!E;F0])W<G/S[_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" %= ;D# 2(  A$! Q$!_\0
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M'Z@<&NYT7XV>(K JFJ16^IQ#J67RY/\ OI>/_'37'4RVI'X'?\#&6&DMM3Z
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MDG:,#GI6K10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M45Y=\3="TW6=2%K8?:KWQ3<B,6D:7#!+&,$;I"!PJXSUY)/%8/Q%\/:O!?:G
MJFIVO]JVL%C"MI?'4_(-A(J#<WEYRY9\D#'.: /;Z*\@OM.U6W&B>);DP7-]
M=+8/"C.WVIIEA(>!1MQM=FW,=P  )(-=+\/]7LKBZGB=;F75M01KV>^E11'=
M!'\H^7AB0B'Y5# ''..: .ZHHHH ***IZKJEGHNFS7^HS+#;PKEF;^0]3[4T
MG)V0FU%78_4-1M-*L9+S4;A+>WB&7D<X _SZ5X'X\^)-WXHF>RTXO:Z4#C9G
M#3^[>W^S^>>V;XW\;7GC#4]S[H;"$G[/;YZ?[3>K'].GN>7KZK Y=&BE4J:R
M_+_@GR6/S*59NG2TC^?_   HHHKV#Q0HHHH **** "BBB@ HHHH W/&W_'YI
M'_8'M/\ T6*YJNE\;?\ 'YI'_8'M/_18KFJ\RG\*/UG"?[O#T7Y!1115G2%%
M%% !1110 4444 7]&UN_\/ZG'?Z5<-!/&>W1AZ,.X]J^B? WQ#T_QC;"+Y;;
M4D7,ML3U]63U'ZCOV)^9ZFM+NXL+R*ZLIG@GA8-'(AP5-<F)PL*Z[/N95*2J
M+S/L*BN%^'/Q$A\76(M+]DBU>!?G0<"8?WU'\QV^E=U7S=2G*G)QEN>9*+B[
M,****S)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#F-:^'/A7Q%JDFHZQI7VB[D #R?:)4R ,#A6 Z"BX^''A.[NK6YNM&CFDM84
M@B\R5R B#"@KNPV .X-=/10!3?2K*75H-3D@W7=O$T4+ECB-6ZX7. 3@<XSC
MCI572_#&CZ->RW>FV?DS2J5+>8[!5+;BJAB0@+')"X!-:U% !1110!'<7$5I
M;27%S(L<42EW=C@*!R2:^=/B#XXF\7:L4MV>/3+=L01'C>?[[#U/;T'XUT?Q
M;\<O>7DGAW2Y<6L)Q=NI_P!8X_@^@[^_TKRROI\LP7LX^VJ+5[>1\KFN.]I+
MV--Z+?S"BBBO</!"BBB@ HHHH **** "BBB@ HHHH W/&W_'YI'_ &![3_T6
M*YJNE\;?\?FD?]@>T_\ 18KFJ\RG\*/UG"?[O#T7Y!1115G2%%%% !1110 4
M444 %%%6+&QNM2OHK.P@>XN)FVQQH,EC0W;5@%C>7.GWT-U82O#<Q.&C=.H/
M^>U?47A/7+C5M'@75XDM-66)7N+3<-Z ]&*]5SC.#R,X->)6=O9^#0?L[Q7^
MN]&N1AHK+VC_ +S^K=!T'K4.C:]>:+KD>J02-),K$R;V)\T'[P8^_P#]>OE\
MPQ]*I-0@KVZGQ^8\08>G65*FN9)ZO_+N?2-%4=&U>VUS28+^R<-'*N<9Y4]U
M/N*O5R;GJ1E&<5*+NF%%%%!04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7'_$CQ@/"OATBV<?VA=YCMQGE/5_PS^9'O772
M.L4;/(P55&2S'  KYE\<^)6\4^*KB]5C]F0^5;*>T8Z''N<G\:]++L+]8JWE
M\*W/,S+%?5Z-H_$]O\SG69G8LY+,QR23DDTE%%?8GQ04444 %%%% !1110 4
M444 %%%% !1110!N>-O^/S2/^P/:?^BQ7-5TOC;_ (_-(_[ ]I_Z+%<U7F4_
MA1^LX3_=X>B_(****LZ0HHHH **** "BBMWP]X9DU=7O;V;[#I4!Q-=NN=Q_
MN1C^-SZ#IU.*BI4C3BY3=DB*E2%.+G-V2*>C:%?:]=F&Q10L8WS3R-MC@3NS
MMV'ZGMFNK:[L="M'T_PT6)D79=:DR[9+@=U7^Y'[=3QGTJ.^U6,V*Z7H\!LM
M+C;<(LY>9O[\K?Q-^@Z"LRODL=F4L1[E/2/YGYSG'$$\3>CAM(=^K_X 4445
MXY\F=K\-/$_]BZY]@NGQ97K!3D\))T5O;/0_AZ5[=7RY7O'P]\2'Q!X<47#;
MKRT(BF)ZL,?*WXC]0:ZZ$_LL^OR#&W3PL_5?JOU^\ZNBBBNH^L"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \_^+_B(Z1X3
M%A;R;;C4F,1P>1$/O_GD+]&-> 5U_P 3M?\ [>\;77EMFWL_]&B]/E/S'\6S
MSZ8KD*^TR^A['#I/=ZL^'S'$>WQ#:V6B"BBBN\\\**** "BBB@ HHHH ****
M "BBB@ HHHH W/&W_'YI'_8'M/\ T6*YJNE\;?\ 'YI'_8'M/_18KFJ\RG\*
M/UG"?[O#T7Y!1115G2%%%% !13D1I)%2-2[L0%51DD^@%=I8:%9^&(A<Z_#'
M=ZL1F'37^:.W]&F]3Z1_]]>E<^(Q-/#PYILY<7BZ.#I.K6=E^?H4]&\+PPV<
M.K^)B\5E)\UO9H<37@]O[B>K=^WK5G5-6GU25-ZI#;PKLM[:$;8X5]%'\SU/
M>H+Z^NM2O'NKZ9IYI#EG8_I[#VJ"OC<7C:F*E>6BZ(_+\TSBMF$K;06R_P P
MHHHKA/$"BBB@ KI_A_KW]A>*H3*VVVNOW$V>@R>&_ _H37,4546T[HUHUI4:
MD:D=T?4=%8/@K6/[;\)65R[;IE3RI?7<O!)^N,_C6]7I)W5S]2I5(U::J1V:
MN%%%%,T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LOQ-
MJPT/PSJ&I$X:W@9DSW?&%'XD@5J5YK\;=3-MX5M+!#@WEQEO=$&2/^^BM=&%
MI>UK1AW9S8JK[&A*?9'A;,68LQ)).23WI***^[/@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH W/&W_'YI'_ &![3_T6*YJNE\;?\?FD?]@>T_\ 18KF
MJ\RG\*/UG"?[O#T7Y!1115G2%6=/TZ[U6^BLM.MWN+B4X2-!R??V'J3P*MZ%
MX?O-?NGCM=D<,*[[BYF.V.!?5C_(=3VKIY+ZSTG37TKPX&6*08NKYUVRW?M_
ML1^B_GDUY^,QU/"QMO+L>3F6:T,OA>>LGLOZZ#K:.R\' KILL=[K14K)?KS'
M;9ZK#ZMV+_EZUD.[2.SNQ9F.2Q.23ZTE%?'5Z]2O/GJ,_+L=CZ^.J^TJOT71
M!1116!PA1110 4444 %%%% 'IGP>U8I=WVDN?ED47$8ST(PK?F"OY5ZO7SWX
M'U#^S?&FG3$X5Y?*;/3#_+S^)!_"OH2NZ@[QL?>9#6]IA.1_9=OEN%%%%;GO
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7AGQOO_ #O%
M%E9*V5MK;>1Z,['(_)5KW.OF[XHW'VGXD:H0<JAC0?A&N?US7KY1#FQ%^R?^
M1X^<3Y<-;NU_F<C1117UA\>%%%% !1110 4444 %%%% !1110 4444 %%%%
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M$)__ $8U>[DO\2?H>!G?\.'J9-%%%?3'RP4444 %%%% !1110 4444 %%%%
M!1110 45/:6-W?S>58VLUS)_<AC+M^0K=C\"ZNF#J;6FDJPR#?7"HQ_X ,O^
ME95*]*DKU))%QISDKI:$7C**2?4M%BA1I))-(LU1$&2Q,8  '<UHV.CVGA B
M?5DBO=;QF.S.&BLS_>D[,_HO0=\]*U=2UO3[!;0Z#B;48K&&UDU(J1Y81-I$
M08 KGG+$9YP,5RQ)9B6)))R2>]?%XS-&X^RH[=7_ )'OYAQ X48X;"O6R3E_
ME_F37=W<7UW)<WDSS32'<[N<DFH:**\$^*;;=V%%%%( HHHH **** "BBB@
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MT<MJQI8A.3LG<\S-*3J89I+569X1174)X3L+7G5_$5HAQGRK!&N6/MGA,_\
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M9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<E\-=(_LOP=!)(N);PFX;(YP?N_AM /XFNMKT*4>6"/T?*</[#"13W>K^?\
MP HHHK4]0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /-?B]H9EL[;6H5RT!\F<C^Z3\I_ DC_@0KR:OIK4;"'5--N+*Z7=%/&4;\
M1U^M?.6LZ5<:)J]QI]V/WD+XSC 8=F'L1S7'7C9\Q\/GV$=.LJ\=I;^O_!*5
M%%%<Q\X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5;4K^+2])N]0N%=HK2!YW5 "Q55+$#..<"K-4->L)=4
M\-ZEI]NR++=VDL",Y(4,R%03C/&351MS*XU:^IQNF_&?P]JFK6FGV]GJ:RW<
MZ0(SQ1A0S,%!.'/&375>)==;P]H\M['87%^Z*S>7$, !5+,SOT4  \]^@!KR
MG0?@QXATOQ)INH7%YIC16EW%.ZI+(6*JX8@90<X%>J>*TN[CPS?V5A837DUY
M;2P*(GC4(60@%B[+QD]LGVKIQ4:,9+V+N:U5!/W!MUX@E1]+MK&S2>]U*-I4
MCDF\M(T506+,%8_Q #"G)/:BQ\3V\VAW6HZE&;'[#*\-VA)D$;H<'! RPY!!
MQWZ5E_9-42\T+5DTFX+6-O):7%H98?-PRKAU._81N3&"P.#TJO+X-NM4\+ZF
MER7M=0U"XEN$A%Y(L<6\C"N$.UR HSP1G.*Y#$[>BJ]E916%OY,#3NN2V9[A
MYF_[Z<D_AFK% !1110!D>)/$EGX7TV.]U".>2.241 0*"<D$]R./E-4/#?CS
M3/%&I266GP7<<D<1E)G10, @=F//S"CQYX;O/%&A0V6GR01R1W*RDSL0,!6'
M8'GYA6+X#\!ZGX7UV:]U">TDCDMFB @=B<EE/=1Q\IK)N?/9;'D5:N-6-C"$
M?W>EW8ZF[UBY_MAM+TBSBN[B&%9IVGN#%'$K$A5R%<ECM8XQT&<],ZL9<Q*9
M557(&Y5;< >X!P,_7 KC-?\ #AFU[4[Q_#\>MI?V:1PLQBS;2J&'.\C (*G<
MN2-IXZ5O:1I%]96]C]LUF[G:"W2.6';$8I&"!2<E-_7G[W7\JU/7*NE>+$U&
M;5_M%A<6$&FJDFZY&UW0J6W%.J_=/!.<8SCI3;#Q1<SWFEIJ&F+:6^K*S6DB
MW&]@0N\"1=H"DKD\%N1BJ,%EJ=]JWB$7&CW=G!K%ND,<TLD#",K$RDL%D)ZD
M8P#[XI=/TW5KVX\.QZAIS62:,K&:5IHV69Q'Y:^7M8G!R2=P7' H ZP7,!NC
M;":,SJ@D,6X;@I) ;'7&01GVJG+K^CP1P23ZM8QI< F%GN4 EP<?*2>>?2N>
M\=P75O+8WVDE1>W1;2R"<;EF!PWU1E#?3=52\\+7=CJEREE%J$FFW%C%:*M@
MUKN5$4J4?SQT.<_*>I.1TH [&\U;3M/FBBO[^UM9)O\ 5I-,J,_;@$\T3:MI
MUO=K:W%_:Q7#LJK"\RJ[%L[0%)SDX./7%<3K^@ZY-IUYING6MTUM)IL4$!C:
MU!E95((N&?YB1QC9QR>1U&O9Z)<)XBU*]O;$RPS:7!;*5==\A ;S$!R",_+R
M2 >.>* -^QU;3M4\S^S+^UO/*P)/L\RR;,],X)QT/Y5;KG?"]OJMH\UO=)<Q
M:9#%''9QWIA:9, @C,1(*@!<%B6SG-=%0 4444 5M1OH],TN[O[A7:*UA>9P
M@!8JJECC/? KBM.^,7A_4]4M+"WL]266ZF2%"\484,S!1G#],FNOUVQDU/P[
MJ5A;LBRW5K+"A<D*&9"HSCMDUY-H7P=\0:9XBTV_N+S36BM;J*9PDLA8JKAC
MC*=<"O1PM/#2IR=9V?0\W%U,5&I%45==3U/5=8ELM0LM.L;9+J]O-[(DDWEH
MB( 69F"L1U &%.2>U.T+6/[9L99)+<VMQ;SO;SPE]P21#@X;C(Z$' ZU2UJR
MO8_$FE:S8VCWJ6T<T$\$3HLFUPI#+O*J<%<$$]#QTJ'1="U&.WGN+B_N=,FN
M[R6[>VM_)<*'(PK%D;)  SM.,D]>M><>D6=/UO4M3U*\BM=.M1:6=X;6262\
M82' 4E@@B(Z-TW"MF2Y@BFBBEFC268D1(S -(0,D*.^ ">.U<CJVBR:EJ"?8
MO#::??B]60ZPK0C"*^2V5/F,608VE0,MR<#-:?C2+_BFY+]'5)]+<7T+,< M
M'R5_X$NY?^!4 :<^L:9:Q2R7.HVD*0R".5I)U41N1D*Q)X.#G!HEU?38-/2^
MGU"UCLY,;+AYU$;9Z88G!KC$\/ZJ+30]4B%S]KWW%U>I9F$3"2< Y43#9\H&
MP]#CI5@:1J>GV=A_9=KJ2H;BXFN6/V,WD3/SA,_NE1CDD+ST]Z .KGUC3+6V
MBN+G4;2&"9-\4LDZJLBX!R"3@C!'(]:2'6M+N;W[';ZE9RW6-WD1SJSXQG.T
M'/3FN3T/PSJ-M'X56_LU/]G2W;W&YT;RRY8QD8Z]1T''M6GIMGJ-IXHD-C:W
M=KI<TDTUTEV\+1L[8PT6QC("6R2&^7!/ .!0!TU%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% $4MM!/+%)-#'(\+;HF= 3&<8R#V."1Q4M%% !1110
M 4444 %%%% !1110 4444 %1W%O!=P-!=0QSQ/\ >CD4,K=^0:DHH **** "
:BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>halo-20230324_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g5.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #,3(
M )*2  (    #,3(  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" $< H,# 2(  A$! Q$!_\0
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MASQH-(T,:6MN-/ANF:\M9)7+/),I *RH  (AV/4US7_"V_&_]_P__P""V?\
M^2*/BW_R5-O^P+:_^C[JN0KZ#!X.A4H1G..NO5]SS*]>I"HXQ>AU_P#PMOQO
M_?\ #_\ X+9__DBC_A;?C?\ O^'_ /P6S_\ R17(45U?V?AOY?Q?^9A]:K=_
MR.O_ .%M^-_[_A__ ,%L_P#\D4?\+;\;_P!_P_\ ^"V?_P"2*Y"BC^S\-_+^
M+_S#ZU6[_D=?_P +;\;_ -_P_P#^"V?_ .2*/^%M^-_[_A__ ,%L_P#\D5R%
M%']GX;^7\7_F'UJMW_(Z_P#X6WXW_O\ A_\ \%L__P D4?\ "V_&_P#?\/\
M_@MG_P#DBN0HH_L_#?R_B_\ ,/K5;O\ D=?_ ,+;\;_W_#__ (+9_P#Y(H_X
M6WXW_O\ A_\ \%L__P D5R%%']GX;^7\7_F'UJMW_(Z__A;?C?\ O^'_ /P6
MS_\ R11_PMOQO_?\/_\ @MG_ /DBN0HH_L_#?R_B_P#,/K5;O^1U_P#PMOQO
M_?\ #_\ X+9__DBC_A;?C?\ O^'_ /P6S_\ R17(44?V?AOY?Q?^8?6JW?\
M(Z__ (6WXW_O^'__  6S_P#R11_PMOQO_?\ #_\ X+9__DBN0HH_L_#?R_B_
M\P^M5N_Y'7_\+;\;_P!_P_\ ^"V?_P"2*/\ A;?C?^_X?_\ !;/_ /)%<A11
M_9^&_E_%_P"8?6JW?\CK_P#A;?C?^_X?_P#!;/\ _)%'_"V_&_\ ?\/_ /@M
MG_\ DBN0HH_L_#?R_B_\P^M5N_Y'7_\ "V_&_P#?\/\ _@MG_P#DBC_A;?C?
M^_X?_P#!;/\ _)%<A11_9^&_E_%_YA]:K=_R.O\ ^%M^-_[_ (?_ /!;/_\
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M"BC^S\-_+^+_ ,P^M5N_Y'7_ /"V_&_]_P /_P#@MG_^2*/^%M^-_P"_X?\
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M'_"M?%O_ $"?_)F+_P"*KWRBC^U*W9?C_F'U.GW9X'_PK7Q;_P! G_R9B_\
MBJ/^%:^+?^@3_P"3,7_Q5>^44?VI6[+\?\P^IT^[/ _^%:^+?^@3_P"3,7_Q
M5'_"M?%O_0)_\F8O_BJ]\HH_M2MV7X_YA]3I]V>!_P#"M?%O_0)_\F8O_BJ/
M^%:^+?\ H$_^3,7_ ,57OE%']J5NR_'_ ##ZG3[L\#_X5KXM_P"@3_Y,Q?\
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M]NCO8K%[@(GE++(FY!][=@C(R%X(YQD9HP_%#1Y;26Y:QU&*)+.6\C:2./\
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MU!&14E4=,M[VV^UB^N?/1K@M:@D,8HMJ@*6V@DY#'G)^;&3C-7J "N6\8_\
M(5\,_P#843_T$UU-<MXQ_P"0KX9_["B?^@FM\/\ Q%\_R,ZOPG4T445@:!53
M43:O:O:W\"W%O<(T<D3H'212,,K \$$'&*MUG:M_RR_X%_2JBKNPGHCG_P#A
M#/ /_0EZ'_X*H/\ XFC_ (0SP#_T)>A_^"J#_P")J_16WLXD<S*'_"&> ?\
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MH^O1QZZTNA1VT5KK%E>0V]E,\GFQPI#N6/=&F\!4XQU8%<<9/KGV"Y_YY_\
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M1^-9U'IH5$XZ]NV\8>(M#&EV&I06FDW9OKF\OK&6T'^JDC6)%E568DODD J
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M**MRN[^OXMO]2+:6]/P27Z!1114C"BBB@ HHHH **** "BBB@ HHHH ****
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M=5+F^_XEMFV"&E7,CCV7^IQ^-95:U.C'FJ.R-J-"K7ERTU=G#U<LM(U+4O\
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M]GKEKH\TDS7UTADCBBMI)0$! +.RJ51<G&6(%:5'2X=;!1110 4444 %%%%
M!16'JWC'1=%NY+:^FN6DA023_9K&>X6W4Y(,C1HPC& 3\Q' )Z5=@UO3[G5$
MT^VN5FN'M5O%V E6A8X5PW0@GT-&X%^BBJFJ:K9Z-8F\U*;R;<21QE]I;YG<
M(HP 3RS ?C0!;HHK,;Q'I2:+?:LUUBQL&F6YE\MOW9B8K)QC)P5/0'..,T#L
MS3HI%(901T(R*S[O7;"QGCANGEB>6Z2TCW0.!)*Z[@%;&",9^8' ((SD8H%T
MN:-%%% !1110 4444 %%%% !1110 5S?PX_Y)9X4_P"P+9_^B$KI*YOX<?\
M)+/"G_8%L_\ T0E '24444 <W8_\E3UW_L"Z;_Z/OJZ2N;L?^2IZ[_V!=-_]
M'WU=)0 4444 %%%% !7BOQJNC)XFL;7^&&TW_BSG/_H(KVJO!?BY(7\>R*?^
M6=O&H_+/]:]7*8WQ-^R9XN=RMA+=VCAZ***^M/B J_H-@-4\0Z?8M]VXN8XV
M^A89_2J%=3\-8A-\1-*4C(#NWY1L?Z5E6ER4I271,VP\%4K0@^K2_$^B0
M!@#H!1117P1^EA1110 4444 %%%% !1110 4444 %%%% 'R_XCL/[+\3:C9
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M^FW_ (Y_]>C^R?\ IM_XY_\ 7HYHC7,G<S$4K&JEBQ P6/?WIU:/]D_]-O\
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M'6%VS;I5C\J;_?7@_G@'\:WZ\/\ A)XF72]<?2;M]MO?D>62>%E' _[Z''U
MKW"OBL=0="NUT>J/T'+L2L3AXRZK1^H4445Q'H!1110 4444 %%%% !1110
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MFDW!URXEN[J\ N;3S<*@R>-H^Z.@QT.:YHXS;F6K_P TOU.R6!]YJ+V_X/\
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M@WJNV-&RQY(S@=NM<(WP]\03Z':6BV:V\PT_4896,J??DG+QJ<'G<H'/..]
M'H6JWGA;7?#YEU+4K";3%G7%RMZ$6.52&7;*K#:PXZ$'\ZDTZZ\-:"L.D6-_
M8VSNX*0-=@R2/(=P/S,69FSG)R37'ZOX?UG4CI^H6GAU]-:TN&\ZWMKBV^T7
M ,&P2'<#%P3MY+';R,'%9R> =:M[2\B@TYN3I0M]]U'(P6%B9!OPOW01_",X
MXS0!V,'Q"T>\O(18W-F]G]HF@N;F:]CB\GRT+;PI.74D8R,<<]*WKG6M+L_-
M^V:E9V_DHLDOFSJOEJQPK-D\ G@$]37GMEX-U676[6WU+3&^P)J>I2SS>=&5
M>&XB=5( ;=WP05&,U&/!'B&/1+.ZF:635+?4X9)5MI(O,:W@0PQE/,_=[L?O
M,-_>/0\4 >H0S1W$$<UO(DL4BATD1@RLI&001U!'>GUR_@T?V/I]GX;FM;B&
MYAL_M;B2>.81!Y6PC,H7YAST0+P0"VTFNHH Y[Q?X0LO%NF>3<?NKJ($V]P!
MDH?0^JGN*^?M;T._\/ZG)8ZG"8Y4Y!'*N.S*>XKZBK*\0>&]-\3:<;35(=X'
M,<J\/&?53_D&O4P.82P[Y)ZQ_(\;,<LCBESPTG^?J?,5%=3XL\ ZKX6F>1D-
MU89^2ZC7@#_:'\)_3WKEJ^JIU(58\T'='QE6E4HSY*BLPHHHK0R"BBB@ HHH
MH **** "BBB@ HHKJ/"?@/5?%4RR1H;:PS\]W(O!]0H_B/Z>IJ*E2%*/--V1
MI2I3K3Y*:NS%T?1K[7M2CL=,@::9^OH@[LQ["OH'P;X.L_".F>5%B:\E -Q<
M8Y8^@]%%7/#GAG3?"^G"UTR+!/,LS\O*?4G^G05KU\KCLPEB/<AI'\S[3+LL
MCA5SSUG^7H%%%%>4>R%%%% !1110 4444 %%%% !0>AHHI/8#B?"VF7<MI:7
M!L='>U\QB99(2;C <\YQC.>GX4^6]N%T74[C[=.MQ;ZLZVPWLV\@C$6,\J>>
M*["&&*WB$5O$D4:]$10H'?H*B%A9APPM( PD,H(C&0YZM]?>N%81Q@HQ?3_+
M7Y6T/1EC%*HYR77]3C;G4[V+PG;3PW<[S75T5NG,OEF(\YC!;(C _P ]:9!J
MNJP>'-1;[2=B/&(YC=QW,D2L<-EE_3('6NV-C:,DJ-:PE9CNE4QC$A]6]?QI
M8K.VM[<P06T,4+9S&D8"G/7@<5'U2IS7Y^EOPMZ^>Y?URERVY.M_QO\ \#;8
MYC01"OB^9+;4Y-2C6Q \Z202$?/G;N'7KG\<5L#-QXL)ZI9VN/H\C?X)^M7;
M>PL[1MUK:00-MVYCC"G&<XX[9J58HTD>1(U5Y,;V"X+8X&3WKIIT7"*B^C;_
M #_S.:K74YN2[6.8\27#Z%J\>KPJ2+B![9P!_&!NC/Y\?2J]Y'%I.DZ=I4E]
M<6=P8VE>2*X$*,W5MSD$GD\ ?X5UTUO#<*%N(HY55@P#J& (Z'GO39[2VNBA
MN;>*8QG*&1 VT^HSTK&>%DW*SWV\NK^]ZFD,5%1BI+;?SWM]USC;>YOM5LO#
MD3ZA<PM=>>LLD,FUF"]/QP.M6);XZ?/KL-U>WWDP_9HHW27+J2O)!;@9[G^M
M=2EC:1M&4M85,9+(1&!L)ZD>F>]#V5K)YWF6T+>?CS=T8/F8Z;O7'O1]6G;X
MM?\ @6_/4MXNFW\.GR_FO^6AP;W<TGA[Q!;/>O=PP-"8I'F\XC)Y^? STJT]
MT5;4[6TU:74[632Y)I&D</Y;].".G^[VKL/[-L1&T?V*WV,H5E\I<$#H",=!
M3DL+.-)4CM8$6;/FJL8 DSUW>OXUG]3G_-TMU\_\_P "WC:?\O6_3M'_ "N<
M'J&H7R+IEI'--# -/B=?*O$M=S$8R6;K]*['P_/=7.A6TE^R/.00SQNK!L$@
M'*DCIZ59FTZRN(HXKBSMY8XAB-'B5@@]@1Q5A55$"HH55&  , "NBC0G3J2E
M*5TS"OB85::A&-FNHM%%%=9PA1110 5Y]XEB2+4M3,%S9/-(T;;)8V^TH_&!
M&>XZ<CI7H-0O9VLERMQ);0O.GW96C!9?H>HKEQ-!UXI)V.O"XA4)N37]7N<K
MJFGC3+F:Z>4S>>DDLL(3&(\JS@GN"0J]. QKHM.U(7NG/=2Q^3Y;.DBAMP!4
MD'!P,CCTJV\$3L6>)&++L)*@Y7T^GM34M8([;[-'!&L&"OE*@"X/48Z4X494
MY/E>G;S%4KJI!*2U77R,_0HF_P"$?C>7<LER&G<CJ"Y+?R(KD]"C$6NZ3'93
MV,ZKYH+VL;+*R8/,N>ASC ->@*JHH5 %51@ #  J*&SM;>9Y;>VABDD^^Z1A
M2WU(ZU$\-S2@T](_I8TABN55+KXO^#_F<W8Z7!!XJU*SC:3;-8C>[MN9BQ.2
M2>]50_\ PCEPW'VU;=F.?]6OF>5D^O(C0#W+FNP$$0N&G$2"9EVF0*-Q'IGT
MIDEE:S1E)K:&1&?>5:,$%O[V/7WJ?JO*ER.S5_NO>UBEB[R]]732O]UB6-Q)
M&KKG# $9IU%%=QYX4444 %%%% !1110 4444 %%%% !7-_#C_DEGA3_L"V?_
M *(2NDKF_AQ_R2SPI_V!;/\ ]$)0!TE%%% '-V/_ "5/7?\ L"Z;_P"C[ZND
MKF['_DJ>N_\ 8%TW_P!'WU=)0 4444 <5XO\7ZKH/B*SLK"T@EBEBCD"R(S2
M7;-,J-%$00 RH=YR&X(XJIK/Q$N[3Q5JFF:7:0SV^GZ;+.9G5CNF1E!'! **
M&^;OD$9&*TO$_@7_ (2/5GNUU'[+'<VT5K=1^1O9HXYA*/+;<-C9R,D,.^,B
MI++P#8:9XR@US3YYX8X;>6+[(9I74O(Y9FRSD 9).W&,G=U% %;PUXW_ +9N
M;.&\N-/@9XW#G=M^T2^81&(@6S@HN\CYN'3GN>SKCKCP +G5+._DU(^?'<FX
MNF$/^O/G)*H7YODQY2)GYOE&.O-=C0 4444 %%%% ".BR(R.H96&"I&01Z5Y
M[XE^$6F:FSW&B2?V=<-SY6,PL?IU7\./:O0Z*VHUZE"7-3=CGKX:EB(\M6-S
MYHUSP?KGAYV_M*PD6(?\MXQOC/\ P(=/QP:Q*^LB P((R#P0>]<SJWP\\,ZP
MS//IJ02MUDMCY9^N!P?Q%>Y1SA;58_<?.U\A>]&7R?\ F?.=%>N7_P $HRQ;
M2]8=1V2YB#?^/*1_*L"Z^#WB6!CY#6=RO8I,1_Z$!7I0S##3VG]^AY-3*\9#
M>%_34X*BNMD^%_BZ,X&E!QZK<1?_ !5"_"_Q>W_,)Q[FYB_^*K;ZUA_YU]Z,
M/J>)_P"?<ON9R5%=Y;_![Q--CS396_KYDQ/_ *"#6_I_P248;5-88^J6T6/_
M !YC_2L9YAAH;S^[4WIY9BY[0?ST/)*V="\):UXC<?V78R/%G!G?Y8Q_P(\?
M@,FO<=(^'/AG1]K1Z>MS*O\ RUNSYA_(_*/P%=.JJBA4 50,  8 KSJV<+:E
M'[SUJ&0RWK2^2_S/._#'PBT_32MQK\BZC<#D0J"(5_JWXX'M7H<<:11K'$BH
MBC"JHP /0"G45X=;$5*\N:H[GT5##4L/'EI1L%%%%8'0%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7-
M_#C_ ))9X4_[ MG_ .B$KI*YOX<?\DL\*?\ 8%L__1"4 =)1110!S=C_ ,E3
MUW_L"Z;_ .C[ZNDKF['_ )*GKO\ V!=-_P#1]]724 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5S?PX_Y)9X4_P"P+9_^B$KI*YOX<?\ )+/"G_8%L_\ T0E '24444 <
MWJ&@ZY_PE5SK.@ZOI]I]JLH+26&]TU[G_5/,X966>/&?/(((/04?8?&__0P^
M'_\ P0S_ /R97244 <W]A\;_ /0P^'__  0S_P#R91]A\;_]##X?_P#!#/\
M_)E=)10!S?V'QO\ ]##X?_\ !#/_ /)E'V'QO_T,/A__ ,$,_P#\F5TE% '-
M_8?&_P#T,/A__P $,_\ \F4?8?&__0P^'_\ P0S_ /R97244 <W]A\;_ /0P
M^'__  0S_P#R91]A\;_]##X?_P#!#/\ _)E=)10!S?V'QO\ ]##X?_\ !#/_
M /)E'V'QO_T,/A__ ,$,_P#\F5TE% '-_8?&_P#T,/A__P $,_\ \F4?8?&_
M_0P^'_\ P0S_ /R97244 <W]A\;_ /0P^'__  0S_P#R91]A\;_]##X?_P#!
M#/\ _)E=)10!S?V'QO\ ]##X?_\ !#/_ /)E'V'QO_T,/A__ ,$,_P#\F5TE
M% '-_8?&_P#T,/A__P $,_\ \F4?8?&__0P^'_\ P0S_ /R97244 <W]A\;_
M /0P^'__  0S_P#R91]A\;_]##X?_P#!#/\ _)E=)10!S?V'QO\ ]##X?_\
M!#/_ /)E'V'QO_T,/A__ ,$,_P#\F5TE% '-_8?&_P#T,/A__P $,_\ \F4?
M8?&__0P^'_\ P0S_ /R97244 <W]A\;_ /0P^'__  0S_P#R91]A\;_]##X?
M_P#!#/\ _)E=)10!S?V'QO\ ]##X?_\ !#/_ /)E'V'QO_T,/A__ ,$,_P#\
MF5TE% '-_8?&_P#T,/A__P $,_\ \F4?8?&__0P^'_\ P0S_ /R97244 <W]
MA\;_ /0P^'__  0S_P#R91]A\;_]##X?_P#!#/\ _)E=)10!S?V'QO\ ]##X
M?_\ !#/_ /)E'V'QO_T,/A__ ,$,_P#\F5TE% '-_8?&_P#T,/A__P $,_\
M\F4?8?&__0P^'_\ P0S_ /R97244 <W]A\;_ /0P^'__  0S_P#R91]A\;_]
M##X?_P#!#/\ _)E=)10!S?V'QO\ ]##X?_\ !#/_ /)E'V'QO_T,/A__ ,$,
M_P#\F5TE% '-_8?&_P#T,/A__P $,_\ \F4?8?&__0P^'_\ P0S_ /R97244
M <W]A\;_ /0P^'__  0S_P#R91]A\;_]##X?_P#!#/\ _)E=)10!S?V'QO\
M]##X?_\ !#/_ /)E'V'QO_T,/A__ ,$,_P#\F5TE% '-_8?&_P#T,/A__P $
M,_\ \F4?8?&__0P^'_\ P0S_ /R97244 <W]A\;_ /0P^'__  0S_P#R91]A
M\;_]##X?_P#!#/\ _)E=)10!S?V'QO\ ]##X?_\ !#/_ /)E'V'QO_T,/A__
M ,$,_P#\F5TE% '-_8?&_P#T,/A__P $,_\ \F4?8?&__0P^'_\ P0S_ /R9
M7244 <W]A\;_ /0P^'__  0S_P#R91]A\;_]##X?_P#!#/\ _)E=)10!S?V'
MQO\ ]##X?_\ !#/_ /)E'V'QO_T,/A__ ,$,_P#\F5TE% '-_8?&_P#T,/A_
M_P $,_\ \F4?8?&__0P^'_\ P0S_ /R97244 <W]A\;_ /0P^'__  0S_P#R
M91]A\;_]##X?_P#!#/\ _)E=)10!S?V'QO\ ]##X?_\ !#/_ /)E'V'QO_T,
M/A__ ,$,_P#\F5TE% '-_8?&_P#T,/A__P $,_\ \F4?8?&__0P^'_\ P0S_
M /R97244 <W]A\;_ /0P^'__  0S_P#R91]A\;_]##X?_P#!#/\ _)E=)10!
MS?V'QO\ ]##X?_\ !#/_ /)E'V'QO_T,/A__ ,$,_P#\F5TE% '-_8?&_P#T
M,/A__P $,_\ \F4?8?&__0P^'_\ P0S_ /R97244 <W]A\;_ /0P^'__  0S
M_P#R91]A\;_]##X?_P#!#/\ _)E=)10!S?V'QO\ ]##X?_\ !#/_ /)E'V'Q
MO_T,/A__ ,$,_P#\F5TE% '-_8?&_P#T,/A__P $,_\ \F5I>'-(_P"$?\*Z
A5HWG_:/[.LH;3SMFSS/+0)NVY.,XSC)K2HH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>halo-20230324_g6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g6.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #,#,
M )*2  (    #,#,  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" $E H(# 2(  A$! Q$!_\0
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MRIV1ZQ_PO+2?^A:\0?\ ?-I_\D4?\+RTG_H6O$'_ 'S:?_)%>3T4?V71[O\
M#_(/KE3LCUC_ (7EI/\ T+7B#_OFT_\ DBC_ (7EI/\ T+7B#_OFT_\ DBO)
MZ*/[+H]W^'^0?7*G9'K'_"\M)_Z%KQ!_WS:?_)%'_"\M)_Z%KQ!_WS:?_)%>
M3T4?V71[O\/\@^N5.R/6/^%Y:3_T+7B#_OFT_P#DBC_A>6D_]"UX@_[YM/\
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M_DBN9_X1/3;3P?JMWJ-\4U.SN# 4$;%4<$X4$==W][H*/ FAVNKV>K23Z/\
MVO<6PB\BW^U&#.XL&^8$#H,\^E#P>%493O*R].MNZ\P]O6NDTM3IO^%Y:3_T
M+7B#_OFT_P#DBC_A>6D_]"UX@_[YM/\ Y(KG_$'AG1XO$%A:"4:(T]OON;4%
M[QH'SPHVY))Z]NGTJKJ?@4V$]W%'J'G-#8"_A#6YC,J;L,""<J1UQS^%*.$P
MK2=VK_UVL-UJZ;5E_P .=5_PO+2?^A:\0?\ ?-I_\D4?\+RTG_H6O$'_ 'S:
M?_)%>=:_HXT+538&X\^1(T:0A-NUF4,5ZG.,]?TKNM>\#:7+<:6FB6YMP;M+
M:]_>,WWHUDW?,3C"YZ>M.6#PL>5MNS]/\B5B*SO9+0M_\+RTG_H6O$'_ 'S:
M?_)%'_"\M)_Z%KQ!_P!\VG_R167K7A;2/[>FCTBWCAM1H;7ZK*9'R<G!'S@@
MXQU)'L:Q(_!]N_AT:Z=706 MR7/D_.L^<>3MW<^N[TYQ2CA,+)7;DOZ]"I5J
MZ=K+^K?YG7_\+RTG_H6O$'_?-I_\D4?\+RTG_H6O$'_?-I_\D5PGA/2[;4M4
MF>_4O:65M)=3("1O"CA<CD9)%;'A+PYINIZ1-+JD>)[^9K73SO91'((V;=UY
M&=HYS55,#AJ=[N6ENW7Y$PQ-65K6U.C_ .%Y:3_T+7B#_OFT_P#DBC_A>6D_
M]"UX@_[YM/\ Y(K@+?P[-=Z*UW;2%[E+U;22TV8*%ONMG/<Y'3K6S;?#\W.M
MZA9KJ+&WTX(MQ<1VC2-YC#[JQJ26P<\^U.6"PD;WD_ZMY>:$L17>R7]?/R9T
MW_"\M)_Z%KQ!_P!\VG_R11_PO+2?^A:\0?\ ?-I_\D5S(^'LB^)&TRXU%883
M9M>1W3P$90?WD)!4^N>E0:3X3TG6-4FM+3Q$S@,JPLFFRL9,@9)'1 "<9)['
MI4_4\):ZD^_]:#^L5UNE_7S.M_X7EI/_ $+7B#_OFT_^2*/^%Y:3_P!"UX@_
M[YM/_DBN0B\&+%;7T^KZO!I\=M=M9Q,T;.)I5[<?=7WYJW#\.Y9->U&R-^WV
M;3Q'YEQ':M(S%UR L:DD]^]#P>#7VG_5O+S0_;U^R_KYG2?\+RTG_H6O$'_?
M-I_\D4?\+RTG_H6O$'_?-I_\D5S<'@R.R\71Z)J)\^/4+5VL[C:\;(VTE6*'
M!!!7!4YZUQKJ4=E88*G!%7#+\-4?NR??I_EY$RQ-:.Z1ZM_PO+2?^A:\0?\
M?-I_\D4?\+RTG_H6O$'_ 'S:?_)%>3T5K_9='N_P_P B/KE3LCUC_A>6D_\
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M1_:W]S\?^ 'U'^]^!\LT5]344?VM_<_'_@!]1_O?@?+-%?4U%']K?W/Q_P"
M'U'^]^!\LT5]344?VM_<_'_@!]1_O?@?+0.#D<&NP7QQ92RPW^H^'+:[U>%5
MVWAG959E& S1@88_C^5>ZT5G/,HU/BA^/_ *CA'':7X'SW%XK,FD:M9:I9"\
M?49OM F\TQF*3!^; '(]N*EF\8^=K>IZA]AQ]OL#9^7YWW/E5=V=O/W>G'7K
M7O\ 14_7Z=[^S_'T\O)%?5I_S_A\SPZ#XB2)HL%I<V4TES;PB&*>+49H%P.%
M+1H0"?Q&:P+W7#>^&[#2F@VFSEED,QDSOWG/3'&/J:^D**(X^G%W5/K??_@!
M]6FU;F_ ^;]-UO\ L_0M5TX0;SJ(B'F[\>7L;=TQSGZBM_\ X6--+=:'<WE@
M)YM+602/YV/M&Y-N3\IP<#WS[5[C11+'TYN\J?X^5NW84<+..BG^!\]WNOZ-
MMCET/P]_9=[%*LL=R+YY=I!S]UABM ^.K)+E]2M/#=K!K+J<WHF8J&(P6$?0
M'WS7NE%)XZFU9P?_ ($_ZMY#^K2O?F_!'@GAWQE;^'[?<FD&6^!)^TB^E17)
M[O'G:WZ5SD-[<VUY]KM9Y+>?)(D@8H5SUP1TZU]/45<<RA%N2I[^?_ $\+)I
M+F_ ^94OVFU6.\U7S=0Q(K2K+*=TH'\)8Y/08KH]8\:V6H75O?6.A_8M0MGC
M:&<WCR*BIT01X"@?3%>[T4I9C"33=/;S_P" "PDE?WM_(\$U3QC::BD<$6AQ
MVUJ]X+R]B2X)-R_<9(^4')X -/UKQ;HVM3P32^&S')$\8R+]ROE+_P LPNW:
MH(]!7O%%2L=35K4]O[S&\--WO+?R1X!XF\4:9XAA!BT$V=TH54F^VNZHB_PK
M'@*!]*S?#FM?\(_KL.H^1]H\H,/+W[,[E*]<'U]*^D:*J.8PC!TU#1_WF)X6
M3DI.6OH>!:'XRCTC1ULI])CO&BNOM4$C3,@1^/O*/O8QQDU!J?BH:AINI6BV
M1B%]J'VW<9MVSC&W&T9^O%?0E%+Z_3YN;V>OK_P!_5IVMS?AZ_YL\UT?4]#&
MGZ/JUW>Z6]U969BEEDE*7"@*0(UBR03SC=WYP.>.4T?Q\VG:+'IMW937*0,Q
M@>"_EMBH)SAMGWN:]UHK&.+A=\T+W\]M_+S+]A*RM*UO(^>H?%*G1M5L+^P^
MU?VA+YZR&X<&&3!P<G);''4_7-4K#6/L6A:IIOD;_P"T/*_>;\>7L8MTQSG/
MJ*^DJ*W_ +1@KKV>]NO;;IY&?U67\WX=SYT\,^($\/W5RT]D+V&Z@,$D?FF)
ML$CHXY'2NBTGQ-'JOB_2[UX;73+73[8V\RR7(V-#\W #<L<'&!DFO::*FICX
M3;?)J_/_ ( XX645;FT]/Z['S/K.H'5=<O+]L_Z1,S@'L,\#\!@5TZ_$:>.;
M5WBL=HU&!(T4S9\AUCV;P=O/';CMS7N-%.684Y1494]%IOZ>7D"PTU)R4M?0
M\%;QONN3+_9^/^).=+QY_P#Y$^[_ .._K34\91)HHT7^R4.E_9RC1>:-[39S
MYV_;USVQCM7OE%+Z]2_Y]_B"P\U]O\/3_(^>O!M]#;:I<VMW*D$.H6<MJTLC
M!50LN5))Z#( _&KEIX_U+2-.T_3]' M(;0$3C*2?:&+9)R5^7N./SKWFBG+,
M(3E>5._S]?+S$L+**LI?AZ?Y'@NF>-_[*\4ZAJUMIJF"^)8VCRY"OG<&W;>S
M9/0=:K^'?&5QHEQ?-<0O=Q7YWS*EPT#[\D[@Z\CJ:^@J*7UZE9KV>]EOVVZ#
M^K3O?GZWV/ SXV/]MW-\+*4QRV3VB12WLDK(&_BWODGZ# INA>,8]'T5;&?2
M8[QH;K[5!(TS(%?C[RC[V,<9->_44?7Z=K>S_%] ^K3O?F_ \CT75-+\0:9J
MR:D^FQM-?F[@M=1N#&L3,.6\P8WC_9P/<\U5O_'4>F^,M9DLT-]I]YY:MY,[
M0$E% W*Z\@9S]17LU%9+%PYFW#3M?T\O(MT9-6YM>]O7_,\.TSQ'!?>-8]9N
MR;6UT^!Y$AGO'G=B%.%#2$DL6;H,?3O7&R.996=NK,2?QKZCHK>&91@[J'2V
M_P#P/,SEA7):R_ ^6:*^IJ*U_M;^Y^/_  "/J/\ >_ ^6:*^IJ*/[6_N?C_P
M ^H_WOP/EFBOJ:BC^UO[GX_\ /J/][\#Y9HKZFHH_M;^Y^/_   ^H_WOP/EF
MBOJ:BC^UO[GX_P# #ZC_ 'OP/EFBOJ:BC^UO[GX_\ /J/][\#Y9HKZFHH_M;
M^Y^/_ #ZC_>_ ^6:*^IJ*/[6_N?C_P  /J/][\#Y9HKZFHH_M;^Y^/\ P ^H
M_P![\#Y9KUCX&_\ (O\ B#_L-'_TDMJ].KF_"_\ R,7C/_L-1_\ IOLZY<5C
MOK$%#EMK??\ X!M1P_LI<U[G24445YIUG-^*/^1B\&?]AJ3_ --]Y725S?BC
M_D8O!G_8:D_]-]Y724 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !115:_U*QTJW%QJE[;V4)8*)+B58UR>V6(&>* /&]-@6UN%U
M>2PMHHX?%TBMJ$!S=MEV41;=HRA+ 'YSP3\IK2E\:ZY+J-_%I.K&XBFLFGM)
MKJ*WM8RPNUB(AW<@;691YI.67/(->BVOA_PZ]S'JMEI&EM-(?/CO(K:,LQ;G
M>' R<YSG/.:CM="\+W+736>EZ1*2[PW)BMXFRV1O1\#KG&0?;- 'G]QXVUV2
M""PL+R_,XGOQ+/<6UK!/&84!6.3<WDE5W@LZX)"\ <Y].TBZFOM$L;NY6-9I
M[>.618G#H&902%8$@C)X()!]:A?PWH<NG1V$FC:>]G$Q>.V:U0QHQSDA<8!Y
M//O6E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\[<\+D8]2>@.#C.O/']MIVI3V.H:/J=O-#;_ &@Y\AP4W;%Y64X+,0!NQ^%
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M /3?9T =)1110!S?BC_D8O!G_8:D_P#3?>5TE<WXH_Y&+P9_V&I/_3?>5TE
M!1110 4444 %%%% !1110 4444 %%%175U;V5N]Q>3QP0H,M)(P51^)II-Z(
M3:2NR6BO-O$'QBTZR9H-!MS?R#CSI"4C'T[M^GUKSK6?'_B/6R1<ZC)#$?\
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MT!)/ZT 3^(?^19U3_KSE_P#0#5?PA_R)FD?]><?_ *"*L>(?^19U3_KSE_\
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MTU+19IM1(>*V4/MA0A F4A61Y22=W"$MW'JGV>;_ )XR?]\FC[/-_P \9/\
MODT:#,/PKJT^M^'XKVY\EG:21!+ "(IU5V594!)(5P PY/!ZGK6Q4GV>;_GC
M)_WR:/L\W_/&3_ODU5T(CJMKO_(B>(_^P=-_Z+>KOV>;_GC)_P!\FK^F1O'Y
MOF(RYQC<,9ZUE62E3<>Y=-\LTSSK4)M<L/\ A%?^$PU/3F\,--;N]S96+P-%
M<* T"3,\SA8BP&7&#N"@X#$UAV%N)O$$AU?Q#HNG^*1K+X1]'DEU7;YQ**CK
M.&:$Q;1D)Y80G/1C7N%%9\WO<WG?\O\ +\OF<ONV\O\ /_,\=TJ/1[7XB"UM
M_P"Q?$,U[>W45PRJ\&JVP8R;UN4.?/@ PHWA%QY9 ;Y34'@W0] U.Q\%:=)8
M6%Q;1QZC]KM!$C1F=6CR)4Q@L/E.&&00I["O::*A:)%/5MGBBIH8U*-/&_V5
M/#0NM:"?;"%@6Z^V?+R>!)Y>_9CYOO[>:O>+;6*/Q?J-UX>@2+7+KPH3IDS1
M8NY) S [-^',@CP/[PXS7KM%%M$NU_Q37Z_H-OWF^[_5/]/U/$+*W4:9J<O@
M'Q!HT]\='FWV?AO2)+>21B!M:9O.D"S YVAP')+>AQM>%O\ A#?^%JZ7_P (
M,+-8O["N?M L1B,-YMOC>!P)?[V?G^[N_AKU6BJ3M*_]=?\ ,FVEOZZ?Y'!>
M,+G2[/Q09I_$MUX/U%K#RXM2F\@6=VNXD1GS@59D;)V@HV)#@D9QS=K]CO\
M7_!NJ:EI>DVMR\VI16MREHL$5S)NS#+&'R1YAS(HR22Q()SFO8:*FVEBF]?Z
M_K^K'C&C?V=Y7AG_ (13R?\ A--Q_MO9_P ?7^J?S_M?\6/-VXW_ ,6W;Q4F
MF'PR/A'KPTLQ_P#"0MX:E_MH(6\T3")]_P!I X$V\O\ ?^<\]A7L=%$E=27?
M\/3R\@B^62?;\=>OGYGGWP[B6RU:\M=<9;GQ#);13I>F/;YUFP&Q(@2=B(P*
ME 3SACR]/_X2#2?#'BKQ9#K^H06$M]+%=6B3N$:Z3[,D>(@?]8V^-AM7)Z<<
MBN^HIS]Z_GH*'NGCFD>$[*^U&WTWQ1ID5T]EX+LE-M=)N6*0-,"=IX#C! ;&
M1DX(R:Q=02+5_! N=:2.](\*Z)<2R72A\'SY-[DMT^4MD^A->^T4V[W^_P#&
M3_7\![_U_A_^1_$\:U-M#TWQZMWI<FAZU/)>6WD6!WV^I6RE(E3[)*I/F6^W
M+% HC(+@OC<*]EHHHZ6%UN%%%%( HHHH **** "BBB@ HHHH *YOPO\ \C%X
MS_[#4?\ Z;[.NDKF_"__ ",7C/\ [#4?_IOLZ .DHHHH YOQ1_R,7@S_ +#4
MG_IOO*Z2N;\4?\C%X,_[#4G_ *;[RNDH **** "BBB@ HHK+\2ZE_9'A?4;X
M'#0V[E#_ +6,+^I%5&+E)174F<E"+D]D> ^.=9_MWQE?W:MNA63RH?38O /X
MX)_&N?HHK[VG!4X*"V1^:5*CJ3<Y;O4****LS+%A8SZGJ$%E9IOGN)!&B^Y_
MI7TMX;T&W\-Z#;Z;:C(C&9'[R.?O,?\ /3%>7_!G05N-2NM;G7*VH\F#/]]A
M\Q^H7C_@5>R5\QFV(<JGL5LM_4^PR3"J%+V\MY;>G_!"BBBO$/H0HHHH ***
M* "BBB@ HHHH *\M\??"_P#MOQ&NK6-W;6%O,N;Z2<X"$8&\#N2.O(Y'7FO4
MJJ:KIT6K:3<V%Q_J[B,H3Z'L?P.#^%3**DK,PKX>GB(<E1:'C\%]X6\%_+X9
MLQJNIKUU*[&50_[ [?ACZFN>U76M0UNZ\_4[IYV_A!/RK[ =!5:[MI+*\FM9
MQB6&1HW'H0<&HJM)+8JG3A2CRP5D%%%%,T/9OA=JGVWPK]E=LR64A3_@)^8?
MS(_"NTKQWX4WQM_%$MH3\EU >/5EY'Z;J]BI,94CTG38=3DU&+3[5+Z5=LET
ML*B5QQP7QDC@=^PI&TC36%N&T^U(M9#+!F!?W+DY++Q\ISSD5<HI %%%% &=
MXA_Y%G5/^O.7_P! -5_"'_(F:1_UYQ_^@BK'B'_D6=4_Z\Y?_0#5?PA_R)FD
M?]><?_H(K?\ Y<_/]#/_ )>?(V:9-*L,1D<$@>E/JO?_ /'C)^'\Q6*U9HR+
M^U(?[LGY#_&C^U(?[LGY#_&LJBM_9Q,^9FK_ &I#_=D_(?XT?VI#_=D_(?XU
MDLP12SD*JC))["N<TWQK:ZC<V(&G:A;6FI$BPOITC$5T0I8;0KEUW*K,-ZKD
M#UP*.2-[!S.USN?[4A_NR?D/\:/[4A_NR?D/\:X[3/$KZI-F'0]1CL2SA=0D
M:#RF"DC< )3)@XX^3G(/2J>G^/=.U"QN+E+2^A\J.&6*.6--URDQ*PM'AB/G
M(( 8J1W I<D6.[.]_M2'^[)^0_QH_M2'^[)^0_QK*HI^SB+F9J_VI#_=D_(?
MXU/;W27.[RPPVXSN%8=:.D_\M?\ @/\ 6IE!)7&FVS1HHHK$L**** "BBB@
MHHHH **** "BB@D#J<<XYH **** "BBB@ HHHH ** 0R@J<@\@CO10 4444
M%%%% !1110 4444 %<WX7_Y&+QG_ -AJ/_TWV==)7-^%_P#D8O&?_8:C_P#3
M?9T =)1110!S?BC_ )&+P9_V&I/_ $WWE=)7-^*/^1B\&?\ 8:D_]-]Y724
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M"'_(F:1_UYQ_^@BK'B'_ )%G5/\ KSE_] -5_"'_ ")FD?\ 7G'_ .@BM_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KF_"_P#R,7C/_L-1_P#IOLZZ2N;\+_\ (Q>,_P#L-1_^
MF^SH Z2BBB@#F_%'_(Q>#/\ L-2?^F^\KI*YOQ1_R,7@S_L-2?\ IOO*Z2@
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M7"(C3%F54!X7)V]^N**.(A52MU5_R?ZBK8:=&]]D[?G_ )&A11170<P4444
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MS6KEXR2N2"""#@@@\@Y'>MJ595&U:S[&-6@Z<5*]TR>BBBMSG"BBB@ HHHH
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MG10 4444 %%%% !1110!%=6EO?6KVUY#'/#(,/'(NY6'TKRWQ3\'@[/=>%I
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\
MZ?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R5
M1_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J_
M_0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_
M +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__
M "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE%
M '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4
M:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B
M>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\
MZ?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R5
M1_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J_
M_0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_
M +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__
M "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE%
M '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4
M:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B
M>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\
MZ?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R5
M1_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J_
M_0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_
M +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__
M "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE%
M '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4
M:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B
M>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\
MZ?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R5
M1_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J_
M_0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_
M +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__
M "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE%
M '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4
M:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B
M>(/^_P#I_P#\E4>$8=0^U^(K_4M,N-,_M'4UG@@N9(GDV+:6\63Y3NHRT3<9
MSBNDHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
IHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>halo-20230324_g7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1[&17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#$Y.C R.C(P(#(P.C,S.C$X   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,Q,0  DI(  @    ,Q,0  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C Q.3HP,CHR," R,#HS,CHT,0 R,#$Y.C R.C(P(#(P.C,R.C0Q      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #1H         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ )P$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MO@K<0P?#JW$LJH7NY57<>IR*Y,;_  S>A\1G_'2XANO!-C+!(LD9O -RG/\
M":^>:>#_ (0J_P 845U&(5T'@;_D>=%_Z^T_G4S^%E1W/KA-1LY)!&ES&S,Y
M0 -U8=17RC\2O^2C:Y_U\?T%>=@?C?H=.(^%'+!6;. 3CK@4E>F<H8)S@=.M
M% CWSX"W$-KX;U>6>18T%R@W,<?PUU/Q9N(9_A?K@BD5S&85;:>A\Y.*\BI_
MO'S.V/\ "/EJEVMG&#GTQ7KG$&#Z&DP<9QQ2N,5?OK]:^VWN(8CMDFC0XZ,P
M%>?C]X_,Z</U/,OCJZ2> 8&1E93>IRIR/NM7SA6V#_A&=?XPHKK,0K4\-_\
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M^,4?\/C],_Z)=>?^#I/_ (Q7YC44?V-@OY?Q8?7J_<_3G_A\?IG_ $2Z\_\
M!TG_ ,8H_P"'Q^F?]$NO/_!TG_QBOS&HH_L;!?R_BP^O5^Y^G/\ P^/TS_HE
MUY_X.D_^,4?\/C],_P"B77G_ (.D_P#C%?F-11_8V"_E_%A]>K]S].?^'Q^F
M?]$NO/\ P=)_\8H_X?'Z9_T2Z\_\'2?_ !BOS&HH_L;!?R_BP^O5^Y^G/_#X
M_3/^B77G_@Z3_P",4^'_ (+':2TJK)\,;R-"<%O[90X_\@U^8=%']C8/^7\6
M'UZOW/UX\&?\%8OA;K]U!;ZUI6M>'C+M4S,J31(2.=Q!!"CU S[5]7?#CXM>
M#_BYI U7PAXAL]=LN-S6S_/'G.-Z'#)G'&X#/:OYV<^]=/\ #OXE^)OA3XDM
M=<\*ZQ<Z/J5NP=7@D*J^/X6&<,IY!!Z@FN+$9#1DKT7RLZ:683B[3U/Z,**^
M5OV*_P!M?3?VEM'?1]62/2O'&GQ!I[=2!'>)T\V(=B/XD[=1QP/J=6R?;M7Q
M=:C4P\W3J*S1[M.HJD>:(^BBBL30**** "DI::^=O'6@!&.%))P*P_&'C;0O
M .BSZQXBUBTT;3( 3)<WDJQKG&<#)Y/H!R>U>6_M4_M1:#^S#X&&K:A'_:.L
MWA,6G:6K[6F<=6;T1>,D9)X [D?C!\;/C_XU^/GBBYUKQ7JT]RKN3;V"N5MK
M5#C"1IT X'N3R>2:]O 97/&>_)VCW//Q&+C1T6K/U%\>?\%3OA#X5O&M=(&J
M>*74C,UG!Y4!![AG(;\UKS&Y_P""QFCQR8A^&5[+&1D,VKJA_+R3_.OS [8H
MKZF&282*LTW\SQWCZTGH['Z<_P##X_3/^B77G_@Z3_XQ1_P^/TS_ *)=>?\
M@Z3_ .,5^8U%7_8V"_E_%D_7J_<_3G_A\?IG_1+KS_P=)_\ &*/^'Q^F?]$N
MO/\ P=)_\8K\QJ*/[&P7\OXL/KU?N?IS_P /C],_Z)=>?^#I/_C%'_#X_3/^
MB77G_@Z3_P",5^8U%']C8+^7\6'UZOW/TY_X?'Z9_P!$NO/_  =)_P#&*/\
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M ,/?OB;_ -"=X4_[]W/_ ,>H_P"'OWQ-_P"A.\*?]^[G_P"/5\'44?V7@_\
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M?OMT1![LQ5?QK\ OBG\2-8^+7C[6O%>NW+W6H:E<-,Q9B?+7/RHN>BJ,  <
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M* "@444]] .D^'/C[6/AAXVTGQ/H=W+9ZEI\ZS1R1-@G!Y4]B",@@\'/-?T
M?!_XE:?\8/AKX=\8Z9Q9ZM:B?9S^[<?*Z>^UPPSWQ7\[8ZBOUO\ ^"2GC6XU
MSX*^(/#]PYD&B:D&BW,3M29,A1Z &,\>YKY?/<.IT%7ZI_@SULOJN-3D[GW3
M1117PA]$%%%)0 50U_6K/PWH>H:MJ,PM]/L;>2YN)6Z)&BEF;\ #5\FOFO\
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M*[\O_P![I^IRXK^#(_'NBBBOU0^1"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHI/8:W/Z&?@'_P D+^'?_8NZ=_Z31UWP[UP7
MP#_Y(7\._P#L7=._])HZ[T=Z_(:G\27J?9T_@0M%%%9F@4C=*6D;I0!^)O\
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M%O\ U]:C_P"@V]?F+7LY/_N4/G^;.''?QY?(****]LX0HHHH **** "BBB@
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M7Z;BCAYMJZW/BFBN^^/VF6FC?'/XA6&GVL-C8VOB"_A@M;:,1Q11K<.%1%
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M'3=[I;KK?_(CZNK<W-IK_D?!=%?I;_PS'X&^)GQ>\ ?&S3]#TK1_@S<^'/\
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M94^@8'&>H(/>C[%UOU&_CL]NAT]?%W_!67_DV*P_[&*T_P#1-Q7VEZ5\6_\
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M^(?B)JOAV\T)M-!T^&[BFCU&YDASYK0%2I2-\X\D]0.M>;_\,Y_$+^[X9_\
M!I<?_(M=W^T-X_\ $?@[5_#%GH.I_P!EI>P7LT[B".4L8VMP@^<''^M?I7E?
M_"Y/B#_T-LG_ ( 6O_QNO$3?*N:QV6]YVO\ >;/_  SE\0O[OAG_ ,&EQ_\
M(M'_  SC\0O[OAK_ ,&EQ_\ (M8W_"Y/B%_T-LG_ ( 6O_QNC_A<?Q"/'_"6
M2'_MPMO_ (W2YEUM]P6EV?WG;_#[X#^,O#_C[0-8U0Z&ECI\\DTOV.^FEE;,
M$D8"JT"@\N/XAQGZ5]%]J^8?AI\6/&FI?$CPYINI^(&U"POKB2*:%[2"/(%O
M*XP50'J@[]J^GJFI>Z+I=>Y^3/\ P5\_Y+GX0_[%U?\ TIGKX0K[O_X*^?\
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M*](0FS=BIQ@O(NT88;<*1@U[#X3\$^'O!O[?%[#H6G6NA:EX@^'<E]J&BV@
MCMK^1U+QJB\*2L88@#G+-_%0\R<;MPTUMKVWOV!86]K/M^)^3S'\,<'GI7L'
M[0'[/I^!>E_#Z\.O?VU_PENA1:T$^Q_9_LN\ ^5GS'WXW?>^7..E>[?!V;5O
M /\ P3W^+6JE)M)U"#Q;8&Q>>(9^TPSVIP%8$$JR<Y!&5YZ$5K?\%'?BEXH\
M2> ?@GIFH:G]HL-7\.6VO7L7V>)/.O2FTRY"@KQ(WR@A>>G%4L7.IB(0A\-V
MG\DF3[&,:;;WM^I\)T445[9PA1110!H>'?\ D8-,_P"OJ+_T,5_2.OW17\W'
MAW_D8-,_Z^HO_0Q7](Z_=%?%\0;TOG^A[F6?;^1^<7_!8[_D ?"W_KZU'_T&
MWK\Q:_3K_@L=_P @#X6_]?6H_P#H-O7YBU[.3_[E#Y_FSAQW\>7R"BBBO;.$
M*!U!_&BB@#Z<\%?M^>-/!/@CPCX:C\&>!-7B\*1;-(U'5](FN+NT?_GK&YG
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M.I/ _@>=[.7R]7OV^Q6..JR,#F3_ ( H9_JJCO7R1^YTO3U"J?(AC 5$^8D
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M<ASRD6"JG(+G@\*>:=U+WMNXM5[NY]-J<].E?%W_  5D_P"38K#_ +&*U_\
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M-M5R!G;LW8.0I!!JC\,/V!IO%_PWU?Q=XJ\>6G@&#0=8O-)UJ'4K1'6R:W4
MD2&=%=FE*H%X'.0QX!^B_$7[='A?Q5?/XGTW]HGQ!X(TV:UWMX'C\$6UY=P3
MA<;4O'@:,J6P?G)SS\ZY&WYN\<_M':1X^_8\UGPUJ_B)[_XB:IXV?6KFV:Q:
M SP%,&5C'&(%)8#**>O..]<-.MCYKEDVE==-N_0WE"@MNQ[[^UYX,/BCX4_
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M_P"*<T[_ -)HZYG]I/QH='\*P^';63;>:X6CE*]4M%QYQ_X%E8_H['^&NF^
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M99QDDJ .6 K[)- 44IZ4IR4K6'"+CN?DO_P5\_Y+GX0_[%U?_2F>OA"ON_\
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M_0]S+/M_(_.+_@L=_P @#X6_]?6H_P#H-O7YBU^G7_!8[_D ?"W_ *^M1_\
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M^DD=?+5?JN!_W6E_A7Y'Q^(_BS]0HHHKN.<**** #)HHHH */;M110 4444
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MMQ\,5349.TUT/E\5AW2DVEH<-11Q17MG %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 *%[]J^Q?^"9_P"SW/\ %#XS0>+M0@D'A_PLRW0D
MQ\LUUG]W'G/8_,1@@A2.XKS+]F/]D#QG^TGXBACLK>32/#,3_P"G:Y<QXCC7
M@D(/XW(Z*#[\#)'[5?"/X4>'O@KX%TWPEX9LUM=-LTY)P9)I"/FED;^)V(Z_
M0#   ^:S;,84:;H4W>3_  /5P>&E*2G+8[)0./I3J*6O@3Z,**** "D-+24
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M'2_^BHWG_@E7_P"/T?\ #G'2_P#HJ-Y_X)5_^/T44?VKC?\ GY^0?4Z/8/\
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MY!]3H]@_X<XZ7_T5&\_\$J__ !^C_ASCI?\ T5&\_P#!*O\ \?HHH_M7&_\
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M_P __BS_ ,&,/_QBBBC^T\9_S\8?5:'\B#_ATU\%?^?_ ,6?^#&'_P",4?\
M#IKX*_\ /_XL_P#!C#_\8HHH_M/&?\_&'U6A_(@_X=-?!7_G_P#%G_@QA_\
MC%'_  Z:^"O_ #_^+/\ P8P__&***/[3QG_/QA]5H?R(/^'37P5_Y_\ Q9_X
M,8?_ (Q1_P .FO@K_P __BS_ ,&,/_QBBBC^T\9_S\8?5:'\B#_ATW\%O^?_
M ,5_^#&'_P",5+:_\$H?@K;R;S<>)YQ_<FU"(C](1112_M+%_P#/QA]5H?R(
M]S^%W[+'PM^#TD4_ACP=I]K>QD,M],GGSA@,;E=\E#_NXKU@*.F.***Y95)U
47S3=V="A&FK15AV!Z4445!1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>halo-20230324_g8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g8.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #-#(
M )*2  (    #-#(  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" &+ J4# 2(  A$! Q$!_\0
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ME6 ]<, <5IT %%%% !14=S<Q6=I-<W+;(84:21L$[5 R3@<]!7._\+%\+?\
M04_\EY?_ (F@+,Z:BL.[\:>'[$0?:M21//C65 $=CM894D <9!SSBI+_ ,5Z
M+IEK:W-[?*D-XI:!UC9PX&,_=!QU'6@=F;%%9ND>(M*UT/\ V5>)<&/[R[2K
M#WPP!K2H$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MABCE.5A7.XH.Q.4Y'O72>![Z*[MKQ(M0U"Y:*10\&H\S0'!X+=P2#Z=*M_\
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MK$)]#&..BTG;K;IY?YGH-%%%=1Z 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M13%*#,<$;4_BSZ9&1^->Q444Z-'V4;7N/"858:#C>]PHHHK<[ HHHH ****
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M4+@6K,8;C#0E#DA@<\G_ .L:R]/TZ2ZTC29K&V74%M)YOM%E<2*@9SC.,G!
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M1110 4444 %%%% !1110 4444 %%%% !7G5Y:1Z#-/>W5I9:MIUQ=%_M"/\
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M\_D?6LW7-(FL)]8E?3K:[M9(E6*XDG4-:@+P #SGI@#K@5W*Z79IJKZD(?\
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ML%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPP OG\1Q^M<3<?#S5TU(PVRQR6Q;Y9VD  'N.N?H*[[3?#.E:9#&L5E"\J*
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M/#=K-<ZC/;HBLTLBM\S<G'S4 ;]%8_AF6[FTQGNW>13(?*:3.XK6Q0 4444
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M<RZAY2PL'B3R VQACG.>>1WIESH=W<7T5U_:>)8D"KNMPP!QRP!.!D\UM44
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M5M6WAZSMYD<O/,(P1&DLF53/H.U+!X?M8;F.9I;B8PG,22R;E3Z"@#4HHHH
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M (BN@HH Y_['XH_Z"-K_ -\C_P"(H^Q^*/\ H(VO_?(_^(KH** .?^Q^*/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5XG\0=>U>R\=:A;V>JWUO"GE[8XKEU5<Q*3@ XZFO;*\
M$^)7_)0M3_[9?^BDKU\IBI5VFNGZH\//)2CAHN+M[WZ,RO\ A*-?_P"@YJ7_
M (%R?XT?\)1K_P#T'-2_\"Y/\:RZ*^F]E3_E7W'R'MJO\S^\U/\ A*-?_P"@
MYJ7_ (%R?XT?\)1K_P#T'-2_\"Y/\:RZ*/94_P"5?<'MJO\ ,_O-3_A*-?\
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M][KP3XE?\E"U/_ME_P"BDKV,G_COT_5'@Y[_ +M'_$OR9RU%%%?4GQH4444
M%%%% !1110 4444 >S_!_P#Y%"Z_Z_G_ /1<==[7!?!__D4+K_K^?_T7'7>U
M\5CO]YGZGZ#EW^Z4_0****XSO"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KEOB5_P D]U/_ +9?^C4KJ:Y;XE?\D]U/_ME_Z-2NC"_QX>J_,Y<9_NU3
M_"_R/!****^Y/SD**** "BBB@ HHHH **** -3PO_P C?H__ %_0?^C%KZ0K
MYO\ "_\ R-^C_P#7]!_Z,6OI"OF\Y_B0]#ZW(?X4_4***;)(D2%Y75%'5F.
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M)\2O^2A:G_VR_P#125[W7@GQ*_Y*%J?_ &R_]%)7L9/_ !WZ?JCP<]_W:/\
MB7Y,Y:BBBOJ3XT**** "BBB@ HHHH **** /9_@__P BA=?]?S_^BXZ[VN"^
M#_\ R*%U_P!?S_\ HN.N]KXK'?[S/U/T'+O]TI^@4445QG>%%%% !1110 44
M44 %%%% !1110 4444 %%%% !7+?$K_DGNI_]LO_ $:E=37+?$K_ ))[J?\
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MWRO^-'_"66/_ #RN/^^5_P :Y"BC^V<7W7W!SLZ__A++'_GE<?\ ?*_XT?\
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ML)=2G&&>2.)!Z =?S-=?1175AL+[!MN5V[7]==?Q*2L%%%%=@PHHHH ****
M"O!/B5_R4+4_^V7_ **2O>Z\$^)7_)0M3_[9?^BDKV,G_COT_5'@Y[_NT?\
M$OR9RU%%%?4GQH4444 %%%% !1110 4444 >S_!__D4+K_K^?_T7'7>UX]X
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M_P"_K?\ Q->U44?VKB>Z^X/[%PG9_>><>'O >KZ3I[P7+VS,TI<&.0D8P!W
M]*U?^$6U#_IC_P!]_P#UJ[*BOF\5E]#%5I5ZE^:6K/2I4(4H*$=D<;_PBVH?
M],?^^_\ ZU'_  BVH?\ 3'_OO_ZU=E17/_8V$[/[S3D1QO\ PBVH?],?^^__
M *U'_"+:A_TQ_P"^_P#ZU=E11_8V$[/[PY$<;_PBVH?],?\ OO\ ^M1_PBVH
M?],?^^__ *U=E11_8V$[/[PY$<;_ ,(MJ'_3'_OO_P"M1_PBVH?],?\ OO\
M^M7944?V-A.S^\.1'&_\(MJ'_3'_ +[_ /K5O:'93Z;8O#.FYFD+@H01C '?
MZ5J45T8?+J&'G[2G>XU%(9O;_GD_YC_&C>W_ #R?\Q_C3Z*] H <CD8]C111
M0 4444 %%%% !1110 4444 %%%% !1110 5D:K?:A8W=L\/V9K>6>* 0E&,L
MA8_,0V0!A<G!!X4\BM>LNXT3S]8&HKJ-Y%(J[%C41LB#OM#(2,]R#D_@*!E!
M]=U 7'GQI;-:'4#8B$JPDSDKO+YQ]X=-O3O22:YJ5E'J270M;B:U6 ))#&R1
MB24XV,"23C*MQU##I5Q_#=N]R\@N[I(VG-R(%9=B2D8WC*[LY.[&<9[4V#PS
M#%IDUA+?WEQ!,,GS#&&5\[O,W*@);(!RQ/O0&A-I=]=RZA?V-^87DM3&RRPH
M45U=2?NEFP00>_I6I5+3],2PDGE,\US/<,#+--MW-@8 PH   ]!WJ[0(****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K EUF
M_P!/O+Y;Y;:>*VLI+PK;JRF+!.U&8DY+ '!P/NGBM^L>U\.1VZW237]W=PW8
M83QS^6?,W#'+! W X'S<#B@96AU'6C>_897T_P Z2U2Y6<1.$C&[# KORW;!
MRO7VY9-KNI+X0CU6*&V\SDN7#!63?M5E7J0PP1D\ YYJ:7PI%/ R3:GJ#NT:
M0F4M'N,:Y/ED;,%23SD$GH3CBK-WH1O=)_L^?4[SR\_,ZK"&8=EXCP ,=@*
MT-6BF01M%"J23/.RC!DD"AF]SM 'Y"GT""BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH BNOM'V9_L9B$Y&$,H)4>Y Y/TXSZ
MCK6##K>H36\4"?93=37[VL5QY3>4RHI9G"[LG[K+C=U[XK;U"S_M#3Y;4W$]
MN)1M,MNP5U'L<''I5#_A'T^QP0?;[H-;2"2WE18D:# *X4*@7!!(P0>M S-D
MUW6%TV:Y"V6^TN&MGC$;EKEP^T!/F^7((QG=R?;G2U*^U"RU.T$9MGM[BX2%
M8-C&5@02S[LX&WKC!X'7FH1X5B2:&6'4KZ.2(NV[]T^YV)+2$,A 8YQD 8'
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M]PD,P,)69]R87(3!)Z8&/N\8.<];10%SC(_%,DUBDD=XTS1Z09[@6X3<DP*
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M/]G3;L8L,#=C^$]ZALQI;1Z-_9>S^VA/&;LK_P ? _Y[>=_%ZYW=\8[5W-%
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M$XQ-M@4>8/\ :XY_&K(@B6X:=8D$SJ%:0*-S = 3Z#)_.GT4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
%110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>halo-20230324_g9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20230324_g9.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $=E=&%S97<@
M665S96=A=   !9 #  (    4   0J) $  (    4   0O)*1  (    #.#@
M )*2  (    #.#@  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" &) IL# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=,#Z8_2O5;G2--O)Q-=Z?:SRCI)+ K,/Q(J26RM)Y(9)[:&1[<YA9XP3&?\
M9)Z=!T]* YC@--T#2IOBGK5E+80M:Q6RND&WY%+*F2!T'WC],\5R\<MPW@72
M48I]D75'63SMWE#A2 ^.=O+].>N*]H2SM8[R2[CMH5N9 %>98P'<#H"W4]!^
M51QZ7816;6D5C;);,<M"L*A"?4KC% <QQ'@^U9?&<]Q%>Z)MDM?WMMI+.4X(
MPV", Y]_PZU<\4_+\0_##2#Y"S@$CC/'^(KK+33K+3U86%G;VH;[PAB5,_7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTKO**SJ4U4CRLPQ%"->FX2.&\$^$1##)>:W8J968>1',N2@&<DK[\=>>*[D
M 8 P!1113IQIQY4%"A"A!0B%%%%:&X4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>6_&C_F"_\ ;?\ ]IUZE7EOQH_Y@O\ VW_]IUZ&6_[W
M#Y_DSR\V_P!RG\OS1Y;1117V)\&%%%% !1110 4444 %%%% 'L_P?_Y%"Z_Z
M_G_]%QUWM<%\'_\ D4+K_K^?_P!%QUWM?%8[_>9^I^@Y=_NE/T"BBBN,[PHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *^6Z^I*^6Z^AR7_EY\OU/E^(/
M^7?S_0****^@/EPHHHH **** "BBB@ K4\+_ /(WZ/\ ]?T'_HQ:RZU/"_\
MR-^C_P#7]!_Z,6LZO\.7HS6C_%CZH^D****^"/TL**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M #!?^V__ +3KT,M_WN'S_)GEYM_N4_E^:/+:***^Q/@PHHHH **** "BBB@
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MZ59KV*/,J4>;>RN6M@HHHK484444 %%%% !1110!!?NT>FW+I;?:V6)B+?\
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MHJC'ECW;^]W"BBBLC8**** "BFK(CLRHZLR'# ')4^].I)I[ %%%%, HHHH
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M444 %?+=?4E?+=?0Y+_R\^7ZGR_$'_+OY_H%%%%?0'RX4444 %%%% !1110
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MH ]G^#__ "*%U_U_/_Z+CKO:\P^%^N6VF^&+B&=)69KQG!0 C&Q!W/M79_\
M"66/_/*X_P"^5_QK\_S''8:GBZD932:9^@9=)?5*?H;E9L6A6<5^]SY:G."B
M8.$/<]>:J_\ "66/_/*X_P"^5_QH_P"$LL?^>5Q_WRO^->74Q>!J-.<D[;'=
M>++\NCV$]P9Y;96D)R3DX)^G2I'TZUDEDD>$%Y8_+<Y(ROI^E9G_  EEC_SR
MN/\ OE?\:/\ A++'_GE<?]\K_C2^M9?KK'7R"\2[#H>G6\RRPV^UT.5.]CC]
M:D.E636GV8P P[M^W<>OKG.:SO\ A++'_GE<?]\K_C1_PEEC_P \KC_OE?\
M&DL1ET59./W"O$UOLD'VE)_+_>QIL4@G@>F.E35A_P#"66/_ #RN/^^5_P :
M/^$LL?\ GE<?]\K_ (UJL?@X[30^9&Y16'_PEEC_ ,\KC_OE?\:TM.U&+4K=
MIH%=55]A#@ YP#V/O6U+%T*LN6G)-CNF6J***ZAA1110 44UD#')+?@Q%)Y2
M^K_]]G_&@!]?+=?4/E+ZO_WV?\:R_P#A$O#W_0$L/_ =?\*]+ XR.%YN97O;
M]3R<RP$L9R\LK6O^-O\ (^<J*^C?^$2\/?\ 0$L/_ =?\*/^$2\/?] 2P_\
M =?\*]/^V:?\K/(_L&K_ #H^<J*^C?\ A$O#W_0$L/\ P'7_  H_X1+P]_T!
M+#_P'7_"C^V:?\K#^P:O\Z/G*BOHW_A$O#W_ $!+#_P'7_"C_A$O#W_0$L/_
M  '7_"C^V:?\K#^P:O\ .CYRHKZ-_P"$2\/?] 2P_P# =?\ "C_A$O#W_0$L
M/_ =?\*/[9I_RL/[!J_SH^<JMZ3_ ,AJR_Z^(_\ T(5]!?\ ")>'O^@)8?\
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M\_MO_P!_5_QH_M*Q_P"?VW_[^K_C3/[(T_\ Y\X?^^:/[(T__GSA_P"^:/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1W6-&>1@JJ,LS'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M $%K'_P)3_&I=2TNSU>U%OJ,(FB#!PNXC!'?((/<UE?\(-X=_P"@=_Y'D_\
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M%EA;63SP":=E*;4\B1=ZLP7>IV_,O/49'(&?F&;UWJ@MAIY2)G6]G6(;P4*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
-BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140357805554016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Halozyme Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001159036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140357800592256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.871%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.040%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.363%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.363%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.363%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.998%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.363%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.857%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.363%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.209%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.218%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Pay-Versus-Performance Table</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based on:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Summary of Compensation Table for PEO (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation Actually Paid to PEO (3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Summary Compensation Table Total for Non-PEO NEOs (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Compensation Actually Paid to Non-PEO NEOs (3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Shareholder Return (4)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Peer Group Total Shareholder Return (4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Income (Millions) (5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue (Millions) (6)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,696,978</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,817,187</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415,581</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,154,512</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.65</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">660.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,453,294</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,992,078</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,398,657</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,581</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.79</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.45</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402.7</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">443.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,518,876</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,374,731</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,812,287</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,356,681</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268.0</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="text">Helen I Torley was our CEO for each of the three years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Ms. Stelzer separated employment from Halozyme on March 6, 2020. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#8217;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for each fiscal year covered in the table.  The  average compensation for the Non-PEO NEOs for 2022 was calculated in the Summary Compensation Table above.  The average compensation for the Non-PEO NEOs for each of 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the Securities and Exchange Commission in calendar year 2022 or 2021, respectively.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 9,696,978<span></span>
</td>
<td class="nump">$ 7,453,294<span></span>
</td>
<td class="nump">$ 6,518,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 22,817,187<span></span>
</td>
<td class="nump">5,992,078<span></span>
</td>
<td class="nump">24,374,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="text">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:<div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,  </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award in the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards.  For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:57.008%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.866%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2022 ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2021 ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2020 ($)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,696,978</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,453,294</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,518,876</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,250,048&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,800,082&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000,019&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,906,354&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,269,706&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,349,282&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,707,222&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200,168)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,855,689&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243,319)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269,328&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650,904&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,817,187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,992,078</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,374,731</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 2,415,581<span></span>
</td>
<td class="nump">2,398,657<span></span>
</td>
<td class="nump">1,812,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 3,154,512<span></span>
</td>
<td class="nump">591,581<span></span>
</td>
<td class="nump">4,356,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="text">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:<div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,  </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award in the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards.  For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for a fiscal year to the average of the Compensation Actually Paid for the Non-PEO NEOs for that fiscal year.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"><tr><td style="width:1.0%"/><td style="width:49.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.218%"/><td style="width:0.1%"/></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2022 ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2021 ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2020 ($)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,415,581</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,398,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,812,287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850,034&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550,057&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200,080&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,501,893&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,386&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,060,449&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,849&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226,734)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959,721&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,998)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,721&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,408&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,285,779)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983,392)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475,103)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,154,512</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">591,581</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,356,681</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="text">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.<img alt="halo-20230324_g8.jpg" src="halo-20230324_g8.jpg" style="height:395px;margin-bottom:5pt;vertical-align:text-bottom;width:677px"/><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="text">This column shows Halozyme&#8217;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our net income for each of those years.<img alt="halo-20230324_g9.jpg" src="halo-20230324_g9.jpg" style="height:393px;margin-bottom:5pt;vertical-align:text-bottom;width:667px"/><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure [Text Block]</a></td>
<td class="text">This column shows Halozyme&#8217;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2022 executive compensation program because it is used in determining each of our NEO&#8217;s annual 2022 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our revenue for each of those years.<img alt="halo-20230324_g10.jpg" src="halo-20230324_g10.jpg" style="height:392px;margin-bottom:5pt;vertical-align:text-bottom;width:635px"/><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group [Text Block]</a></td>
<td class="text">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.<img alt="halo-20230324_g8.jpg" src="halo-20230324_g8.jpg" style="height:395px;margin-bottom:5pt;vertical-align:text-bottom;width:677px"/><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2022 with Halozyme performance.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Revenue (as used in our 2022 EBP)</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Non-GAAP Operating Income (as defined in the discussion of our 2022 EBP included in the Compensation Discussion and Analysis above and as used in our 2022 EBP)</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Stock Price (including relative TSR, as used in our PSUs awarded in 2021 and 2022 and as described in the Compensation Discussion and Analysis above)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the financial performance measures listed above, we view our stock price, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 320.93<span></span>
</td>
<td class="nump">226.79<span></span>
</td>
<td class="nump">240.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">113.65<span></span>
</td>
<td class="nump">126.45<span></span>
</td>
<td class="nump">126.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 202,100,000<span></span>
</td>
<td class="nump">$ 402,700,000<span></span>
</td>
<td class="nump">$ 129,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">660,100,000<span></span>
</td>
<td class="nump">443,300,000<span></span>
</td>
<td class="nump">268,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure [Axis]: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure [Axis]: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">Operating Income<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure [Axis]: 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">relative TSR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=4', window );">Measure [Axis]: 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Measure Name</a></td>
<td class="text">stock price<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Reported Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">$ 8,250,048<span></span>
</td>
<td class="nump">$ 5,800,082<span></span>
</td>
<td class="nump">$ 5,000,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Outstanding, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">16,906,354<span></span>
</td>
<td class="nump">4,269,706<span></span>
</td>
<td class="nump">12,349,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">4,707,222<span></span>
</td>
<td class="num">(1,200,168)<span></span>
</td>
<td class="nump">8,855,689<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(243,319)<span></span>
</td>
<td class="nump">1,269,328<span></span>
</td>
<td class="nump">1,650,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO [Member] | Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Reported Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">1,850,034<span></span>
</td>
<td class="nump">1,550,057<span></span>
</td>
<td class="nump">1,200,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Outstanding, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">3,501,893<span></span>
</td>
<td class="nump">801,386<span></span>
</td>
<td class="nump">3,060,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">390,849<span></span>
</td>
<td class="num">(226,734)<span></span>
</td>
<td class="nump">959,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">(17,998)<span></span>
</td>
<td class="nump">151,721<span></span>
</td>
<td class="nump">199,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="num">$ (1,285,779)<span></span>
</td>
<td class="num">$ (983,392)<span></span>
</td>
<td class="num">$ (475,103)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockReportedValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockReportedValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>halo-20230324_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022q4"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2022q4"
  xmlns:halo="http://www.halozyme.com/20230324"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="halo-20230324.xsd" xlink:type="simple"/>
    <context id="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic233aab1402747439a99eaeeed8ebeec_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2aa4e90521e74fbda5fc78c806b80fcf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27d40edd3894424da8813a26e8d6173b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f31ca4805ad4f31bf9686ab3097fe4d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i951348a08ad147db83dd0bb1e4382682_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia04ec946f88c42e5882937b764c87374_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib406196d7595400897664d81791bb3f0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia09b21b978d940d7b4cc0ab07d252950_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic6b9a40f09ae4019950c233f8e16c789_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6726fe3095004f08aee055c5fc65a129_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i73e8b974a7fb4565bf9cd80e6b9a30fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7ea6d01c149b4df1a874f34555a8ea73_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i486c1364dde840db9e11001f598305b4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i25825bb1d27d459fa7e4cda106965d40_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1a313ba358404f54813109f614f52c34_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8189d53cb944b81afe0d84f0854abf5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i66ff6d5bd97145479f89a20ad42fd15a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3ff7284bcbaf42cf850afd12ab927c00_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if7230eccd63144b181cd7473b5e92360_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i87a6bad5804241ee912f12ab5ba61df3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3ba339385284259ba286ed4270a14a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7f94abe5308e43378c7f5196dcbd8017_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if0218f246c624e68baa4cf97406a96ac_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib2176be3bb204ee1b5cb0212d4e70bd8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idfb7b7c9fc8e4cc8b741377634d02e07_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i052e13dd0ce144449177390340355420_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie6eac36125f8409589042ca5c735ab4f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ief61f2c54ea74e2f8aae9d1e44bbb344_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i860099e12a694c44b167d75f32a8a497_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2d54128f996942f3b0b87b094ef4a4a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie3f864ec9bf24217b9cfe061a82096f7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id3f6d8398a7b458eaacca7ac3fdd0c35_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieae581e574ec480d840feb807df086cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3f9165ecacd456ca5dac168f8ea3db0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i79a81987b87747ad91a4f6b085db1629_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i34373954fe8e4556ac5d61e920cfeff5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ief15cebdc51a48808cec748bb98ec8c6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic7f0a86c0cb84565be52505cbee9db9b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i476176300b1742fe94ad802bfc6aee95_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7b2a90f9c80e4bed99a628adfd8e5349_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-2">0001159036</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-3">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-4">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-1">Halozyme Therapeutics, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-5">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.504%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.857%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022 Pay-Versus-Performance Table&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Value of Initial Fixed $100 Investment Based on:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Summary of Compensation Table for PEO (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensation Actually Paid to PEO (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average Summary Compensation Table Total for Non-PEO NEOs (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average Compensation Actually Paid to Non-PEO NEOs (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Shareholder Return (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Peer Group Total Shareholder Return (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Income (Millions) (5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue (Millions) (6)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,696,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,817,187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,154,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;660.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,453,294&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,992,078&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,398,657&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;591,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;443.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,518,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,374,731&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,812,287&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,356,681&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;240.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="0"
      id="f-6"
      unitRef="usd">9696978</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="0"
      id="f-7"
      unitRef="usd">22817187</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="0"
      id="f-8"
      unitRef="usd">2415581</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="0"
      id="f-9"
      unitRef="usd">3154512</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="2"
      id="f-10"
      unitRef="usd">320.93</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="2"
      id="f-11"
      unitRef="usd">113.65</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="-5"
      id="f-12"
      unitRef="usd">202100000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="-5"
      id="f-13"
      unitRef="usd">660100000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="0"
      id="f-14"
      unitRef="usd">7453294</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="0"
      id="f-15"
      unitRef="usd">5992078</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="0"
      id="f-16"
      unitRef="usd">2398657</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="0"
      id="f-17"
      unitRef="usd">591581</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="2"
      id="f-18"
      unitRef="usd">226.79</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="2"
      id="f-19"
      unitRef="usd">126.45</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="-5"
      id="f-20"
      unitRef="usd">402700000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="-5"
      id="f-21"
      unitRef="usd">443300000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="0"
      id="f-22"
      unitRef="usd">6518876</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="0"
      id="f-23"
      unitRef="usd">24374731</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="0"
      id="f-24"
      unitRef="usd">1812287</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="0"
      id="f-25"
      unitRef="usd">4356681</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="2"
      id="f-26"
      unitRef="usd">240.89</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="2"
      id="f-27"
      unitRef="usd">126.42</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="-5"
      id="f-28"
      unitRef="usd">129000000.0</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="-5"
      id="f-29"
      unitRef="usd">268000000.0</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-30">Helen I Torley was our CEO for each of the three years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Ms. Stelzer separated employment from Halozyme on March 6, 2020. Mr. Matsuda separated employment from Halozyme on December 31, 2021.  Ms. LaBrosse was appointed to Halozyme&#x2019;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for each fiscal year covered in the table.  The  average compensation for the Non-PEO NEOs for 2022 was calculated in the Summary Compensation Table above.  The average compensation for the Non-PEO NEOs for each of 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the Securities and Exchange Commission in calendar year 2022 or 2021, respectively.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      id="f-31">Helen I Torley</ecd:PeoName>
    <ecd:PeoName
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-32">Helen I Torley</ecd:PeoName>
    <ecd:PeoName
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      id="f-33">Helen I Torley</ecd:PeoName>
    <ecd:AdjToNonPeoNeoCompFnTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-34">For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#x2019;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#x2019;s LTI awards granted to the Named Executive Officer:&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;the vesting date value of awards which were granted and vested during the same covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Less&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#x2019;s Halozyme LTI awards during the fiscal years covered by the table),&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In making each of these adjustments, the &#x201c;value&#x201d; of an award in the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards.  For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for a fiscal year to the average of the Compensation Actually Paid for the Non-PEO NEOs for that fiscal year.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:0pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2022 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2021 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2020 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,415,581&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,398,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,812,287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,550,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,501,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,060,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,998)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,285,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(475,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,154,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;591,581&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,356,681&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:AdjToPeoCompFnTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-35">For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#x2019;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#x2019;s LTI awards granted to the Named Executive Officer:&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;the vesting date value of awards which were granted and vested during the same covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Less&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#x2019;s Halozyme LTI awards during the fiscal years covered by the table),&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In making each of these adjustments, the &#x201c;value&#x201d; of an award in the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards.  For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2022 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2021 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2020 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,696,978&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,453,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,518,876&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,250,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,800,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,906,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,269,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,349,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,707,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,200,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,855,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,650,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,817,187&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,992,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,374,731&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="0"
      id="f-36"
      unitRef="usd">9696978</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="0"
      id="f-37"
      unitRef="usd">7453294</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="0"
      id="f-38"
      unitRef="usd">6518876</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ic233aab1402747439a99eaeeed8ebeec_D20220101-20221231"
      decimals="0"
      id="f-39"
      unitRef="usd">8250048</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i2aa4e90521e74fbda5fc78c806b80fcf_D20210101-20211231"
      decimals="0"
      id="f-40"
      unitRef="usd">5800082</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i27d40edd3894424da8813a26e8d6173b_D20200101-20201231"
      decimals="0"
      id="f-41"
      unitRef="usd">5000019</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i4f31ca4805ad4f31bf9686ab3097fe4d_D20220101-20221231"
      decimals="0"
      id="f-42"
      unitRef="usd">16906354</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i951348a08ad147db83dd0bb1e4382682_D20210101-20211231"
      decimals="0"
      id="f-43"
      unitRef="usd">4269706</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ia04ec946f88c42e5882937b764c87374_D20200101-20201231"
      decimals="0"
      id="f-44"
      unitRef="usd">12349282</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ib406196d7595400897664d81791bb3f0_D20220101-20221231"
      decimals="0"
      id="f-45"
      unitRef="usd">4707222</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ia09b21b978d940d7b4cc0ab07d252950_D20210101-20211231"
      decimals="0"
      id="f-46"
      unitRef="usd">-1200168</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ic6b9a40f09ae4019950c233f8e16c789_D20200101-20201231"
      decimals="0"
      id="f-47"
      unitRef="usd">8855689</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i6726fe3095004f08aee055c5fc65a129_D20220101-20221231"
      decimals="0"
      id="f-48"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i73e8b974a7fb4565bf9cd80e6b9a30fe_D20210101-20211231"
      decimals="0"
      id="f-49"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i7ea6d01c149b4df1a874f34555a8ea73_D20200101-20201231"
      decimals="0"
      id="f-50"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i486c1364dde840db9e11001f598305b4_D20220101-20221231"
      decimals="0"
      id="f-51"
      unitRef="usd">-243319</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i25825bb1d27d459fa7e4cda106965d40_D20210101-20211231"
      decimals="0"
      id="f-52"
      unitRef="usd">1269328</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i1a313ba358404f54813109f614f52c34_D20200101-20201231"
      decimals="0"
      id="f-53"
      unitRef="usd">1650904</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ib8189d53cb944b81afe0d84f0854abf5_D20220101-20221231"
      decimals="0"
      id="f-54"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i66ff6d5bd97145479f89a20ad42fd15a_D20210101-20211231"
      decimals="0"
      id="f-55"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i3ff7284bcbaf42cf850afd12ab927c00_D20200101-20201231"
      decimals="0"
      id="f-56"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="0"
      id="f-57"
      unitRef="usd">22817187</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="0"
      id="f-58"
      unitRef="usd">5992078</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="0"
      id="f-59"
      unitRef="usd">24374731</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="0"
      id="f-60"
      unitRef="usd">2415581</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="0"
      id="f-61"
      unitRef="usd">2398657</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="0"
      id="f-62"
      unitRef="usd">1812287</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="if7230eccd63144b181cd7473b5e92360_D20220101-20221231"
      decimals="0"
      id="f-63"
      unitRef="usd">1850034</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i87a6bad5804241ee912f12ab5ba61df3_D20210101-20211231"
      decimals="0"
      id="f-64"
      unitRef="usd">1550057</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ia3ba339385284259ba286ed4270a14a8_D20200101-20201231"
      decimals="0"
      id="f-65"
      unitRef="usd">1200080</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i7f94abe5308e43378c7f5196dcbd8017_D20220101-20221231"
      decimals="0"
      id="f-66"
      unitRef="usd">3501893</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="if0218f246c624e68baa4cf97406a96ac_D20210101-20211231"
      decimals="0"
      id="f-67"
      unitRef="usd">801386</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ib2176be3bb204ee1b5cb0212d4e70bd8_D20200101-20201231"
      decimals="0"
      id="f-68"
      unitRef="usd">3060449</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="idfb7b7c9fc8e4cc8b741377634d02e07_D20220101-20221231"
      decimals="0"
      id="f-69"
      unitRef="usd">390849</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i052e13dd0ce144449177390340355420_D20210101-20211231"
      decimals="0"
      id="f-70"
      unitRef="usd">-226734</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ie6eac36125f8409589042ca5c735ab4f_D20200101-20201231"
      decimals="0"
      id="f-71"
      unitRef="usd">959721</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ief61f2c54ea74e2f8aae9d1e44bbb344_D20220101-20221231"
      decimals="0"
      id="f-72"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i860099e12a694c44b167d75f32a8a497_D20210101-20211231"
      decimals="0"
      id="f-73"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i2d54128f996942f3b0b87b094ef4a4a0_D20200101-20201231"
      decimals="0"
      id="f-74"
      unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ie3f864ec9bf24217b9cfe061a82096f7_D20220101-20221231"
      decimals="0"
      id="f-75"
      unitRef="usd">-17998</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="id3f6d8398a7b458eaacca7ac3fdd0c35_D20210101-20211231"
      decimals="0"
      id="f-76"
      unitRef="usd">151721</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ieae581e574ec480d840feb807df086cd_D20200101-20201231"
      decimals="0"
      id="f-77"
      unitRef="usd">199408</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="ia3f9165ecacd456ca5dac168f8ea3db0_D20220101-20221231"
      decimals="0"
      id="f-78"
      unitRef="usd">-1285779</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i79a81987b87747ad91a4f6b085db1629_D20210101-20211231"
      decimals="0"
      id="f-79"
      unitRef="usd">-983392</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="i34373954fe8e4556ac5d61e920cfeff5_D20200101-20201231"
      decimals="0"
      id="f-80"
      unitRef="usd">-475103</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      decimals="0"
      id="f-81"
      unitRef="usd">3154512</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="i3e959fab3e754929b6edc9bdf8470801_D20210101-20211231"
      decimals="0"
      id="f-82"
      unitRef="usd">591581</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="ib41a6beaa6994745be705a1062025bc2_D20200101-20201231"
      decimals="0"
      id="f-83"
      unitRef="usd">4356681</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-84">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#x2019;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.&lt;img alt="halo-20230324_g8.jpg" src="halo-20230324_g8.jpg" style="height:395px;margin-bottom:5pt;vertical-align:text-bottom;width:677px"/&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-85">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#x2019;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.&lt;img alt="halo-20230324_g8.jpg" src="halo-20230324_g8.jpg" style="height:395px;margin-bottom:5pt;vertical-align:text-bottom;width:677px"/&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-86">This column shows Halozyme&#x2019;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our net income for each of those years.&lt;img alt="halo-20230324_g9.jpg" src="halo-20230324_g9.jpg" style="height:393px;margin-bottom:5pt;vertical-align:text-bottom;width:667px"/&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-87">This column shows Halozyme&#x2019;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2022 executive compensation program because it is used in determining each of our NEO&#x2019;s annual 2022 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last three years against our revenue for each of those years.&lt;img alt="halo-20230324_g10.jpg" src="halo-20230324_g10.jpg" style="height:392px;margin-bottom:5pt;vertical-align:text-bottom;width:635px"/&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TabularListTableTextBlock
      contextRef="ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231"
      id="f-88">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2022 with Halozyme performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;Revenue (as used in our 2022 EBP)&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;Non-GAAP Operating Income (as defined in the discussion of our 2022 EBP included in the Compensation Discussion and Analysis above and as used in our 2022 EBP)&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;Stock Price (including relative TSR, as used in our PSUs awarded in 2021 and 2022 and as described in the Compensation Discussion and Analysis above)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In addition to the financial performance measures listed above, we view our stock price, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.&lt;/span&gt;&lt;/div&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName
      contextRef="ief15cebdc51a48808cec748bb98ec8c6_D20220101-20221231"
      id="f-89">Revenue</ecd:MeasureName>
    <ecd:MeasureName
      contextRef="ic7f0a86c0cb84565be52505cbee9db9b_D20220101-20221231"
      id="f-90">Operating Income</ecd:MeasureName>
    <ecd:MeasureName
      contextRef="i476176300b1742fe94ad802bfc6aee95_D20220101-20221231"
      id="f-91">relative TSR</ecd:MeasureName>
    <ecd:MeasureName
      contextRef="i7b2a90f9c80e4bed99a628adfd8e5349_D20220101-20221231"
      id="f-92">stock price</ecd:MeasureName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>21
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( (F >%8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " ")@'A6DPLN9NX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R$G*!B;-I:.G#@8K;.QF;+4UBV-C:R1]^SE>FS*V!]C1TN]/
MGT"M\D*Y@,_!>0QD,-Y-MA^B4'[-3D1> $1U0BMCF1)#:AY<L)+2,QS!2_4A
MCP@UY_=@D:26)&$&%GXALJ[52JB DERXX+5:\/XS]!FF%6"/%@>*4)45L&Z>
MZ,]3W\(-,,,(@XW?!=0+,5?_Q.8.L$MRBF9)C>-8CDW.I1TJ>'O:O>1U"S-$
MDH/"]"L:06>/:W:=_-IL'O=;UM6\;@K>%/5J7W/!5X(_O,^N/_QNPM9I<S#_
MV/@JV+7PZRZZ+U!+ P04    " ")@'A6F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M (F >%:XEL#4?0(  /T&   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM95=;],P%(;_BA4DKJ;FHQ\KI8W4=ILVP=#4#;A 7'C):6+-'\%VVI5?C^VD
M69$R Q?<)+9SWM?/L9WC^5[()U4":/3,*%>+H-2ZFH6ARDI@6 U$!=Q\V0K)
ML#9=682JDH!S)V(T3*)H$C),>)#.W=B=3.>BUI1PN)-(U8QA>5@!%?M%$ ?'
M@0TI2FT'PG1>X0+N07^N[J3IA9U+3AAP101'$K:+8!G/5E,;[P*^$-BKDS:R
MF3P*\60[-_DBB"P04,BT=<#FM8,U4&J-#,:/UC/HIK3"T_;1_<KE;G)YQ K6
M@GXEN2X7P31 .6QQ3?5&[*^AS6=L_3)!E7NB?1,[' 4HJY46K!4; D9X\\;/
M[3J<")+I*X*D%22.NYG(45Y@C=.Y%'LD;;1QLPV7JE,;.,+MIMQK:;X2H]/I
M6NQ SD-MK.Q F+6R52-+7I'%";H57)<*7?(<\M\-0L/0@21'D%7B=;R ;("&
M\1E*HB3Q^ V[Q(;.;_B:G\AJ<W@TNN'-T;5GX-M'$X5N-##UO2_IQG+4;VG_
MCYFJ< :+P/P "N0.@O3MFW@2O?< CSK@D<_]!?CA4$$?W!_DEU<H'BT](.,.
M9.QU6AJ*W)%<45STD?CU6TP5>#@F'<?$NX.77!-]^*?]F_R'_3OO<,^]:;>X
M&RB(TA*;Y?N$6>]&^GVN,14_#PS00PD25U!KDJDSLPS9P$,Y[2BG?T.Y-MLK
M,36N.3RC#W#HX_0[15$4Q^-WT7#2AQ6>E"0&LG"%5Z%,U%PWU:D;[6K[LBEI
M+^'-Q7"+94&X0A2V1AH-SLWQDTVQ;3I:5*[ /0IMRJ5KEN9^ FD#S/>M$/K8
ML1-T-U[Z"U!+ P04    " ")@'A6!7AC?!D5  #/BP  &    'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;.U=>6_C.++_*D0V6"2 XDC48:DO((G2,[VO>SK;
MR?1@L9@_%)N)]5J6O)*<8_$^_!9)790HVL[0@WU !IB.+),_%HM5K(.'WSUF
M^8]B04B)GI9)6KP_6)3EZLWI:3%;D&543+(52>&;NRQ?1B5\S.]/BU5.HCFK
MM$Q.L6EZI\LH3@\^O&/OKO(/[[)UF<0IN<I1L5XNH_SYG"39X_L#ZZ!^\2V^
M7Y3TQ>F'=ZOHGER3\M?550Z?3AN4>;PD:1%G*<K)W?N#,^M-Z 6T BOQ/2:/
M1><9T:[<9MD/^N'3_/V!22DB"9F5%"*"/P_D@B0)10(Z_E6!'C1MTHK=YQK]
M(^L\=.8V*LA%EOP6S\O%^P/_ ,W)7;1.RF_9X\^DZI!+\6994K!_T6-5UCQ
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MP/?TVNOZ VW@,<M_,+(__ =02P,$%     @ B8!X5O+O>ZL& P  +1    T
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M1AS!%( &#(FB;A\\V(^"S3X5;/\@F/T"4$L#!!0    ( (F >%:7BKL<P
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MFKWZ\X'U/+_%K7V)Z]#?R>7C -[/2]]02P,$%     @ B8!X5FZG)+P> 0
M5P0  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULQ93/3L,P#,9?I<IU:C)VX(#6
M78 K[, +A-9=H^:?8F]T;X_;;I- HV(J$I=&C>WOY_B+LGX[1L"L<]9C(1JB
M^* 4E@TXC3)$\!RI0W*:^#?M5-1EJW>@5LOEO2J#)_"44Z\A-NLGJ/7>4O;<
M\3::X N1P*+('L?$GE4(':,UI2:.JX.OOE'R$T%RY9"#C8FXX 2AKA+ZR,^
M4]WK 5(R%61;G>A%.\Y2G55(1PLHIR6N]!CJVI10A7+ON$1B3* K; #(63F*
M+J;)Q!.&\7LWFS_(3 $Y<YM"1'8LP>VXLR5]=1Y9"!*9Z2->B"P]^WS0NUU!
M]4LVC_<CI';P ]6PS)_Q5X\O^C?VL?K'/MY#:/_ZJO>K=-KX,U\-[\GF$U!+
M 0(4 Q0    ( (F >%8'04UB@0   +$    0              "  0    !D
M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ B8!X5I,++F;N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
MB8!X5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " ")@'A6N); U'T"  #]!@  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
MB8!X5@5X8WP9%0  SXL  !@              ("!P H  'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( (F >%;R[WNK!@,  "T0   -
M          "  0\@  !X;"]S='EL97,N>&UL4$L! A0#%     @ B8!X5I>*
MNQS     $P(   L              ( !0",  %]R96QS+RYR96QS4$L! A0#
M%     @ B8!X5K),^V]4 0  Q0(   \              ( !*20  'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( (F >%:-]RQ:M    (D"   :
M      "  :HE  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( (F >%9NIR2\'@$  %<$   3              "  98F  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     *  H A (  .4G      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>43</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="halo-20230324.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="halo-20230324.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" original="halo-20230324.htm">halo-20230324.htm</File>
    <File>halo-20230324.xsd</File>
    <File>halo-20230324_def.xml</File>
    <File>halo-20230324_lab.xml</File>
    <File>halo-20230324_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>halo-20230324_g1.jpg</File>
    <File>halo-20230324_g10.jpg</File>
    <File>halo-20230324_g11.jpg</File>
    <File>halo-20230324_g12.jpg</File>
    <File>halo-20230324_g2.jpg</File>
    <File>halo-20230324_g3.jpg</File>
    <File>halo-20230324_g4.jpg</File>
    <File>halo-20230324_g5.jpg</File>
    <File>halo-20230324_g6.jpg</File>
    <File>halo-20230324_g7.jpg</File>
    <File>halo-20230324_g8.jpg</File>
    <File>halo-20230324_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2022q4</BaseTaxonomy>
    <BaseTaxonomy items="85">http://xbrl.sec.gov/ecd/2022q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>26
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "halo-20230324.htm": {
   "axisCustom": 0,
   "axisStandard": 3,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022q4": 4,
    "http://xbrl.sec.gov/ecd/2022q4": 85
   },
   "contextCount": 43,
   "dts": {
    "definitionLink": {
     "local": [
      "halo-20230324_def.xml"
     ]
    },
    "inline": {
     "local": [
      "halo-20230324.htm"
     ]
    },
    "labelLink": {
     "local": [
      "halo-20230324_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "halo-20230324_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "halo-20230324.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_def.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_lab.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-2022q4_pre.xsd",
      "https://xbrl.sec.gov/dei/2022q4/dei-sub-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd",
      "https://xbrl.sec.gov/ecd/2022q4/ecd-sub-2022q4.xsd"
     ]
    }
   },
   "elementCount": 219,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 6,
   "memberStandard": 3,
   "nsprefix": "halo",
   "nsuri": "http://www.halozyme.com/20230324",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20230324.htm",
      "contextRef": "ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "995100 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20230324.htm",
      "contextRef": "ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20230324.htm",
      "contextRef": "ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "menuCat": "Notes",
     "order": "2",
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "shortName": "Pay vs Performance Disclosure",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20230324.htm",
      "contextRef": "ia685f3fe53c944709f5d4547df6c341e_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:PvpTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 9,
   "tag": {
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "localname": "AuditorLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "xbrltype": "stringItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "localname": "AuditorTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelFaxNumber": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fax Number of contact personnel.",
        "label": "Contact Personnel Fax Number"
       }
      }
     },
     "localname": "ContactPersonnelFaxNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContainedFileInformationFileDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the contained file.",
        "label": "Contained File Information, File Description"
       }
      }
     },
     "localname": "ContainedFileInformationFileDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_ContainedFileInformationFileName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the contained file.",
        "label": "Contained File Information, File Name"
       }
      }
     },
     "localname": "ContainedFileInformationFileName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContainedFileInformationFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The SEC Document Number of the contained file.",
        "label": "Contained File Information, File Number"
       }
      }
     },
     "localname": "ContainedFileInformationFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_ContainedFileInformationFileType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.).",
        "label": "Contained File Information, File Type"
       }
      }
     },
     "localname": "ContainedFileInformationFileType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r73",
      "r74",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentCopyrightInformation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The copyright information for the document.",
        "label": "Document Copyright Information"
       }
      }
     },
     "localname": "DocumentCopyrightInformation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentCreationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different.",
        "label": "Document Creation Date"
       }
      }
     },
     "localname": "DocumentCreationDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the document.",
        "label": "Document Description"
       }
      }
     },
     "localname": "DocumentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentEffectiveDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases.",
        "label": "Document Effective Date"
       }
      }
     },
     "localname": "DocumentEffectiveDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement",
        "label": "Document Financial Statement Error Correction [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b).",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]"
       }
      }
     },
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Text Block]"
       }
      }
     },
     "localname": "DocumentInformationTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_DocumentName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'.",
        "label": "Document Name"
       }
      }
     },
     "localname": "DocumentName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentSubtitle": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'.",
        "label": "Document Subtitle"
       }
      }
     },
     "localname": "DocumentSubtitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentSynopsis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'",
        "label": "Document Synopsis"
       }
      }
     },
     "localname": "DocumentSynopsis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentTitle": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'.",
        "label": "Document Title"
       }
      }
     },
     "localname": "DocumentTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentVersion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The version identifier of the document.",
        "label": "Document Version"
       }
      }
     },
     "localname": "DocumentVersion",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAccountingStandard": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element.",
        "label": "Entity Accounting Standard"
       }
      }
     },
     "localname": "EntityAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses.",
        "label": "Entity Address, Address Description"
       }
      }
     },
     "localname": "EntityAddressAddressDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityContactPersonnelLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Contact Personnel [Line Items]"
       }
      }
     },
     "localname": "EntityContactPersonnelLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityHomeCountryISOCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element.",
        "label": "Entity Home Country ISO Code"
       }
      }
     },
     "localname": "EntityHomeCountryISOCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityLegalForm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc.",
        "label": "Entity Legal Form"
       }
      }
     },
     "localname": "EntityLegalForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'.",
        "label": "Entity Listing, Depository Receipt Ratio"
       }
      }
     },
     "localname": "EntityListingDepositoryReceiptRatio",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "pureItemType"
    },
    "dei_EntityListingDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security.",
        "label": "Entity Listing, Description"
       }
      }
     },
     "localname": "EntityListingDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingForeign": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt.",
        "label": "Entity Listing, Foreign"
       }
      }
     },
     "localname": "EntityListingForeign",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingParValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'.",
        "label": "Entity Listing, Par Value Per Share"
       }
      }
     },
     "localname": "EntityListingParValuePerShare",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_EntityListingPrimary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity.",
        "label": "Entity Listing, Primary"
       }
      }
     },
     "localname": "EntityListingPrimary",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'",
        "label": "Entity Listing, Security Trading Currency"
       }
      }
     },
     "localname": "EntityListingSecurityTradingCurrency",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Phone Fax Numbers [Line Items]"
       }
      }
     },
     "localname": "EntityPhoneFaxNumbersLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityReportingCurrencyISOCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'.",
        "label": "Entity Reporting Currency ISO Code"
       }
      }
     },
     "localname": "EntityReportingCurrencyISOCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "currencyItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to serve as parent of six Entity related Table concepts.",
        "label": "Entity [Text Block]"
       }
      }
     },
     "localname": "EntityTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_FormerAddressMember": {
     "auth_ref": [
      "r48",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former address for entity",
        "label": "Former Address [Member]"
       }
      }
     },
     "localname": "FormerAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_FormerFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former end date of previous fiscal years",
        "label": "Former Fiscal Year End Date"
       }
      }
     },
     "localname": "FormerFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r46",
      "r49",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LegalEntityIdentifier": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI.",
        "label": "Legal Entity Identifier"
       }
      }
     },
     "localname": "LegalEntityIdentifier",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "legalEntityIdentifierItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NameChangeEventDateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type.",
        "label": "Name Change Event Date [Axis]"
       }
      }
     },
     "localname": "NameChangeEventDateAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NameChangeEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table.",
        "label": "Name Change Event [Line Items]"
       }
      }
     },
     "localname": "NameChangeEventLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NameChangeEventTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period.",
        "label": "Name Change Event [Table]"
       }
      }
     },
     "localname": "NameChangeEventTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherAddressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other address for entity",
        "label": "Other Address [Member]"
       }
      }
     },
     "localname": "OtherAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_ParentEntityLegalName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity",
        "label": "Parent Entity Legal Name"
       }
      }
     },
     "localname": "ParentEntityLegalName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_PhoneFaxNumberDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Phone or Fax Number",
        "label": "Phone Fax Number Description"
       }
      }
     },
     "localname": "PhoneFaxNumberDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940.",
        "label": "Registration Statement Amendment Number"
       }
      }
     },
     "localname": "RegistrationStatementAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "localname": "Additional402vDisclosureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToCompAmt": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "localname": "AdjToCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AdjToCompAxis": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "localname": "AdjToCompAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "localname": "AdjToPeoCompFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AggtErrCompAmt": {
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "AggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "auth_ref": [
      "r56",
      "r68",
      "r84",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_AllAdjToCompMember": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "localname": "AllAdjToCompMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllExecutiveCategoriesMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "localname": "AllExecutiveCategoriesMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_AllIndividualsMember": {
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]"
       }
      }
     },
     "localname": "AllIndividualsMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "localname": "ChangedPeerGroupFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CoSelectedMeasureAmt": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "localname": "CoSelectedMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_CoSelectedMeasureName": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "localname": "CoSelectedMeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "auth_ref": [
      "r53",
      "r65",
      "r81",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "localname": "ErrCompAnalysisTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ErrCompRecoveryTable": {
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "localname": "ErrCompRecoveryTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ExecutiveCategoryAxis": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "localname": "ExecutiveCategoryAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_ForgoneRecoveryIndName": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "localname": "ForgoneRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_IndividualAxis": {
     "auth_ref": [
      "r60",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "localname": "IndividualAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "localname": "MeasureAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_MeasureName": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name"
       }
      }
     },
     "localname": "MeasureName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_NonNeosMember": {
     "auth_ref": [
      "r57",
      "r69",
      "r85",
      "r104",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "localname": "NonNeosMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_NonPeoNeoMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "localname": "NonPeoNeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_OtherPerfMeasureAmt": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure Amount"
       }
      }
     },
     "localname": "OtherPerfMeasureAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "decimalItemType"
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "auth_ref": [
      "r55",
      "r67",
      "r83",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "localname": "OutstandingAggtErrCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "localname": "OutstandingRecoveryCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_OutstandingRecoveryIndName": {
     "auth_ref": [
      "r58",
      "r70",
      "r86",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "localname": "OutstandingRecoveryIndName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "localname": "PayVsPerformanceDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "xbrltype": "stringItemType"
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "localname": "PeerGroupIssuersFnTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "localname": "PeoActuallyPaidCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PeoMember": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "localname": "PeoMember",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "ecd_PeoName": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "localname": "PeoName",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "ecd_PeoTotalCompAmt": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "localname": "PeoTotalCompAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_PvpTable": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "localname": "PvpTable",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_PvpTableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "localname": "PvpTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "auth_ref": [
      "r50",
      "r62",
      "r78",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDateAxis": {
     "auth_ref": [
      "r51",
      "r63",
      "r79",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "localname": "RestatementDateAxis",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "stringItemType"
    },
    "ecd_RestatementDeterminationDate": {
     "auth_ref": [
      "r52",
      "r64",
      "r80",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "localname": "RestatementDeterminationDate",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "dateItemType"
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "auth_ref": [
      "r59",
      "r71",
      "r87",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "auth_ref": [
      "r54",
      "r66",
      "r82",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TabularListTableTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "localname": "TabularListTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ecd_TotalShareholderRtnAmt": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "localname": "TotalShareholderRtnAmt",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "nsuri": "http://xbrl.sec.gov/ecd/2022q4",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]"
       }
      }
     },
     "localname": "EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember",
     "nsuri": "http://www.halozyme.com/20230324",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]"
       }
      }
     },
     "localname": "EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember",
     "nsuri": "http://www.halozyme.com/20230324",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Outstanding, Unvested [Member]"
       }
      }
     },
     "localname": "EquityAwardsOptionsAndStockOutstandingUnvestedMember",
     "nsuri": "http://www.halozyme.com/20230324",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_EquityAwardsOptionsAndStockReportedValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Reported Value [Member]"
       }
      }
     },
     "localname": "EquityAwardsOptionsAndStockReportedValueMember",
     "nsuri": "http://www.halozyme.com/20230324",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]"
       }
      }
     },
     "localname": "EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember",
     "nsuri": "http://www.halozyme.com/20230324",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "halo_EquityAwardsOptionsAndStockVestedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Vested [Member]"
       }
      }
     },
     "localname": "EquityAwardsOptionsAndStockVestedMember",
     "nsuri": "http://www.halozyme.com/20230324",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 1
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r101": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r102": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r103": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r104": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "6",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r105": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r106": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r107": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r108": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r109": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r111": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r112": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r113": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r114": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r115": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "w",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r116": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r117": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r118": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r119": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r121": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r122": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r123": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r124": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r125": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r126": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r127": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r128": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r35": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r36": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r37": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r38": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r39": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r41": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r42": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r43": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r44": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r45": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r46": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r47": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r48": {
   "Name": "Form 10-Q",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r49": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r51": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r52": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "A",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r53": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "B",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r54": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "C",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r55": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "D",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r56": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Sentence": "E",
   "Subparagraph": "i",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r57": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r58": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "iii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r59": {
   "Name": "Form 20-F",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "6",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "Name": "Form 20-F",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "6",
   "Subparagraph": "ii",
   "Subsection": "F",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r61": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r63": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r65": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r68": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "Name": "Form 40-F",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "19",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r71": {
   "Name": "Form 40-F",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "19",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Form 8-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Form F-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Form N-2",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r75": {
   "Name": "Form N-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r76": {
   "Name": "Form N-4",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r77": {
   "Name": "Form N-6",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r78": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r79": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "i",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r81": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "ii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iii",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r83": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "iv",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Sentence": "v",
   "Subparagraph": "1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r85": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r86": {
   "Name": "Form N-CSR",
   "Paragraph": "a",
   "Publisher": "SEC",
   "Section": "18",
   "Subparagraph": "3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r87": {
   "Name": "Form N-CSR",
   "Paragraph": "b",
   "Publisher": "SEC",
   "Section": "18",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r88": {
   "Name": "Form S-3",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r89": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r91": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r92": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r93": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "ii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r94": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iii",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r95": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "iv",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r96": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "2",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "vi",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r97": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "3",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r98": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "4",
   "Publisher": "SEC",
   "Section": "402",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r99": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "5",
   "Publisher": "SEC",
   "Section": "402",
   "Subparagraph": "i",
   "Subsection": "v",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>27
<FILENAME>0001159036-23-000029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001159036-23-000029-xbrl.zip
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M"!O!6$!3/0!5EX?/;0;N:R?@ODF8:O4Q/QB%G'T[8 ZPTR'S[M@B>O6V1 A
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MHI/0CV+CKVPZ>X>-/& AOWRYQ.X?HGV"S6%!J81V2$V5.;:?G,U''FA_[,.
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MY"). LHBC.>B5$SB@Z7@,L)ML-5X$!P(&O#X*G4$FK!E.ORMX/R2;OT14TH
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M6LRH4L,T *UC8A,'?@Q,/Y5_Z(B8V:H<%N:-$GB57L$M^X5FH]'/]69LJI)
MX&]*"M0,?3$(\,7NEBHL)^=#;P74(Q.>ED[P4BGENI%Y-R%'C@-B8G@LHTV!
M\B&SYVB^R+3W.<[Y3,)61,=!>2?ZXHC<C*@L3/+5UW'(7%]Z:S=!"$PH*LB=
MP4\A9]Z;W'BHS@SF#!G&%K'6,X9=9.!& 6:2U]MXJ#56A?*^,-C[L?O7OS1;
MK7<'U\R;X8_M=W%(?VN^PQ1F$*EJ$5@WRBU->+R"GFT1>K9:-Y=*.A?X[O>
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MU4!H^7?W<"DQ5S-R.[ZP;?JZ.NNI6A'0,/U1LK1 PU!XZ3_-I*N$<GD$&/*
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M'O8)-7NNY31KF<OK?+9C#GM@QV1/-?1^SJR136_E+[D&I5^Q$M;]?1"0(T*
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M$98$-H\8Y%:D(E@E/1_JQWH=863EI\O!PD[/^57@ ;:25WEZ2(*RUYK_2KN
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MA;(Z0L8R&@C1QP$3L^I[&TU+UNWY&.30NRNOAB7@6T2!J*R+-12[AG6?&X3
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MELY%9XMDA(B('W(:4?@:%);[?^ZDW^4$9@\9>C"J2*\/$H3X"_%F06&"F6>
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MT\=&AG2<CIT>6T;7H3O*7(NKD8B'84W:54@+^CU)_T;*_I1$3JS^/@+)E()
M\?HX)>WOOQ\&M?WWNO;?>.*+1*:)')>SJC+LT@T2LMRNP"X;.[8%^J4A<T@R
M?N)@$AY>)3;*XZE/)G)5F\,@!*6"W_%<&I&HRM(2M:'P?2<A%7+A;&C,)G%<
M23K9R2@*T^'("H HV>_R+K61\*^YZ16YZ2Q@A&TO(+=OZ(>]F;VAD3]@^V.
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M]/'JF-\O#*B,W_A]YC#/YBK+P0D;UK>X8=VD <7Y>P)>43S@,49\5#I&:*6
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M>^I[E.7P_:S)25VE:]OF]E89P^VY,]0<46M6Q9D5;O#D,9S6-,I*A*B4BGH
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MR+$\H[PX00X*Z![OEA ?#CLGWVI2,"F.VS4IF!1'^T<U*217'(+;^CS$*-/
M6T.HSM%R8+W;KG,O*E,$M1:6)&K56E@*F<Y1K845K%Z[UL(:[[W6PNJ '!\W
M#FHM_"BA#FLE;)+CERB\M\XN?NU>_.^9-0D33+?C4,6I%:<$;H-J&:O  A$5
MP+DD%M6#Q)NB09!QDO;AT@0NB*V=R0BA=EJVU;;"R.K42KU6ZB8ACFLR$#\L
M--;H'=#AH*8#T6&AD5_O6XN?;*X67Q^40(H#LE$SHR9VPSTL#$M]+B7#"FY0
MVW':&WLTDSM&'2\5^^(U_^_@]-7:61*B)@-%[6HR4#ZH)L/S<<-6J^:B -TD
MW;P.M7PM8N%$[HA'!F"1=3@A%YK*R^MC1=*EUKFRI)$Z#(1NC< (S #>)K0$
MMC.Q+4?(]FD,5\<Q(A(+V72 %EVK]5.G^1,6_M<4?6Z*<H>,MJ"5I=V/TB%!
MS<,[T]WPHO9/G5:]#6O?AOHTY.OI$FOQ2LWW;<8<U%9,#B\,-XAQ_\OB_G#H
M1!!39]TP$M1@6)LVM6ECT&&O)D,=5=%DJ/4QD6&A88'O6P]+>+!:&YO:^#.'
M$:S[,*)Y/),H3,)D.A%6?:YJI6M4=XA 1!*[Y\Z["Y%1$!9C@-@9-/>H[R3.
MXK22[=+EU-IF0JH#YY0<.81,4/1-1)P4>VMJBI9V(BE (AT2H(;]GL18JOV(
MVG6O7?=G,19.392H9;,.[U8^S3$A3FHB*:$4J_#M/+"QFML6J'U[IK*3K1;L
MQPL(]M;Q0DPUGZ^VB6BWE[?=K];IY?75Y77W]LRZ.KO^<GG]K7MQ>F9]Z9[>
M7EZ__/G<;JXL*WA8%!Q6OBH3CX&M'H._VELW8NSZT$WSY&HU&\?[2 B$ ?1P
M_*_CSR)M5L%6*@##G0\'[?UOMO7AX.#@&\-R?C@XP4_D.& /+IGNTA>SG8H?
M.OMT<>=H7UV\WYJ]&!\X2:-)&(M8(>]EZ'P(BAG#2GL"?B=*<"SQDQ+@RH8)
M;DF#W(.0<#5[(8Y,9Q1#^<KT$(W/:.<&CR-4XL"'U19A%N6-%L+:7&R-7^80
MPIZ#&HD(AGTQ8 3$$ %%@]D?&2B)7B#'T1,R(BWY]\9-P^*(B.]/K:Z+ 1#X
M:9?G6.-]KB*XDP<O%=M6#P?(*Z12>*1X</VTS[OCC2>.RQ/J$5$.&-Q*(N!J
MARGDAG$2$S,X8VRA^=LQ/B;T0;[E+,E**);'8BW'CY6[:(+\FBR./ZWNMBW!
MBY3L0!^.X/1)E$^@ ?(TC^P&CK)&3M^Z'PEFF7*T86)+S_=3AA;5#.;"^R:*
MP20<IUHO;O;)T8]$HNP,SV>.D[;Q>]N*07IZ U 100)[#=R;1![L*.%R,N'A
MP<@(A(6Y))YFX_FG;Z]#E,^;*@\4D5BCL^XC(HBBP6KV@_4<"3'K)0I_6/:)
M,:<ZL+FP5_!9GY^EH:6[:=]+C$<["!AM2UAQD=^1D'E'H<*Z&FMZ,@)FH_0S
M+,G]'J/P\\ -P0+WJ;&>6*$"YZ"3,9@WC)RQ.E2!,Z30DX9M%0-80D)(UA-B
M4N9(4$81E:KD;H9GU6%<5]A3^'6T)^Y"_XXQ8?$[RX>K8]>9B*W@I'GXZ.<!
MO)'7Q]-M *1;7^AHK1<G?0[[]X2/6+DQ<9O""G:F(:@$U 0(QWUQ=IG#XD9Y
M^SE28VE!*H*&D]?8EE/0S%XL#PSR,2B$J>+L?(>EQF"VD>WV3/%>+K%(!.]:
MH"E2'Q[FQV%.E LUZ%PQ]L^5S)<SM#H+\-]>ZW@9]NM&8*Q5;6![H0VD^I/#
MCQMCC78:1($J3&DO.PD2WAH-R@QENZB\%0ZZ7>_1L^]19@_@N0OO,6+%^-@9
M<'?)7 <%V<UZHH:=SO:YT\E3XVW 3M<':-4#U!=C< &22!M@OD='YU?'#_^>
MCK6"L;X*!VP!L,TF5C?A,R=8]&4G[ \<U!$7YS\TWKYA) %W\:UPR(X:\FQ,
M0"$7&F0^VZ:D$<BD8-<CGCL30 (T*#/][%+?MV!JDZF*,@Y^BC<',AC*J,3C
M@?ULM0Y^E+YGQ>/9H,'9$-56Q+Q@UPN<MV?=NDT[>?O,QB8C 0NX+C@@.)UG
M:OFP'6-03QB_,,9Z&(&)V 3UD,9@%KS)3$HY!62J1H*(8 @_R(9/Y&=:]!R?
MF <L%Y'03(Z8C&9@L,03Z =1X 0U+"X6G]US@N]67_3(G)9K*HN&&($0.[]@
MT. 4 \8H%=TH<CP,*>']T!&#93H3+U%C3422T$0@$,AX!;TE78;.6'@/Y'J@
MT 0H);##Z'NIY=%4\((4;77S^>A#QK!(\!72Z1[BSBHGLF%U8=MXD(D_M>'D
M9_N%6X1#5_!!0RD\L: $:>R,8W-4RQ>]@9&06V9;Y[<L.O-S?\9 =_)]?6E:
M;IGH!*^*!Z^N0W!FDM,;+R8YFV]0<FZOI?(MDLQCX1 0E$)T J/0IZJX3((6
MF JV\F5>93%J9G&A=9R]O#I@=Y7%.!Y();"EWLBW8F&$2U2@3QC=6;'LXM+4
M#\0P3#S'5$BG^8(P^/U7W6;25>5A'-L_':5#QVM8YP$&Y:3">&3K>>UZ 8]E
M,_+*R >[EB:;*87K4+I'YS3Z'AQ-@9*!0M?&R^&_<3*<1]?WJ4B"W5#0,*!_
M</X5)B1BX5?+\=G3O]A$I#<A\#&,)F?=OI3$GV\C+RSIF^L4$3^N4T*\4.CV
M+0C'6K-OAF8WQ,3RNMV:K^)&PI]0@I$S35S9Y@5!>">U%\U$S(N5)^A!I4T*
M*LE$BV#TB$+4A5(&EH\Y3^LN]-,QIM.2<.\\^(M*[[(J==N88\A)C3E3,5]=
M[ZS1S;_-SY0T4M5QEO-UG7ADS(MU'=]56ZKGLV)"2&=!>4JL(KAD 6O'S,AD
MJ7#94(L9^C/8E62*50#R45?@6^>DC>JZ=7&[-1/<I&.0*].\7+K%URJ;V?BX
M-RC+K$IM V\,)F#D_N</(\</]X ^G6:GO?]_PZ/&7Y/A#^"%)E5?Y>/C)T>3
MAU7F\!V"E'S F/&\]VF5UHV]^LQ ,!$:38Y;+SLTL+/Z!+KYW^T?'J]TY;S%
M'C<.#T[>R%KW&X?[J]WU]=?:@B\/5YL<N9;%'G5>8&;BZK=]?1H<-4Y.#A>Z
MZR-M*4MVF+#4>6X=>E)0H>5#I2Z<,2BS,U5<8%T.!N"G9ZB2U67%ZB6;^(H_
M+/33A6N"UTF1+LVRA]_WK4\(8W/C@(TV)1-IY\,B,-C;2AC9PH:$6*3?85O)
MD/$'D8*I8G7'6(=:<\D_RXLON&9L";*\B7>=6R#WCGD \U] $BJ@*ST22\]'
M!K=:# ;5;2?-)_1U+N(BOW9?RJ_"%X%UKDL27R1^<T@%.H\MIJ0("NF_UVF4
M>%'H1'/QJ#D'ZE%HZJK]7N* /#O/O.:Q6K1;Z:AE'W46PM^I*;I2_U=-S2?-
MYSDYLCO'AS5%-X4_MX@2%S]U7Y2OVL](S:950E/JH]THDAX<'-DGS9-__$?K
ML/FQ2-SG9"TB1W-Q8JQF(\H!W!L1?%F4J3T7\UVJQFPE!B^\]DJ"\W'2;:!$
MV#\^L ^:"\'PU4331%L,7JTFF$:[;!W;^T<+C="HB?94L^5-OBR6V[\H>\PS
M34HH]D:LCW:S:9^<'"UI?91SR$L8&"J-'(08SIBWL_4OW^8O5XU"OB4+\YL3
M?9>5M.MVR]^65#]H']C-%:W+=TNT5:W+=TNP=N?0;A_47+:.H.W;>%EL25IW
MX.L-6I>M$W#;#IJKQ;;J\-6"QH7GCASA6[_I8N[:35[.QFBN;&.\6Z+5$:RE
M;8S]FLOJ"-9<&^-YWO:=1;!:QT=VN[FLC?'<$:Q*M-J7;M(Y?*P6C'IT_J_P
MO_EM1F6]K(^T)[TI8)(-0N ];'0(@+>(/)L!X>D&7@F?]Z+(=]0+CD_!!KLI
M06(\TL;[_)UNCR)LO!S7T!U_1M 3SUV C[[>GN?ZQ;8!-*2+$"B1(X$^\0U=
MLR,.\5K&3E]AWA*(2Q*ZWQ%95T1[P#81\"\P)[?A91U_$]\)&O,P/=+$XWI_
M[ON\$R//]1F/IB]\N$6$JWF_3=/46T_DN,#N>XGUA<V5"W=*KYGO*D]7N<ZZ
M0;ZR+B?4Y/O"E%_RX*^7$2+"EPJ#(<A^VDTX-(3A89Q$C<0$VD*X3AH3[/94
M'R6<.2(4D#,VWH8!W,WC7EC^4F$TT38XC"Y%0-WPA7@0D>O%"(CJ"M'G1E_^
MY23R,ISAOC/%GY- (1QK1R) S@6;T."Q?,>060 4G@L+<H8&#"N=!\)\TD\4
ML"[=%MX3(^?."R-$JP")%#%JN()?\8&&>PAX#I_$J#RILU5!O!/^<$8!>J^W
M@@NUY%'#V^_=\>0UZ_KF]_JX90]GI!E$"2"0>Q$IM#9Y>,8X<" -U PV/CM.
M'(>N1VCMV<G4C(R<>054MNY''K52>Z!TQW UWH%QR(!Q,FP>ADY0YUF>2X-Y
MLV,?$U)R[@SC=EH#/T4,9FS)WTDG5AA9_? ^V.7;NR,G&#*[UXBLV<9W]M\B
M(NL:K>>YU"P*TN6505(44I4*8>Q\-Q6!"W]X<9([3MGIF3E8YG&BHXI0)EIG
M1 )OA',EWH@JF+LK-S-R:9;*I+Q9<2)YR/H$44&P'D,]# 0OH8D0L*L#^-T>
M(M"BO^B%B%)&WBC>PD"#I/D$*.7>"BF7U*I7+Z](YZM-8ESX_#MMW*Q+QG";
MN"L,W2U4\ "1V' Z1$F P PDR'EUY0?WA3VU)??B+0Q*D#8VG3?<!3(1!FF$
M(&TQ;Z%&",@YY1,P(\(XG(RF9)1XHKB?$G VMYTD"LMO:+,!$L\:'MGO0X8H
MX(A1N=S4XCDVQ*VQA+=R[!]%/[HJB$GI4V5B$ETVV.<A@>VB$/2]P8!%)AD-
M(#,IZI$3FM+P[+/C1K=P(O3U-$824ET/2+B]N<:A3G&*3HXS!$LR9GZ26%D$
MVI/V<$J6Y(@P0/9@WO"R85(7W9O/W?^V/GEA(MQ1 '0<(IY27SQ8.SS""55#
M=ADQ+LXQ"D(<P 4"AP8^X0"&R.GS2ATK<!C0UY*HNW@EW(U,3X* 0AQA6'ZB
M<;^"6/$:4@5GXN *+]TD[ '%.BT;:=M"VR$D[U:N8HA-''H0$@*KXX 9FC#R
M <PM"WC QT/31Z2B*-:3(B35X8(!C;<QGN\Z/L(<1M:_4R=*D+WAGTB$S)S
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M?KJQF%"AT!_*S JU,I99D9!BP\ V'ER8XR:]IC@G"I5 *\[4)44VR&:6LD-
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M'B;X'N)Q/(NAGPF@-);-$*H'YZFIB@45##0+L_MJO<RB/-XG#_B="-V]2:A
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M-'#Y"?N<-0'*@.<U.<:<*@6(J>IZ$R?+J1) 5VW74(EF'*+&;O<H#\U>\E:
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MY9K&CUS=IV%_+#8$6#6_T"CY"[0^RGI*1PQ^\<%>@F714TR-7'Y_SM>0"J/
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MZ*C(>L=*BY=-"%V;YWKPI%;/[CFNL4U2J].SR#[21(GE[7Q4K6=9VR5>KJ(
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MJF=I;26MO%1>NJO2G]/?A3=Q&[63F?+25EW:Y9U-UU3#,>3&=MY2X.!1>$V
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M?/DM%6+Z+,Y9NFLQ(=HZ.>&T,8U9:E3_>Y^6LQG1;^RJGS+Z_8H.8+(O:?1
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M!Z<U&7HZI$"J*@;C;Q3&N,?B\TOH-X[Y@D-,1:^GO,5K1Z5:YG#; AQ[CE=
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M&.OCF/-S!MJTN VT.%[+X;\'-9-YCG0MTT&*.? LFWD\U9E]0$E\>+]R[2R
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MPU5UXRB ^)+%AV"Q:ZH:(9*_I\I?W5,1)5<SMLQIWC>/SR'?65:./%F,396
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MOUKB17"<D7X2C[,9/!1N'8HKH@2.(+C!5:!3!)[!%"5 &= P+6RZB?#B!XH
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MMJZ]NA$OK)-7T_==]J9*I<B^G !BQM0\O!C]<Q)?P1-XC7[QF.<O]V+I;MJ
MIWZD\.?+.(D_CX<@<S[W8<%57]D = ^U76M@#)AE^)YI.IHWL +3,IU@8/N&
M2=B?[W 7TXC&H2UUHAOD0HF!DO^X8'[P\N;'B.\(=S#@FRCQOU]PE3:XLB[
M0//I"">9CMG!R]Y!O?4TH>+JZM[7E!!KYLY+B.V>;>Z^ZGT_<T7WKK/MA X]
M6:^GF<W:]&SVFV$;^R#LMH7_1YFLH6W7!.H(DR4]S^O09%UK]WVP]C-9IZ=K
MV^$TK!F5-&-7;?J/1=I6Q+P6<4:;(L[0QRMANEY53%=QM%I?X/RD2F]Y:7LO
M];HITK^7D=V/<<@#GA_"GV T/X-?X2L,]'*'VIO"Z?:R06+; 1FP^R76":;]
M&Y&!3Q6&I!D)2O<62&Z-&Q[/KWC$N]3/F48SA+DNX^XW15B,T\<X9_I<%_#P
M*^(Y'+:$BU/5:W#F<E72;;5\S1)LUX*V5=_-]I%2R-?M/4W9?1)AA/TKR\=I
MK%R:30BVG@KG0\H;!M3[)X>6?R)53W7=?F8YV'1^,F3*Y:<PBM#7_%RYM#:A
M22=>M 1KKKZEW:#?[RX*B1J,L2V"53VAAV$01&S?A*Y/7L8#\5[K4<^*FH6G
M_T,J6K$H&#_G?OYQ%ESLP/&/Z6A#&F7_N-!FH@ LX0H3M_/K87ZA<)]&#D_Y
MF;^,Q\.K(,FOBGN!'4 KQD<0H0+[XO4D5>;O+V;?X+64C>[+1FG8H5VWG8@X
MH"ATU26.2EQ'RLBIR0@8^B FGT%2?GQ[@B)Q04I4DUBJY1(I)*<L)%P^*EIE
M<UGQL-L\L4S5(KJ4E1.0%;TJ*UR)5$YO7_.8B\B\%! -Q$#7>IXA9>#49 !/
M\_PPWU@8R,5K0HR>;4EA. %AP!0D(0WC[.H;I:.7GUDNG!>_)EDVX;\]X;_.
MCZ.]W=H.DG5/81TNY+?)+8MXE\A/C&*Y8'7U3KEG7+RV;6T=]S;VVC2M+=]@
MC$YP&WL9[A6#Y-0(ML'R,)AG>0/:-YACF9[N]6T6^%X_&+BP5ER-\.5!RN5!
M]NA[(>;%:T<U+4/5/7,W>D_R_]#\?[I_A5@7KRW$RE2U7?G@I!@<5 QVY$(A
M-OI0#,]5;6M'CC8I"$<3A*>[28@#BL$CN_.H26G8MS1LYPA!WZEN]QQ/LKF#
M;-[<U^%=O"; ;W-'O@[)[WWS>V-WAJY=O#8UO;>?;5QRY\D>"YT @TRCM\;W
M?,P\DTYQ&_BB'=M1VRF";; \^B:A=I]1:GN>Z9A6GSF:18EF ]&MOJ_SY:&5
MRT/;H\="UR]>VZI%7-5U[-8YZB7_&_'_Z1X+W8 %;ZJ&8ZJ.T;YHOY2#]7*P
M(Y>%;H(IJ[I$5_46Y@9)0=A,$)[NLM M,*M4P[)5NX5I0%(>:N5A*Z>%CLY*
M4^NY.W):2#8?E,T;.RUTIW!:M"]C2_*[EM^;.RU<9+'7T_;"8<F=ISLM/-"Y
MMKN.0;. \#/X0Z^WAC$2XV^"Y"4QWG> \;Y'^"@.R35!Y"H!N3[$"W!2AB9$
M/XS'++A&4U S''\P" ;$[SNF,0A<D]KZP&&N[E-/P\?,X4^M>(NMUM',@19?
M9#)7LE>:S3]-7_VTK1R;RY\&Q^Y?0$W$RL<".G9Q=:_^FT-1EC!K6!;-J']?
M0D[F]RDK,>/"&'$SIQBC>14>MT#DU01DW$RA,$<9+3#*WW'<9E7YE8[34/R9
ML^@OEJK*)YK1= S_Y-DXH (E;K$+T^1)I.&3-AQ67S;L7#]E=?$YDW:.RQ]2
MXE;#?CMDL<^">3!PY1<:)7_!WXB&"T,")P3 N<;'+##&9^_C ._5^^:QT8OG
M"D(W'$,\VQ;/A@'27DG"A@/, Z^2GL*G41*0BQT=C9(PS@6D7WGW!*YX&3Y[
MS2L*BL,D!0<:$OA?-.:#& 6=%I?*J>YJ>CMWM6)'*:"I@R:[RNO;HN/'.@AO
MKML"EM,P4I*UJ-\KH+YG].0@1(.,:TBX^D<5@YGKQZ+SAT(+@(5:<. 9;3,#
M[ST+I=T,J9P_<+/GE2H?URE?2ESCS$V +_%U4YAT$1$S%@"AB,:?Y3"(4!5A
M!#_RQ<A' V,C#?,0(9MCA ,MFKO Z,.0PY#R/B]@]<8!$)E3FM-GL@^D+!MA
M?Y@?+'H4:[@J1Z\5954+@ XO98X_6X'A./SC#V^@7@?_N4LF_DF4P#KCU)PW
M3@<N"5SB.'1@>::A!1Z86SZU+8LX5&.NMXEQNHLWN%D^=VM^[H1Z ]!ZKN91
MT[0]O:^[U+=LK0\V8Y\-C/FY?ZCK[<.5D6B2,J,2)KU[.(3P98&GNQP&9@+B
M.X7V?7M]4V+NXC9>ZI*5"+^7PIA$R.3:5D3%='D/EI03+UB$%P;+[#[AR,#S
MIFE%P2G?.'Y(J?K XHA"G^LJU"3/E2$#Z1<WU4]V5?<$4'=%3ZU&"GK)))2(
M96(*M9CYG"I9#C)2-D_B ,HC,0/QS3P!"M;<\KNN^34%C_C-Q<]?Q!BSO_N\
MSU(#T/GI=E)/N&6O*\QC&J NQ6VEN&H*HLVWAD*IUQJ&O]Y]+%^<4ZSH]+-\
M*B_7'XJJVT.M);)>A<PN6ZMO6XY/*?5UQS1]TS4MO6\9<.2S6& ;=)G%LWZY
MSS['-;S^(#")9IFVR72'DL"RB6YJ?=?1O8%VT7B[L]SV;W=<2NU7A]GRZH#N
MY[8\#REQ$XVSXVW"%Z\GP.Y78"--._O-+9&R$5]AI58MUX=[.*R*<VXRSK%)
M'U?-N$XGK0&+EF_XA$(UU(RD;FEI2=%[@NB]N,0-Y(AF8"&!TZZ,15_ R2:R
M6FCP0MQ6:3I5Y)4[1KP/8_5ZWCM&"'=%<BMR+FX1;BL4XEU(]I/E^MA"S'N!
M'5>(80K+A%@YED,"J<)[3F+_*A -;GW-Z] :,4,1*@0H@ -LT4XH P-D/^(C
MU>+)J<49D=N[$BR$=;D9(&7TH#+Z*TCG,863=U?#5CKQ8Q-!J@A*95,%*1RP
M<$X)UAJ&,TVG>3/0\C1;9R8L/%.5AN7!->BQ]F1.%=[5%;L0I97=&'O[AC^P
MNR$(3E*VS +QB&'ZF7!BK19$T69RF258-*>.DY6/F?:B[3_.!)1P?NO<2)/K
M*UZ,RI1GEEDY_Z*?-O>*/9]3TPO^[IIO%GO^%>OB/'K^><M[_K6L>U^M1ZB!
MAZ?VOK4>J/D,#L\9#/J$,N9JID&MODX":AD>=8E)3$:D)^GD/4E3FZ#HXLJ;
MS(:9@HU]TY"' 89)()J;-]GQZ3 9QSDJ,&%;S%@!_ +^F+I&WJQX4M'#EOWT
M&0NRQ1&2- 1!A*>*H8K8[LR]?%#0ZO'DICHM?,^BB:I=&KG@NG\--=;K\">T
M)C[2<OD8PUM_QS>LY =EK/#C\SZU:C7TP%E4QA3XUEWPISA_5'H"STA"P;Y*
MS( S;])]5_24YNUR>9,F'BSX<'W[9K+!7M^^5>Z24>@K#G&5<59R!1]6AFVR
M\9#'/I"?^&.,;7]1\"?Q[II)\O["_QWS#LA<8GH*3QL:)CP$)8HB>+OE>.Z!
M=3>KRBABV' Y*Q(8XB1G?/'--O&<!,Z+CL] &31CBN#Z->_>K'SEK;EY9@S,
M0B':U?\*/@G_&O9KYB&6))\\95T"Q/196?DPT2IZ/J#?:^[S;8TTWTWRUXKX
MG= K;Z]OE,N*J(%:0GH5'<^?SZ2  %'5R1?5C(I"\14)&(5PP\A958CK4C%Z
MZPR[CA!V&LD3) 9Y05M:M(N'-_+#*)SI2[ZV6PN(ZXK.)!6N-&G,.DN@Y@U=
MI_<=MG.JY_0,F[?FJVN<NJJGG^7TM"T;1J[LEJCWW'TT8=SCL,U:?!:5_7-'
M)2)LU*-W1MM=$[5MP"302%V0U61T<9R.XSR+\>N",MF!(EE0(CL&Y5A)QQJM
MD^(+[UV9UQ/X@[!C_SU)N;M\]EP2IYXX1!)G.7&T)<19IZ>VA.IMH:Y:IYGJ
M)6=3.FA*0VKLIY73>EIP+]FS^=+!C5_SU;R8M^K].M'TI\@V;=3KY\ '"4VX
MYXBMO7JJI."O&TJ,7'MGLO:.!_I<K#VG"=2S7'MR[9W>VCL>?%FQ]MPFH&7G
MM_:.89#/'%V*T*#3\XY7'?E/7H7Q#H, 'S  \'L9 "CJ)="=7JVL4/XYS96I
M''Q.TZ2OE]K346U/Q@#Q=<.@M$],37= M1D>]3Q&&6.!R_J,^9N8]+Q6;".]
MYEV\=E7=TE3-7+3GY;XNA7^_PJ]3:C)/LW3"''/0#Z@U\!W7=S6[[VH#?[")
M3;VQ\)L:-LUP-1!^=Q&12@J_%/X]"[\3F!H+ L/U3%,W ^JZQ*"ZS=S )H[1
MW\2HW5SX"0J_AL)/%N'WI%5Y=*NR8DK2O&HG7KT7:<]?YK)2?RNS4J79*97/
M6N5C#@SB4].%8W2 G_L#SW9MVC<PJY.9P5[-3E._>$ULU=-LU; 6?5ERZY72
MOU_I]RQBF"[57!H0TPGZKA$$6K]/F&FXNNWJ^[4[#00XUFU/=;1%9Y(4?BG\
M^Q5^JIG,]TQ[X+J^J3/+=77/</J.;?JN8SCF?NU.1'O75</T5+UUIRYI>((D
MO9W4G\YY,Y]@;][P\KR*U9E)L_,L=4_?U&SBV8%C>18,YGJ.;9N(D^.1?M\8
M:/LU.WEG 4=S5%UOF^J1PM]1X;_<:.?U^CKI>XX;>*86.'W3]S7:UYQ MW3/
MTM:;G1F\[S\NKIZV#&QLN ([O$KL1:?_<[D"Y K86[#+[GO4U ::1YFI$0]D
M'N-? Y<1VW=<;[^FIX/!+M>R5+NFXXBT/(]N><ZZ/'\OT$XV#J0K=_?%[?#3
M.U%F*1V>YZYZ;$>W!\S00.5HYD!S*6.:9?G6P+<M2G1O-Y;G(/S)@JN_6)I,
MM(XK:L>)_JIE.D=*_>E+O6,P%^Q-DSJ#OFG95G_@^8&K,=R'#6W =N/HK)%Z
M3TJ]E/JC23VC=J 1GYA>WPP&A+J..3!,R[*HRZAC[,;,7)1Z2VNKU$O[<IEG
M4T")E,;FNP).9"N?)D=W^(/CEEQ/\2C*H=\F<1 *$(D_$!3DEN9AQJ% I(UZ
MRGIK$P>1Z=H^,6PS")AK:D'?8P0&(0/+<PW-ZIOKC=1=.(@L@GTY#=6HR0R2
M[B$I__O+B+-<W>KW28"I<5ALY3#3#[#.P[.MP&S@'WV*U.O<+6I[JJ'+7&@I
M_(<6?D(-8O2I88'F-P>6Z1*#:-[ )O"'[AO[#<M;!@J_;6FJI[4M(4O:KG.^
M46ZQ+IB?D[S0K4Q7[C.%AT0"3OH38_D:(U9:K5)QB9B^2UPOL R_[YDF_$$'
M3 M<]+%:)NT/K'UY5BVSK:=M*?6G+_6V/1C8@=4//(<@!(<W<#VJ:S0P]4%
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MWD@K<B05T*6"3^OJ/<U\;YZ!*2V:JG+%JZ8B<Y$;VHX"Y8]P9?D:&N-4O3E
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M1B&VSDVE%./ %KXC%N;=7)N6: "2X\SS=0<#;D2TPL04_Z*VAVD99O"8L(Z
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M?OK%UFJ5SG/ H%(MV<AQHPHRE6KGM=5D.4F8T04RHU19K:<MT?+2JKF,X@S
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M0R"1&9P0J)@B!Y<!SX& [^>S\8&J,)ITIXZ'N>+2O94.X+:^5HTG#R2/033
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M(1Z&(5))".Z$HY*(DGVU?C7ZJ2E^F#)NZDZ.I?L_AI<.\G/YQ>3:_ O<5"_
M">=<R52B)$C<&3=0*<J4<N"894)QIF((]]7_EQ2GU@>'+>MF/X3'ZH>[YXQI
MD-!(4(G2F!'W>8-CE+DF1HP(X(G$BN!X7^GO3ECEG8NU*2C]C1-\#5ME. RB
M*$68LQ11A0E*>8P1L"@6.&"QY/@(T_N493]D23<[(3I6)]P,N?W$\P+DC;X$
ML#6SVZ?.M=NN&L,E?IAD&<.9<EN3RNJ=*G,[%0$$(HTY3U/) KYO1[R1Y=0Z
MXQ@EWNR0>/G9XV_Y[NFUEL.K?TMZK?\!4$L#!!0    ( (F >%9L,Z-_5TT
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M4S/<O7>?MIZ>'E+5R'2_CHFFKI[.[XOP;=RX44181$I45$IGA]P.G?^T\+X
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M$^'8ID5R.?L9R-7(1/M=D1M).J'=_7'QZ>:,JJN%%U<E3AT'VSS,3G]9^GF
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M3.?W,'UM VV#OQ^F\Z]A%KC+V.#0(&]S+.:R=T"P^Y_+MN]_ /W;;O^:0FQ
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M-/2D@=_K^)BJ5%6KX,HL6%GMMJ^4H<66B*^7D2R,3OF"1I@842.RNI=3G'@
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MQD 8\ "_XGC;5N]H!F96D#U?5L%M?FO6=YWT/9759L3E :@$$ O2,8[3KWG
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M:"G\\;0S'2H,9&Q6:Q%,V8,.N"2)72ROPLX^BS[GL4%]/SEBMTYHLMIJ@SR
MCX3M,Z"<\:1T^ET^SKPN'16K9XW?SO _W;XHC-KB%^QW0<-LOMVVXYU0"FDU
M]-<+<":;4.KXD*T&90U1$H@($WT&BCJ;9?!ZB++]7$/$\TF=WO-^#DVC3?IY
M/QI%WM7OO;#;/57SX*^M2Z033_D5*-G(6Q(G^>XL2;-W(\SO/0ZV.326Y P4
MY*GT!"8&:=>IKP3P@"@B5^UE#!W!#(-0HNU6@<.4VV5)B07YU"%;1/1B^T7\
MW*K/+^B&.#B5"=X@OV+<<NQG[Z]'#I*HLMS-SM"K00U.$5N,WM4UU]S.%6<K
M%25.]G/QQ;87F5,GTQ:*755:!8=*JY#1%:I0$\.&NEQ%%'*.IVQE6S!2GPP-
M;!9$*K6\=C7WE\YHTQZ[X#"#GKQ-WTY%Q1 VX.4A?SI8=4_*1)_>7MD'1BU>
M^[*WW2*GKU;PT2Y@@S4^2R6F/-G(I)L1R@,V#' ;<FA),]HT.(W7. ?;4%&]
M+(MM9K(?/D0M;U=0Z7Z>WJ6M8*FRK43XU5'*PC>;_G/&-')12P)*O @=1=YD
MILBVZ^9&:E6Z;2OKGL54"_WZQ-JKH7*6/I9DX"A6*S6G$F?<*K@ 6[[ ?6B!
M!P@CF7>*(/<LBAY7%M)_ 4=6G4/[X*B+N:@DFSM1NOFY&KEP9H4'.&@4=:YL
M_I3!9WDN=MRH(+[.3:/K]S_R%8<::TH]6#4*>[M))A:YKJ_J^PKF=J7[>?%S
MRVS0+Y'T8^A>C0I3-C:&AKA=-%>$WP^APK"DBZ*748'YDX-A3[)[@VONW=YA
M&)12GR:BG:FBQ\>*@*VKBG-?A?.8(. \15!N)S0R#M!NGN4J,\+Z=LQK%3T\
M C(TV[R7;QAEA\/,TC5T__B[[HE>.;Y2HV:[\Z=5&V_L%#)X@5>T__*"K^12
M\SG'E,P7K1O@:KQ_1]$'C*94 +9O(+5K<-+RQD8D<D_#OD1SF:M41%N%+/*=
M#UL#+=.#M^+DFSB9Z:+''4%?>DRUNJRU'BI*09@[9?&B*-GZU7GDP\;@5]:*
M*7O6[U%*PE+^N%ZTA<\$T^QG]VK,U%S!=UWVDX3,)QB![ ?%G[/SR^W[^RNQ
M0J5Q*K&$6;T[5S>K6_&W$DX7G>3[D[(GK>P#D\!_4/8^SN;GUU RX% ,>?XB
MN 6<IL+.;LE61K_OL#\H &H1BTO9+SVI:$XJ^B8/6#6L#N4<^G%03K &C!F4
M@%X/H27QQHRZ-&P!SK%VU23=X-/+YHSRGM]_5L&RQ6OP'Y4>7/9,51N1@W-
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M@ET[?6@)<L;>5W*A&IN[>Q945AI5K[O!E&HS*4N%=M'$.DZXG'MD'X?BTBU
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MFJ?Z01'C^4R-$>?_/& WCS.X(I@J?S&'4@$_JS94JN)+P0M&E.N>CN&/HY$
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M?@Z"@HF%A7T7FP 'AX")G)B<Z3\LB%;@(1;*1U1O-!0: /4A"MI#%$0G0 4
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M LZ8XQMPCS]1>/\BV7S'\=JL  &T/U\)4PECD'A<EAK](W6A<?6*M&LJ<,!
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MF[8J#:,G10"WF+SL,)P8F 6\.Q_6"ZK)!].*168TVR.#4*8! OBZD8T _)S
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M'D9QB=VN[GA#<W?Q&Q^;/;>EZ&3^GO^DAW+RBVV&HFAR_W>6U42U*!JJ1FQ
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M_]";G;'Z.*KO*6P2_8#8OJ>,R0DLQCQ9A2LVIU86/00'\2V\MI?O<OZ M?;
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M<?3VTG#S+#UK2XRU^!&M^0495,RTO:VLEWBT@K1TX0YU8O-,4]"PA+GF+N@
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M#J^@T3SAG+<\T;%O>T).'M;I@OYHN KEZ^C*@)(I:R?4W<&F6B<[K/UQ/)\
MAEL9A6,;]:DZ_=0]'/S!'/WLS@-E,OMY[CZ_Z)G[JB@[KPKPEB4-<.1, ?7F
M^%%J3[,O\[ZZ[[Y6RY8XMQ)#<]FBO.]!$M1)?;^8TA>^PJCDBB(O6#(Y>!A6
M'$?5;H&+8[M"') T9+L>]K7N%5OZYP /_@=HCI$=&RIM;9@E4LSZ=4FW3"?R
M7#?#:M:#RBOTSP"S5V\(T3:H'P6@QU,[.8;'C;_!( LS:Q];3O_YNTIH2;=
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M!+!A=QP7N&48#N]L<H*G=N@+H;Q& -A\;]IVM2<"3TPH$< =I1NF5E($\-Y
M 0%T^)G<J#D]?T@E>Q("4X6'.B S8$ #H4*!G7CK?%?D-28WE#T(H!MR3O9;
MT&]!_P<($C91'Z^)I=Q0S[R-_31O"_=,]MWV3UUF7HTLY<_.LZ:632_+J"*Z
M>9O-#N\010!7$I-!$E'W/P3A_C=A\54Z!-#?2'0;ZKYZRQ-2 Y+LDSWEE4<
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M3@C@A\<G$.01 DA*_H@ YNXA  2@I/\,"UG29RC_31A+<C/W)^5=!%!1EHD
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MA8=E(S-@D@1"7Z"T*+Q" )T>2"A$XVYR0X7,U_/\MZ3?DOZ/DJ2'!7^BGHP
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MQ;EO7X_GW(+Z:Y=)^[IS:U,@B<7R._I&]P8HQ61/B?J9+IB"'IV3CX([/!!
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M%GF;7U!39C0YN>Z9*I4<KMTGON8RXAE =N(9O=;"NK= 4)Y\I^XG_:+;X+)
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M7\1VY%M7I<Y/5E.AL(S3SD97X:K0P25TI?/[%!+CC#(E&EE#EG%$"?GQ+75
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MK-[1KMR+5CB)?_-M.J/#(J[W['#B\25W<)F%JRBE.)P#9XM86HQJ6RC32(#
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MBM+O\>#=C%SX8FW0G+)I9@',J0<BP1:;KP]"A:S,R3GPU'K$/7H0;]?/.((
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M_&95AT!J8H@<+'I%_GW)<9O8GUPK]4!(9ZZ599K)839VS)6^,%S<+R0>8A1
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M%'EC3(2& P:"505GO%N/T<).[.SG:ZHMR?*QOL&S2L][$P&'<D>HBDY.LXJ
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M/Z*C?J%3,]"A\=ZB%=X/93WS"<C\P2*[BA5?#>#Y ZB9EI,T$3WN*^L!J*7
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MY*@RF!![ZSQ4N:DPV:N#0%$)]*5LHL>==9S_7H"%,"9!L"PPA_]M4]]P"\3
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M"I_Z@ 2S/N6TU[Q](2[\F'(OM<Y<![Z7+J!NE]1\'W '"(-YU ]#)\!OM3=
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MW/]'_H.;LL"OZ11D%/NY,A1"VS'3VP_/\G\ 9E5U+P3+<&TP\8_0(3*DT;I
MC%NH(9@WQA-CLB1X*U0>042B?U7\85B%<4XO_WWTQOW]*0MM&-X*[N?;R9)5
M?H;@<>GVE&!DD:-.<;E!3%WESJ7+-0]BM6[>NLIZFM?P=C#3GMI"MT@9U.#L
MP^^>L)M>%27#P$%YZ.&%SX-577K8Z*[/.%TPU_:S<F/#HLM5Z8*GRV.:RL$I
M#E*PHMV8\V+_) +R-K=:O8 Y" +L'-[0HB):+>YM"V'* ]P'#]?J<2KFL##9
M@_ '2']4>@=A,RP'2,+(#5^,%,O/;L<81F &%PK#_F_IY+N?"SA%+'R!62HN
M>WLK >;N=6C\^M/W-V]I5CR"6E%;B<02?U6$>KN/F4O-S+B/X'[OS,LLX\P,
M+#=QL-!$%,Q3HY^"RX8DOT,(_WFA%P$;BX M7=35T?4VMW0UI1VAV42]'5_@
MT?UL'F^-Z/'='U_GV70W[4;G:]$V: ,"YE;)$, 4NW!];Z5-RG+$R=-&G_);
M6Z^70JZ7>-[#]R=2]A.UIHJ4PNH.&]C+A46K;;Q/<&&BG_([KK?)S6ON7HVD
M7->JTU7-: WOVZ2,^6Z,(<EN\GK 5:A#\K/./+!I[=(R^N?2VTY#Q=#1L%J@
M+7,A;=?1!.6-SK/GKETWQ-$>\2'?6ME%^(;H953!A-LO%LQ.OD/R4.NH\LB&
M^27M1J56A2-YSL4=Q/-NOGMQ"%=MVV&B0]&+%S+K,^M;@#GQRO)=S:[3INS
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M)_NO5X@V%Q&ND7&O]3/(&DB#+E84)Z$YG7&SZK\7=/J&K-\.5<@_"W)!"8E
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M!WE5(=#]BR^\FE[&8%X:JLZ(3.W7[.^"\(@7WH2$<*Q]8DXD7;CW.^R7;*J
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ML8Q)/?5@Q2J%\Z'=&+_7WVG1-KK=GR,,LP>=@8Y^C;/!:FO'L^O!%B#.QH2
M8%>\ETQD+EXR*O9"B7M,OENZ;W9ZU VX1@Q3:Z4(3H2,A<M3DS6N@<U3\(S)
MD6$ ?+/.+(PL@)!XX5+"2$HJ; :4UET(QEMX=436D2F).3O$1AN.S=3 $5")
MAV1M9 _T10E"]5HQ+8BNXR?LG/0P@T<T_#IK=L9,O;;G9=S:;HND]!3<2U[4
M):(O@C^]Y>+R'8WB<$F=(5=!(RJ^[- =KPXU:;?[>&T;*9K]B?G[20Z^]1"Z
M /'"EL414:@S5+QKS/*S6$1MQ&P/5O0:]A!Y:H@^2ALY.9\RN98A6TS>\'FX
M6-^B<O5SRXO7.(GJ9 J?5Y%(MGU4%[<^:^:XVSUJ=4V<%E\/QR /$YQ*\$J>
MW'$0,"P5OPRTY(6N@$^J^$D]<^IDRL$%Z5$R7"8_&-L(NP%DTE.,'(<LR[C/
MR4*A4VE@7GC=''9G1)$\\9"7)BUMM 01PB^TO*G8?QQ%_,]$$O^T8BH*2*_P
M$=6=;TGKJ;KFF='?8H?>++>O+8C::J&NIG2W"B L&V/G5YSX&9BQ:AQ*7.AK
M)@Y39=&=+21A8\H,'>?,L'5_=%M;PN>8S[F^F^(0#M>11W2($#)0@&NF>/)Y
MH9Q[MHFO Q?(XW]A_[!?S1>=T)0\I(]X,?WQV_PKRCK8OAH_L0S%&Q.'*'G!
M8= (BAU?O_*A=$O-/6X0P_B*^U[5Y<?P@1KL9*,(9),"E/+QU+H-XO4QHDXA
M$%\+?I5"4K- $U$N\>@'C7!,C#*#W[-=;@"*V&5)Q?68\)W8RM#'?HI.1?P?
M M0<U*M+B?D-!!7SVXYH<2X)^-+HOSI05?)<R9,9MQ^AEEG#.(L'=V&OYS(V
MH8(!UR%-^X<*;5V;UJ9/[Y]C5CW+\08EYZ]];&"^N)\X$A$CG[P5SEZR7-33
M+Y+G3QZEN2T<Q'Q5+6]<!:PM<^Z!)6]931G\2G@(8U?WIE%EHA3[-PC=L4(<
M0\P=*2?!-Y2\$[R86[8,03O7Z# NMK&/3QHM)=Z%899OTHKF(TX0NDP5T<SI
M=6'TS:WAIJO O;D<)I81+C5D#\^#0;&?Y+-^"_]FRLGB+<2WSDH/65U#0B+N
M>3,BS4Q:Q/D)0$DBL7,,>VF!Q'"/JXSCWLM__C1AHUM>]H;\2QQKW?)J2#G#
MCJ.F?V1NB+%R-=GK-^+V3>AA6]^5ET$Q]]MK'TM4)0C8JJ!BUZIT<#]HA^\W
MGI&BR++]]W)[\K0CR1.NUX21A7)C5I\U8E:KWBOP=C7(O?WRU;H7;7T>H>=M
MR.0U(R(CW 96J:>='L@:(U+MIX*,&6(S-TX,?Y=SN!\H"LVINA9+ Q'*\I6+
M%A)X7Z?38EYJQCQ'B'.$A2(>&[-N?,\=?A$WS,Z:;?TV'LE+[N:WZO![M!P+
MWB9V^SB<YS8\5K^B"%!B],B\126$M<3J*&/HGB/(G+P>JT8W#WH WE8VA,$F
M-^3AHYW%Z2AFR)\D ,3/1NHR/EF8V0VDB@%U83B5V4MFBKN$G.M?0_S:NQ=C
M,J0!8X:OM]SD]ME>%&,:U!']&- 0(YE-$E,R-Y&GLND%M(<M/A@#Y1:?K5@[
MB.)9LXWD.I\I./1V</3N]4Q56Z0_->Y\ '!.#0E8I(Y(YXPYC:TCP_F9\#?F
M0W]I !P=C%3,&',58\5.6_NTE35R41NO0'U<KVI&Z@7/5<0QZJ4!,TE8"L94
MGYZP#9&2_Y3I# ON+$UV<#+L!Q9NE!NOD"6I]6?YL=5QN+HRHS%?,&* 2VI1
M)7%[[RK!IR!@J/Q1)'*9V)*RM74"YALPOYB$@W&K(GW::7T]F5[ Q)]"$ZI(
M46-90S(=T2O#/T03+]42+QQ,5>>G8Y5>2C>);Q2G_=:UBX]TQU@R#F>F'$M"
MZ%F8':C;]I7]''72,<N6V>B,3?ESV_5[YWG^JKU!1CV%U%&:$O.?8X_%7I1;
ML>]IFZ?X1#MK@VE$N+-MB'70600D!L14 !>C++^VE>H]$>&L;2W<P9SMV!IE
M<D4,3(MO5OD#)-X:;6OYHL)_YEUI26[<AI?D .YTHVUG*\-0_[C2/0)8=^_>
M[<54IUW:O"0D<UOKF3=DD)<>%7GY<R$?BT<EGB=)C\W_,E2L-&9/V,"WS8,D
MA%ZMILP]B@/)MJJ>F^OKRNHO8$4J9=]%N0'EYYKYA;^4WD2@HH.B@\8RO;EZ
M_$Z!FB >41[62/H)SR@1O>3-ESW]PR+&B9:'>=]UA>/G),<Q#&IN_/@<5LR&
M/JU2<?8.B^[J/C+[>T<#7?,I?\VUZ#<M>QF:(*=JZ2@>) 0-[U_$JXC%BGG:
M\XJ@:4*7XWX6^D59MYB$%9'X7MJ8M:.Q1YI)*B[M7J5^<<\=K;I(G"$4 ('?
ML6(4]!5&B:G@4#^-,90_S$W*[K*K-JFO\]T ESL+4AHKLAUP#HT0@3B) 4 (
M8_:1](,FSO0=U_XO!1:)SNNSWH1?@N76(HSS!F3<"G5K?4XI-+MWYK7;3:8_
ML50.@^WPFHJ)^8?KW_QZ0OX="\?! /LY@E_.);?D&-SI<ERQIBY)R:#F0NL9
M[=N$CYW^LWSK\6EQ2*E 42#LCI0Q1-62\ G)M[D?>B9 IW;Y6^/]6-!JKA+X
M<>8'#+&V&&N"&NB3BTRZH!)5X81KR>L"5TKNJ\]G/%C3^T6B:\)-*@>YE%E&
MV_*/A>0JF+F!)U>CR@S)CHF3F=Z"!F3W,N($CZN2IO@=334TL7NT=<WXR/#.
MS_A_I*:?^<NY5ZR#OU[*W/3XZ^G9?[RQ5J+PT_ 8O?$!**O)>0!R*K7T_NZ+
MI&/W,69Z,X+E"_D2>Z2BD)NT9#3JAGJ?<[!\\WZS9F*.1ADS* O#EA+_/J4K
MFV!U,56KX*+:3TQ'X\@>VT,R-\0=-M-CM>U<),B+3?G%HF2CB@UUVTC ,WW=
M6[0"@80\9,U1WS;2T_S11Y.53^O$=G4DKQEA!G&5):Y(+3.A(N/IE F=,HBH
MH 2'H^[PIY),0]=O0/RZ7;>NAF:RK%A,4$H9>'K4:Y/HJD\04H5AY/?#Z9=)
M2B&SR)/.C/O0<1!-=XN2AK^ >*,MJNR;ZFP+M:[EQCE6E1[B^I3UVFKP-H8>
MHF08+:-P>1VB/23 )U+;BV*"K8EUF0JWFU!O0>]MG6ED5DJ)L;N!UH=PWW8)
MT[[ER*_)J98^TUN)SQ.U IS[J[6-JUNCB'P%ZN8JJ*&1(4]EK28F/J2N*C3X
M#V8J!+XP#<Q5W"(.P>Z?-\\O<80MUML473I#X7ZC0DY0&U M$RR7]EZ7HN^I
M]MIJC8,!*C2_)]NBMB'D$G=6XH1/24"#X5H-*6;DEK58VT(7GG>-FG:^Y:(S
MTT$[KS<G]C.G;/F#=H0+@C>:QR2S,C*8MN.>H;J>;W2PR+(7;-MJY2Y5D1T<
M^S'8)XX8L!>+2<BZ_*I%A=6D17 WN;/3X)FD#YI&6(WQ^,6/B/0)B)![?HT0
M-':H65H )IU<C"PRT'^R=QJ?D5P4,[^^9-V_-4CR*LTPAX,DYY)6?11?HSYY
MKH^NHB44#W%@P-3$E'A6^"65OD8K@IOKNVH;;M4)N W/6>T8WJ!1#6O#1Q>^
MJW?YLQVV?">](N,B8K/KYU]7!.W.7IK65\E7-1IC1IY($;O_7KT(Z20_;RM^
M )#=QE:[%JE#?EYP2AIG"_6%LZVG2HWZQ5$VR2%L9FPF KL>[%E6I+16+JXT
M"\4;38D[BV[K8A].].LUI>J(AU64/)EQVBF1&P\7R]C8?>7/O[CZ,L>T1,X:
M#3Q]*RV5MX#LK2S*%.[+"P>K3(OP$N::RYD=[KY5F'?WW;YX=3-%D10]G:IH
MZ2%&=$'2T@J^$NF,QALN(#&&++I\2XOVF;ZU1%A0?:]W>*(^:>>A@&%@L!B_
M.+NA([T^$\DFD9Q)'+%I.YC-3YN_&JG;@B[DMU'N[NYV<=S-;F>L8S(1+.V7
M,OE.<@XPHK("#BPRFZZ'KMV\0#C5.[7X':Y?>)M;9_:_MO\(B4:.2*OKKTI9
M%>P!F3]'V.+1(J((^;K25/8 6.Z8+5@37NHES6!Y&;_IDYE?M06N/FN)6A;N
ME!Z]^0*I6<QFT+' 77_4;!E.:$.C!.WFIB#+4S0OMR[@,Y2@/:.U\3*N@&WW
MBM7&UN9GP!GW<]6O&)RH++!V4)K'> [1!02O9(3W-K9FV,:',-LH3*1$Z>/P
M<.IJZQM@/[^$O9.02[Q3]"G/Q)G AQ:%[XG$=B9RO8'JML_)G^:)5<_^XRB'
M=N+9B>Z"5)I=;"]V\?'7YU9="V^_2,Y#>P86TW3GB@W,=%8F(N;FKO:<YLHZ
MW RR.$Z&C],QN*PXH=#@TH #C][L4#-4]++T\"2JA@> - X^ @&[4QU&&;I3
MRMPMOM:KM>T6GSCMJ586W<BZ2\CZF@/3M.!+JV(?/#[JL2H_7U"XQ_-<FA$7
M_WU4"6<>A^B/X\919I'I+,DMTC;C21VC2_BR<""%W._>OBS?*>L5_6'<&=?:
MI'Z>-B]]S-?6AK/PY69RBYT7-V<7L'3'YKF9@V,>)SN>=?&1+;Q=L&BO"LT4
MB)>^CVIMIE0[N1^&]'F##D_M6;LKZ:H[XVC RW"1=%3'<S<M$ "TJ0@@Y:WJ
M::3D]++47C?.OUJ3LR/B/, .GY>>UPQ]X?<_DJ=I*(2JC4VKU%;4Q<OR_J*G
MGD?M%A@NY4&P_?MU2MW#]](.(H>Y,! 60<=+"EED\_S=X?+B\'_KN*B@&?X7
M'<K[CQS4J]2>_6N2.)Z_'-A-6;:[(J)__+'D?RPYT]+Z!W_-)_P/4[L1_/4,
MW2[XK_D%)A#J'RE!4=12J1US"FZ6NA WKPG,B4"(DB!IH^C=0G$DS:V&"=M]
MYXN;#8L-3__U\745V(2&I09@="-3UG?J^3Q]9!;N7+I5E#L[1!T&C@\=\(9]
M>P.+9Y,D"QL1)%Z;%KE'G1"'$9&^J/-?07>N.WAA.1\U=?^IK^^W"K])*V"<
M]P9H&+]4ZNGX/%E,RH*=O7U2N*C7 28)[ ?9;:!LM3$7,)3V>:* W<Q69:.&
M5I8Z8B/UM&?U>8!VTFPU 20'Q68)!I(SU$H1"AASZ5/M73ZMZ!YG[(51\$=Y
MXS7T*!ZM7SN(QJUO1@_-@OF_>Q#E;/._5TT=FP?YX\>P3D2V[7LR(IX.YFWI
M.J^O9FO&CE[%:3TM!!C(4H:$4H4N"OF$H+6!3L&E55L7D9U9&]4MM4A#:OS8
M673:5*5H)4S# :?.1VC^U=CTLIS!_:[?W>[Q9-$.>9\&.9^-Y]S/?576^X9@
M%#:E96K-KFFF&E)KU(2C"V3D["1J!?%XRKX+ETR9'(6;R2^'#S1H]R,17P48
MD=FW4YLD*N. &VQ+[,Y8A24::V(7L)NBFINLCN.#<5Z^*0<5(!LM.RH=TD<7
M620^CQ6:X(NLJT^TF)UUB>"(DHGX^D/?V$5XDV0U1^<P-=@Q8WLZXCV/]<D.
M/[_">I2$/)V9RB<T 9$1) _ADJW9JDKI# DI'K"K<+;D.Y%Z8;W[1(<H<6Y=
M/EWZN-QR&W&EZFJSD-=O.0I-$4#L2+GRJXN5M^P9M=^7)U\78-R5JM4U&;Z
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MP(:/CVR(,VBH$Z,??:VF)Q7TR(;COK$HL8LL]LU_APV-^J^]F ]G+PT5J\1
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M!6YYNN--[$560L4NA%_5,5VQ5SM89WR7I7$MM;"Z",(=Z[U9HYC'Q&%/#A^
M<[!V=3 7;UL#MV@G5" >Z\GKKJ:V92S4A0B!H9=L(CBP_A2N864;-@'XWE=H
MG<\B48CX=1L%NK68EY'RX*U..@YEY9%MXPH5^J[N5)9KON5%"]FHTVX1"6V=
M6]2&UM,#[O2?O\C3I;)Q0]N,$K?"Z@L6]*T6Z6*J,<%P_BZ5;;YSF@U)_#E"
M?ZY<]H:NSF)84-03?7*$]W[.RZTX[^6MQK<C/XX)K(0)S$1QDYMS9M%$E!2Z
M:QA)B(2\JW#3DXG3-S#8.W$C?R,7\Y/'QZ4XE%B8Y.<AN6^;/3;@[IP64&W
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M6>GS7KX<&T@.F-0SIR0QCJT<7;^-DB\8$(0(#FV@M.RCSS*/5N,@NSF^XWL
MK,<^,-LASM'(Z/)8O/,MYRI 6$5&Q/51W5;3OY25:IPFTJH;'RW5?/VCS@7C
MF %]WQON:@@S0R[]R(C4?[J$OW-^3S%Z:T&DDJ0Q:<O+4S^671^9Q8RGW^3
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M 5GWEI0:;H>*'0U]@'[EI]$?HV1REQZ'PLM_KYHJWI&/("I@N.V+;^F4)0\
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MZ*X_;BW>DY<VKFY_O327=I52UVK4[\NTP)54(/]TWP^][ :+!JSMN?,#[1'
M9$H8MUI'Q'P<MBA_Z1^R.U>08O]9IV/#5.43AVNE*Z56ZKYEY2"C1:%M_GM
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M:/A&FB*8H+P1P4\D9A&L)9L.+SR<2=$7%6TI,!EDCOSR2<F_-Z3G@*$H!#>
MR_R?JB->V@W--,(4?6(,IEW<4OATR_PLI48UY1J%VU?^)/8QCY%.[R/8-;I9
M2BB1)_D$U33C)4;]8)&--B_*T1:I5ZF8:(,/=0\\EUT&SZZBF.NG'-H82^86
M31$F36YG=CGID>.L$$^,'&N<]VJ#OZ)8)+HMTU^>CF@T-68DQH]D"?# 1:.I
M&3//0/MET]AIKUEK?^;34!VI[POJ,;>3S6 )+JY+] V-\.X+WAQU'U8Q2HKO
MEET$%"_PWD3\NK&%L1G>49D848?G"X79H?3F0I8Q[QG?N%<=J#?#+*=8\E[;
MZ@V^3WW1JBNWFX@\+/MINL71[3KNR'0W1 O]C(\_FY=.=XR6HY9YS.D45&:W
M35Y^F].?7:[;-9C@3"RM(EOI<1J_LHLFVL'_A#E/88D*9>XG>?,7O1*$)N"]
M_^9WV7^RHU5S)_E?+#/OZCRC^(ME+55)_VHBGU#R?RY<=CX;]+$V:6WO>'ZO
M?[\2YM:H*4Y_-8$GMA)T<7TH=AND=@N*]Y,:O] ;=/>@$.WP?%B:PD]T/+;?
M[E-UH'$(KBKTQAAO^Z98F5342C<]H06X4D4L'VK)O(3I=^U67)+=)G1,,O0N
MY/[9SO% 50K0G7_AU9M=!20V*!;'__R,BFH;N>G?Z+_<-I6)ET7> .\!UM-C
M^1?NE,JR?)OH_D8EI3+OZ*EN/1H_N]ETJ(QV.L4$/G\SRZSL7<L4C._A:4:F
MPSYWWRJP/.I,;/89P<I)NX4F[(:'(C*@I!U>D/S,#YMDN/%F?TP =NGK9B1V
MKKW5(:NAJ(<KI5;1]IT=86CA[&,FZ76SJW#>1R&:GESDZ96N9N]I8B)/M!YU
MCH."^F;K'(KF.38>*A$@4J NES7R8(:CP=M5J<> 51$=/N&%()UZ9?4GY=]?
ML59-/L?9_WB1!Z^MYJD2TP(+L/,P:#V7J>1D.1G?,,MV6@5+KBFUM),,Q5@*
M2-?UX20F(AU=$&5J:Z;/A5^<ZD5X1MO%FADH+341K'_]LWTPK\W"LD<34;A&
M3&)L=^YBS!I#\\8R)G"#,T[6J+S"KD[KN^&%WYM&L (/[W1FR@#+<--N\G:"
MW'E5UEHOW//\K2)%7I";\-FP*P7BZ?KS[;SL!HU[ +YF1@<#&.S?C:M0&\9@
MO;?F^)>Z;,O1.=0&@;PME&!\4&[X58&A9O.&"E-@)&.X.29K\??:C[T&EA:0
M-/!7]>T)*:?>3515FA.)'>8"[#'.J]((KGC M)3D>3(F2-PN(QW893PJ^D*Q
MU=ZEKIOY^Z_'S<^;!T[Z@1-X4A\+C54.&5;G'47A@V<#'\:'DD0G5!F'MZ1?
M'L2AD\YX&. F87EOXT19JFB9[@&2S7]/ZYF1%;"P-SGZ!/'Z>1J>[K&7)P [
M=*G3PLB+\A"Y3?S=I)N9]:W/*.V+Q2;J/J'8.V&"57\Q'GCNVI.!A@B4)HQ&
MB.]\35_OK^+XYTW5?@C01-@"=:5#N7F\K?T27[#VH1Q'VUUF\19;!V[>EFA9
M6/C0J&X'.?.\!].F?NFCA>"A=,R\XS7K9L$GAMV7LP#P<^7>L;^JJRDM%8WC
ML]_,FK;X?*8!)#H8[1'UU$^=+/8NY8LUG.'9X</RVXOU!L+3,:U=L\^5?Y>8
M.."IK"Y(S-K"#$3K.LL-#C)TG.1ADNU&5R7<S=GUFK35.WK_.+>VH*2E6R9P
MO2(\Q$NG=1@OU+)UK*,^.X#]VTA"<]8:"?ENILL/KA\&[0V_,[AH@6-4V-*^
ME+6YTA>\;]!I=YD6 8$D&QHC2QMN$:I;19PD+[A= P;R;5+5;3P^+@_P+K/M
M_0_VWC*JKF5;%QU(( 0+[I# )!#<W0D6@A-<$MPU.&0BP1T"!/?@SL3="<%]
MXNX.$X?+>N^T\\Y:>Y^SS[VOO?;N;6W]&']FJUGU]5Z]>GU]C%[5+UXI.PFW
M4TH[IW>A??TZ.5V::[G2BF^IO)<9;0LOV-2B:4_I[>"',(\I+Q373!#$L>/4
MF$IBR0 ;: I0@EPA;VSE#^>R7&7+"Y$%:D0;:[QQJ)#L0PMK#VH#U@3(SY_+
MT:A45(^<P^+';]_:K&.)6E>G)P;WBBZ5*I3H3II,O@Y@SYX3MW]MFR+W9@09
MHC;6)&Y;I">8$E^+[V*?']O?$&F)]W!<$B+..TP$7=1W%5(-H!Q'CP0IG=4A
MQ""7\CW@:3&_-.<;*C#'3S2P2:,E3;RK;#4B<7?@/U]M^/6[8=K*"E)DS7A)
M4E0<A25)L-!2]Q.9<SD2RUPMC:)Z_) 9CRDL+(LM?#)E+<6P^;.%,)0/LIBY
M2D)/Q?!2AU[4:=-GHU@O=,*OG1/:O1I.)V>DD8.-N42(O_6+7.6]\#?NLO=5
M'JOH?)T?(6/!2_9V*P)UQYY-E[8?-GU('X%@6ZLR"LD)].Z>%*.P)N)OELV&
M((<P9-Y'8.]VBF^^VS&#H%5=.GNB5JH0*EYN\PBDA=5M'??:7"SM:87_C,R1
M<?' D4$T%GVG*-/?*R9RI/BST9BKE"/9S+@NZI7Y!S.!.JEL;+!H$I*!*]VI
M;+BZBCX7_U6;PM4/$+GF][7#=!UPRF9B@?:BKJ<,UL[ETN>$6P$*[GY-GH5Q
MY)#]:'Q.5.+"_&W<3\H')+6?;'K80X"(*=XL2 1_XL,H73XF4UOC<"DR?&Y6
MB,B_NHCO_]V%AW^JR4*,GVJ=ZWIZ,]8CS 2J%(,#Q<@0@9)^QWX<O: @$#4C
M)Z&GEZV@!-F3+N@8H1VS($FI3%\[)8&#OMPK:-955-AR+H>Q_ZZCG5\#+O?.
M"V56!]]"/EO4C%MS4YAJMX+<)/4/#_?2S\:3#%CN/GN9,U[.'JQ^::ZM#X>.
M9K0U@XY=,*01A%.=B .*0#7NX2U!0J,%4#H_?-:*],S^Y9/8*U6"Q;?CQ1 ?
M2\&F]9X]G(7G5:0?.KVURS:TCF=%GTUV_[;PG/-M,<2GX9<$8 CIOT?8?8\=
M=&=<8U5J8WZ9;=RR57?G8+.US&_-5_#V-G\<Z0^X@0Z_:XP_'D9;7>7->#ZU
MA8PLL+RU=/U$+DMG=OD@&W%IF_'3\%)0KEHKA"6D O,TAO$+,NDY+2W=U\Y6
M\QRO))W]^C]YY6/]NN(S-YBJ;C3+-7_R)_4!TH$W;U!Z,-C8[--UIJWM2Z'H
M%(HMU5'O&3R[[%3#I+,/SZ9C> NA^L'G]PK*MX(ED*ZO=B8A+H$6"K6^HG?\
MDT5^MIF:L@Q<ZNIBYJ%]\=O&SB:[TC1YP%=5M,Z:2JXE#)N\& K(@MX<Y/?U
MD)$IT1;I\?.[HM31K) #3L*TE<-5/C&D>NFA3U04C0@MK!?77R'0F:O2GM.I
M&T-;)TLR[_O+=/QY\J^*< (GXSM*Y@],8X>4]89H,#'"KV,#'*(N/>"@3RE;
M5&=_Y&JLI^UU63N/=3/@WUB(&/D3J7XJG>1]8$!(:EZ5DX2>,B)HU'[OSY/R
M)-J8$=$A-?)E8Q$]T"9^TVI8U!0/FSJ#2N=3G_Z,_/S%)H+%C?R\ME8+'/ E
MZ#.+#,CF0551DKNIM"OETP5H?80]=91CP$NAP_UI6R>HX:[2U7X+0O!O$UHK
M(Y\TZ3CMZ5T)+^G)LTE@*?84VWWN/&_'>WFD_?(J6=;Z&80[JAW1J&>T#S"V
MOR.\@.%2O-S96_DR91H^-IE R991P=L&?!DR0R#I(([S$RW<O>0>H)ZH2]L'
MV> C @=*T4-([J9WVFO:VB2#;Z8U_3W[C<S4WLI+'?8SL&!^V-K3AC)5F1?=
M_Z2USH4DP>.;T811H9WWW>UPMK[<N2'N2 CTK"Q'@?]4PQX^LR^XC<#>T]!=
M^CU^60H3]JT]ACX81]A4C&4P"N5H1)5EP0QJZF>%CV(4/U,107]BFTXI)F_T
MNEZ'=+7&J=EA6";F>5Y-TN&J5P_/IS#^E]F@,VA6;%>2W4A)66: 99#-W$#(
M\ZR!*B/?1G<G)&]>?L(+_O3G4L8_9P0'LQ>EW\1SGT)=?9"%6=><I?L>#K@_
M"+ETH@8QQ7MX?!8B-HMZ__X0,;6>$/")U>U)+]58,LM3#@Y3&_5KDN;Z ;M
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M%@)%P"3&.5+I5B<,C1*(<Z(:[=B_XQ\B\U*XWIR,>7/1EH(/TEB?HCK\P$?
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M4$D^&/ZZI=Z;M]E+.0P1K%LC'')P-XQ"?R'YT8ENF2TM(VRS7.C/Z^*?.)8
M!F!>!'$M1KB?4UPU62/PUT-W>47CD.<29+&Y9?%'STS.0IICBB%"J>OP/_P[
M9'AL<^K-&;BFF,&:-9)^/Z',OK'4L8$6MA9FR-N_$^'X#^XHZQ_7PN2;J=>G
MK156##9GZ=P'+F6VM3]9:]YRFZ9L$;;MI0$<_^AD2LT3B,]K&1IZDO.TVLOC
M/'3%9&9JI)YIX0*& EOE:VD )VTQ?V@K'N/O(LMLLU,1TJ!%.3U5$YWC]Z$&
M<+U6*>Y)D7_IT9OO!;W0H?5GCAGRGHX>R\VY+7'.O5YL^S/KJ'?=Y79(2@Z\
M:[FF]U4]PN?P(X_ L1/W(T Y@BPJ8;SS7T.AG]>]*K QUM8ED8H!UB5/+4ZS
MV;9\5;5?8O ;K4V,(&W@#?^EURG_>6B'>;E@N'_8]&#M4(#E= 1H;7/N57#H
MIV6TK'7')Y\R\H]:K/^I8SDV7[E';)-JB=3Q\< )A<9@EA3/3!$N["RM,\(5
MF,@J/V2Z4ZUE*RD-S^X''*C<.-V4$AW;Z1B#D,DJ[7<MA/_<(;!-6WQ;#_DV
M_LF#!)6H+-DV%6VZC%2F=[!&% >_O8U(HF\K(BX=-DSXM+&BBC\"[1-+=Z$B
M9,_P(@T=5V68#7459,9*#N1=^FT+9=C+D G%;;S/?"X#RP1I6YY<JDLE4V+.
MCCI^-@FH;A+D/^>3DE%KQ]MWVSL=\1VNXA]7=.:6)<5,B^T, _@IV-J:.RA;
MOS^ZWMNPN6UZ!(KV>IL!,R6=1^ O2U#C7SGOIY$,E_Z% R_[)R*F_PLT_\Q0
M#&?FKV)D9Z95G@;R4$D]U=Z-^;#7WO-R+D-@V6ME;_@]<ZFG#-E^Z$]SOH_=
M^3W]3)PRKYV736D9YS$<A$XNUG(!JW\BHIG;?[6[B1#CJ@O_!;^R]L)50:F!
M=@F)5 3\LO3)[FDCW58,[AP@SV]D.J'X9)"17HZKTD=&NNPR8Z6,DEPR]H4R
MJ+4(O*(VRX[1EY%E9'2M_^CJU'1<B$_&3&*LN>5U180H:W7%)/VG([040'C"
M'MZ!&5MI;_^)2C[/_5=05!/^)?V@'VZAM6R8\G=;N;[C)YWF1F><LE:*F/6N
M<8S7"5^Q;[555D=(VO[Z)Q]D84A>9&_ =,2A2PVQU$2I5JAI[,GP+EZT]V;#
MSNV!)PU#.[6#VY@:V25N#<V"C%[(>>B./_&] QOTR98&6$K?*?[W4CO'R#K6
M6AM^-<\S5_^FMZM>7^;W\AES6U[J,S4\*,?%1:N*IK'P(-? E8FD=YS-5R:G
M![:@_LA__2'!N!P5GV<PW=G@:T[:!4@(W]SI->>1MR=YFF-ZM0YU;^)KM94A
M](QY:1I?24=?MPRC1>3QBSG4>Y5;V=OW@F_ORLK;B_2H!W^5(_^FGIQY1F,#
M9S@.L7<_\%^,<UNK9_04?Z+"7=GO0U9']543X\A5?["V\ZR948V$A9S/_0L&
MI1FK[>J[O$ 2B7)EH>)&&+'UM8#*;9O=WQ/JV6;#@SQQ,X*<ML<W',1\+DPR
M#.;*SM8QASKY=U>K08/Y"8,=VJ/"D):CEQ $Z56ZC_+-H!-5HB6[RCM)C*GU
M"?L-D4?[QUW55>_N= ()UVM<!=1-A8)NXB._0,O\!00%[R()\<<4-COI\E[H
M2=;VT1$=<Y&ZA_<2C;NZWZP<D(/A724EJQ1KNLMFKNGXZ)[(_S&2 [!,#/BM
M,M0Z6K3@5U5Y:72[.?'$H[\YVA__@+\P@]X]8B<B$-TF>%7*Y-&*K[E]LP[=
MA("MBUQMAJ#:LJZEE55$U%&1/,S8,9E4@I*BO3K3A=I,M2Z%4-GB;3X&^[DJ
M-IWN?('3CO?1W]5J]>2=TW_8*>@%E-;GZ.E;5BPR^POP%W"6+E4NZNNQR==M
MY<VFVQ"F?(XL0_(6F.Y@VR/>"F8XOVW6UJX.N"[+27)S4J=W(77DH]/VB25Y
MC9JFNDS^G--T/Z'\[L7D1?<)1A/4%]()&BS\\-Z-&[LGPW,>/L.4S(Z^29O1
M'G^&YIL 4]:49/P\NEQOS+Z,B?ZYPO<8&9"#@\7^#6W#<=+L@JNE>))Q5!_'
M+&C!C+2>NO:'>]3OV=.'$ZJ676#94].^P/R2G-)2T%;%YX[YLQ'4D_(@$JHY
M8&/N\PAH:7C_X-W9M2CS;E(J55AMII&9/&+*E4V>NTUV(U?[S/'".'+ P/V[
MZRG<-I']6",O!YF89O%&;-LBMCF#*F,1F6@5?(2(PA,BA#Z$S!(RIDZE2*5J
M[J^$Q_??\7M42&$)): H@G[K$.LH],'+EL\IL<-B<+U728RF'Z^*7#X;<(:&
M:G#<FK)J6,H9E,>[P3G =>)$EN'U[4$7:PV7YZPMIKN(,YHF)7/Q?E-8.<0/
M8-RG:0SWJ6:]_=R_T+_9''/"6<=9</@E%5DB^?>[R /'74RT,5HB:+OUG+?L
M)QNA)E.\B"^HL(;&>EOX*XF\9N5:-A(8(P\-B/>69C"V?U@+*#H>6E-*>EHS
M^)?C2U+/<D[:XHGC5NKK:^UR&HGXBS;>+Y<O+T\SERU>%;WWTQ^/U4C1OM+#
MK.YTIC%)6K%!P7++.>V@/D/IYP_Y:3FAO CCE^&D/;=F=-I1!/G8:%#EV\"E
M]R^*Z-E7E9%?))VX1L@PZ=[1K]1X]'6I,SAIHJ0"K^@?@2S/-B0;S(*+# RZ
ML9NG4/:JWC"3J3Y_8?MD0>IL88&C.TU;9CA^Z.OQ?% ;^;=U@[HYA9>N$:O<
M=;K:&F>(SM&=GM!81DCV ,<O<K,AEX(72'92"" C];*=!\(%Z_O8?%?F3OP&
M@4HBDQ#H^L#9\LHWDUDXWK:A%9_S;LWF,5O*F,UQV>/T0)KQS1 >DN%&EL1L
MT=/LGIHAKH(G9B@IR!X"Y)Y(>LP(T!LU>-::"]SDYCRSLI%KJBSJP\UJD5R8
M[9'I%9A.FM&[BM6<J!Z09H(4]>5P_T[RU)J;TYDKML9&3-+CYDOM1:;!X.7<
MPV$.MGD=\/:.=676T&=,.OK"_'EXU(:F:/6R+]+S'8FM $9.,L92".9S5^<]
M=1<V#O:551,0?(\ATOYW1<>J?(2,0<"MIQ%< '55Z$H:O@/=Q"?F;T-]S:?*
M.6>C\5FBP_C2J)W1AG36UXW(T=5.T(=*<EVG'[#FT!6ZM&K2T0I8(I94G>H3
MG(J'MM_T@3 9*6Q;@'7UC!H?SS/0\+(P<G5%URLI[M^:AJC5KX0-5YQ/(GZL
MEFSSD?6DNMFD'P>YVGZ A$A]ES5TUI-.C2HP5K'R WGF'%*\/1KS%JCLU)P:
M#KPH<;;%6X0L)OR<7=!$;&1&+ '%X@6/>),%J8JW\2(U1*+L:J7HL5?634+X
MYX(@YH?9OAJVGK<R??,=S*#EMM'"IU@*.X\F:>=(@&?$DG)+YEC=_^>I!@>!
MX_#Z;Y3KX(XYKO&ZBI4(]V,YMCGIR>(+<TY9A6=7:NAB.M<)2KORE5SN&_X_
MW8[V1,CB\/2ZCT"5X1">5[4-O$MD39M&>O(L&R_36+YNGV^5:&2(_C=OT?A/
M'YVC8 &OE;+G"Q+6JV3O9@?HW(*$AAF\2Z5W"Z4474M#ZFQ#82[JBW!F5M8_
MZQ,.:@8K"0=J$(MB?:#>7%:>3BN#TK.H@E)N+1&:UIVBE D:K5,4B9*L1V&P
M0>7FJ\SE>R%HQ^J1^BQ^-D&R1<>4R9DZR/0;SSHY!KIC.E8UF8+657@&V%3.
MRR0X;Q&YL3K4>;SZ,\HKG\:?@GL);H=?RE#NV&OKQCC5$Q3J9 ?B GJD3D=L
M"'E(N04%:8EV'UZ=; 4T,7J1I3464I=T!8&PKN4W%%.0K N=PTYB?;1/^F)Z
M*M_]VEYFJTP)0,Y$:@*OAC?_%J*K:QZW@@Q82\KQB%LZ?@8::R8P9%[*82DC
M83JXDRZO-FM+<4N)E_.%L;:[6F>?K48>]KX9K9<JY\5]GK<JC&_6@@T)6.LB
M:#4*<1/(C_Q^:F-E2BBB(*IQ=J=^+ >)RYU/VC=!;=O$CT#1Y[=O?*T:1T7E
M%P%)/E'Y,,G)OX3R)FRL7<"]HQ8:LS2$OT3EN=_,(GA,'WR"V>D%ECEYDXKL
M?T%?[\2?[T0RERI7,@%*P'[VBQ2](O %KKLI!]J%KOHJLO^Y+M. T@1GD/+4
MO8M6D]EIHBI:#!X<#T)!+]F.5&03D_+*4WCQ>M;6J/:P6QMI_ABD$OG#-#*!
M1L!IM6G@O='QY.4WR-6=<'$J)1F^M>"!?]& 8'//_6"S'>9O!X1/"/OTZ>0X
MTR;'PX'%PBLDYIO'D"+])>HN&Z$I4/J0-N?#-4H_Z7*8G>LK\BV"L&J4K[/A
M(E(PDG?-=3CO3K[[3SNT$**%.?6^.K9S+9%%W?-2D*]MJ72 7;(65_!3O3:F
M>K7B316II&=^@BH>VNT>Z0?AU^8_HE>LBYBZ8_@0-A7V[B=O !M@1$J>R+G[
MOC $#_BHY VTP?L0-3P"0>?I:.8=M[K-VK+.]L05:@;[[G2%OC(P^*JY)[W$
M=F)=^4.")!- 65CVD#H'^^I2;H1]D;:M7 -/F8#-.9WCGRWQZMPU?'+[D2YX
MQ9+J'UUA1?ND43G..TDK BJ?2SQ%ZB#C'+;/R-BZDXZ4XY@49KL'>$ZS4OL^
M,-0SS&'( UNX:!?I6%=;G2W828L4+RV$C6(V-%?)/\38H(:E1\OS14#DCU8C
M??>92C(:IS/"2S-E5JTC%+.]II@(S$C)<PR;W:P/ L,$9&V7+\>SF\<Y0W4I
M3Z'FN;54E]$K7!6??3:?[3U,6:1ZW\(U0,J/:^I.+(3PB)V:JV;Y*^<)[-IG
M\@&D?D9OUJ%G@!=V<6EF5( :$2*I+UUI4>'L=I+.340>=ZRY36-N%!77:,H7
M19F]F8_"*.:U?-Q^7[RX[B_GH9H2:#FDX;^\L=*6#8D*!&3<&\ !3J@) 6X=
M(IT#M6%]!]$1N [N(U340M2N[Q4P'@&;GZ5Y\MP4)IH?L'U/E\D*DUU8VX>!
MR_.2$AS=<4^I7*D"LUI+%_.WKXT4I5XM^SY'Q-H6X5SC8DF.]!,B"KB5.D'$
M-E?W-VJH",ZNK["O_U9$I&PDWH1P=:.>Z<GHI7OW^O7TZVB2@UBO),T2B:;:
MET96\=*]D@);TW[#RG!C>WR#@8'GP1=R!FO[,#OK,^.9P5H&7+N,M!SG'+[-
M%,[M:OUJOWQ9*YL8/#7>(*Z%:P3 :"U6IFSGY=X#V01'<HJ;2\T1"LV5"QK"
M%3GXQ<G1"W"'W.?E5IRK=-5QFQX(>A@?5SK@'];:J)C<UB/-QF,@1?'VB2GG
MY44VL3.%"I61%Y',:"]X16C&<[\VZ2.Q#TO3< QS3)EJ^4\5KCZ$<Z7?]8 S
M A'$.!+](>J(%[Y['^K40?0Z#EOL.2D[0ET9Q$/ACD:-KS70*?B@NMG\66[K
M[UCS,:K^QE>(B)Z]TV2TA&<G"NU%F5+%J8;W\-I^5K%>\;9)(HTA_K-I@:6L
MNAC1Q>8WL 3\[.R%7C=S%G[JL'52.ZD*\H FL1Z/(OU ?<RM!*E)QRR+JZ8@
MC3XC102NY;I^PL_#I5(6YPK^-\8'::FE^GJS@WG=198X2]J:0\F@D#=M) E7
M&FO\'HI450T-OCU#VD7]RH2OQ4$QO!U9/C$RYZ4VG:OJWYP$V1X!Q<HI95DO
M/E;&49:^$F+R\.I\ \$V#D_9,5NGX8"&Q?3<;!D7SM;#-;TRB!\>^3H\ZY'>
MY^)VK]5\R+WIAU%.>DL-@3=)^G'V9J--5=?ML"Q#!EPT(T7V25NA5ZX&;=VP
MDH\$0Y"04[8*?J0 ]9F(YRJ3=1=W]"KJ4^<'+Q91+BRCK7'/<AOXJ? 6[VA!
M"-44*CY'^CR60M@G&*%>^9HR>4MZ&K,:6B5AT7.-Z:"%XCGV"$W9NMZL&W5(
M?]$.&,N3M<2<YL,D5=#<RSTWH^-X$'8N-X8&'O+,JC>?K)RM?,L4<W6C;#3C
M9AK.@5(A%^4B6T8-:PQOCZ/*+@$,JI?L"/:BB;.TQ)'C2):UDB R]$;A08 X
M"#\_K__R" 0Z.R[U\NVZ^S5/GBW 4\<H=QE7#2^\$(H;WYO2A^J13!2+'=[*
MY90?7,Q_,[S(D!"4ZM'"B,W5W-4*R*"L;@D:L*7Y?K#Y*JQ/'@!Y>J=)[<DE
M]+10^-AHZ;ZCA53(B=DN" _8+#D]'/&>D]ZJ#T=F7>TI'C^D- RENU"'N4O\
MCH]BP-""C^^9?ZUCIT''0S: LZ=+Z:JO53'>)(>[ICRAM=:AR&#+@?RZ_O[7
MLF/M> F"(!U%J!!*&E3[V]0)&K]+'ZR*LG2MVD'1A7-,RY*+X";W(=G<#M0X
M'F:PRU(LT,KJ0@/ZM.&VQKE\.J=CV?*B=B0GN5LK5*"&GK,9EF88@HA-5Q?N
MNQ6^%#7HG/Z<(]Q6>KI)&SG(,"XW1%O;K%2/K<B>5(EPM%W8@_9ENN,@X![G
M&.4I<MP\'"SO@U1&LBLF&?KK=/YM]-=3Y)Z.SA'2:2F]US^U=^.%L:P_CYP/
MFDS_GM+3ON>ZF5<PQOT@?QMD2L<5VPZ0YQ'MBY+'_O24."ZM</*R_5Q$WY_7
M-:[K%M5/W!4B8J#Y'8.-?YQ!B/I*7&7\Z*@8\F/=3SY,UN$#&STE>1ANO@GY
M,I:>*8C[@3IPU3H@.7=7<;C0S04_P$,]Z'V%-5I&&C>YMPL>^D5OD(#$Y]7X
M0)DFOD_'5[Z8_-(OY4@SQ^])N;C[  S7M32_$"3WTNP3G(X&51EJ6'%T]FRO
M9W%YWTI&= U5>*%C_!J95R'MPQO7][H8>^IRJO<!8^\BS+6FC*%#=MGF'U)N
M$?3PRES%N[3D>O+RDAG%5H>&%6ID43)KW8@^<ULR_5Z+%SMD?1C.=28^Z!XJ
M.FY5"9FRQ;'$;@>;OWT8'__M\.P,20S(MB.1$4HDKX;;2T(._@+&W=F\%&F-
M@#US".M[3KL8E@./.:&6:T<.7]O0<I(7TJ0 0RWAEY^4J]06=T$)D?E@'S6&
M*^ MLWRYIUN3YW:?FK.P&)1F6R5R>JU48.)5*#^"#$HQQ'W^"TSBZD2@R5C0
M&X[FD[]">DTTQ.XS+#XN2)O<\T#FHYLS$6MAWJG*4-&(61GK\^J5 _N,XX$>
MX,F]1D8EV]C0.I)GN*I+MZ[+V;*CN<E@@[?^P9@$V83W;D]-&,7R1N"!?IRZ
MJK&N.K#C""GYE?^/:EOF),HA7F.FO8@ZO1\9IC57CCUZ%"<6'Q;))[*;6 P'
M18HC$K??ER,C3Q.6-)RV G.+NP\\E=.&X\S5>R04&-T_/US&;^+7I_" Z-(T
M53&;][K=<^%Y4[E7:?PYO=S.M=$-WG+BN43VN2Z@LFW9*?]"P/(;26IF#N60
MYDQ>>"-[00#C"CA=!<(T7Y-I^PPKM?6OVP^Z;D;F[;JGU+10U(Y""&T.!#[=
MY-16:57;=<+7@X(Q$=-\I+1,(HU7?[2\UKBZ61-/970BT]/(M:\;JJDT &&+
MA_F+^%0=\NR(#$N'KF'ZF+IH7%1^L!BZKDRQ?I$;X9#F/=F(&9R&/7' ;&,%
M40%QL9"$!G)5T4KWGGCVL9\3<7;O\NEE3.GCB\W,Q[I4[2^++;7<#Q_;GWW%
M2\R3=7(['M ?BUGKNKS4G_FAK2NNP-J+I0BGT:<HLP6XOP NP!BN YT/C#+)
MG=#O+@%H;OEXT>."*&K \LT:7JV>TK)&&:<PL=:5KR"]8OF3_^ E3V77U29,
MV_W4'B0A4 XX7:PVL[^?4%$;*SE:#5A%K)/;(_MMPHL+KL[+S)!H^*-4O&UP
M@@L7!=K%7!%)L'4I)<0DPDPG.[-O':N/<XN<JG[*ZNY3"_Z84[BA2DW$S9*5
M>0$'-Y$KC>FW>0P[@6HK+O=IB"Y46Q\J8^EEBS?85%0C;2*RO3;BUXZ7Y/EZ
MY>?X5'N38"X)1]2OFLU?P@Q"K'5,\Z:D)MX\3T$YAJY4R978F)=A5PV-<KSK
MX<$C4&L25=H'BD)?/G6!&\[#^[UT)SFU?Z& LZ@];X'R&8PXLJ,\C'J-Q8%(
MDXC# NTJ2W[=ZT1$GC9GG66N9@?M-O^IV4Z6:%(C73+Z[EDE80;"QM#F$-_Z
MS<@70="L]FPJ4Q]TCK0=>7;<2 ?KM)2EB974F6;*)\VV1,YM!?QRN^8KZ30G
MNKLY\QK;3@)?A#:Z+>MUCNV*=6--+5 J2:_=24Y37W[%RAW$Z1)O602NJ=<T
M8F,UKHM3%ERX?I%]7%HSW*F%GT)%_#4T3RLH]RS[I1:EE:?U/ N/%3;[-#(>
M[^CY>-Z]]\Y4P# X$6;[VK-Y[O)P+LS493!=[XG/M>][?EX=L!0D;C_DU'32
M95:*\<BWQ5N)/YW;/^"5E&P7=C#6V3HL%<P9OQ,O6#3[^NH$5XAZ8BU!KJJV
MKERRP1#W]YG"-]>YU[6($KU:EZ9CU==.N!/4Y34>$P#U@-A/"8"ES<K([E!X
M66[7XOM7K.-Y;A8=\95[.MZ#D_5?-4H!H<A4YG/1_30A2 X4.$><N+&=2E"F
MPJ^C' ?VYKF+R>:YJ#;#U2Q4//0I+CW(;^J6,/M7%;#VN*)EP446HV 3[:'A
MO+UPL_+B6%G?!8&>%W@*P :&Y7QN=4W:*LI6;8A,R4PU&Q_\*/:+F)Q3%,0(
M?N)?Z>UZ>/6?IH6(1S<_IQ Q4!JPR9(7S<=\S4E"=(L,YK@]8-KJ5=:X"NQZ
M5AW.M;@Z2?(Q,8[X8X(;E3,&O*\@J^)5I\XDTU=*!>N\A3T"YS>NB5;GC;!:
M-X)]A;?/10G7D:@*>C]$ZPU]N67G[/HYAD ]]OR0M(N=S5M$C>?:>WZ>0F7O
M(X, 9^:.[,MQ#@]44;1P!CVYRC>]QM#?+#S4KL-Y9+1$RZ.NO5TPKFD7;K[)
MP8.XGE1K@E2\3N[9W,0-5VT>0GY#UHJV :RD"]M0KC/,P)N(7-,""WP"/D]T
M!CECYV,;&^3!ZO#.F6GI%I*1*90571(%+!T\=DE&%:M<C;IYUB&BQ !W; 45
M=:8#QK(#$*2E-F1S\>,<B/W5%_MMT>40X"2=:)?OTC_WA"LQ<]XBH:8&RH#M
M5>BE%!9OG/L]$<ZP/GBGET>1#T[;W5</>I7=&Z-]%7':-[<S=6!QF1##"2F.
MO4ZT3O$'LI9]3L_T0NUSS&O#[6S.;S4')PS>_BZG=\M'>:U-M0G$MJ_%*F*B
M;<MZ.+HVO$EALHF+6;4W2]Y4NVU/)OKDL54"SYL>Z,*MN&@!E<QERF$Z^,9.
MXK'7[DJEKA(@<U-9H6S7AA61,HVPVGB$V_D(H)B49"Y:1O?G61Q@-1!L6QT<
MW-4-,,<,R7QN2OFV)D :IEYMKH4?FRD.TF)*-,_KI;)U@O@8HGG)C["KH/-U
M&S0$6QUTN80-.OA2=VUX*^L8;H( #'>?)WU0O)S?A:J'@U?(RB?N)(K,CW_%
M/C^XD-).=-'Z?>AKY2MR.@J[7<:0,#.'$=R4'PM<MKR=,N*;FT?U,RY\'V2H
M813#>>U\MP<1)X67YBU3+3^>"LQ]'I"8K:'EQL91<8W?ETR68,G2MAS'\S3]
M=&8<NDRSF5Q0ZY0W*.0:879TUS;+@<9MR^4@;%Y>W@S3'WN7Q!'^1:XWL$[U
MB=GB+W/J-1&6O3'TCKQVIPQ&:W0OL7H)A2"AI;LMKX^G(];&JLFT528.&)@H
M&T]+;:#JJ4*##%5B&O?[Q2*%:?X^9!(>V%>68K)SR=VC7S8:&M1D@[NS;!.U
MCY"LC'T.,;5DGR9(2ZN+8X&X8T2<2I8BUBJX8M:Y"@T#127LQG[,FR?GA/'J
M"MFQ3&/Q_:4<VC#>1$X59>*L^-GPK[Q7'NHT_WT8.GS&_BW)]ZFVQM9X$9T4
ML\K4&C4I&\YP8:0ID>Y%GU=2464U I*?E/;<R-SPU#J:BY]IZK-/.YU]NCR?
M(C+*\9QNTY2G*(E<OJX.=# +]9NFL0$*=^T+$L0+:"'[-( Q:=E9OC?FN@O&
M7+*(E<ES=?+_);=5GW1ANK">DW/:#M^'H?!;#$=7YP'MN/E71ZT0R=@;#9R!
M()G/.,_'J6M*U7WB:1#JA2!YZ'$ES5T)+[7%<<<*<V) G]@+M\Q #B+];0>Q
M(L';_R$%44PLK +XXY.TVB-PMLA\NZ\F-R:45\)9U,C RB1-=@,.5W@$GM^G
M%[=>CCP"+X!66"/X^HC@'D9[J]MZ=QGZ<(LG_H!U*ZP)/LI\P 5W")ON,=^?
M"W=X,]^7+CUX=#\"7B%"T[:/@.#J(]#2K?@(?/LZ/*5_NPWVISB.G+T9>&J
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MSFBF-/PD>7F"^0C:LI,,%R5T<\KC;\X.F+*QQ=^,-7X_YWF%=152JX=#T*F
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M,.:<P=\/O&SJ)[ ],'*[5,TB0NOFWW)FV:Q/S*=KN><.5Q2#/C^V]/VHDB!
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M+*4#VMIPH,3 =%W#1_7_FZGVLFC< VQ7GVZBBDIX$$V#1IQBZ#)A@ASA]2@
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MQ0B>]1P)#UW3B()2,TO7#+K8EJF&]G]<D<6!@4[J*F7VELKH>2LLHOZ.5^@
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M$JP!';/<%P#%8O3]#@B_:X4TM<?N@'V00L&C7 -4JI7U4-T[_$/7$&!/[#?
M4U_T ACDW7QN2H%7G_X*9JMK<6FN#S;36]21[<&Z($LN5X$M0F%'!&#,RDB]
M\LX_Q$[?/R'-[O^;NY=VK[R\'Y3/@OWR/QB6FQ>/,"FY'HNJ50U12*DX9,9@
MR_;S;V4 !%&8?6]!FP^5!$/<?-.6M8.)O#<FOQ ,://8B/#1CB[8)@?%>CEA
M*IY]49@''VG/4FXTFWQ![@+UH7LK(#>L:E!J8@I-%+^$]0>6R0P/B H,S_3H
MF8Q<^"CUQUD:(,BF;J5&,O.W%6T</;9IUU+E.UA\EZ+!H2R,N;">T^<6T>KB
M@\1YWF@+QX-Z/ZH8MJ<"',^XBF&'UM@(6W%J@0KUC>A>+_7.>8U)2W='S0Z+
MF@R?=,+6!FEQPBJ903A>'PP96TR9G";M5O-K4O7>\*(%9=R,;^ W7="PL=\[
M>E-H F_LR&PEJWI,R!A3DGJ]R)6F*VR@J$.'1Q494(5055Y3'*XJ,T,DPG[1
M,Z:N3QN^@E#FX#/\WE(]05+[57E(G,<3V^@QWZ!O3Z,T#8ROX=K;GAT*1F&$
M<5R1%T"T\YZ:LGG^R@>1]ERPJ1/ID@4Z).7,*/T/WY@AAO[E7FQ.?BI?(2;F
MY( ^37O7:<W)[<F*H(I,$-K&MC"$M67T^>UVJ*@6"FQ\S (<-=>M>3\O&6/&
M.2J_N;\');$"R0ZGY%"+Y; 03'IY%V6P *POW^^_[6GZUZ-&6+-,[C4\(KW"
M5:RRN 4=.4YJ1[//-.:+W#"54K8.EJ(<(1)>ZL_ODE-,&OC()*99'W.Z7, /
M+0W7#PLW%94]T%20-_[4E6:$]/R<[=)W4IQFA($#<2+N?WQ TO=:OWW\O/%$
M)&(G;,";0+H4]Z/LJ.[!12O6Q%2U:?9'&IO<N/X,S&]N3:&U2/T'S8ECL?H,
M@4H6F^.O)BG<O^@X9%5$5]<'X:)U_F<W]D8%K@UEW'WWGW/Z=/%2]54S)M7!
M*RO#A"Y(W=L+>1H"-!D( -S"M2<%]235>4>PU9G-[A1;;N1[>(5WBG&2<>C#
MK=;$H8.=HOZ^@F%_IM^9$JM+%BU21.;R/7LEP(3.4,[1WUDN-&LP2[':WO#S
ME9Y*:P=ZFI\;HN:.M<WE*,*%C!>X^A%IMM:EE2LLX+)SPG9:S8L/!*7J ^]9
M^P*_>!QX". =3^Z\ /28^@EP$S@@=OR[HCF^@CK,J55GD670/!V3LR7N2*$%
M='%QZH:,?1XZV6DV+:SZ^[/S&,)0'@^#,S11\JB?HY9.+K1'G0W^Q)\TS&-R
M^<FY /S26VGN$PCUN".ZM]=C\SJ0J;RI*TH71]_.B-C"'SM<](E\_+N R%5;
M=J@6&;. L$>16#?7QMQD?MCN8;MM](WUCX66T8$4Y.A%RMN'.IAE5=VHCHU(
M_8'^1"*VY'PY%G0P[?;/!VS),VH*9J+DF("+31HRV>ZJ(2)O\C.SU VS^ >:
M(1J[Q2XA^4]OGO83/QW<^/O*'C6J("SCCNG=)IZO#ESKDT?+9H \PAG9B/;(
MA-GF(QW\UXZ(QUS'Y->P4OI/=WL/O&2ZBWW*M):!!JSY=4<V).)/A6,.)-ZR
M2_9$XI\0*&Z$'<1)MW'3LP\T[J]3KT<^);+6"'/V" ;%$6*%U;##1_@+80N%
M]2B'WG](5S=M.X@4M*%LD"XS2QH]#[2",^'P!) P4FQYMDX@ J7L,3=1PTO3
M83<5L?+3G_/I4MU 3M92O=@E\@,[F'5OO_2S=^Y23!?>QN8LZNE)"6L6525C
M$T90FV[%#E8+VY%L_Y#=;Z0PR>"$X8:9F]0-NHFLI)SA9F!MY2LF/V(N-DP1
MF&/8BLBS_D6<!\B,(>U,8,) YL=E:><&DAH;A'^J3UF9EPN>S85EG_HX+1S:
MXMPT:/89!4D]SF'&$*XDI[%E]=N]?H:BBZ!9"82#Y<CI*U5$6TYW=4OMXVW_
MT&<_M0523EM,=9\2[;UF[OORK6XA(5<B-YHN?G'.CX(90BIOFIF#YIXIE[KR
M&J>XA69GO:?!UF ;-1[VNV,\/M,+<<,E7SC,'V_[V&4/YCQ"ZU1%IBJA<:N>
M 6:3K6S*,*DDUTNKZG.^K)/Z/J_O?JB9#_H>-#';S;Q<=U^:(+=Z8@U6P7*%
M+J:/;F\QC9)0R*YN=U'S^=T#96E]8+-^,7Z2@PV(IZ?7GS\_'2M7^N[&Y"X,
M Z;KP,]?7+"9V:_I-A=W/'AGUE,L3W\%J>)H3>@Q*T^!07'WY\$,F-_T2TN"
MQ*B+BNPT<( FIA7C-V%.3+'%$+GC$8V)XUKL;R6 G)2=-^)9;P;S'$^+'+1/
M;7@[;@8XDA2+.\@:D3X"&0:OP3S\-(Y(NBWMO=\)KP1:-GL%\M%K2(4K)<2&
M#=@2W_CK\C%1_PP@>(@088"KSFDB\*:QY)*S0J_(BEV5(UI0/"U2J'>+(^?
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M".M+["5(H8NJ!<6QIE 3^@::A,T6:_8?0/FLF'*.9K Z#SAWH0_FS[XHN1W
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MD06<9@NB;M46QUP,4TN[I S'9=T-DA8*'X;HW4X:@K=JX04*BM=5*@Y? >9
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MCI846ISLSY1_"QMEB*$BL6Z'K#/BNZ[?Q7I4!]QGO5\X>8)[#TB,MEN\ [&
M=["/+H8. KBC]=\RB,E)^(O?M5->=(D66?:&R%)E*-7DJ5Y@E90^C*EV&6:)
M9K$!OT!&Q-K#9YSK [+,-D-:U=<4-$5=X:JW/V/;8VZ)4K+^OEKZ..UHU7RM
M<T!BM\W6P$U7MY+\'4V8WLIKPEFVRKX9G_V=@T#RZ*3E)Z7Y>I>"T2!L]6(!
M<2P@]I )^;R8G&79*\#*6 %I(OYGJW:ZTXBDYV%HFS! 4D*:>4V4 G?R079K
ML'JK.G!)(_=J,"!-<GG640>KO@H(E1,-_'/+JJ 2+!]HI$[G 9E"^&RQ,<@T
MMUT?\E)S5A+S-/;$/_=6;[@&0V52B ZP4T9H9A^(&V5?RL+!\0IHZ/]L_6Z=
MY(Z]2@"A*>+64SIH&4.WM89+_D&_]I#'<$VI?-EXHHP<#')F)&(+CYV@ZF#!
M8?WLJSB<&$'*OE#&%=34-%]-WYRBA,-[.&M<93>-&E_=-ZI#KTV'*(Q '[#A
M'V2%9_0LWG*A%GWFGG5L9V;'V-"2Q-G7@-&B'<67]8D7F3G_>_U^)\J30<^G
MQW3H9>),$=MH?J52?(S/9CTUW(:8[CLQCLI70"_'=B=:[MCH N;QLBI]P$K-
MQ_AH8N=1@A92I ;A[D.Y^^#]MLO2V,J2<7M;(%Y VT;V%#M-1P2%V2F/\ $E
M<:V9?'ANY!9P9>P54$?BQ&"XV]H>0SX()AR5_%:<[TCG1!X%L+J=4.(*?A;E
M[\Y5$2*^SK7IGX6CXXO064<P'[PR!%HA3+_IOL .NE5#=Y@S.O*-\])@R(<$
M41NU/8;?0W_.H>2&M8Y8MF?K!OP+.K?R;E1(Z7^+O0")HM?;ZX0DDZS]^66C
MB1S0:'"CCH+"6;^#=D,\]WD+L46_&"KPQW[^M*-NP//L:05Z?YCM65/;UV9I
METL\"ZF@4+P3<%GAK95G#G:59)WY5[+B]3FV\G8MZJ_Z7_:;C[="I_2)"C[.
MY8:%'^/IWHD:IP;WF86(Q-R0,2-D7TBD!)38>:%H1U.W=W6U=B4C)@I%3B2V
MJ/2%2%'C"4VXN__+60(%0_HS?2[!_.TW]F<NSD9@0/E( .%$YPWNIB(Q\Q@=
M"R*.K]5;-N6>WYYE;XMJC@TF$N=*%\Z*DMB?]U(+%;<4!_=-TYGLA1!WZ#*/
M[/[W-J_^OP]-JA;^C1$_C6CP'Y1(VI3_PVV[L=^F]\/NZK?4<!0X*X0RW,FS
MVB$AB/*S9UHE4,^#?>/EJ:GP51(GDID%?QKXE0<J*<.1P1R&^5QW>-B*517'
MWE?>LI2Z[#C7'Z\ O_U:]<(@L;U:#W$\*DIE6S##Q#A9_(^5#'.9F:(>Y\[1
MPJ!U UX<[F'I[$6%Z Z/:GL#_K!,U4KP9\0\H%T3?T-PX.)EZE41S;)V:L.R
M7;?MRA67P2V,&6&J^M84S\3@(4_KS_P3U9VE$@81CWXT+OE)_2AI3$42%)*#
M[&T24?/ -!#OLR7M5[,V?/J2SUZ4LT#Q87*THFD;S@HIF_/B.V^B5 \_[+]3
MG?-_8ORO\B'X/^#5_O\R5;KX-90^$HQVBSJ!="W0N5O4LIQ3HD5D]-U'4V8;
MF9^@TUQ748L@40>VX1NU.&*=0.*Z5T!8VB1^^>J*H1+2^%(TAJZ$?:)S4L@V
MNP^G"X+G&=@D?NLSCO3V%TP#(%%%@VC0LOI6;T.]/%PDAB!+S_EB$']Y+?G%
M?7^.)X?F^9.\?I,TFQ)A4S'TT!%C\/[DDET3B7RGA_SG&4Q>Y-+P^EF?:,*B
MX==/>T[,IB/T 1LH&'SG!D$27?(231B@"W(; /AR$/8*]HLKC';F2F*>-4>J
M@SC79?V+IEJ)X7&*0:,L3**M@ZA#,A[^:%4.(NOQ > J,R.Y[\8K4?,5N*P?
M1BL2 :!\2T_A03N$TL*6+.<H74'?3#GLR/WDR2-@98"$59O*O>;*V7H).1S<
MU09BLQ,XL_%B3'>AZ1P!=M1V_7&)V-%:B[:_R!R!'/%SWSSFAJ#173X6-.;:
M4(W .\I?NAU*K.1GRUGF46;X4XE,OOY;-9Z[,[>N%_N'[+-!:?@J>Q.1A:F(
M&T$1T[NTRDJ3]15V%?<D5A*KKYLM4JCHI*0KN<BN*O\T'3QHSB/F>Q'L]Q*Q
M*;"K1_]DSFU8[),FU\S;\"B;' 3??AV_:ME)UI70(0LJ6#8JB\0@)B9+S1:E
M[8@PF_GP"YRL"WS'($R">""T^\]H@\H[AT5+F?-VR>2HM05SMNW 5$S*\9BJ
M[W0]HZ&T+(ZW3(#@S"DJ?'[)!YGM2[H'[=G9W8$[M[N)'6#$ZI5C?)S#F^"<
M,M'T,B' C0AK;E)Y:6WA\A$WDG9;,..;!O9@+P"XU5OHEK!?Y5)^>T6.K'H]
M$K,Z9V!'7W\*7$%+GUS9!KUNOG= ='*;!,>Y\L#]<M=%*_97=L91<G0W)EF3
MWNN_GWV!\C])9K#UP]M&N\QP#]/%6=)O-_";QDLN&[ =N3UXRF),QU9BWPQ,
M]+^UBVLT5TOK;LCIN/"]L$.8+Z^E;G^XO3,,"WNP7NZHL$HG+MKE[N@)>A1^
M-+.9JACJ!"I=QDQ/5,K9EC&,0S59^\C6:PXC8<G+L7%4;/LNHUA>+"@Q@)M,
MMM&_Z"0F$Y)+L3 G/XM44U$*FV+8C=@S!I$R>DM_+&5X++(<-D$)3%WX]4-0
MI#;^E@I;I32+$8)EF:Q?=XUDUAYFK3#JECBJ9UDS*Y6/U1"SYZ^[8_H@5UL$
M35$51#Y:SIT(6_%_"J:E#CW+QM]G0<E%  ]8'$L29BD\^4\5B*5YGKLY.TO"
M@GBGG(J'PSWWB/<<!857IJW440HU]$5,6E]*:HY]G9>?NTXJMB/'-_($_5D8
MP0G<792_;6%-Y?\I/O'_5_&_AL><!9U>,8CX?;8_;WJXW"SO%U2*+_R1Q6B'
M4YL[*66E&JA+7NM-&V Z)$ &T05B!LD)3H?(CM$;_IGLB_,OU:'/.ZLUZ2:H
MO9F*U FDZFR1M,G=D&M29"!*K[E:89=;QB$,&'VT[1FV3$8;\/#4LLMDUQ&1
M*UFH;OY6;&!(.O@HM9N*N->I=+#><1J(M[%F1VS@5.CN/6X@/,>>N\XH 43&
M:!Q+NFIA%;$E_W:0K9VU$0&;> 5$0=9DA"$OG#!^J/[)B9YCZ'!&L0:1^0@*
M7<$7%.%5H7R;Q8HM*@1OH-R"!Z7J #4D0ZG5AREUBL>YUSI:QJH'COO:DF([
MI^2!JP=V%UETY D3'4* R7$T0*[H$&VNOTHL/7X3)1HCVDW)5?$PB"];@:S$
M.K+86UH;[U!S4U!U+ZAAV*?8_<"=Y6LOC3^HKX]8EX]++DE^5QPB)31\0X"Z
M=>ZOO3FSU3XF.,./'L7)X->^PMQ];9YSCNAM845.,=Y?L[AC3AWW9J'N$CEX
M\Y1-H?'/\#R?]2(_47/([ $F[?!I\IG_X*,277;*-19K:=?%W;EZXZ6O/F-.
MEW%G8TLT(_OW,>ROQE8T2J0L3%*!]ZU5\;I;3LW5^H:]R?8&&+X!V;'6P-*T
M9"[Q$CSKV,$W-9J\J8]M=T<8/R_6SL.<?M"8H&-B74UI7]?,<-:@G-EX%Z,)
M1Z&8E='C>5907QL;.1=XB\HUUOM5&K/VXE!##;."BI9EA4<DH_E'O=6Z#=(C
MG^W=:HW&;%FZDB]K+/%$?22LUJULV&M)4;"$*%@." MVU-[\W3M*[#^7<&:!
MZ3W3B=202TD&*SG'A]NE'R/&+5N$AO/E<@3Z>F)WV+).>?Q(/98S95E+SC.H
MZ=!H<,]HU(8)HQ#.-N?.3SKXM_P"6(%18N'0>=2&_CA/-=>3.!^Q$!L+MVZ4
MA)#6*;1GWO:+%3O1,D@&9.+#U;Y]-ZU289HPKO#*F/^P(A,""N*FKMQ.UYN_
M6$N[<*6/L"E^8*)D5U"#X<I&$'438G5J@<#,ZH*-4I#_1D"AQW<JKHGH:M/8
MAF4=IL?4,@13#/=2K#OO^\+1>\Z6#2_R)D_IHBRDE@\]BP./#5B)9JN3>EIK
M(H\W%-_5B:7_8=,,7N!NP&WI%8#A@2D_>HC1%A _L5BU% $,Z.]#U_LFP )#
MHYF4VK3,#AUP?!:]"*S8,B]7KC:1 _//]I 5(WV@[2^1WA9Z%#X,#<JWFN;F
M<A1C*O.^_Q#ZQ C,L=#KZ$]B8$^LDM:P_LH;-(X (,>X-35NN3#^TM?T)%X$
M%.&,VT2:Y>P;L=%6F]CW^=X=I"@$VA!<K'Z([2;Z_3<O[RV\91/JAXD/1&?W
M8UR.[\%_$#KZ3F%+';?IHF*)'6DP,11Q^P0,+5Y>.Q(Q$G''U3O7D_1JQQ-F
MRQD*%$(!>/#!+:XX0,D$.LL>/JQ\;&V*KR:MVM-6HRZ6EF46;;9R,JG<J/X4
M,]1C4!)]L5"]$-_;)Y8.O[C^"N"5Y?IF_),PX$A6T1<W_N<FA7:GH73+O+]Q
ML0-X/&EEV<!$FI,DFE<P%5)+LF,^J59F< W,"_W#T/IGU#! 5FE.LJ$Z<(3B
M3O&8H[></5F8K<\GEI25=R'AK!]W2;GT :GI%8 %&W"V]_*AQ37?78MX6?7;
MPSKNXF&V=L2CPE#:2=$0C @D<? D2ZZTUX*-5HHOQVJ*6JBLS.^9WMOI': W
M*57>Y6)F#GNS6/CY>P>\,8*J6DTT#EQ=3DTN'U#8'AJ9E%WL?)I^YB]:A?6!
M/,!%AS-][$3U?'GV&4Y;WZQE0F;^G#;X.+D23//6A&YM!'F4""YZ"MR7;^N-
M+][/BN3LJ[VS-B4=;PC@74' *TW:9(MN$HP!2<A[Z=?*F";3L;U+Q$/8YMZO
M47V'AB*\GW,Q.OMGJ==UY+L!N?#9+7IE 5I\$:R6[=TC";)&0E 0."YFZT2"
M$MBV$7&.9^<(6;3C%S4$L[:I\*IXM/!M<+U!-*L@;R"A*D?1#\CW%YC?UNG(
M4DGBVL_13M=BN\N@#[BB9MWY/.G6G%.63UA29O# .=3OM?3;8S(W,[-JRIWH
M1C!9\,]M1\//+^Q=W !7X:K/1,]B+0M<-532H0H1ZT^J(O[';FA:CH+X!^\)
MS'Z0%PRMFGC7&$A&9.YW4:ZZ<N3$$;5-O,SCK0[^\=BR5UWX"@+T=UO5,=%1
M@(=1/*IS$ SGQ22KUAZ^*),9YRQG_O1)2@*#(=]/TSV%5E6GT>BQO N/^_Z\
M:5_DCU 659'5\?/!W(L3I"EA'46PH-VD>]>]%LY$Q]AJK+OEV5[1PS$JD03\
M[.;!/D6 S=KG^)9YI]>_)9&*F;>RE&0G=5!U,'(3Y-2W_5_8>^NH.*.F3[!Q
M"$Z"-$YH D&#0_ 0/+C30 @.G<8= @1W:4+C[L&E<0CN[C3>6' +%DBR>>=[
MW_UF]ISY=LZ>G=G9.?/'_>LYYY[G5MWZW:JZ]:LKNEA]^I$%H>W>T&-(MZ 5
MZDHEG1N;F0E;4SI&H^[$#2 $>SG9ITLTM.J\CAV.7-1H?J&?1MOU#.XQ2O&.
M@'>2;MP=,68KR3 GH/X$>5#$R6T3KPGSY(.S,?N6I'!<[GO);\<XT#F/N_WX
M]T;+-A%^LB5>X+<9N@O6KU;>B"*+TN*M-%XG&;FGH:!")C8]/HUIT!I5;RL!
MTC2B9_Q,&NJ-BKGX%*U%1?-%63UCM=%+(36@&/(TY=.#8V+)+_,+#4VI;].3
M,Q0_7/7@S=5&5SW:G#[\J):\B\Q;ST'W<GU78T.]RM<+<3AGKKG/YU6Y0@ML
M,\S@BF\S3/D#P+VV?51QEXQWQ5E6K06+.H"T=TDA.YSJP(B4=Q9W%W%?%7<P
MY@H6W2+SPFS=P2^?9STV9SF05,0F")5-LH((B'9T?UX&X#QRSKF-^PS<FL3U
M0'S!Y1F(D!'KI4LY]#*@'%;PV]5-"T#4=12@[T(JJE+\I663YTW3;&^8'?W,
MZ@B37+=-P&GIN&VLVM  C*99UY2X@?OVB5\GGA^]$Q^?KS[O!8/\!66$@.\G
M_MXCZX4DI2PY;AO;F-H84BHK[<!!L59: D_!T O6WBM(2O;3FL_B&:.1U LG
M7/G6L5"@_N3].4 3(8V#N1_W ^T[PXJ/G@/.358V5$>PZ^'-[QWZT)9[F=O"
MW^O3C\V%O^=KEU^?17;.I"9ZBVIG*XRLQLL>F.KX/SVZ6?RYTZA/<;R(_KY>
MA;/T[3#H@$E!%J\;68C-N23"2#20=NYS22=Y(EBN*J;Y8@3%8:O:2\RMQ'KU
M+)SWL9 8A5$F;I8.N#Y2:8,\&)Q6.#QO:?IB+?K!Z?OV'&EWJ> GE0=65=CY
M\MKZ,:,WA<9]7:.:R/O!\XH_ *P#_9^LP<=NOTRV?)MUFU(!3_AV/O>4@M#1
M1("B G\ %$MK]O[ EKJZVL9OWH%Z32TM7N2+XH_?\7 N?TYA_E2(:!AWE*^;
M.Z[2 6\XXV1<\K\:>AG\*%U.0"RKK5!Q %L==*0HL+T:"GL;::,U5A#490,B
MH(>,MRMMK<G*W/$6VJF(9IC,GFY!L!&QJ<#'GC<$1!G %%<+D?U*W>@M[)*2
M.QBPX:$T?8%#AV045'#+5U0;@2T+Y'OIF!H[\FK\;S X][2/6@">OR=AU+_)
M1Q52[A*J$E>>N2TY;SZJ63=GX2WP,,0](\S;)L/>K$>GD^ E.;_C3WLG]U6F
M#*R*$G%;R>!UWA^WVZ?4D[+V^HD[[W^O'2A"WUPUNE42>LV ]UU8SPBV\C;>
MQ12YCG-%P'N"0?BBG]N%B(\/&UL5X*$[F!.Y3O])$G6YMI?.8:(J,*PHW6;I
M\81ACWEG)_.!^D PI#/I;8<JXP /$@=LP4&NR:3= $,3F> 8W+WCK5XRC%85
MUJJ?@Q;%S9=$W=[:6P5IO'DL]7RIYYQTI8%3*1S1H!,&!.O7D*[*6X;^W3?)
M.'JF_F:\<SI&-M$"=.;(":B4'B+A/?>1I1VZ>&>S?*_'CVJAF4[R(Z%UQIJ.
M=$(^W'6EG7:=I/$HD4*8/,5%W_15[&8XED]--^JKT2/;Q5NMNT]4!YK]A8+?
M)@F*#-O+@\;Z[KW-1URP-RD3AT5S;;[:9;/."G) A(5YC59-2E_:B$]'ULE[
MG!"X.$\"48BC08'X$)_^H%Z!\6+$SE.[^&<CQT:"GU/'T%XF)LA+.",[XC[_
M+Y!YJ3XRFDC</F&%_A2*=7>FJ[@Y0B</::UY<Y;UL*Z:YX2^2?OS'P^8/XOA
M*T3729SSR,7*;W]07Q248'CPW]><=T04V)0K%!D:O8-?<,8_[ZZI!RG+K+W$
M_('_"%H$;YW80I#JR-B6QG31W<9L])7V%O/$ B>:NS"=S5NJ@YE 0;8J=L>(
MI\CO/P>JO0M!KSVRG+GRWSGJ *V5'A-PV=%?FDN:JV&[O+;&9XA4+5_I2>=.
M)K^^X:9'L5UC7NHR6A(,"PEUOHML.HU34T8%BHUP3%Q+1<&6C'J]*8+WC=Z_
M%\HI471\TW#%V0EVT"@QWQ'%X<K*_)QHZ.SWL;FY"6$KSMNJ$H8Q"I4FS O]
M!G?=O4IR2_O1?21-7ROG;54]R/7ZI@=UN:$N+U<'WZ,*O02FY4M/P.31>.,4
M"2<\LG& "!1/Y.NLXJ2*)>0!^HII?5.+"]9,NQ/(XV)T+^QE.*,JPW!34F*F
MJS1]DIRL#;.J!2:,MGZ@8G U:M_O?<7A3[V2K>]N8FYML)M+Q2*$-^8;*XI+
M2>%D,2<=88RLYC-I.CGRWCM'E%53) +,)3FI!A<]K><U!.V).;)8&L;3[@Q%
MQINL9KJVH#[Y',G&JZI*J:N^V=?LH' >9!F$?7WG(HE: <>O_?1\9,-PB=H\
MEF1]4>1(^*L3MJU":$,^W[L*.%=Q(<DEW=[7W"M64UC?I*5]$7FA-G#897('
M7^?"!G)QG3%YME[I;J<.?<5#OEJ.;-Z/<5T">#;H$P=L<_SB&-1OO%R)SB(3
M<3N?J8BJ_'A+-DQEUCP:!DW;@>(G9J+2?_/-N]T+GB&6%%R=H15&2V C!1=T
MM->R3;=AKWR&FW=HR:1% %,X[G+>Q647K!K9<^ #GX#E:N@94[1&PEA5XZ%C
MY]@;JP#OYL)@$2TTG$H[I6TN[7?!?;>4"[RKXR7V'HWPFT3CV QK W24+)6$
MU:H+$9&\<[ TW3CYOG[.LU.N'RL'E3_0) :2,6?M-3(VHTGB;,)O/VK?IMEF
M_C#%*0/<M/XN>1&]];"FQB'?+I30,(#YD?_KY=+F54RFYX$T]3-]0H8^S[D7
M7C_HF-S16O<4"R&U9"J.V/W>:.S>?*)RIN$.*FRE E(,ZVO@NQ2CN<K*1=G9
M+95RBV=]X[N(!E?V$S8TSFJ8BM.@(Z-#+K%T?LLW;*\!!DJC=3XY3&W#L>=?
MP":5<PHNV%B6&FB;FW%]I&?@6Z[7R*$%YT'.+:58EH2!BK7/9A72M]T_-3 ;
M]-.,O&;[>;;>XQQR0>PDULN8T\Q48LM=J1"P=_54?P >+BW(O,[O-'&JIG5W
MM27O(3^M<^@:[%.&H;!;VQ<*V4SL:,1Z&D 9)R].$?$$M(WI?S4(,O[6)R%_
MI7:>^-J]%SGI[@FUVQ^,G:ZH9^<UOD6J$=OO/YIL'8@S;8G] 9#823)=8*S;
M34=NJU1J*:'\7HW4B3(&\;%AS/Q;=J3F$?+5V#8;>P$A1D:QMS!B^-R<CSPH
MD]:S>R]0F*T*.P"+RD_X17XVVX7PBM;4!.AU1:A?5T;][J]5FT9>$_50!! 1
M@/,=F;PN_C"*R\V"?"4L;C_($)E+:/2?:KNJ1<ZKPW<NPL,9%Q&.)) #=U]0
MU332WD7FF9GRR-?2$   8W4*IV#:^%L@CR/W#YHA0?PR'M#LM5C;L^8,;"6R
MEX8ZM71@@.L&^=P_8=+[)J50=9M.W;1]#C%NOV1D7[<L@Q66>S-=Z!R*$3*@
M!(*I0=2[M=; $$G0U"E/E>/FS"D*;%>U<\6"!\)CTO.O#!K$O/IKK>[_"V3C
M+4WNP'*=BYL+515DJF]6V>*@8Y*GRK#<$W,^)T6038Q>Q[^5</7*5'EQ&,SY
MR>27-?FZLD^6KB)6(4_5(^;,[C-Z"4LQV$,)VNGFI^P\.VEG!=9>CZI\JXE;
MV*E;9E_C^)2[ U]28EF"*8G#E%[4.CX"/7V+CF["5*RIBQ&.I8PNRA$%0BO)
MS8=^X=N)0_M5_(]VFRH=KGT+=0?IR94Q_.!"/G"-=)>"5/H,(V\M*R<_(BFK
M,&DF4/AJ\YZ+YX>L;XF RZIXBL>WCU@A=<KX3Z\<M"P3G6>QOA XZSH*,&!4
MI3@Z^M] /C;Q]<4+/F##K47@0@F=!\"HK>3(B5<R_2YD7L1]&-IU,R$>4#HX
M?!CB)SY>+^"Y,%N:>G(/#*+'/O44EL!$5O?RD-K[:/'<A,8(:PV7_LH7%,O'
M]^1^+/-*A0$&T92.CU:!<ZSA?OAE$&%3Z=J6CJ#WDE[/.[ANO"FD^Q]K[F*;
M!H1)T%B<7(>^+IC2WKDMH%#]#0=,B!B5/852"H,9?A("M4<S&MLZ]5O10]<T
MAIZ'C=KAC[?G@_NRY7)<8[[M P_&$=.UVS!RR8\Y9NI&E15WPCISU^/48N5@
M%4,'[LF5%)6F#XXW+(JC(%@R35HV51>FY<NN+25&.LOW1(^L4"L07M'7%<%Z
M,-5X7R@%7Q[8EBL4Q#9*P#L(6I"*H=GZ/F6SX%X \<7.<WIUL]@,21/B9-'M
MB^)%Z+Q:I<2''Z0?M2L49OGV4L-A]8B63@0,C3WF>+70AFY00FR1ESCH6FBV
M2)CX@Z.[:^7RH188":>X &&3Z/+EPJW")7!8Z>JEX\)5:H)4WT+.DZA:9RLW
M#50XO&V+5JV2HW*N4S<3![732\I90]KU[6S=\8_$FBVRQAL2-HY_H0IPGDPW
M@T*X$K.Q78U^S@?;MV+GE2CP?CX]L?QLA9$Z6F:R$>9J:K[Q1'!TDFCM(.5G
M:(1P4C]S9]>Z5B_>6R0%V]SI1^S-#WPM%N, #VJAM+REN^ZSW#FW_;;VV:U@
M]8:FI3 QD4OY*:H4S,Q3#*HG.,JS\+/>G_UK54=''&7'C@$N96Z%@R[,SDV
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M*T$EHQ/'P1.\ZX%\)UR/S#PAT-/C:J99MWN$8@FXO+QF#Z7BW:6YQY_5W9Z
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M+\J$(QJ^+(3!%B_P41[WHOL>:RNNLQ[K'OLB^^00C=I@[5D'3H>Y!DI> 2V
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MY4$/.E#R?-7;CV2O\)!YAJE7WY\%/.66E\G,KO$SYA$LL!2L;@R94_FX<1/
M/!)0YTUU[[?V^_W:??TW3ZJJ]>6"\ZK@CXNN]L)AJ#W<M)(O8P>@B<0X@_.V
M5#(QRTTW<E^]A9.&>$(3B"?3. )1;UQ7>A\5.H'34N5PV__SBRI6Z%D8$U2W
M?32T\760@+F(+NT0:"6A:R@7O6!O7\S?'M/MY\;*'\ 6PYQ4;>,?@.TON'J=
MPX#X6HFUZX"P>?OZQ&*?\"*%WM0H2M$MTAW?':Z29A6W&5"@YL WN&=P&R$M
M(?RT89N\.8>TN&WV^I.ZVK3?+WZ5.DJHV%J(-X81UP@@0XV/ZJ7H9G9X)M[%
MD]^J=@)4CY*QE>WHY^!?[;B=$_IB,6V2O_U-VIQS4(/CTG3R182_FD(=-J<M
M[=QQC]>XZ#U6C31"F,Q]'I>&!?>$D7KEY5Z.&G+A?4D&X*S7[G$WA@N[)8;=
M+4M\P"^,F$3Z7F.?L,7H& :?>H5K!W'1*%U]3)] 7D+2'-Y"G[F>(H6@8A%+
MRSMN1\:_)OM.U+6F'7>F!584'2JJ*G33SOSZ;*M8EUZ- K5<GF2U:!#M6@_@
M\C;]]"C_&\-[+PBP(2*FM16B2$[X(O/Y%>OQ@EUV-7:C=ZI0:GCCEK;EVVUM
M2HQSVD:-9*L&+',YMLF%9((#*V$Q7TPB=S,3,A*E,86-?M#$.FHC+AJ3/P0\
MH[CQI'8?[PO"&VN!\1-MNE)G<E\%$8\G)5.11U/V'96GS%:>M$O]3ODJV [7
M5/$A-UWWVO/:M<;UR%D5VND>D,=WRR7:ZQFSN^$UJOCKC<3@<;/P*:[>6@P_
M0F*F'CF94@:@[/:)B-T'7(,-XY<PJ>=D0*(_@+-3FG 1&M?/40?MPI4!/3*Y
M_:4T ?5B2IQ:LM_\!^/D8VN6@$#9X,_]+N&H:$()[C^ 6JK*'=[5@Q'NL*,(
M4Y0(WP;/Z0H_T\HD3I4,@'3B,#T@XL64^$L;5TAYNU+) ?A#4^Q-Y8@Z,.<$
MX-;#GM@6*.M9MKX]P,72G\E[] 8,\=T2#Z7E")MCMKK,?*Q +76.N7U_32*A
MH@X_]:7:F8-JS>SL^_&.[WV]6J[A(S8-KC3,)994E3RT\^/QMJ-OG^ZN&))"
M60C$H)9ZA:C?2F"?Y +1G' QKZ+ZYQS\C/U448ZU,I7]&';(H"[B]$-KC6\V
MMA/HZ$[*(<!] L-6G[5G:'OT++6+;G8"'!*4>G.%4.?8T*'F-AL8^HJE71(K
MNRZ9:98P42IZQQ-"+2"BK>.EQ1=5.TS^MKK'BCH@^N8^:._%Y)9V1W)%2NVZ
M1 .7.]F7.%<J[BB?P#5I$5KM!:H%FV0+3>9 NIZ8&F 7:R=?P.O_["KEOT>=
M.+9"M.28'T,Y_D-3?:.02Z0#*3Y5BMTHE#;3Q[.*4GWFN.+QP\./NMHY^"62
M)4FUQ@T1\14V[9W:!7OK1SJ+AL-*OG97:I2#:[^!I*@S0?Z"J0OA+I4KMJE)
M,R=>5W$HN<]:UC2TM<P@.""_Y$63H>Y*)<U7-4+#+<-\I4MXM !LYP$VC(;_
MHC3=@,189/$T6V0^#N@T'A="\$,RN>AF)?[^-O[W[YS?+P*Y%PE]H5N6=X6W
MKSN64W1@-')!:_E?%#!P4D:MG1_J##.>T"2,\ Z3+WQJW/[]:?L/X%O)'T!D
M%8?&^=Y?^]^[N?2((WQA>TRM^)G P73=$/2$YNN'1ILXF:YK (4#XCV:R=(A
M5/R86;AVS?@U?L3J1)<<;6U-K^ON"2$#9A#:L&#.KA?]0S^U9!)VI->Z50)\
MW3:W-?:9+/O]ARX &7#I+*#9"^2XUYEUCCH=^:W2%FOHL M#35@G3ITEK$SN
M!1TKK8[#\#8],6CU=4L/;F\EV681Y<#<1O@"96.Z*%J"*GZ[0Y<;<CG&;_5:
M7 .;$+'?J_+PZ<W-<P)A$II(2YA8:J^\E1X7T29OFG+2KNLWX'TMF-HQ\I$A
MWPZNAX1.*W*/P=Z4$\P,[4B";(:XFD7OHR^)C?9/_6F'7?,/A!B0V,(S/Z:M
M:*?A;TRLPW23=AECJ !=HO?-9O(0A5YZXI1>GV3$&;)SD=/)1($7IB )F11P
MH5A=R8CGH6*)G%#Q"72%OU^B)YX3A#K90\M'/^;WYZK8F6D^:[*%U>6D,4#.
MWS+I,\9@FT.*80\]*:1W;P8F^M; "E[/9].VL[ *9)\%HO?[_[RW\FMBO);J
M-9P\_^TYA^"H;AJDWC"6$XUB>T2P<&OY#5$^.;O\2$2N1I74?&54<V=MZ]__
ML"-EM<@M^#<BX$V9^+6AQKO_Z?3!A^ <33)1.-CF(K0OW5 *V6.W;3[Z]X I
M-_] ?[9V-A*[(LJ,>1%LPK67!0D0+&QR]HZWDD(RBD4LOQA0776_-PD7=S5F
M#?<3+%^!0$OM9_IO?*%ZOV]&QIV>I*U+TQ4"5X5$>S9)#/9KZ.0CW<L'<Y=?
MU-6JEN)2GO YXK=<3#YIIOWI?"!-A=0\=_5JO=R7445^]RW]YK-(VG<91N_R
MTLQB8A>K$3T@&D=\L7Y1_%4G>J,D(R+^'2)'H]FQ#E0W@3FUUM86IDN@HQCV
M1O$)6G=7J;C85J7I"A@JJP?GJ5^Q;[IMU(,$ZDQ< DX8)[9J)R@!08,2@<$Z
M=[X2O^-M;/Z14C,:]>FQW4D65G!_F3@78@6*">13%-E5%,DE&KNK?TN-/)!R
M?(_H?(7.^^[+%?I]ZG)SR1BE*/-?WZ7-1+:+8IT<SN%M2:V/S$N0'G7I&TX$
MF6HQI.9=]K+)U(2"G-.+Q3%<LE_.7NO.-767M%(QIE):ZH:/+-'D&OLMX=]&
MLHJ;Q[PG<#"KY>TN3V55:6@)7 %RH6)"W"QV^T;#G)E6-1-H"=B F!C?XM6G
M$> 5*;*NMW71SCMK_6)?ATDQ8[M(JB3-Y3>=,V/T.;X>2?X]9T(HM3KJF])/
M%Y >WUY2K_:LNX46DD62>^;7<KXMO]P\=S;!"3^FZ5T'UDU7SBG1%:(S<8Q>
M"9<]=")&E^[0?:6>'/WD62E8KI#=)6:7XF:3U!*."!]MJ8>O(-2PR9VEZ80?
M0?3 \X[QG' ]]P:G:7 OIM/0826SN0 W&EKJ59BH>'::8/16+,?6:8>C1S9M
MR"AMXAM+K"KFYZ]V\VUO$W1U@Z$O8PM)>&/T'%KRO,*N!GI4)9>?SW*[TW"]
M.1C[.G+BH-W"E/)<D.9-C0B.RR718J@?OW"8=9,SG_$]M6IG1O"7R2\S0K_#
MJ]-F&U]G3F'G=LX^\I;99E//'B,%.KPII."JI>A*3&(C"1/*F4'=<:C5V][I
MRDX&K^*]'3M>@<OU/@<7/11M23IM.TOCR:_3F7=>][79$%?MNAS-!0'()7/,
M@2>9VE-O2>OOIIPVM!9C$]X'4:/GMV'64];3QN^2_@"L['B*-W?]UL:?.GYW
M_EU>(N%S,83M&<79+KQE/>5V)$6D\LF5J[>H$%SU3IK";F/,30D_L*OF367P
ME1E <2[H/=&;3INPW*!]#3#X"E-+E5/YX";Q)A<,L;A=.@Y81C6XB[V\IK.0
M__9<9"+%&;0EG+3G$(H:<!X0']O/3JW@8NZA3-=KX5KNC(*\KU^7<83N)MN&
MCAWQD_T-]F71<3"")/BDN0_\F1\HPC<1-3/FX2H+3$'K+ ]@ 7A:DQVID_8^
MFL4 JNO'YOQ1#JZ7T8*$VLUES[.HO9>$*Z/,WO8A9RYH(N\2FY,'%#$OV6/H
MZ=/I:'H6Z#]"_\&?Z.F^5,C976F7X+W<]S_]Q7MFU+K6=',3_*EP73H??XD>
MYR4O 0:!I5^'',!UROX/@/C$S6 KSN:2\'O;R^?&[7M>-RI[0U1 18Q1\[/+
MDY6DJ"Q$#KKAJJ+?[EJQJG-I>S3M1*+2<W[EE4!V%5"%Q\[Y*E&R7@"!5QCJ
MNST/"G>B] -\OEBHJW]'\2E[[?ZNF05AF_-]Y!#S$XY5+Z%]E3M7E 2&O%S+
MZY"W8.;1L'=@A2=E(+.<-8RDN,XYM/HBR&^B\_6@G.5%K6[+63Y.HA0R)1IV
M= 5X5RM[\6P,EB[C.:'NW-,NZH5O?BG#=./'\%V'3,YU _EPL6CB!-Z0\WO"
MID G]HP[?FU(R=RL7J1[6?9[R?/N+UX[<2(C$0\D-0,RPSMD,CCD!05WYJK$
M*O,5;D?AH3SY46Q62KPL-7$+8NY,C9>]HX291*H *]7*.TJE^B HS[N6U.+B
M^%U9&Y=*VA3I/FND/HB/_V2;,(9'I%(%\A[#T"OE76VH>)8RVP>*&M%,]I.8
MB."P>_&IP).-JTU:/?J<\[W3'AI4>F@UTL%TQ'9'D8K3!3DT43%BD$*@/H:/
ML8CIA'7@1^KJNHTK>%0IEQJ9V]+<I,3R%NY5@$O%?1)5 M@L%Z9]M<](D[Z>
ML?6)M6?AM4?YT]X2HV%:/4WI6:">="%;S(!?SXKGI]5,FT:[GP%1?CSV B>L
MRBW2,!E@0]@Z'O#MVR^R"<V:R1P3K^2)!39(#$P/3TI6EX8)DW]G.3EP%?N-
MI+%-U]6969*[3@6),,XS$-R9JQ/:$[HEX<-AX]"=]145J1R!25:,V'$QO^9M
M.E6 DF?^G7#WP,@E:KQRK9K\XPW>OJ.( G>?G$D?824W"6&+Q6<8>ZX4L?F<
M6UK*"/]0CZ^")C\;G]I8\1M)S8>]3YW6KW9"N\LE>>L7$!Y3$S&,3=FCVI1<
M N%C!G.R[#MY*\UDFV:T5RNE^Z>=U*L3;M<F8%[DZW?#?"G8'YQFVW(Q,=?'
M9#8SL0"!KZ2Y7E1O.N(=O#XMV7I0B8[D.DGC?AXE!M?3L:8WL,;2U$W[/(B?
M[1R5HYVQM?-^60]9^+0+Z5[(!U9@0:Q"L5HEF?G.<:4O_@!&U=!V?ITZQA/R
M>_TUUUY^Q4KR,^2M6B4B93)YYR#XUG-[@ZY>YYKXB;U1?U7EK[)2<,="66%5
M!JBF1U,;,M+= _-5QN9_%)T4!T .LU^<P_.(RHKL4VK_XOC'Q<0Z$5V=#\UA
M&+ 8?3$E=N=,ZJ[6X"W$>@H$:T>KX2GP"R48D=C+YUW)_^DR-)W/5+9)3,TU
MJL#UO./49EYI'G3IR-06M\X*5Z 8V&T2[>75#L[$TF&5XK48=_0:[*6DYX1W
M+Z#$*!JL.9YS'VBSJ'W? 0A +[=%V5U',@D -H;&7JRFG8L%'3.[X,U;>)/0
M80I96H&2>!D]8P%6*B;7;M!J%<I+L++8JZDWW3_>ZNL$8<PZ<\RAZK.7@@.7
MM0-5&^SGY!Z66_)H(H?V$CR]_':MNYU%^Z P( +HURGOO\BG$K-]YV&Q(;I=
M9*&R1><Q[\?SH6!=%M-'+\752O!H@,')&9>!B3'H#2\F&1J&*"T)4>-A;^]K
MR]F[@2UF=6YFE]NHT^^49MILTLJG;(!5;)3(!$?\!;67MOX4],,,PJ8F##\C
MLZ?U4]\,_(LW+"NZ49<JR=^U)NP^F!O+#1D7>O,-H+(%UFB\.3'CM/@R9)P?
MLH1'!=STU:/OV 2/0W0[VU3E1<P[FJ\*$8G ;:GO%SUX@"I#O[H1->E5&>V%
M0+I<>RFBCRPU4S]^R;_D_KC.4;H\E@NDF'H^9+ E&N@V(<(*K 27FV"@C YN
MA1;')8K3W&94R"H2VN"AR?(N505D. 0BC,[=X\[P]]B_QP7"/NF/1QGD1DXS
MLRD/VK'4=@]W2UJ?9EK07E=]Z^ZD:3G/-VU85-!H;K.]50)=TK)SSV-X>URS
M[@V* T1RGW"4>O'-#MPV-C6^&;A2@%'E6EV]XS-?-N5'*,!I.?C81,V?G?RH
M+!<CQCM*%ZP*+?DLF)V#U='?*L-9^D%!CY1O"-=,.>PWY^;58F9Y-?[[211D
M35YE:$.]M;-ICD'=X'S/@%E.FD4B,M8@MB-P"#CZF]Y6F)YBFAL.%HR"K#3E
MC'CW"I#^6LH?"2*:TZ5USD0%<IK:_<:9\5,J!ANO#$+]\[$048(I(UA*BOBA
MO]8W97#?9P8]6Z"O=C__/?BFMA51V]QN<'*,E5O_H $3\X"__=S+,];,)2S.
M.S$+&R%*B11G\48Q/#6P+_YE'C<"]H8O]RI^G5;9LWJ-M38=A[?E)(U)VZ8>
M[KF A/87'$XK8E46569X4UU2(%T%?,/\79LW?ZU>S=9@Q\:5;-$Q]%$8$2\5
MUL2KDYH>S"BSWENV\15@$TAYCI)&XNZ],R-5JK8W)9MW8R"5@93W6PJB1Y>N
M"3; [J-6H+?R1&@/>1C%.L+BZ>FW/8NM,2GUZZ9O;#I4192G!W1EC2:L0$1.
M#!Z\.2ES"VX!Q#9@6^CN'(7BQX*P]6X/LUYTXWY1?:F!P6&YM<M-HI"_& VS
M1Y(9>ZGAJXAFF>[FU7B&>>EM?"3+.TQ=0QAZ2!+A,9_.I:RSG%=>7\E]E>C3
MMOUVP?O\< *%1B$L#Z))EKT< ^RS)N#1&BUPELQ7_8@<BN,Y7MGR;O*6M#DM
MC'=4DUJP$?]Q6V7W""PW63J"IV>705[-[U%B[U&!HE#"2N3Y]&8)01$D;!J4
MBXQ)"5CSC]J;L?B]P=IU\2?J4(F!,JAMD-4'YZN"%"I)/2-Y8Q$ Q4&FOHV'
M0"7AV?51#[QH*]:ABB[NB3S8;+ VL94@<SN;8^+]5NBEG4]H1W9#K;']E#AU
MS)7\U?W7"8./Z_U?8ONLLH9QLIT4G%$T+_UD\L9+1, N)[2)8S#+09!#';-9
M%1%09_N;,F!?W! 53VQLM+*Z<N!)/;Y0L&_;:1AVR!7Y/!PN*B0_%ANBW63]
MZ(+-)WM\Z@9^'[E(D>X9O@>.5G&4/#TO&E9,F_\V+\_,9ACBQ?.%9XJ2,2I]
MI6<QZ!+_X6&HBF>@0E L4I/ CNG_:.\[HZ+8MG4+4)%L "1G07*6G$2R@.0,
M(EE"@Z0&P29+C@J204 R*%F"Y)PS-$ER3DV0V/WZG'NW9^MFGSWN&?>\-\8;
MYT?]Z*ZJN;[YS6_-.:O&6*L(MU';\OM:,24Z6<"BM3;0267KA3 %;=2'?&/'
M>T254:5=7$FK9*N]Z^&<N^)D(Z5@4K4]D<SJ[=3)LM.BW<<<N55<%GTQ?29E
M& 1*Q$FW"!Q]&PBR&/?8+^YWE?#8YKUO\=;(XDR=3B+#FXD7+E@\.3Y<R(NX
M.3>EJP,QVV"T]K1@75?(H-A?GI$W=89" LFK;([T(R5H\I"/@G(7&I<%T-!M
ME'@[W<D=.MMA%@I9Q[X^K[LPNWX4KP4O/IXIR,V3FN:*ZM<)$0[95ODD>@0'
M\YPYCX)5)<L#&:,B96FI5JHQRA*)#P5XW%@CK6!ZI)J53_).I5RVB-INS/(7
MZ&&1RRCLA<=_F-!OQZ^XI2=Q7& W^]D&!W;;NTX]/)NT%%KQ>LH! 8@B2]W<
M,+(?';@AG(KGP4D=F<R-0WOJ/[2@\6QJR<.'E'8E0>G]?.!ZJS*>C[ 0B-<O
M<CVO,+N=S&6QUS/=A*Z]RJ[Y'=T[UFB,CD+*BFE(?RWD^R$"V.?YZ;5$V@VK
M:HK4C'Y7MF2L1W9+7%U?K4OLZ*(U,)CB65JVT>B61G3?!#B%J6GXJM27WID1
MQZ<]#47!G!KA\BUOJNSA0_/M6"GXR6#&=B7EP2[EY:78A2)@8?T:OWS4J5 3
M.AD[Y*DJNY+R,D"\GT@\,Y>6DN6%J&JF"57 2NDAY1N2AU'SYV$/UW$.#,6/
MO\<("<9'948K5DW+ ET3 OVYO .7?SJ&G&TV%&HPJS_56F(]2:@7,*UT?#,'
M%V-Q68K,)$MKE(<4QWRC;?&I7(*B*$ATHMV118*2:/H1!TZ;3&\*%J[?BO*?
M<X/!6K:I)]3=G6]9H>A)TVU_'C3;%>QU,(PT[:Z!X]J4P![D K'5N4QKBR"B
MT0I]:V,G61;698^+*RTN(J5W;MM^<=Z. "#*"."NS)2=V.JLV/D9Y"0!B-\J
M7!Z&MFG'*I@'-@V*]1#?;%1+R2!SU+9H$"6QOFWIM+@<A)T('V1_+_?4CY@/
M1)6#599D"YB@$13^[D54Q.^!HT@^W<OR;_,N7*^X6<&@76%Y/PK_DZKQK5RL
M)&,5]6?/'$Y&9>'D)U8L=R8+B(.3VXP='[R]2.1<N3%]#]1=*N30QJEG9%N%
M %+!"&!W'0$L6/X$7QRG=.!P"B,KMJ^/7U</7*C/YO+^P_3MAX< NIUO_5#)
M]@7:?#Z2*FV>A4^S[?B.C%5OEY_?SP!BN[88EJ="[6\ 1&-_SH>-+JL?'R$?
M%A;/V"V1NMIH^9VNB$I[NIBJ5%8W 6'GI5%2RNO@5XH) C9E(T$+5?<XHVB3
MPW/6JCKG'W5\8Y@A#0<*\?Y)%'DN!<?E2\]9_0R?B)I&;R';^1V#"-&"%CAO
M#*7WA1!>ZO)ZWK6^\.;>E_=,?31N\GF$U-Z 5JFZ!P_].>0:*=7_G/Q_<O+'
MLB25GW)"#KO=RBOB=^FAJ'YW[C-0GFP#BK]?:*GR^Y4U?_]< >,F)0C>6@MO
MGP!=O#D7O3#I:>\>#_]:JY4$!FVAM=Y" $W,EWG.>)R0LM=32S8P2(3+W,+A
MY!SQ(N^:*&TP1BUGKI0KV.;9*QU"A7>;=[8%0![NKD5H3ZQ#"AWE(]0&;9V(
MJ*JD*VO>R(-US=$"&QF^2U0;5T?$Y:;A5H_#)>,@NV)P?UV-1&L$0-U=_ST5
MB:R0Z6^[VG@HLNY"G82$<![9BFU#?259!NALSJ^7P9ZY!7>)6HZ7 R 5;;&]
MB!>00WYKH^\KW0@@:@T!^+U20P#IS;I(.AX:742(DXYHXEW00E,O<4G&+T]+
M$,"2N]@\Q0@"6+,?J]_MC4, M ,WC@A\$<#-8R1_D@'E"."U3?TI1<2)3+G8
M&1EO\?F!&9+ 0Y0ZJ6=(+D1R$<# ?"%D+I$=+I,!O[VM#'^#8PV_F(3 1/Z#
MZ-^(J'>4A3>$7$&J,J05^D7A?*SR;1FAFP;A@4(4/&+<Z85 _[5+2[1/'SY!
M?D$^^ ?47GPY!92_((?\##H-9X,9_6?@E+^ 1G,/7BE44QD6MC S<2@RW- <
MU_7LZ8E3:7A8^U+/GZK]#D5TI?YQ4>Q_?1/DGQW,#*VNE20@7][\34;A_$0#
M4;=TS[1MY[#@) H\*N<\!/#'D1O_0)G,+W0!L_]7J?@/H'\/H#%0P!9OF$E3
MM5*VX\*V 7U=2<""5#@61WHRVBUN.R4NSW^KYI^.;O/:$D*A,#'\%W%B^QRE
M_O,II(KAT?KMI&@5UT'5J^GX*&.#OZS][S0+OVFHDT3GD&MNS@_@?BPIVR58
M@V8-5I;6S+!A73<UFT97Y1+(%UR3'@!IZKFQF7!R6'X0X\8]^;ZK3QCEGJ$U
M3/6YCJ1,5,V;K&(BNM<%6?VFLK,I%MZ3=^X3ON4QSDLL/J29>OQ5S[E/T$3$
M,\] 4F?X\$OA0OT7;</EBA;,F*K]-?X- =X5=@LW!( YR1;^H6V\KZ$,%H R
MZS8S7LR;O<#/7JNP@".S14@/(R7R+_GTEB'V=%H;;63IMK>4GTM"7%!9&,V:
MWHM[K]5;T?QAR54B)^A#"7"F09-ADQ&2T]>]="FZ5=)B#[E#4:+:<XK8AG95
MQFLEK9TS9UG+-ZV,N,N,F[F^7',<IK/@57*CCF@ZAGR-GMWGM1TOI/$9E/.-
MG5KW3GI%PH*>KGV2*#OBU]:WQ^\MW*D@W4'@^;)!S6D.?^VL?'72QNY[CP13
M06A-PV9HN#7N$'SV0&Z4VO.YK0>I1QD&:)FK^)%$.T/J4(D3UB@%U=#?21/2
MOHFD(-:Z\AP^(\+_'1_[,"'@ "Z<A0#L1T9Q5B_<%.#SF=>3__G*<ISE)!+_
MT#'7* S;54FRJ$II50XI$[T3:2ASAT7UB+/"4:4#'<?,3%P8F9.-0U7$<=!J
M2NW8)3Y*'U+8'2]W+U>1HLJ7+[6%+ FXP@^0NM3($K_^[.0-7#*%$ %\RD<
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M%L!#WR-$7TNC&:#=^N.SUW1-UW1-UW1-U_3_*"F8NQ@[F[LSZI@[FUL:NP
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M(QS"79/C[G@W:(]]OS-RNJ)A4G.9C_DSGSS3G2,!3EJ*03!YOX?,4D)Y\=1
M_<_* FVK!=CD76<K9YW"\(#*W<@$>8SQ6QB,9O19Y*,&"-;8]9<- ;QWYF67
MO+<KO=TSN.M)6'("R^XP)+THZS4""\E/1** $@C"[; V;7=AXM*/YCPI>:\S
M_0Z!$1DDV(<2\F*#5(6P/J(^ELM&_0G>X?=@TP E]2G?7U]?P\ ?D?='I.DW
MJ=<6 C5_6I<\/VNVJ+1SH.7 ?1+LT*AM7!.T\G# UGYR:?6%%9)G-&>,:OE
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MTB&:;FM0_M96X49ACJJJ-CDVO71\R#)Q8"+]O6BEAH8#HH9M39',@>6+;;F
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M7LIYZ*4K<>!F 4)D5)+=M;0?!9#V!9R>]>)KW8YM:9-'RD9^MY0)L5%>JEQ
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MQ'M#G<7!,.D'(,+FO-)-4=VTO,(M8NNLS6%]O6RGBKL\9(58U-_T*6)2'O:
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M8U\&@XI)25'K4ATE9)"K/0])>D"AO.<Q,W2D\:C%4/3@5M[RE%Z'8)$U/4N
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MY!LBQ#_;5=Q:(;G:E4;*$Q=K&MUUO;$TPFTG*>-=:F1SYK[_A,:P+8J0V%^
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MT7<(E22;H">HW3^-=G8/W<N*>ZIG:VF:*[VH:D9%0"D1I6>/P2'84KI+QT0
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MP"$=X/)92\;.<X6B/M1!B/L6I].B,HONV,!6W6IARFO"1QOX5"=T-@/_J47
MY-_X6L+YX*1[I)1E3&A'FDC6W?.VK-]A)WO?X>ZGMARG:;P;4[1'(_Y_E8>W
ME&T'*:O'E#TSK!SU$C%UF"9RW5\/LKZ:R3?!>Z0XF+_]B Z'/*9P%AY%DV-
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M[OEU1G8N!V;'#S2C_301A>HOZLH3'\RPX]]R),U7>/)V(D^"B9%BI_1HFEI
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MUIOGB4*=J--3L<'E]7%=>@54>!G4<2G1.F\' .!+*O^;FV/_"U87]XY+7@'
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MYD5!_10).X737?!)4&/[+,:X,&'I*L@OZLJC]+XVXPG$DRF0+HP]"1DW.I#
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M'[;T)L\Z2>^:1FULZN)R2"CRR^_3J6"V$"76"Y%UD"OQ%_@)+M"'4*2EFW#
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M:%''V,24/T"F$"V_;^"PYI]W1FR?0[*8LFPX^>E5;J;0;J)=)%8*LB6!8ZC
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M-?&@ Z$OYV?DQD4VSV6O )I_SB+E%=#P/,FOQ[@:N[(]-B XP0-*G_D'M*^
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M$8KJO \TB9VD.[_M'3>F$I"8>9(K9LI#;A][NSKN<B%P^C+(:(VJ'F 5>PX
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M OP.6W@YAVEN+"'%_)+UWY*>F20G<;Y&.%4*#E</]GNFPFZ#^"I8E5C,VUK
MV6BFH&VL\9!R-])2U!!N7_Q,RJ@#VW(WQY_5!KH;(E(;K;V%8#C?;=1'M51$
M&;\;#U;G/5;YGZ5TL0V-;HR,E*8[KH:[-2$>&7ZL@HVX6,/E2P9*WI '=Z-N
MU"68G&R$J7I8S'N<YA@GY:?<?;X338UH5R],6Q_,)Y&YPA:_85XE=Z^,]@:2
MR$SG.6+-WJ2<:ZO)+<ENP>K4'G+DO>0MA\,:\$>./04.?: #W#Y@(9[_(&D4
MJ0&HS&'(,=YD&.+0G!_]TOESK:KC=(\0YC%[MPP_)@8&UJ^MCZV(+Y A())-
M2BX6^=R SM?NOQV3\;%3BT.7AXMI?XV2>6_%$CD1<CHA4(0BW/Z@C+H^8I%;
M57HX6C_ZYR4"+^NVR7-Z8\WU_)/,O!_\-0R9LNS,WB569=MX*O!\$O_52N8R
M[7\,I?"U:+R8B/0I/_QDE&YGHP-5")PI$%..$??\W#&<9N[/-;R"\RE\J'HD
M2FSR_7);<SS=; "-_;Y<HI&2(JHVM+$N:L2'*78G<BOY]I>I2XD998PEI9\V
M-,R?M=0NF[.VM64J8/1=>^R8P$-N.L/-?=86O3(KB1#&2BW2M\.HOU$?FG,$
M!*ZKPXJL+$:N:]#L83GQY'<'=$GP/WYCR[_2I_/_J#?4I0*2?G=I'KD,-)J>
MO^39G9L/2D&FOG!L1)!6\YY?Q'.RUJ3K.(29=_$ QA!M<.>BS@[*].7^&7@:
MV)Z(G\R=AQ_?YG\<<>A:= ^!-C_R#XWEKPSDOX_K[V7,1 B2=5/ <K[S4VUW
M)K6#L=7+L1%[+CQD5X:8,73[UO[L$>/F7F?+\AW,V4)I5XRJMBFY;GP%& 7(
MJYA</'G]X["T/6/A\XF&2N\"N"<YJZ'(FZ63LP);'C(% ?G6(N!THOA^>NS*
MFWF]#IHCE\/ICHR208?2B9:0->6&#R+#C/W;LAY"M#';U2LW-=KY)44AL)5M
M?_S\T2*5JE'<'S]^P)VRF1KKN:4EEO&^]BF/= J8?G]<Q"[QINF+K-(SK ZZ
M^; FV8GYKKY@E*K/R7*D58%YM!.;@62;5"/ V2$_![:'4H.*&/Z)N JWNUU8
MEMQ^95W* 4@T#@(%6&ETF(>V?XE#-"6&^5*&.,2&=OF.:9.<&]]I76,*(8\<
M0E3X"@/-?/ Q1O!)Y6B$4UE2- 17F^IN1MXG[0$[.LM4UM;TL[F*#KX>>9$(
MJ!4P1_(..5E#^5TG\36;+H%SR@*ULG\T9-C0K82ZF/GRK#:="?]T\8ZVHG;Z
M./]]7/*@<Z>>7)7#D$>SQC'@>GOK(GF<S3I_4#+V']J^H&/P1\?[O3 G+OES
M8N8?7AC>^4ZMR&T>FF>(Z3'=W?OI9CY-\+L\;2,BN6JS!U"OJ%08&!^E2VN,
M<E1U7.I1416"^0TPZH97(M2YLX:&2??^=4ZHT?EA[15P+HIR[?4"@3[1?!U@
M$Z,ZGC[F=SLBAH6">09O6( E];HG='*/X:O45D@X($I.80-GIN+V.SO/;Z3T
MH1+01)]OK6&=,6"]IM\J;WNJ%7HI6>',X8>@]!OR#]HYBZ[9P,U.S"-RYSZ2
MN;RI]($UF^3B;!]:1^D1?MG8MZC"\HB642.A=#0 *P]GC".H&&M;4[SBE=/>
M'&T3>%'DX!4P#?PZNNX<LF8ZL4BAI<C_E(CC,/.^ )K@);+[))9-?H=8NJ14
MTF_G\QQ)UZ[;<YIHAD+:\'%-Q$)(!$&/H1LZ8SCHY[SYA3JX@[CY?#\+X='A
M@R(YL/6I>%3$!J<+,@9!>]/N%E7"M/Q]8'7&N#,VGK+QG+@5!VKESA^[+YZ.
MI2)R/HJ=W)EY8KZ:G(86"P%*,0*[S.*:/:EQLYAS)'_TR*=7=40Z$Y*P,J)!
M>.ZAI,U(_!+,>RNYG>8%3.UK48255#0Y]]G"97<D)LVS9_"\&9X*P0Z!3Y,P
M>AK8%R7*"D)QOT#D[7M#9)4<%CX;XSN?[_N3.$DE"L0QE_KCKA86-X:KG'%:
M"??NH6_YM]_2<&+_F7!#]ATGK"D*7QYY!43NX/OS=_KYI&\KI^AMU8.5T#FJ
MS7RJ5IV*O#"&\-4KG0IV 0#/,EIW'.CY]M=4PW8\NU2U_._%LK7UL^E];%C3
M_8]P*,9(J'?2G@0C*B-B2WM*%$5K4V#7$U$\US\@'<QZ-SZ11GE;4QYR^W4H
M4?ZF>,G"97Q ZS=E-<IIJP.S[#E'3<GJG:>N"#>PFBVW,;S0ASV&D_3/_1@&
M]RB9?UT/B<Z*0.F.3OT7%862VP",OLL*@\4++Y&KP0"\'+T+O#;P-$.;W=\+
M>Z=??37H;PLV&C@=B=905FX/T_L7Q:A-&G=W^'TM]WN/ RY[B_X1OE1$"!Z5
M13,*+5(TAR1"_?*/SNII#;#V"[39;@FZ_E3I0[78^UT62'TR:L.[&,4V;6E7
MM=^<CA2#;JX#$JE7(!4&:=T$>>\ETB":P)8D4L6H6N=/GM(29WI.]Z;$LG@X
M63G^],B0#CY=K@P_"0W7&.7';<%W7 )PIBW/(TK\/5B1'-K-;TC[=S"I;5AM
MBW8"I$R'$K/#=B,'T/G6OLAH%HTAR!!J!OWOA?AK!"],^C+6,>]R'C]YLXWA
MK<BYNM-AMXB*_F))/?N^R3+P3]M\135:I\'CGQ48.V>K.++EE7%F):J-N=UK
M$X4,K^+2"DK_'OFPWA7T/83-R"^Z');P@,]EF<P#MXPHRQ&X-S%.Q;]9,'CR
M9-Z*X2YX^$7?\U8!X3;>X&.#H3UH[-26T7'=+8^3J<7$6:K08SZT^ALV]7F2
M5^&?"?TO7%= 4 .M4? ]C9_S:';3=I%>U,@"^MB4@11E,=_/(5!0/XFP#D/M
M<-<!MWUU]8M)4';G8LF]>-M&XR3%T4(VO9^!J_V#Q2HD6X_.*E%()/&Q;0$4
M8!H8;.$DM"*L?V=0:GQ$[I2[>.N^RLU7/,M;N>MNA4AI>6O-^)CHMZC&' %F
M:63A0P<;?5):PDAM=I#FYE]+<[3<;C1HF#T!7UO5@D/F39PVL201S3[';'AJ
M ?P PAJA8'V_5L0%'9&MP)^PM8P2I@+O%JT5$HW57B3BHX,;.%9,WJ[;"<8&
M]I\O8-"BB+#>77"-MYM2J\'NS-E>L+2"*/@CI9NATEL1-,VA_@#+#[);JG\9
MR/H]?07"OAEA"+T,6B"JN%E>G3*&BRR%M@KIF.;6A_0!_+2B [$//--]=?4/
M8/[$KB-,2M[P+Q9Z""N4[TFQT"9\]U(3DF]%UM:W B,;=>%FTW\K?)R*4%@P
MI*L9LM_/5Y,0&$J3HK@4X(+JXL=AKX G9C&6EIG3,SC[WY\!DU3Y517<8Y-L
MW0K+M%D6_I9P]0#_(%)J-7?WS7:<6S4'BG$*M2:PCS+<F;V<%T@GQ*$9X\28
ME-W,Q]LBEB;:V-\&\RA,,"Q5V/(FK"Q' 9C%<"+&4,\-6-KJC]\T;%)41%I"
MXS6"2X*7:$'XC)\EF 3H?ICKN%+'^"XB;TX2W!4OJQDI;FLT=L2)\BBE; EM
M):2)S&R</._AGTNR1ZSHG,:MU5F9V10OR=F4Z'?;.> M4^+)XN/Y(E-B5#EO
MPLEGUN39>:/1Z%*I+5T-Z"LVH[&".%WZ<LJ8LF[O TB>^N9G1&;[LL4NT.OF
MZ1O2)] XV)RMZENBEN;Z3 4WT]5G"'B&8M]DNOW9K[W(FJBQVN!-&52/P)::
M ,LUX_'WMMC.U[9>(@QONV['W%9].X?^V&[*]O[+SL?4Q#8K#W&-^%5+%TUI
MN4. XQNJG:,XNS,36+]3V_A=?!3_.RCO*W$7)XDU5[RC>9$CR,CY^9O(Q/I
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M8$FE?'6PV%@O8_18L(I]>L9VO#-=:W6T=H !(>A+;-=^HTJI]V0_L<#ZG^E
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M=:_9E)Q3BG\E :<[2*V</[E$D.*$W8  W,M9UA>#9G-X^],<_4A2K%%UMB>
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M/P:3"4M:D]E9&;D9TO=^!33MDUG=B&A%@I<I8GD/%XFU+_^  [XT>B?GL\0
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MNJ :0>I<ML%ZF]/=V7^!C\#C<@5T;K!6-1))_L$>?>$W'APYQ[KI?5W+9YT
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MS5!_9 G=Y!0<]+L8,*J]\.LY?UM2>:RQ8C!5HNKN".SGFYRV8M+G9$CN]A!
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M(M^-IS?GT34,IE#E)?J#AE>X&O"6<YO7!0S5MU&%:PCT^B'I6L.ZE(V-:;Q
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M,#&G'7TAW3UH:J]OF@,^13_:.)BN5NU-$+J/)DCV[E &RN7AB[Z?^2$ EJ+
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MZ':OK**7@R0NSB(#RQEAVA"M8&IK>[_$@=U ;;F!]ZI[*T[\*T]:^I(Q#GJ
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MD5.1Q-K)7XA<+$9NI]OB:$-<[Z[*Z&)B/,.A[1:S6,%.KUNCE]%K>.O54PQ
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M%]00YV6#N'9!W@ZYIG3+H<)?K/8OIAP5I]Q\#4=7)U_E"X8R]?+#M)[!(?M
M)<QR&<42[&FAB[\98  SV3@!F $#X&$ LQ5UY9Z\16!!QY1236/M0X,+4T1!
M0YOFFH=K>'OX9F@M QB;C7SHVT<94TEK/_3P\\(A=;5M.V=A^8M/LY)T?V,5
MMG[:&VZ]U$DY1=6BI1NRH_1H>70A)'<A")EMOB>3YOQ&UM?2]JT'LK)&>1ZR
MJ%:IYG@GP6VAV;W[XPO.[X)4<0_R",F_#7N?SD^+@WN<@FKCQD?)D^^L8_-$
M^ZNYP[R;98CDIR<&-WD_S6]=\;*20[Z"2]E8CFU!Q^J4.)OHK0CB%=H5\BJM
MD@%XK\9@^.D'QQW0/;BJX69L0;@B.?I-]AH<M*KIJZXIWZQ.LZ1DQ/[LC@AR
M)Z*F/5Y/0W= ;[)8,[,CHGSH'8:"S",&_8$!"#  CU7^)%X&L'_L:V5"\S&P
M]J-!=->44G.LV#"T&W.4+V#<?A_'A+=R2(MR!J7MFLH+ ((ZE!X)_T!M(.?S
MZ(V4%GMFFY6\7+2+R4@K6+#1]-*K*"_]UNU6O!!*[!JP"@B"81L3E?IO?,^P
M3A.Z\4<D=V4O]NL6G><#Y2C]&Z9:O)/9\8MDU##, ^_K/\MQCP%P&\PG5Z*@
MM%PB ^BR49\:7Z@3MU,E/2Y*$\.O3=KVQ4*TI3XE]:;.09)P1,=*4(FC@# M
MYH4@7H!&-:ODM*/%^V&Z#(!7CCP%/BWIF4_E"?<;.0D5;U<ZS?GID87'O.E;
MWJ1R$ZM7BKH'2LF"H(X]^403J$\QI)K2RJ@WGG[[V;"ZK%UZVH,X;364/U:*
MS./M_YZS5'>^!3 KB=#N:.=Y\>6KG9Z?L%B^X,)//H]O<QF[?W9FALK#X \2
M869U:9*X>A4L)TWCH3%T,93> %0U>-F\<PHZ)'ZA?WD%6FSO?9UWOR5LX.SS
MYXF?PFZ=E+^]B:JDN*"[(:QP/US4%H(%X^G+>V.T&3()8JU(GG'M],,-Q.8J
MC[M%GP;L>OE_U O4"UL=2#F=@K\0YZW$M*\N''A*ERQ+='RM>Q_CP31YZDWF
MW F0G[+!>LQ ^#[,3@O\NGR"T-/49%U[%A=B8G_]DZ#/Z&=#YNR(RF( K?Z&
MQU%P$K9C^C[D55P4Q@UWWU"$V#O_8!.>@($49GPFF/<OJ7YO>/L.J9VPL1ER
M]C'VQROGB7,O'K:,;BA2])@M?[.UE#Z; ^&A]T'8T#)4E5<U-2F?'2S;=P[Y
MXGT1?N)T!<E/]RK]GJSX2&5AY_R 3C0OIO6W9GV4,:T>YXF-FR::P<?T+VG\
MFM(95J%:4WZCGGZ58=;?Q)H_OJUW_[;54B+ZQQLMO>0AQ;BLC48X#I8/H%8I
M$I[3Q!M]X/&P5E4H.>D+?*8(+0E:$PD(DD+![$@_56XV@:J)ORM L'[LU%#C
M;:!_[DVJ>JR->0K9-4W^08)HG>W7$2S1*#5A"OH[@HIA]D8A>@0K5*FF:YC?
MH% 0EM^NMGG\HR0#N#($2(0A-EU60W]8K\PO_2#RSM8M-1(1L],M\/O9\G;B
MD<V2H!]$\">YOZO,8+%R5:V&M]1PHTZWZH/VIS4L3J4BO/)6ON!\93L#(/I:
M4P\T=^%Y^\2\&$ UHL/R_:3C'$(8=37.2O?"BX\W)JQ?U3Y:^39V?'O^8"6.
M ;CBP*-Q2P84$;!A':^XM$5TAO!1C9O[%8@$<-Z.9%A.$-S?ZA3\Y4.(-_+H
MY*?7$X7E_MS^\L<,K_>QS6_8-*WBZSJMXR!L5%8\/&%:K,DC/YRS1>; *U_S
M#AD%DBKU-CK30_*!2H1+EGQ:;;>(D%\&\J"<::C;999I\ZT4,P'-OI,_=5)O
M^A[4UL8<RY.C->-F"K'$:]BD#S,8\*A!%+UONDJWW5K"OBX9YP5/V%'\6DAR
M'0D3JK+?#M-)CTET:\>XCI^&K97H7I[HEI.EI],UJ:Y$R-(\\4XW5@JM!M[W
M; 9 V]D;3;8$*\Q2H#4LM-9[_8-TM0M4OKS&1FDHP_UB_;8G:R683&  [%1E
M(C21+H\R)8EES4+W@7+&;TG01*K%R_.J&Y-'N@84LB-<7>@?EWDT/G\2/>U^
M$9-1R67") /VA)2G%"_ZJ%XRM@T.'H4LX?#VCT"Y&7C\[6I'H=WEIO?"B%DB
MX?IHA=K1L]D3P0$Y6;H:HM<&9_E,-Y*)T.4^)C@/K8RYLS3H3:8N-3( -C(M
MUQ!J291JTQO2Z^[@S35=KDZ:EIRZ6R#I,)JH=K_@PL &^$##TM_#8 RI8)-A
M\L?39,QI^CY,*]!\"N79W\0>QJQ3A?:\R0)OS1G.:U$S"#M .4$],,( WJ!E
MPC6Z1K0I"D\R+?ENWWWI*71IU/*519:CF>[2DDRD00\!0Q7KN0;6X5LI2IA6
M"%K  3V DS MO*T"%Q$WTH.VX&)UFNTFVB,DSQ\V\><0%?NUOC2.\HOG''^$
M;\ZD16)FTBV)WMU8XBBF-JY#"C>>2IXCR5M&A!!2A2P4BF8A,7P]BCN0V-G<
MJUE"KJZ4*RK>PE7F2']?;G_])85ZVCW,S&,<AY:TVAUL-+.]F#:K*QT9S3*#
M:G[9!L>M17]E<GI]B @.0WCILFBL.WRK[A51K^HYWO&@?<62]P]H>7GERY7#
M#6^::E+F1NX@;?#C/Z1-Y-/><]O:.!3=0%^6DGTE^X7]^1K EKZV9K^*[4G]
M6/CL:6ZBPFPK9S23P3[9:/D^?R@DG_MY)1;-@A["5$TO&W@3F,,3"1=#04@V
M@K%TC7H00\AJ.G:77$,DEWEU?/!6^-F?IUG?5!;?WGHB^5-@O6WWEZM_,IJK
M@8$%7U>Z=#T.I>BO1]];N&Q[E- G"2)FNZ.H5TBL73LKV-E43A!ZNH&DFT U
M?=%+O@LW?5T5,]_0\/B=7/+!5Z><\P6L +0UIO4Z9J8<QX&9R47PPZQFO3%"
M"[?[EMWP6#:U,F+0K%:&K>V;\W7K#DARL^R0_%KSI]K0=+O)L\3J-N1X_Q%3
MVLH/NCMN)@-#O*0*(0<-H&6]IUEQ;OZIV+I,JH@^.7/43YL!)#'W[)@'&>,*
M:=*=&YEBXW>;R G/$=_DTZLS,T>%S9$'OFF8SXO4F$&>8E^/+O4SZ5^K'P/P
M]4^"$R\S@/&R6::]+F&)FQ,SN*428GI'K>&%7(*EE9H%M9%VT2SL9K?[EJWM
M^<AEO912%;C&]1?87YC9[K;56 PG]93@?;IH.&LKA!^EC*R194Z<2-@QEUD'
M,85OMF%CRT=2-%I6V#]&&3J/??_"^<.Z#3H>3?X)JA)M"6'+R4QSA]6!$*+^
M+&=TDXAV)3N*'406696BC*,6<FU&#$SL?(WG!*LG&^W&)JZW')W6GM7X #PH
M0-_&M)Y 26+WPQ"D*CIO+[,:X=$-:-QK\+/R-.@QX2_CQ5L2;C\K&.TRB90I
M\9ZG?LV3Z,HM/KZ2<<OON[7V:K[</ 14TEV^-BL('@M;/HU?C9.<3PY)Y<*T
M*N-F\NIN42UH+PV/A3N/^#H9'OWUQ=&\R,2C>%MI.=!OI=@7<B'Y4H^REVW.
M#5@BM8*Y3:33)Z>%<#,O,=6"]W#NT*\YLUL=JMYD=]#:PV46>P_+016=52Z3
MP@E/V4VH/IF2;>XG7/0EU)A11+-OZA4E-YF.^4[.Y0NNS),-:,U,3\!Z F=.
M*JZC0*E6B'@;K$!->+"UA-VW\*!KQ.;R9Q]"YK6?/+1'V+?+M=]2]9,\F*XL
M&WOAEW</?*847H=.8"Y$(.TA#$G*],,^1YD/?T< 5"GB,-$%60%F7K1@;ZHR
M+@FRO]&5J5NEU!I2M=;.>J0&[<8T";5F5I0:4QUI>K>CUJY+,$I"M&!XFE50
M=TA:,HHDQ;@+U0W%)24W%FJKV@M CPO5U>;82^_J*#9/M;K/6Q180*/*],SG
M+;9-21YX>!)NYCL"5(J+I+-18=B;H")%&=UGR#W<Y&'86&&D[2\\O;#V2]+M
MW5R]SI,_ZE(O#65;Z7P<'R[V7,:G>&B<ZU718EF'4(5'R<;@KIUH@/5X;AB&
MQEQG>;A09QE S##E%LJ#Q+^4,5[22;LL599\Q8KXP"Y2>4W?2F6]ZVV**-.-
M=GL_6(!8E2,C01+E)/4N&-S  )8:29PMS7#08V;2V#KN1%W[PB-/1_&W Z*'
MZ3UB3R_:QS_S#A+F&K83CR&H'C ;IHYB6J]@?"K'NNG<6(J<!;-[7]"B-WZF
M$P23J4HPEDIH;"73:T6=JAH%ZH:AF[V7924)'3O?+EL=<DK-@8QG1+!=*GH9
M^(U8LGR8B*!S25$@3'\AQ5 BW WNR713S#MC4[N;3X).L\@*Z$AWI]V2&*F;
M5DU^9G\_]K/2TDM?K0G,1MGSI?,?7Q7V'8_$6#, ,324J@)"9MY=P0MVP>/1
M_*#3C.]!7:_FXZ01G/=L+T=?8&VG=\)W4X_ M]<?9:#O66L/ANMW-DN0YF.K
M(9+ABAV2YDFHP_A<L0D'XG0"%?["O-Q3[T?N$#KD76?ND&OAZP:--^]+YFSL
M&( >!CP&69IDCL!^L(!0^96^3B: 90&E] %L+;;C!NPP,9V,TF6E:,[4I@=@
M"K]V#-JUM'5?0*YHOR=X\[IFGTF<<@D(D9^(P>1;+_40Q=N8Y+ %>A];-1K9
M1":6M$%9;X3K6KYM]!T=SZI+I1W9(="S)R_XJ4%HI=F1!N.)2OG[_B#(8MY%
MWUOG(W47P[NP%S_S'@8>N[0]!FIOW0W?FD]UU#2"9&*)-O )\C29G?;'IJ!H
MN"-7""Z5Z=^N,-T]!Z;=\9R%5U?48/8['N\F+ZAT:TP@>U2N:#S83C=H@D4,
M$S#$<]-?,Z!?><D>8 S%F#Z@>\!KNGJK*_DXA8!9/DUXYP"OH9KD3YA+=[W:
M47KK-'_6][)E4LYK!J!:6?A65O2L.M%ZR:/8&T.\)@@J9RZS4EQ1E_MKS&EY
M#. W?]%O* G:$YAJ^=BG<='1!)65"M6G0V(*VXYW0NL:1A3H1W.N#FBN311A
M+F:34XO#XTR&@Z4]K&I&@JTP5CFF(UIE[]'#;B]N3)F1MW36CU'ZWS]\*SNC
M47?4[#J $6[68D[9%/HPCGC5$A>/UAMD+NSP6 CQO/57J1;ZX;?]?IO6H/6R
MKZ$^6"'[PB4>2;:%3&SM//B"RR);PJMNE#KQY"3(,>>])7,):)R2!]_A4YE[
M_[O4V<HNYM[ 2PA;DIY-Y1_[>9OS <Y3NXD^1%),EL3W$X:T)FYXY.D?E*]+
MO9IQ)[R0[;0:EAQ/2.^I?*6U"NI(T;FS2E"N0VBEFKBN.ZN\WWYYV-2 4,4.
M^>A9<F[]IR0/Z7%[A5<^HT'.ND.2QH9F65'+\";F<B-$U00/SAB(SV:V5K*$
MV\[615*U_;][HH6)L:DRT04WMB)@S[MN%+I=7JO=ACS\U#$7:<C![()Z3*M1
M<"6HB%F*(%0F2=ZE9Z#5PXL5B)"65(%?O(>6R\#830G5C8P*]:.UCSESGI^7
MV@J\^]A)7NL#M@7WM8_L1GO'Y')O1R"\AKJ85O/F(]X[D"5?XLX4!#S3# 'O
MG(7PK\(]>Q:=%W6J:T/Q)P<.$OM[RS#"T:)11L]NE)&A9*;[&@4+OT/^3L,U
M<]&'L#*&RI/A5>0[H.;,R>H<Q%CHENGO/\<_O_:_&Q(Q;[#V2<A7[4=V[ZK+
MVH-TM4R^HTWU\GU+*X]=W(K&QI#9#C%YF44+M9<6=D)SG7REBQX_;N)YW<YV
M(O]J\I%K7^5,QPN X$X@$,/7+!G..C,?U:1+[)GUC]Z LX"LK3N7/>E2Q)+8
MC<W!8%\9KN9?II(IEF+N'H$.7S.</WT:WNYASN=*6H$6=JR$SOV.8@(^HYSK
MUYZT[Z9#$-$RPOU-IH7M%9ZCMU,3ZKYN#]J=Y]-(TD?4(5X&HEZ.\ C:T6XH
MEERX<*JR/14\J4QV #]0+M%;PO1TF5WM-:5-6FV;3I)4['Q+%<VW?T=NQ.L;
M&([:#*X0JFK-A*U5+%^4]Z5)>#Q6E;XF\7LURP:4*BQ.5O@"=\)^C9ZU;H\/
M?N\$)A"2CPLF8@^&F)E1W$OPTNXC4S?*W=TOGK\=S#%MG6S-[A-&6Y!I_D3+
MQR$%HR!O^MK+[?$EW;CX*2D0.9,L)MQ7NCA*-QTI/:ZL=V.![,DW&J;AZZ\V
M-2F?1GZBP"*W/<%T#\MQQ&NIX[;M4S)@"$41TPJ%><] 970>^^>#J?C*KAS?
M<Z,M>=)#8BS2PYU-NB/9;D^X'E: A,;&0*%:+;Z)T]0%YH"7[FZ<&.\^'GHW
MY #.+W7"EIQ&,E_FI9C^;.BZ5[Q YR0F9#6+467Z-QWL1@:O9L4GN)SHJ(IP
M='A<4][D>ZOH^Q^H#M;271)$J*,>4J8$_\+5I';E0(5!2SKW!/%.YZ@,A"@8
M%Z)?JN)"$L@I^6:BC8O=B'>1S>D]TRW=58?2W4;>4LUP[F])H#5<GQA?& EM
M0&.1_DXE7R=,O#T\//Q^M[,[4_:CFT_=3.>9V8M$0,JXXB201NW#M.K"9RIQ
MKT:9;N@8CFQ)2S4$J'JT CK3Y29NM?NRMF4SV5RS"$K<]P+!>G1%[D:3140
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MKHG2MU>6<+F:(O$LP3C&J"SFFD.^&D=_9+#GOZ$._PL"*V/L_P%02P,$%
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M/SY/: L].NI^Q<:Q%Y-L4<GP\FB!YFAL14W,[VHM?F>5AZZD^"B.(7XLM+1
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MA5<_?; PJXJ_6QE[$F*9.3Z>ZFO6L_#R^@D@!N7A$W@G*B)(?^/R*HZ<_&3
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MFHIF4FOT]%WX9[7^-.QD]"]02P,$%     @ B8!X5I!$Z2F")0  Q$8  !0
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M,MM6:WQ$)=]GT,I*7Z:,0$:>S["M]).]I:PM0A5IVZ?H#^ [[/\^O%SK!"Z
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MZW<J6B:'>#*##PNC]E4J%+P] @UD!3&1IUK/$/MSBC,P)F]VP=J"-S<$+/#
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M//@FSV6)V/_%)2J3NHWNF)*0ZRXM%X"7$"%/N9]D]F]31?R+L?\"4$L#!!0
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MG)0?,_Y"%[_H%_VB7_2+?M%_;^+CX>,7XT']B]+SB(H)"(GQB?[+8R@< E@
M[H )X(;Z] +H 5W4YX^^%>H8"I4 R"5\1FMW=V<Q;FY'-RX3<R=3"RXS)P=N
M;Q-G;EXN'FY  N3M;&)F9^%.;VIA9>,HR;K?"&&EMS&79-465.91=GYD86TC
M[^MJH>[[1,/,U\Y,U)P5)$6()^$MYNW@[(!"0?3>#O:.;F+>DHR_S2Z&ZO\X
MS,TH)>%J;BFF)BW[US-0WR1_7XN7EQ>7%S^7DZL5-Z^HJ"@W#Q\W'Q\GZ@Q.
M-Q]'=Q-O3D<WIK].(&WA9N9JX^QNX^1(_^.[B:F3A[LDHX>'C;F8I8FEH*FY
MN2"GJ0F_.2<OK[D)IXDY/R^G.3^_N; @KPB?):\IXU_9FYO]C;NSAZO];[S-
MS;@M["T<+!S=W5#:X.5FY/[?RQ.E(LG_I?I1,J+.$7OD:F'B;B&-:E(_S,S)
M@_H7U?C=S%R\O"(2W#^=)\']TT+_+VA+2L+<3,SLQYJ<7/_"7MW"Y?^;M>UM
MI'Z"UG\1%'7\+QT4!Y3[X>+B2G#_(_,_:H/[K]Z'ZOW-5U&_I/\OH%],?C'Y
MQ>07DU],?C'YQ>3_+29_Q[L6CBB0ZX5"L\A9X!& C85U#0L3^QK6-1QL;!P\
M8GP4QL C([I!0$Q!1D5)049QB_HV*P,U+0OM+0I&+D86MKL<]SBHZ+GYN=GY
M6-DYV'],@H:-@X.'BT>*CT_*3D-!P_X?)F0K0(R#1H/^"@.-$4 G1L,@1D-^
M!N@   T+[3?ZO4! 0\? Q+J&C8.+AX\ZH?H&@(Z&@8&.B8&%A8F)&O5'C0.8
MQ%@D#+P/KMU4-<%F="'E>QF=@</TL+R-3&T8RLQOZAJ(BT=^BX*2BN4.*]M=
M=@%!(6$14;%'TC*R<O(*BNH:FEK:.KIZ9N86EE;6-K9N[AZ>7MX^OJ]>!P6'
MO'D;&A/[/BX^X4-B4F96=DYNWJ?\@HK*JNJ:VKKZAO:.SYU=W3V]7T9&Q\8G
M)J>F9Y:65U;7UC>^;V[!#@Z/CD].S\XO?LB%!F"@_4[_4BYBE%SHF)@8F-@_
MY$)#]_IQ C$F%@/O-9('JM@F+C<9^5[BD#Z,SBAOPV7B5X.2F;H.XY$S"RRQ
MP'Z(]IMD_YY@@?\IR?XFV-_EF@$(,-!0QL,@!D# /H(!_@A&%R)A+1!.8&/G
M*'#FF%C*:1[7)Q%[%RCZ!* S3!T+#H#;9V&04S@("01.(X%SQLAWX .-641K
M#>1":JL>[X+@]O4@1>*4E9)F8[?^4J-L=I'.[QY( %H#=[I" D1(X%L-&"&?
MA2!?#$<"D"4D "<?0@*]9#VJAL;39TYK<./S#_ZVM>">;22PY'"V>(F@0P)M
M]JCSHN7@G!!J) #N0 )GG.E(((8C*C-R!RY\@."&=VQK-B+DC)$ OE,7$EB$
M(@$$OA426 T%_32)01 IV&H)D@ #K]/I%2\>B*$FTP\01B"!$-0J]5%R,:O^
M<995MJQ+$"$<\@X)\%R,.R*!Z$DD\+,F?IY'FT&&[J\BA4P4>L$C(#]+3?JS
M-NOQV!!#'6#N9230+U6M#UG]]U0G=Q) ?0Z^A3 Y+IA' DRE2""H=@6\?P9&
M EB52.! ANZG24H>AH(JH8M]9Y!#HF*M_7-:\,^Z9?O#'*ZDJE?IP0CC3B3P
MW]A"&=![;!Z$#W<=1M;WOG0I[)IZS!&\HA#9#]L@RW<HL3.B1W363=Q3<X_4
M>JNN=M!>=AZRAS!P640")1QIW@825E\R:I.W[*C&#9P&SCS9_GR)6OMAU8M"
MG++=B)MT51B\X57[.P/)L@CM@6[HQ6DG2'7BV(&NRW.!9F0WBTK*-$)<I9*#
M\[,Y8;\"I>03><GZ?5W9(%P66]_&XYB9^<GTO,3L HUW7FD+\AO_AO$X]$<=
M5F YZZD6]W@>G%222)2^#G/L9BV[W3*NK3T"*=\GQ_"W"*#$.(_G]WDC*F%%
MZWTEX]Z-_3K&:.]B#^7!79J%G=7^S83_E@&GQCTFDMM']+=.RO3T%XHX<FU"
M/S;AX<SSVJ.C;5!N'_46MC#'[7%*J&3//Z#Q]8PE)33-I)?(BAXNA^L*#NPX
MGRJ,PHUC+H]1FK0MT+!30. 7(P%"T#>:R3]W;=MMO4O(:]80S>K@$?RZ92JC
M#P7X[86GN9PO[HN(#!D_-H_5GYR'TTF(Y1211\UWWQ@YZGQJA&54>?.W<=;-
M6(VR(V-XX[;#XO&%]3&1G?KYA;'3MLI6E_:?\]: "E6"<\Z21O IX9]*N1A#
M/::*F[W<5UW&CDI"#_8<[#Z+92\P55"EI>8:2! +)-!9R0M+ 5<S":[.O)/'
M!6GDKUG[=HZ.O1"EZ])V&N^=!DKSCL\I?[[@_Q@URH6#X: <6\0=85^_!*T&
M=QXE3*GG#%A=BGO8N4_X7%WVGTYOWJ85:K@7^[WVIE"]^ZQ$8_RL;>!C3+J%
ME1*?+5=V_WC"P@*G/*.MJTO2#4,GEBN_L,5_P\YS(W"6#';;VEK8C("J+9]>
M!^':I;X<53[B##-^(^,HI[P*>A+3<C=T8H96:P'?(YI5/V6-FC*,[ZAMB"GV
MZUB#MZ2/3:T32 7$][YP41=L[!+TYR%%Y<Q.>/JX6-&IVC^V;Y3%J<HGP"HN
M$"*T<+8=<9Q?:$L>P-8PXGZ6 [YI]/! 0;#]\[U:N; =Y@A@ZXE42E+]$A26
MW[MSM.^%<JC3"B:MHHR!@3/N;2C?SWS^> F9@HG.')\77Y>_%[] :,CZRMZ+
M3[Z\AX>X0PAW=267"**W!E?/F?U>G*>3?8VCLU*7&]=4(?JM"),(!<5FJ/MW
MDSMC&K17QNGI":LD^4;L\,6)-"/P*X$_YUOL+^&=T";F^;KN4EI+J]8Y[8RK
M9P.J5_V)VD'[<P")?&VW7<,>&_RM'G\YFF;'74SGK(PB&N?\Z=']\2-MN+UU
MCF[AH;N*Q=CRG[)B/PT1(&12@PZ@ FBNRKTD?:5U1G&'9FK7+-%SQ=/9V8DZ
M68:4J(P'HGC\+W<'/#KP@U)2-(0.P>MF8N/+L:Z+%SL>D'\CQ>DA@;\F!:M?
M2>X7#/E_PD+:9=XJFNE&4*.WA0O,-BZ?;*"&BN7HQ+HK6@P/F%=8PV*-1;2_
M&E\'K<9[JZ,0,OB"@>-+O_/1IX-+0;O%(W'G:BLU>/\F6V;H0<1H=P#]F9T6
M[%:G>/K.<Y4J'RK.],3+S\J->8W="TR2A*8H.U?#G*[0P0>6W CV9M-NA&):
M(Q)X9BB,!.06M16,@FC\]7B>AFH93[K%YU*1L?3/2A AR$K?@;_?1 *QO&"8
M!OB?9C@(G;Q4J[4X0P*)=.IY\VG82 !OLA-RA(NRY0?(60%H2>^L%O$2=,Y_
M"PF0&9W+T,W$-7)WPSNVW"\K6U$Z_\=A.3B',3D2^,J*!.Z@EKI<N(CRU+_,
M_L'_2;JG-]U/)WQ"V=5N>?$"$Z7Z?F.XYO,U4K"MU@Z$[I H?W1O"..G83IH
ML9\^$KB?#D]$^7YHJ5]FY*[B?,(*RM7$_*>_@?]Y..N?Y-;<?Z]ZE:]? 0?W
M2^6I-/Z95D#5')[&D><A8YNG5B__6>N19UHMG$C@HPKB,<K[.K5;4!Z?X]@'
M^W$UIDKM0$'_/*[ZDT9/O[ AQHJG T#K_Y;"#7(38.@=&FF=VBICG!_'6&-F
M9M8]WIG'W'&MT[XGM=FE@?>/2TT _Z]66LWZYDB4<\]*V4K%V@'G%@E^-@<N
M*R Z>(LUPF:H]#ML5M] JMBTS+!FUD?Y"]:'HW::I<B1?U3Q\O\I%0=-G1%U
M75BL>GF2$V'"4@ISQG3ISDZ99JJJ"6\N:Q6Z.$C"53AF>EA>^TQL%7Q;%?IZ
MGW6+8^K3)Y]P!2DKBL51!*X2+F91LD0,HGLY(L^,,W4GP*&IKWK4XU//181-
M?(-5)[ZDH#WGZWS'PFJY=#2+VR_?SH$P.GV/R>B,/&N9'3:1 &9I8>%BXM5&
MH'"'TRU^<@>VF"<*PKQN2"#RJ12U=[4.<?:1Y!X#Z%+P^3Q9[5\-S@_ZX:;,
M+65G&?DZ2A;/;R4Z\>VZS]O6TZD.:#:AHLKG\$=*[YXT!2L4,W9-S7B+=BMW
M>^K#!IYSDL5T?Q%_"/*"DRQ02JXB#GN=[ /8MLCY=!>DF6OC/!LLQ\Q]713\
M36"/U,KBOYQP\RU8S&PVC+M*924=-]SU]RD]]Z*K VL;]R,.VSD#Z+P'OQQ0
M%QKRFW^M\Y[=O9'"(XJ-5:[G*8;].5QHZV"YZUJP_@2GZ,W[7C$*@[BM$FD?
M2LTSJ^(MU(Q)31'&4 4=><YD"=.5#N,;>RV3)^_4UD\$0K\E.APRYLWW#KKM
MCYV69+5?.%9GG7D22AW*C:UX6_&E5QC=5PMPQ7#T^W2,'W:Z90?)K$@3<HOD
M"*U-@(NJ=G1QG5I%M67!9<K&N4L%DF6K;E4*E%*D81O$J,@R6Z558Y6&()AU
MM[2%H8_H&QH-*^5'6R^[<_&)CXYVC?IDM"?7X-&[M7!B?UTC^%#]4HW1-5A+
MBI60KU?"R1L]7# 8;2Y\S'7.?4LTZPD4%"'P[FS???M:X++$KHL+;I<L$5:9
MW=RG0L1HP?Y>L1_D6^RQB)=5="21]X;&V"X+C$:;I,,!E)9[I\9*:R7H?!+X
MYM5Z5'";'FK\[GCQAI&M<M;[F[UQZFZWOF0%T3W_BG?2P&[V0>-=DVE"'P)7
MA9"\:%;"=A:55HB+]I[5U=3R]CDYG.A\4'(ZZ$S9W1Z2'!*8DA"&D8P7$9 W
M/DF%[.0-U$H9(8'FL<.4TX'GDJ1@:^6K-U>+4+_%!>Z"[O-T5+%"X#T "9%B
MG+D*T]>G"(HV0\^N^7;7J4E^:"#=;\(@_;J$(7/8;G98.?-NV@T0_139OH;F
MO2\%7JK&7O ;WO*2?QKD2_]R$9M?_8K"_ZDH_"OML3>;+77#8X;PP%,_@)XT
MBWO< %P$A:ITEU0NT5%X\?OK$@-9=N]W;CEY9KX:9HKPYB<QH6PEC\R2RU%G
MY94@@:E;RDA@^'1\1%O8# FPJ!@B@3*N9"20M5^8_1$]E.W/6U/R0V@$Q#3I
MH5SVW.RBWA:_LF#G_*KKC _A.@DY+Q.9)9:L)MKJZG')Z.<6+@<BK?*174[Z
M^N:F" 4F_7>EE84.K3C%U;7B)(!!@. ]*<$1I:DV7\=[I=SDW$>ZN]GS^%_D
MI:."9L(4R]#>#(I\)$*ATLBW5@UIA^K#CL_,:+/D:,,[B^MKO7-9[0%'M1MT
M[T&J*64BF4Z89VG/E;0@Y39-L^+)"A_+[?0M;YNW=2C$64]RG(8]J[F_>ICV
MI6-9*)HKFFROJ*LM)\:"F+WIDES4KWA',T"3E:;FVA,^.P4_JPRI3^['C5&#
M7"U=X&&+*=:-TP#+^<8Z"<L7@KN,/+H/\&/T1,85..MBKHE]L]I^J39N**Y>
M-5ZL/)A^-YZ8J1-BQG8O3+,\B@\-T]RE4^_?T^G_CE8/":$[4)*XBT*B^J"K
M&W$H"T-7$ I60:"='[ ZD^2%F");Y@O11KIS=M_]JY?NBU=T_H8L;IZ@ XWC
MQ4OT3<B%U$6#(H "P7_:UII,EOKF/>5?:\U89EFM*I#&^[Z9(IYRN>=:P%]X
M_0/%MV-,R_I\*3KOE,YLW99"K+6T#PZW&5CZHX-XA<RIT:/.O]TU.WCYXIK=
M:&$BK*78*WMJ<\#!ZRK=R05,>LOK[-&)=83KH@@[WWW#?AS*BZ?8#&#H1N>M
MVY2(SG=/*R\YBMNL@\;*V>(V^#A2\Q.OC=;:M&)NI&A"2&SXO<&M"_1US?6U
MH2<;.F(1J6NBEH=*#.$ /<EJ!@4 TQ#8ISU+LK;WN&N:M-S[]/,RA^K:O%@5
M+)X[,KJON X_BI]AA582HWUFH*4\L^OK%M/3M!OY;CQONNN_!/>H%1Y$M>9W
MX="O'G_$0U!6IS^H&I60XJ3,J!WMZ/.J6QF<$^:>;YM3$B:0[Z8WO_EU6 8@
MZSIK[$J0N@V[GFIEYT1:4Z=;+6J.S?/PH$B^+U!T3L6HSS#.52R]8QZDUSCI
M6 UFW/-78PE=D*O!*M)\^FE*@564Y2U%[T?\F][[*J\^<V<WIYY\WS<M?_[B
M[=J]BCNK=,\]<7IZC' V*"FSB#H);^LK..IUJX8R5\8?",6@ H-?=$LW?HC$
MJ^W(8K[%I=5>L2&WHO-#L/7T8N-5@N,AI@G.Y<:^F>CN=UO,,T.Z$WMR-]NB
M3?)T#W-=AY/XPVQNR#Z-PR#OXMC3:U.PU*I*PPZ+7%OMV)EDYV']]B+]P4C?
M*"4 H%6ZP=\M2F;\ /8!1O36I+8\7#;5)2LW@UK^M2)MCCF[LWSK["S$MP\<
M?%K1[6HYF1FCE%B<'4?5>DY21/P>!W:>+I:2WV9O\?QD!)KW$K)$T5R3?BFW
M^W!1F1S-+SP1W2I*R(MN?^7V]'XHL&W]FP?6(0$ZW;9/!MX!(S")GCMCFLR/
MH^O(),S=]-0#4\[U[[BNA0^VAZY!4"E"Z;<4P?W7%($+_BT!6* 20,&Y-0H\
M7B:@JD?E+4]C,!PCIRYZJ39&?MDFD32:*@K_.0$L:6#$3SG'3FN?*]6]0L#V
M<51ZO'1W01HXQVS.3QC:KB\_,</7RZ->KK?U%'<WMC'GZ=<6"IU-RN:6N))2
M#7+I-Q5RE-T/!O5A$A>:B@)D=Z6L I+ ;>",N^,;BE\6(-#K">UI=RIA(<&<
M@O-\=Y>K&PE4N4@YPHLT5M'E-"6W49DD:-[BJL7=Y%LI9?(:=;_QM%*=7*-3
M8B2_.#]<I]/<CPZFN1Z^E'JS72P]$*[KX!X&:]YI4%72F-MI36"^P2,G4A(G
ML#U\^<# ]L[@R@[G4O5K0Q_E-4J) T^G+F&S%(].MR$%FQI(H/WD3LM%@*>8
M"LY9;E]7 $7-I'M="6-U'1<Q%YEF5S>;*VGTN(IO*S2]<^BZ=\NB?M( M_VD
M]"/.R5DSZ2^$TQXS U%"PCDR4/4GS2,MQ)N>OCFIG7%C3LY&^&^2A T&5RUT
MT/EP0.'>.T:8L,?DM^GT"1D1@C!,+S&ALMSY\>*/PET/.,((T%]_JZ6X&&;9
M/RA527\X'^-4"1>\(K*"3G:&$W4:T=9,N&_;U17O>;",:CJNUK[\_!HC/>DI
MA=NP@MNTLGOQLC\6DPV=_F@<^?;.XZX]'JQN.&PP  E<2OH7?K[7Q%W4]E%/
M/_=M0)KQ9Q=/IDNF\)JVR'V7R&-O!%?:L:<A]5,0-62)_S9IBQ2MLK1>U6V-
M%C.#G=FKC!,_UZR]O6Z5Y%*!\=0F)/ %5%A;&M?CI; X=)AP;G!JRY:9;2)#
M^A3M/]L,%CLBSUG22%&9F#,=\49QDR/YS 7EE97MZ2<_;K0,X]ZG92%5O4\S
M'PF/D_1"M#8X(2);2F+J?XKD *FJS+]H!L9O6UB_-V!(-I<CAIN,")S+IO*N
M\C;/")(FXJCB<OJ4#3],E#YY[5,@SE15Y*_?F40>$IV_Y?QPI>A!+>3JH!Z4
MX^W9#+OU6>SD^VJC4/P $KC'&? @\J%O^N?E>E.WB>8&47'?\81><.+A^.%J
M51;U.>1 LO3IV7#6_4[W2^K""M#;<JKT=;!B:_W9= $OR&RDF)&V:=(&%#]S
M*,8Q'*P?%#D-R5_3&(#%7FH=R1_-XR^7OA%4(;&94,])ZG#SH'E"PGA]XMEU
M7+-M99AQI].-[P%<8^[;TI76G.M3@?(*(JU;C_!6)!B0 %,)ZHHQ_HJ"0:;)
ML)L(Q=LHY1ECG^-!^0N<L]@*;+ME)!P9EE)2YL\ACXJKS[8+,^CL1^QS:.&Y
MWH?G\<6B4MS?+^:;G(U+2C/E8XH*74S8ZS$]12DL)-O4B'*\Q\F^%<0\(!@B
M(ZH&JW]?))KW!FF.'@V Y,?CK8O,#]5F%-";1FC@@T48O'.==:U#WSB<.@(H
M*J#-15]U%"0RM=3T/#&#I#5D*(!G["^WYV+LUGRWX" 8T^>TVVQ1BX+C%4B@
MKWERL.X(^Q.<T(9J?NA)A'M:7-:A\:H_IXQS&OE9>:;=3OQI]R4?K Z7GXAS
MZ)+[ZCJ(:F_;?73J]*Y6GI[$V/QPQ]EBY^3"+=CUE*\!)T,[PEXW9^"%&Q3C
MBO!5DF85Q9O+-)UKU;%RTF.$:\5%Q/A-7>O+(%[==$MM/&H1K=5G5J+%D23>
M_"HPF<_JMC<-98?UE>TQKW]T> ]TQTG NH\_L4#)DYE'!VN%HPV4.(M@_6')
M'V/FA9CHV>4XHAZA7U=1M,S5RH>)NNM_XJPVY!-7B@NZTQ2H/TY$8>-7QDCQ
MN1N :)[[G]T8@K&?7C$X'%G?7(>$+NAR]1*R%,2SO&?%N]_3-N@JLJUOUCJ1
MN87_?KSZ=:J)CN,=_28%SW>L'S CPSMBY'JTU\1]GZG+=>RRNI(GP0('?(1&
MM@,=-8I>[1T!L,U% ;0!&R.!YFI(=>-X1EWJVF@1U6[\*8]TI:BQB-Q:F)!B
M?%NW")W7G?4LF!&MI'!-.GG'R5LS?J,W3=\98_OF$HT3IX(YZ#X.^A0GJX1<
M6%17]_,;&LT7#Z8TV"7.2+S1%G>IQNY'^W:),9D4O])ZX??.Y$2\[TI,B4.E
M_%Z-.J8/PY?4,,^TK>O:V*+K+\3P?4;69^XNB49H7,\;(XY6TZ3E6SB9W36]
MV!B2K>.TQ24P?6?[(J<F\,FCVZX!]N8K@KXO\-::4-B<P9@ !==504<W#95=
M%WB10%1I,'B'+?T"M_C'30UC4,]@:;N'@*K,,VLR=56A4MN36BAG9W.[@*OT
M=UIF-9XOK= 'V!2%'JF%X#[NLUM'!:&-96EO?FPV$D")KG!]Z1!X'U%I$)4$
M7_.W@HY8OH//V%\A@;>%1UH+@\QN?"%PAC0T))#!_0@)M&G0P97IH,'>V(C7
MS41( .LI&"884-\)&XQDB2_VHGX"W?1Z./*P?'7@+GZU&>5YA0&;!,&EFU(,
M4Z,@Z$_X%=7 <HJ$A&.,;"9/:CUC9&YN'C!;6MKHW--7K \+9@7V6^E7PZ@J
M<[TSAS3UB9T(V_L\1^\&RSS]2O&A*!DJW^I\BUV>.<S<326&<=W*^"J?Z-0<
M'G(V_'MG0I/TN4@(OR"XF@&QDQZ%!*BJ"0H%'DIC8FSKD-GNZU5]=<=L;#ZD
MXUSK), QTEUEWI56[>.]$F4%2!A=5/7(R&>%V(H(09TV+H5RN;9)LEF9AH,Y
MQ3%PZ3Z7%TI8WMD><\#@R".S*!S,=T((#NCNW$&'3:E-;!\!G4V\2"F3I7P9
MT8?[$EPXXI$TH3U9>J$;?L(K#JR=6O'"8H_?,7OE\Y?N+W/2Q7_!JPCA3$]5
M 5Y&Q_#Q^PY]OKB6Y>0EE5YB4_MT*M Q.W!/6-\93=25J._K<?>C^U3OM3P2
MWE0I*^I_JMHU;=]3XCZ[D.>*[J<-.,->^^Y[01406V(C=MPX9^V;$Y^#)]0=
M,[AT1]/>"C.?GH:X$S#*#&4#_MU6XO1G1>?'ZZ@J\^-UQY_OA!O\E+%>X*$*
MD']J.87;Y&+D::<-.>UM>%Z2.A=H<Y>:QB1G,=WM%TH+6X2QIZ9!*@,<OD1;
MS[6'TEA@4EG+J?+SMGQ^KQC92.'1W!_I^D]+E;!>QK,<2C)=V?N(!EL0,*Y%
M5.PBK!ZLT+U-"GFCNRNP?"+FLF*;HL!]^=GSA"["+B0S]*)!PT16HDQ+KE.K
M5*WI?$N\+#.40_T&2EP,LW:Z ['OD.,K(D3P70@Q:#5C&W0,!4?E>3]"R!G>
M0D RD,#73N%E5OA[22M$"]$!V8$/$NC&&,E!?$<"G1<TXZ2JQGS/2%75]&?[
MO#S(FBLH[R1^=LD\MF0% MR)W'+/P$NO8>1-%I!V&U_?\],*WM89OH<($= +
MP<4VF-H6W0T5YBA<@5R'\M:/U\+E@%?;<Z\NM!P;&*'@H&(XR[.M234TJ3P^
MNJ95C,K-42C&V"2=X=C2E\BJ5I. 8L6AY>=((*'G0EAQ?,>CD:QQU$HW4X+&
M6>.">&I\YGSC/@SK-,2#V.,9_#;SVY:==]_ECG>-5I;V;TR?Q2K?\I2S(XK7
M^0 ?KLTX.9+<&I)N/TMU</!8\MY=^#*Q?'&R+(XO:O72G$>BG[1BCX8&W97W
MJZ\V_S(=H<J2OT*)P#3QO9P*.YT)89 U^2:ZS[M1"LVW<S17Y]@8HE)Y+C9.
M7FO^!0MWFQ(QRWW>4)M%A/%_#4N3(;)S8EZVH0]?(ZYZ*'M?A^F&KMMW>4I:
MZ%VTZ"5:"\%B+',EEO)+@7![AQ7_[\DBU/H83!0[O#V[^G%8J7$EJ=;Q#?Y5
M0C6P#7,>6>);K*QX(C0Q8*JTOWC7?SB._AXKBZER/NGW@1+6N';KA^A]-3N6
M;TY]R2SR#]Q H&R]TAY99H $AD!P;RUX7WUJ8LBRB*!2\74[?Z+>6VIQ:I:I
M&=2XY]"M(LV:58Q7@6Y&8*>L[>'NDJH&4L]AO6UR[:C9Z<<'/N7M47LZI[+)
MK1HKM#IDW912]2?XZ>>H !V))]7FA@0DD !L27%3/.\*%3,?;(U'D \]?M4I
M=E(-?F[FG60Q4%U=]7#]+J=Y]+(-,Q][:L4=_!)J/%=<VO!GAOIV>K15VE*W
MJULJ(I98R:%MUH[,]XH(B >:=>/,+>/EW*K67MS#V9@(^!L?N2DN\$8Z0H*M
MZ7EP;2-[AAE5 B D"AP);)7_BU6I).+UEVHTR9GXL)2\*IS25_"=$80UQ(S<
M<TH2BI!/MI3'>J]0=_W2692Q^N\L].)=JK0^Q1#P#,JMZ([Y6FL\$3O9;3)9
MYB2P\:1Z3YZD/-U2W]12'O\57! C^)9<4\M4:34*[X6H*/UME=99CW0\;[P^
MN>%]SCLCZ[>\A/ETFYYF!QB$[E1$5SQBB'+.3O\0WW:M.>Q M"!)*\$JTT9H
MQC&1*-K&-E#$;$[?-F*:.?8LJ=/#*'(=DFT]/]YBS GN/U#RQ]<=DV#-V:Q)
M\M\1CK+VK7X?:'W[1B5_9[47#P8!?S V-C;FM_%]D@[NMPZLR1T-MW.LXZ6H
M6ZH264=7:ZQLF%3)*CC8^$S>I\>R\_ $V!Z'WA7TGKV80 (;5W:>.9;I3F=T
MJS[QE4OC22?M"X94)\K""&+J0O$W10QXB[Z$Y5S.&5 ZVQ@Q.M]QZ+V&E(;U
MW$DI_^/(6*K. ELJ<9O3B$>B-^K8TVP_BA(0WY^38Q798RMT;824+L]>R=?$
M'\%)C#^JRI Q_2&L_L_:.H(&W'L/FG?UTAX)'#U$1>B?:@_@QQXHL+X#7LW?
MAIQ@C8*/_(]1\7X*"?2J3X)W\'-1X?YR:_.?$T2!V&"I388-_Q;5ZV2&(+>]
M[HI(5^_"\6_&)'"C!<9)PM3LQ-&B#T7>FTQ'W%?8M1.-SCK:;PO[AAU]SN"F
M[:KK6R<\?DK+2ONDMOO^ 5-TGFP/SDV-'URI^/9DAEZ*=/&$AFG&2%USBU,0
M59A'Q6GV-WAL)2L==/@>X1YJZY<(EAJ'0"K-_@C)A(N4 ,$XO;'OW4E9%4)9
M#XM]7$>UK8BT[U6%*ZFAKON = ^/07Z">TB@1QMB#;G>))J)9;VCM>6!!.(G
MC9M$+^C>!Z W>&C*X(62W6\%GN'!"C9XGXRM@-47LZ(&"L=3FXFPH+4OX0I.
MR^'L>ROR:6P,C:$*M-!&#1[F;REC 6)0N;?<?C8%1M.;MV[.#@A]7PV[-L<C
M>=UN\7OI3>HW\;QY@G:>DB*K1V9*T_F2^U_/V2_EQJIJ9O-M3K5"$,GMO?!.
M]=(RRD?YVFCOH0\H!UR3-CI4".P:T_2QJE(A:]5Y>T.3=.X(QJ9)F2,K,H-X
M!:.4TBV_<:-HZ.'CD ?#>Q(V!;+%:^NT0G=0 L70!"Z&,"$NCL@D)]LDU6@#
M9JB??]H3Z+5 5PI[[1V;_R4MCX; *JWN$]RBN.V3L4S>YC.Y')O\57W&-&H:
M\BL0P_Z35.'G97T5YUV%J1:.ALW@;Q2WM-6-YOO<7-<5<EWWNNL%R4BU58\R
M]'RO07R6YE6Y[R5+9H>EQ\L<@59F*MD^$F4).!C-&HQD0"KLN]G65#0DQRY#
MFXU4H,W5=DIO-WA?#Z<JI-DDFW(0+:OYIG77ECXP*L-A8HJR 51E2(-_%*]D
M?=[=B(<ME"COS 1_O].0]%- UU]" F]:P-&IQJ^WK#-#6[^R-\\O3GOZ)==:
MM?!J<8AKH?1@#.7>U"3SLF0M ]N!1^G@8"10+'=2>X5*!-U(X&(\5<:IET0T
M,>NJ& D\!L.0 **:;F;Q"#5&AP2VM:Z7@N\DY_2Y.5D)'O4%12R0L62;WL>0
M#%;A_$J0-OZ*-6R]8M2C=MR>\UO+"*;%<BBTB<3GU:G9 %NCZY/KVA%$]&-U
M;5C3"_^:]P;L;,)MJ?=8]7JDM]0P63'DQ++$T<R'V>/^;96[GH"A0JM9Q$*M
M.XA,J/I$(*+;_$!@>5/+8=MI37XXAIJ.Q\J ZV$,FH09Z3DCS>"D.&C7Z0*E
MGD@D</P)@0I!N: S)( $]"H_Y?7>6+>,_ ?&G@O&4EBQCO/3*Z+[.@))+;5>
MF9N^IILU/$;SQD;X\BMU]3R,,;2UY#@;9Z#&A<I\,M(B#7TK.1DW3RD6R#N]
M!&683%#\A^6!4K.T&?B<]' 65JR;A.I[CGJ5ASB2WH*<I>%'^)\<+2[-XWL=
MT.JC2QTL:OJ9BMZM%^P_Z.ZOIXE4U25;=1HV<*R$<2N,-HGZY.MV/'<3S&J/
MM.$,^DSR*;JF\+WU:1!(B-H15^WC>LG6;8GAHJ =!>8A#RM[1Y;PG3WT^Q*E
M/#Z#Y<+O\9" MU4@P$Q\G]-33(_C)N(F(9G')_=$KI[F]YDORGJ&"ROV-?AV
MITHTS#EN?'ZV$JV;)/=9F?]IV5C)/D-#942?ZG-2V:J47G&,H*DT'2NS0$\V
MEN?#$XN33F-BQA?[%[0>9,%^%AGA-%N66\;,3SC#C,T3=F_;H#PK0'91.$!T
MME9D@V(]"UKZCA.N-5.IVS[<D6?L'R6^1\A S!33\X62XA:[Q@%>R@6:W94O
M..EZ@A@>1V1"EUY1R-.F$3^II."$W'G)XK8(6,O4 "7Z(]JZL.#NI_CYS_BP
MF?AF409\XF#W6<AK4S"\)9B)SU %LR""\H$("S HC_: I2%L_=VF\[9986:9
M*:SD%5?J<U_'M4!QDLQUCF2%CTE\B\X^7)F/ZE*X;JU+$"0%@JFG*-Q]CE;M
M/GAPRF_N61!AS)8I4-9F?7KV()):7GTPX*,[Y#AC9%C#O=BRVZ!,N,&@6++F
M1#/AB[DN+UQ>AW#K.=^:BJD=%8C2)PU[1$+FA !LHV"=;G4(&3\_R+3R7/#<
M'WJ0XIGEY:32_4S,ER,ELGN!.EF#RL]K1&#1SHX$"9@G?U$*8J9(,DPF.Q!1
M:TT)Y(].8ETF*SA+4!Y1KH3,.G(MV;UA2EQYU^.:4OL>$,7V$C'PH ^F%W1
M J5;W68RIM8+W,,>VY!*FP2^IF!N,9#0A(Z6]P%VXDVQE^RN4N;,?GU#3.+N
M/R+(']K/^R$-BC^EPZ?8"C*D3['_N#%6\H?*YCX6J>K?&HU*)QU)*G['G8D)
MY=J$\[<X$@5@ZH ZN']AZW;>65!)ZO,N;5>.O=I:I\JVB&3M?/@3E16#3O\T
M#*(=-N93W\IO_!+:$[R$Q?%O4,EW7^)KOD-Q;E-#Q,+$G20;'7;95RQO=]C9
M3U6"TZX97NOT,'S"<)7C7"]C@L@@<CJ-!/=-U/-Z?UK*/Y2\8&K$>I7&5<HX
M6WBS%0D0[%:Q1#Z=B./RH+$P PDXTSEIG<*;[2"9H6=;XP7:Z1+STZ?O>8Z@
MT-7<HL!0MB+E]M^WDNH@%'Y2U1,K,8=*&C5C8E$B"BTM(8N')2.AP'G!^HR=
M>#[G7J9U;GA- T^;NJIVE3<2:-LNT1&\>FT,XWWIRPVO486S+HX>E$H.^U&Z
M^-M=917V-VB]?^5FH-+F@NB1#(#$^VIRNDO7Q#3RW-LI\:#.KBE_N9$X2$;L
M"KXR.IZ@I7X(-5=R6]Z,OWS::GW4Z#DHB9^N,EJZ4*"7$&E_9"<WZH?K<&(]
MY9"@&N<FL/CX" X&.%['Z[+&Y:3)QLB)6GGVFFTIE#KAQRD&'#O<<H1 B=*Z
M-IZ&U(>,G_YXRF01QAWNH4(23=I?,W$WDFOP.M-3,:LQ%$+ \JUMAY""'<Z\
M=FZI-!RJH.%*&H&60,$\ :\FFFXW<*/;(0%HQ%G#Q.:L0U-(;]W1U#P2P'AU
MIIW_KJW=VPN'0U_SRB=-")M6+>VN1C['HMR5#YT\"J'!NA=^<Y9_KC]*<NN=
M*'Z D0[0":G*%>;$&7B9.WW52GM)+(DMLTP ;W <LI8 Q[_0"M=HJ7Z>FJ:K
M6BLZ%Q#WU#,JK4N&S.N2RVE?[CP=FO5[I_@\T\K2=*OTDUQ>59*T<Y]K6/&:
M\H@T@? G40K3>B"-/PQF$-02XEN8;VB31ETSNI.C@_?=RP97=U4!OY=>9^YS
MR1<-#JM]-LY6LDW0M!O8%]2/!(+H_M;CLEXXI4TM<O$4LY\9K/VT1348-5&C
MK>6BFXR_0IIK&+:C.TXY2B>"D0)UQ28;W J@FERI#C:\/?%<.^Z.1O7H7LRT
M??H:>6--1>'G%Z+FU"^M1+1H)?7_($8F# $IW?YH]_S]#9[P1U'Z-%%B21Z&
MB+[DRV&$%9SM]\[=P\\&13F:$G(?!Y8)Q1\&"J1T7,^M-!!L[M-OD"6YKR-6
M4;8:V> V-%$#JEA''($3D0#>U^JW&34Z<X&ROOYV8N$"34E@%]6&^O6&D([Y
M!UP2"MG3[]YM<X*?6'\<YRXU\BFBL2+?&Q%UPV5E<I1GJ;4*9*Z"=BP\<IY,
MPQ^;T3G:S.#=EKH3LRR:.G8ME&']"WJ-J">.7%_0=NW(]Z(&L/'D\9:Q/A(P
M!/4<U#>)+[^#$&['>Y[,M)9Y!"IQ"NNV!"Y_4ZS$I6'.F%V= = 5<(=.Y0P;
MK[ U6D;@[F9EUNL3Q>@ST@=R];,[+X5B*%X\6G5U6119;TRZ*^AATGG0F!4*
MO8JO79I__K2:BG]^9BLAW^L$YD(EY]@B;;WUK>;@6Y=GD%HV61^W2&L+U+-<
M($;I3H(/WY1W\,I3^6(/-/O3J,=A]:'2T;J&7N8A;$1,(J*E&IEI>P@M.*3G
M?5'Q%0H6\P^80)MWBT[$$,E+L]^M*L?"/\??:JAO;&P(:_VZM\@<]F:[D<&O
M'2]"Y^;+K][L0YK!VY^U&P8_N'>->:A4/<!7C!&.6Y5^4?[POGU&3V\;-F;8
MS7%59?$ XX1SH@LX$N@_Y";Q=E,=Y^*.A#/BM##:T%V"/L\8?M;*0%,K%RA=
MQT5HTHLY>#@TH>.@=^4L-?L:ZAO%<'!7"51NS@0U=6G(EQA-97A'#M3KAM*0
M-/K03&8.*]@XT?NFV11[/S>"W2ET66;(ZC5A*9T*JDEV$[ACEX'5G7(9*BY;
MCVUKT1"6^G%\G]Q:&"$YXF[GKRU=5U%#5?Z\T++Y ;N^#U_NNO4L$-.Q)NM(
M)-FZ;YWY9:Z9&SSFY04QA.!3M)!':KRZK\3I.L]87VEF7]&E;=%OUZZ(?C7?
M%Y:/@<U$T5;RI$-V,KDC2?AUB;MN\<K(WN[TL6Q=T,=X#I]'^??I^N?:2)]]
M!&*',*3"9<0;#WT#T*=U;[LCR"=4@M:KR,$0)W)":=:DE-FK.B6(:/<<9;?1
MU!"IKK>;;L5D56&]0$T:Q;&D;JYF$BA&_*V2')-%O9K8RWC*R^KO56IZ<@D7
MT]Q?'>87-\Z10.+& O[P<3._X5OZLG$!0V+.T*$\XRUBH_L5+S*P"J_9D%VC
M#F:KZ[I!L_+5.O,#*A%D_Y_?H2)[NT*K\SWMQIA3ED-%-HNI5,0B>WK_>LWV
M@)2@[37::^UM3Z1&1:.;VZ^G)Q-]:7!^?U7LW=&_TC5^(F(SX(D$7GAWDJH:
MNP:X_YC,RQ@/SM6P\2;\>,:Q:K3'%6=I%4%\9L;Z7=)N@2/I#)Q)B-_F^;3"
M(<WC4GK.K;Z^[8* J+U![ZP_@&&R9%$F4PH)<';<DZ+E*M6^\D&%:0/L[)]W
MT<A60)3VU135S^WJ'2T2GB2ZD$K#HWJPZ8E<!GV/CTHM2[RZ?;E/3E\Y%:MZ
M*5/Y?+W8-W*6RF*"E<P16L@VF9],'1Y276^A4M7?/Z43'I8A.\G;Z(C&K\$2
M76;C3PF53S=S^SJZ8!_&>ON8*.F"=FPEQ%T_^30R4X)L&4?0"7OS].:<+*O.
M:[5@Y^MKYPH@ RM8\7[-#!(8Z@>=0K6C_.Z."#@$3*J&:%=$K'O3TE*^Q;9#
MYVT[-IYHQD>0H>(VY#L1T=7)XHHQ0VB.8IR-3.TIN$UJ%%O/HPR:-*G2]\AK
MMP9R>$AT!2?UKYE$!)@@ 4A@&63)^$P?\0**!!8=$ +@=@BT]@H-57"US,+M
MDL:>0^K!B9.^J0F+2 "8OW0HA<,[D  8R^TV9QIEM1,A3HX<D\;CH&?@U^.E
M9]H(<B3P40)T.@L.5[;Y5GI]:K[3PR:GD^9KF;OS0!P31*].,8R.SVG/>/UQ
MG *'.-B8R3.4K43]64'"I(I#91^>EY5XR$CQA">J1KL'^68\4H!W<',J\E+-
M::_[G Z6]7NG0$,+7L[?R(4$;)6OII  $VK=O_<$0XH&\A_D-%K'E\\M5+++
M5M1I*/>C>:Z2D))TRK%2T"2M.?D9%EA'V4U<O&_P'Y](QB21\7!P8)2^;<E6
MWDM^8A^(X3S-W@%X:87>SLL"_PL&&VIGE6I5T(%C>,*)]LV.>W<O=QF7NW<^
M[9$.W'/M,8Q"UP>QG5.GU34N1=Y<] [DH)N?%>[CF!\B*0M?T:422>)105?.
MZ;Z'_JJW1^#<])9G_=R_XJ(8*FK*4;%_DKTX'WD 6M$CKZB:Z&-Z@3ND4FRB
M<=K",-HDGCT]4- K]BX1,82G/]/G?"#_B.=I="'ODL[1KJHJ<VCXK-#WHE2Z
MSS.6C8*?R4D,.#O+M.(7]D;T;33UQ?7-"XJKOBV5AP7R=]IIL021)7N4;I[X
MKI5$"L0*'H]0,H5RV+"@H0&5%?D:!BD6;\ARY)1"]/\1#6.1A11Z=\L,.Z[6
MM"2M90=AQEXE=3T/JE6/(0BGX@E[=O.0N)4UQ_"5_NB>A_3H;HF674BU?N<4
MKE90!%F'.WWZ(]EOQIFA^06V-;Z";YO&<@\</D=W&=LX)<XQA@$J]UH#!- <
M0SEXF^1R[KSS+Q2<N&=/95&?T.<T_^%#48H9*Y;*?;<(_OL[ V)W28.?RCWD
MXY#:-RPK3Q-Q3--)T\^NBG2_CAG3L(>F3\%$>?ZRE3YLU?2E>WW6?\G&/-DR
MA*HD+.U.>36"PD$8<6\#=(%3:EN*=5;/ +[=DX?0G>W*.A@Z+M6^&PX3WDE<
MWG"M(9F?$?%ERVRI.GM1>$'X8ESB4=Y4[7Q=?830!3GE%7N0!XC0]*:?],C[
ML!=[B^_MP3D6>@;O<UB&^>TER!2_OMH:@:MDW@> :\!WE&V,,0/B__5# C*
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MAMGJ35>ZS]C;6^O R^#>\R>2IJ%B\.)S<-2HG>/ICYH#!B;]/G%3'ZX\[NC
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MPD03KYA%C\E-O/IP,9L0>"4F%3%NM@(CZB= G^Z5R(1(!]$;ZXWG&-5N7K0
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MM [Q9*6BN'R/_%'(27^Z+5D*SIIET&%HV6WKIN37^J243+&-@+Y8_R>"OE#
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M?'!(^O4[QW?CP-QS!OP<C]E+SG:Q@"+;G'R_LUBA<&Z91G><Z:IR\R-ZFZ9
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M%:QT?I%TO)"<''-Z[;.+5#@FG*J<S0D_E@K.R%MSU&]-T^VT\ 1?5U>I<6]
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M^?,7FY(S,X'?K#[EB@6_<]._\"=3-YHX3)<C'_:@;!GRJ-*9NK>V!?X&"U*
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M&IL:FZ@XK\HKN9.N=%>Z&!#;N/+UE*^ -W42EH-_H;*]SN09E('.I9\6/EM
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MGZBBV#EI&7EY>8B(LKJ2K)JDG+SLKT&HZ.GIF1B9N)B9N61/\IV4_1\WR@>
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M4. C(0RO>KM?3<_?L6@2:V?C*JX5X_Z=1ZN8]GF\OU#A PJ >T[(((<S&U&
M0TBBZ[="+09&[?#KPL.(9KL9CSTN!2B1 8'/)[-!V!!?FDHHP)0I!8AS7LD=
MSO9GLR*LM9G[TJM9"_8SBGUD455!OE0^C,[ <4;!VK)9*P<<+B2_LWMA4;2E
M)!P40%9HBRWD:M/C_9+A_KD$+])6Z0=M]K0>.5L]]_KDDS<?31"1\81#:#=D
MAX!8[8O"Y%:>U!_*JN[<NE-4'XJ?Y',*W#W;YV)^$?$O CM1@"<=K9.;TBX(
M CL%F+V=W<D?ZS\'^5>M&@DV>/%;,:V#]>8E00I;*;.[=EBW;EZ!)S+S @,I
M+L?N/[RDE6^B$8U"HL6)NH/)K34\9Y+])5*J<QF%M$:M==N-NONILD-JI:OZ
MYU':1569=KGSL/]6#NOBMQ%VR=F:%( ^(0JS<*<?-+08!6A'<L8UFC+%G/(+
M-6$J%E(\ISMG(&5WM DKM( )0\O4X2/">5RG,.[5R9]>]-_1:]>VJU!?#FRK
M7\!APWR8[^1XN0D8&VFUAAGO)EI?72RT2/Z\&ON^Q^Y[%P6 $%#&#8%1/J-S
MCLK?F-KE87?H#I7^RR2B+(U#S"M:ERY#IV7PBB0F'B29%DKH_3<1WT;<F4_L
M]8/.)$3*&[B/HZK%,\;5Q\[A;RG#Q=121)[J6NTE-:XX*-"?J<^2%YXKZ]&=
MT8UVQ*4]$<%4,[AGM4JG<C-T3^* H<]]A(967U/Y/M?T4%6^Y.UP2)'K/7[1
M6B]9\>Z)CS'DXVZ!Y%!%"D X!EI,ER@\LD,Z[ %*<1*4HD$],Y#+2QHT:X8U
M!<CII@!D&BAAR &W/*-15^27WM.SO1?8K?'S>OCE><_OBGR'3?RYU!L&?9S:
MK[FT:;GI\1EB*("0 .BP,$\*L'"WLO0&432BUMA,$%6(9AC3IFLI?7#N5=C/
M[]?' C*CY]HI --$1*LCT;LV?+GIO&S3J4_<C=2>F:!Q4-G.4Z 89RD E_%M
MG9.WZ1YCYOQ[$<NKT*RKY!-FOAJU!CH]>C3.7KQRRA>H?6SZ+3JAQS%S^:[(
M+3R)UG\8$K?'KY00QO?&_-X46WPM>\IB9FZ(U^.^<O8C.]A'-<=&"!X6J?XG
MY#E%%64Z<$.F^+LSW&3.Y1 QCL]W.=R*<S>2H]?/(AKA/<,4X,BN2YJK(Y?R
M9EO _+$[>SQ7^1SY3&K;8&B,U;[;SY.1JTE.7V;SI3GF9W<2/B^V;*EUS986
M9%,]3DQY-E%\UE-CV:*'XQT+0<>'+)U7_UFK6@VTOI!.,FBD1,2";1&,D<^7
M&T4!/G:\0@R-8?:X2U-=I^OD]WT:76M_/D(HY*DI"GE<"P*GI]CZNLUBD"X7
M4;KR[;D=%*.6],\<V4\-171<'4/X1=/G:B>%VX[/7XO3?V*AU/SZPD2+AQ*W
M$HUC,3M*9K]8423M!^89EV[M"I/G@U&-K37,T6-=N/0)]K""%VL%K*O\1P,&
ME;#3:=HS@H3Z:T3YKUH7[48].9XES !S9)%T7("?T32M1^18)>+H^P+;7:GC
M/A?*[K1S_53;6$WH+!N#,%A]//'-_>=S67?GHVQ<MX?;66ZWK)?#U#_>*CJ3
M,^@1L&8;GSI/:[R'XHLO5BB?\M@5\(;M[1O-7Y=Z/*8_H_'L+3TX[=YIAP8&
M.1]>'HZG?OR)Z$]<GH=%P=:-J[%[!#*8"6"\FRKB1-&[<44PB=JDSA]MC7,6
M*:?3G&/M9]7E,@64=_C%K35+3W&L>VN]]'SKKEFG5;$XE(M%&6X-G<F0L7A#
M-[0Z\ZFF]UW]L>5U>.?YY*?JYQ/::\<-.P-Y6_@[4GZH1$&]IQ_190^8K0;1
MB@]O0T+;$-.T0RTZ]A(J9U]R[[[#(1@6X.[A4J'I<U*,NO*>%X7'5)#*RBB5
MXOV.SXL).&QVU;[9>W3\A-X@C:?OE9:3.G+IJZN(ZO+R?/NZ7LM!FLMO-3T;
MSGL&\MDIDZ\O]*_T.$71#UYO=94,GS_)(A1_>3[>4Q,[;SF2\J[0WV;;6?AK
M?M2%S.>9DJLYC[&HSW[+U\I>&,X+8X*"J[<PD?=$ZOHY9OOB/@P?QGV&)KZ&
M/\3OIMOL94JU/1>8G/8I\+RYRR35\7/=4 EAA2NEE[!MU&V,*GQT>"SZOEY3
MQW+T$#U1XD@Y/N,2461#I>.E^V@S?X,7$LM5)$ZP]?$2]GVJQ'7MR;'[^=F!
MJ=C%FX%S@06*;M/?JYY;2BS?DCD$575GOV./7TN/:$&LRSM#MW8YR>%B#>L-
M459++0H48)=KRVAO/XT":"MD78>$T?]DOWY$?!$5 EDWM*4 J!+$\]=J'KCN
M!;@.H@.SRU:&65Y!+)Q!^[QJ D/N^J]8B=6J9Z%&?-S(HP!#(PB5%\1S+W\&
MA4;O"LU8$)^Y>9'1T!R4*C4>HUW,BLM/_<3?S:U1]%Z5+[<.TXA0N3I??H)Z
M@>7;/OD"3PT)CB*'WC9J6]L]/8+]"B'QI<R940"_W:Q$,NMZ-<=RIN:E$URE
M.T/+L/L/4:J0[6!'0TC)]TD!Z-S%4#(&7'PU77;1[WX)UH-I9[>PC#0O#J<
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M@!R '( <@!R '( <@!R '( <@!R '( <@!R '( <@!R '( <@!R '( <@!R
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M3XXNI;X9MQS3]7&5C8AWNJ6BDOU$>BITU3PPFJA 2@7C <%-[M[[_) ".&7
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M?S?J:U5B&HP84+7I03A'%V>73#XS<>1+L6'$BHD!:X_N3E;#70Q4M/"/UR+
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M6G4+TTX;0M7N)6J0 A"$B^/<%; A:$$<J>7%X:B2PS%>;-5GKH8)/.+""OQ
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M/CVR1+\(.V&>%NX3@V0AQ%SM7SWM)'GOIU"Z\K&GUU,>?Q0J?##S9IE5QZS
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M<F7V-_QB6GPQ;GWS]X]>TZ^R>4//32W(Y^C<<?&!F<-I&M(\!3AZL<10T4W
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MG1()A*+UG[<HW ,LVO!'-]&(W)\.&-?O>YFPMK5#2(B?P(;1$['^W+:!&$7
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M%W,;1=-OM>*3-U4WKZ)*.]*0SXDCT^$6&,-@S#RN</IM8  >5F(M0^C"<WZ
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MFG'NL,O@<>YS:R<M9X3O3(??U[5581T.M;K[)N5GMUT% 5255A9,1,UX#U+
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MJ:)IQ*0^FWY/0S&TO8POL6 79O7J.,NPSBL\=J@["QIO;5)@,B)?$1DW[!C
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M "V_ W&S84U5S>%?D'UG2LM[IEAM<D:$/67'8<(&516 L6CW94+O^U>R[(H
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MBW<AG4%B/KTCW7%OWU'-SC&8FKWP:?"LRD@FK+IAW>[1[%C>2Z)NW_C36"3
M[TY9J!_:]&@H8YBGLF(T/D<2([<-/\=NK1_]_10H&_H1CJ?[NNLF#T0RM5,#
MU]"W6^RD6JLISZE.Z>B/?HKJFHS(4-BG$631.$MC'3$=R:*3D%6A$$!,A)Q]
M^[; 3%B!E \%=*TP[/O<W;;'UP>I;G/QWX@/"!+R\L$L@_0/M9DX*-3=?$U#
M2H24='6\RU>M!O<<'RGF9X4U_7IM#=M&QE!%T&NY[KTPK+@)9A5QO6X6-ZR4
MLL+-\[:O,];Y_;N96[=89F/$@ZSQYS%Y 94.P02^H7KYTK$NT\+E[0JZUDO-
M5'D4\ >S48*'LD#7T:^@JN UV1S?@41%4/]<M#)F*L>0NU8P!&;*P9U*LDF+
M\'T/SHNP.Z3*$]73]Q: GL/3BK %N>F>!(!*AE&\.E8#N?G&8&<<&%XA6,)X
M*)[VX UW1 P+6S;_N&-KP+/@U4W0^[OJ3@OAM0KNCYS<O42SP@2Z_C3=4V@0
MT/!^9?]![WGH8O)G/119*/ .R(WPA0NMN>[2:5 "#5/@'=/,Q!I3Z+_H7Z#F
M&";0G@HFXY976[G#O/K9^873DX\?%PI$8BMEM(O7Z;U ^(NP/;M4C>IZ+ RF
M5_%XDMO TO]1=,R<ABB'S\/SCLZ$9%A_;=$'/4,K2<81G8<J-A8.K.U4Y]_?
MBZ0'%!;*    ]Z*G!U'B%X3,+73N'];2#S/S9>Y$1KAFA<U+W8*$SI#AF3#Q
M:JP>$6!9BU+#@@.JY5#N1>#5\"#CV[<H*-@7&I4QU?B+*HB-2D\+]'ZHFP--
MQ]P"2[9A)>G.Q-?S%$/]2J[]'4@^JP?NTBL/\[3UN6.YT"H<(M'86JD,Z!:9
M%D&>F+G0. T< Y;RIR&S"1#L$;VNPUZI.,'75YE+._L'$-$K SIB8.LC;O48
MP)5-8$<1/6K_HY.WA @< S"'?-DX7;9C !!XZ3"=L_GW/\:%7N00(81%+A+.
MZAX#HON5N,8_SQP<'% ,+>W18EVBDHX!2LK;QP#2HF- Y](Q(/C6,F3GB0,0
MK0['^X;Q$88[C@%]?5\4\E0^0EK37.&' E)0+ ^( %3!2W<22<_*?D6T@J?'
M -3.(Y6]4BDBV7=V9>0#_D#F[_:1%0:L=()O;V_1%O2O_9[(/W#DT5%1)/'T
M"(WQ>1#]_'=$1O]A%UG1Z\\<\'A\P(JK]ZF35L!_>CJW@OB%S%)L3VITJ,=@
MYZ"U%5_P]G;D;_[!=(I 3R1;AD"-%_D<=*C)JD6W<N.C.=0@OD?IN:AJ!""'
MT_/Y\,YZ_86)=G:G*SG6[P6R$+=)7E.81#Q2>E5Y@\&)9M?<I90>H6E V?:9
M\VW%(_V4O[NBLW>(YAYE.6!I+*7D:E*9$'2'(K\=W(>Q(9Q%H3V0N=_V ^Y!
MJ%9<;KS\W,]^M_A'TS<SAJ:=AQ6/# 9@CP,:I/5Z<V\]T8FKF:V&HE7D+^J'
M5F$3?!R8]KG45(#0-&#"'2+O''ZK39E'11$G6XOMV97A^LK[![G]5JY*Q*W_
MD@POD7T4?_HTQ!H%65R<^_^J2HOSS_O[T]!?3Q.TB] .^(M2"$*T9[EG<+M,
M(_PB:E_T7F*8ZNY\+VVNCQ.Z>A;J1Z!:[C&9W:317RH#'HY=-AKHFEF,_=1F
M(6=!(D?)5ZK^XYN2CX!F^0=FKR<$YO1I?LNL&FK_?P(Q)QV7%TS%++9"J<#W
MOYOWX[6S]%>]7 )PJ?D!=E=-^:8>HFIC++-2XL,7PLOIPA(C#FB13/B+P8C@
M4 =.5&M*:0%"V?WJ1.E$/CUG6&&;*+N'Z;.S/\W&,$J!W]B')@R*]PH3' RR
MB(BP+12/TU,7/KFO^A/AZ?[B\+U_VV+_7U4YUO],Y=1H\1>Z5:*4K'QYC=68
M5[)5GO)BMB.]*5HVL=>TB%L*WC:<6DFLSK@.CR!)5S?Z:$]Q^8U5 );Q2IB@
M3'+B]:R*0G$]$\OVJ7N'=6H#MA7R"M.M6A7^+5^G3BO9V3%'W1IRI<Q^+1_X
M;)SB3A@?3+IJU^+!Q#DE^L?,?S^DOHW(MD*&\8O*6:!XUV+1=:C4+A<DA*K%
M3?(Q?#SQ_O.:1?9$8V;\>_/F6\RP)##1!9'ZH'/GYZ)S/'%/!H7'/L4^T\MM
M/;6D)V.QZK>3%;:6_>Z%9=%=V_D,SG1-LPC8GS):$/8W(7*+_*^-%O^WZ%[K
M'W5/_#]T;^8#I/]1W=^I'/H.F8UN9/Q4&[H+X5HQ2/]49<PG=''RXP[U@B20
M6XD>_LN=":ZX.I3M4C1#QT@0%DW)+VK0,T%(.P,)$ISV0Z#EYSXY?T_MC??L
M3L:#?LM*# L/BE<5K*/65B.XR2PS+;/"X@+_J1)P2K[NH=.R$OVI )3(*4\'
M)$W2$11I1-/ZK+Q+D&&W]NOY6']=;@%'KPC6@[QV$/H^R(]PK<$[Q+5']PZ-
MJ,G 9M7[16G.%S5'EEE5>6$EBE@7RZ]/K(9&5$^,01/,0)3],8 1,MO!=?*B
M01F;61C^&( M/P:0BQ(W',97&KTN9X''OP0]S<2' !&#(#+(XC&@'8J]$?SK
MK7 T*5A!HMP(0D0>10#Q+XC<'NR ]'5P_?\%_\8""!G\9 'DUX(G57"T.I=_
MU9:#%"=O&L39[NX5H"K1RQ &VHEZ_&O1/C!PYE-GRTS @!(P2(XC;WRZ0U%X
MIVNQEYG*7A?\%KB!;'C.MQS%EU5C_M@-='-J['LFJW6_#@=1X^B?T$..Q_X'
M4$L#!!0    ( (F >%8[5V:SUD8  )-Q   4    :&%L;RTR,#(S,#,R-%]G
M."YJ<&?L>P585-VZ_R84411!NB6D0;H906D!">F0[NX<0D"01D!IZ4:Z04(0
M*>GN[NYAYK_UNR<^[[WGG'OON?$\_V_Y+&?OO>*-]<;OW<,@QA'SP'UI<2EQ
M  D)"8@$_P&(A?N78JYFQ@ @*PLP  !P"T!%$@"0P:O[X(UTD!F "EXC@=<:
M2<D_/@$*<&APDP1  Y]A@/?"8 =(-G^N_:/]T?YH?[0_VA_MC_;_:9,P<M1S
M,'*A4#=R,#+1<P2 &Y$H/Q$%#H@<<B-1_WS=$!WU\QJ%DQT HJ/_<OT7='$K
MZ<>.?Z"+/]H?[8_V1_NC_='^_V[LC]DY^!]S\+/Q4+"Q\7,]YF?G^C>?@3@$
M, (< 3W  ?QT 2@ =?#SQ[4)^ Q$)0!BX0ZEJ:.C+3\KJ[4#BYZAC;X1BX&-
M%:NKGBTK&\MC5D 0XFJK9V!AY$BA;V1B9BU$NU??3$MA9BA$J\HE^UC6]JF1
MJ9FDN[V1DKN<LH&[A0&?(2U$^.YM05=^5RM;*Q %4;A:65H[\+L*4?[<G1^\
M_O&8E5)8T-[0F%_QF?B_S #OA/[$BXN+"XL+!XN-O0DK&Q\?'^MC=E9V=F9P
M!K.#F[6CGBNSM0/5OVSPS,C!P-[,UM',QIKBQ[V>OHV3HQ"EDY.9(;^QGC&7
MOJ$A%[.^'H<A,QN;H1ZSGB$'&[,A!X<A#Q<;+[LQFS[EOY W-/@S=5LG>\N?
MM T-6(TLC:R,K!T=0&VPL5*R_G-I@BH2^IOJ!V4$Y_ _M3?2<S1Z!G;A'\?,
M_)B#F8U'^4_'S,+)SB;(^LL\0=9?&/U?T):PH*$!O\$/GFSL?R.O9&3W7SMM
M2S/A7Z#U;X*"SW^[ "F YH>.CB[(^M?$_[4V6/_%^L"K/]LJN)+B?Z#]0>0/
M(G\0^8/('T3^(/('D?];1/Z"=XVL09#K J)9Q!3P%$"[<>/F#52TFS=NWD)#
MNW4;ZPZ(,6[C8M['P"+ )2(DP"7 )R:C?4A,2D.*3T#)0DE#1\_(Q$A$P<K!
MRL!.R\#(\&,3)+1;MVZCW\:Y<P>'@82 A.$_W!"? :Q;2&^1LU"0* %D+"04
M+"1$.T . $@WD'ZV/Q4(2,@HJ#=NHMU"OWT'G%!Y'T!&0D%!1D6Y<0,5%1SU
M L<!5*P;V _91&X^4-!#H[3#8?>-^GB+2K2T!5=Q8)^:0]_>#_TV'CX!(1'-
M(UHZ>@9.+FX>7C[^I\_$Q"4DI:25E%^JJ*JI:Q@8&AF;F)J9.S@Z.;NXNKG[
MOPX(#'H3'!(=\RXV+O[]AX3TC,RL[)S<O/RR\HK*JNJ:VKK6MO8O'9U?N[X-
M#@V/C(Z-3TPN+"XMKZRNK6]L'AP>'9^<GIU?7/Z0"PE 0?I3^S?EP@+E0D9%
M14%%^R$7$K++CPE8J#<>LMW$%E% T[-[0,GN>PM'-.IC:0LZ%8?B/JZ^_<!M
M/&K.!9J#'Z+]E.P?$\SO/R79GP7[BUR3  8*$GAX*%@ !+B\'4*7AOQ/Z>&K
MJ\0"9BPL66H?0ZU=''S2RS@1 ,$Z4=;AQ/@F/?6V;:Y"O,OW2*2TNW6,+ B@
M/4'\0UY;SIP.DZK2S@2A.%_7YRX4E%0MI9,PJ.QW@Q!9C;7M+7J&H&[C+O)=
M_R=$G"K&48NR5-HFV@PGM*8=ZMRQKX1L/Y.H) ,X"F( CK(+#YOZI*R#_=3#
M "(I8M2=%^QR:$(W')KW2SV9$8"(/"P^'@$$IS'U)82TU1_D!&T_(S<?CA(\
M'U5&(@T?)51\0F)(<A02C0"^N+-\L+!P\/#,N[L8YSO*;3MO '$D<2(U)?U0
M*F:\048Y6/D= 4RH!ML:7'57%&!Z/KY9D7M?00P'^#_4D=H\%:-%,LT.V!@M
M:,8?1'W>^$Q[! EP9AN?R.3>PJT08.[<?>SSYGRS*36 0WEPARM96(99]"$3
MNQ/I+:$W0F%Z4^?W.NZF;6H4=A&QMY%4\ZFY(+-G$* :^QX+7JF.5"0;P40\
M7)S*3J44'$_&.Y>?CE&\,O0X*8K ,=\I.(>V3KZ6IOF0<Q%C2YRIA<PQ1>U=
MN<XO_-8L??U@H\HW!?5N# NZ9[2<+2!D@<<:-*G,736Z9>>N7U7'HU @V<#6
M2>Z2\XV.8;W@X[I[96=8S@%>B1E>$H:.AF9FNKB!#[OD4AK\)6V(3?&Q#;ZI
MR^+JRT\?>BOV]X1UY,49AR#<#O!>IY/$$E.5%,JANV$740:S))S/;BH*L6/F
MI25NVJ::'^!59F]I%(<Y.!]TN5,&TJWPJ:D*A-QK7^$C.QET);MDK+=H?_MB
MF$6#'D>0*(+CB:TK\S0V9HYT-0*X%>!W[CTF&6B12U49TQOB:H1.Y^UM]=GI
M(L+\M2N^#)'0BK^L*P*PBC),65GM*59>-EPB:ZS_+I"164S$>L&L!!V+.,:=
MU)@JRDKB'HBCQ[ @BN.C1@JW$/(4,FVBM7(4G#,W;4A/#.QQ7R+L)ZM )^FH
MSMPB(Q_;@XEE?+'QLK(CLW[UWO-;FN?XZ1+D^ZAU8P%+VBS&L.-;@$>6/J3G
ML4BM]LWO[DB1;L7Y"*"%6_7,A8/X6GJ&)=%Q7\2AB@^S;G[D@R=-]M=+J5"9
MVQM,&K.\XU;4D7+;?O*,.[.^,R1K_H96\IT:?7E..,X\,@2^A1),#:&E0A<Z
M&6-'>P4TG@)FY,%3VB%22[6NL%HLM5O+!)U4A/THS7H:P^@!. I/_/YI\>1_
MN6>$+Q)F1E'&\;B&4[]\)4TN*O!2VV(G=;Q:=^+#E6Z<9Z$!WVF_^XK@HX&[
MHFH9PR5IPT9OKM,G3SCJGGL='!\++I;%RJGG3CDD9'E+1P54PYN.:M,;$(!<
M4[W_EU'N'6A^1[3A\[KWDS1"?JP4RI<-[F%!;SC/+9T2Z^NW@JMEK#6Q"MVV
M/MFB:?1/;7@0,NG;K:Y,3'V<'M"!.MCEZ8Y;\$^[9XTTCQ<_?R%"O/ XTVMA
MSH\QK[ZI7AC38NOEC..HW\O;'($,Z!0>)EQVA5E>=Q\&*S4E,EZ6;! =JR:9
M7O84%)I)F17JZG!-OM]=JNU22PKG7@O'%'3W&!Z-KXZ;91J:][A68:.*XCF-
M'(\AF4=5B.10+Q3UPC (?RLU553G!OVPSJD@YD3F\W\@VOV;$5#W157T88?:
MP]KH40D4RX'K%8K5VAW:MKK71V$RNDVQ)<_D,<Q]E=MS*+A50^?7#HJS0_J4
MEVB=#?@?)[W+&MKE^^K)[/ HS\PE?PM[[@Y''4&/R&,O*;04_\/\TUGL$::2
M8I8=SZ=E%H$]X:/2VQ+9:BG"L2,#2MMZU]P2(V;.4 \$P!%7OV_0:^=:=5E8
M=:I:=E$^Q?1DEZ^KS23<JT#6T6RQ(47&2]JT:'9L>W_*-];'![#K8V?;F"W1
MG)N8^7HP.=/"D3.KMHRANGE#+3NOS9'W>U:#ZF*?]U0;1[*(#9>7AN9&>E@T
M-A66FSH!$UN*UR8OC-&!)</,+M^"0U?">&$AM!W'[YX($Z;0#<=W"MMIY"I9
M4P?0\#I8:PA=D9Q/>@@=\'^KY[@5FDUZ>T]YH%)#[_#.7#AE3FJ4&='@.F]K
MI==JEKS1>&ZS,D'S93O(ARH"@'O"8]%.ST).(!<W32U,@\YWY2G<CR*6+?!U
MB)F]N/A2V,-V\'M@E0)$12YYX^,L-M8+_I-2 .U^L2X<JP1[4VOS\B( 4VW'
M%U8S"4G6J#B'ID]5;04D[%S&<"8].";(2,EL(KA>/*U<VQ>=+3E6O=/\AHBY
M=LIZ2+OYR<,(/^\<W/@\BZ:'8X[=;SAW;GNX&HH2J=+:Z9SW<41UW+0HJQAB
MLL3'4XELV2-Y]>!\)$$N68I16M<V2[Q1S*RON\N[>"W\7'KT O;2U I;C$T:
MHQ/52GZQ/UM<8DGGBQC.^L"I0N6NX"-<O;0ECVFZ])#I[=MTZ3[_<,\HL,!+
M8$[4TFD".L9' L_62)#%W4<VEQMDL[KMBK(SC*MX2JQLRC09TX5WI6;\ATJ4
M-M2'WV40M[=A\;4FSU?RJSL1TS$/NI4P+P7 ER,8 FP^]G-1N]SO!5+H%1:I
M*,5>*4=HC1&>[B#;W)G4X8Z+8%/U&^T-CHRCC10J[W,/R;,O.S=IY787V^F,
MO PM-'F'//O<TQJ%5.X6K-=@9Z=$AJ0?;ZQA>Z0$KNLV\S1774OT2'.FA4GA
M^DSJ*<.UI*#BY)R&3@$Q8ZXU<A);R)/SR\6&ZITX@Z<CS$Q9E+.R4FK K1Y"
M7DA:<?JM;<?F-\_4+E1.FR>FUL9%TX]:A(*(Y;RN-R3NK^B;+6E-#FC*;,TB
M@&4G5=71..DB-X>[-=:!ZL@F1YD>5[P[*JLR-=@S==*#0-#!AE90,+<Y&4,I
MO"=\ZD4-7F$'<2@GS3W)5PY="&"+J'OH>(.E(NR1!;'1,-Z@6]. D1UEF@EO
M'[OM$X*3:UD^U>@8*:C&/;7:O)H.'GC\Q7:$A-\B<>[KJB$)3I.,CA9?F)B4
M5I!/=> ( G#\U'9:$LT[94_E$(GY-)Q?55=3*550.;P.EU3#W.H&CH(&,?C?
MD[_=51PO=P*:2FXF'-'7)+H@Q:.']_:)" 704E<_4@QUBN$TS1_:5.$NOV5M
M8[7P[EB*YJ7!^0,9A]P)=?:BE66\[3E'&88\R/,$ODB'SEK]D!"+>@\/.Z$O
M[0JB=L&DK26K9J]J_3:QF L'>@G7#SZ]@F*)C6P+&WE@*R@;CA[G&IFN#&\/
M?(\ULGA]0W+S5J\42T'.YQ?R7E:$44\IW-Y9HWTD% S1&MB5KPBR'\%!B8H:
M#$EO_5V21>_4Z&DX>!2A%^64^[F0/[_J%!8H2TM#JOE(*11W>=ML0"MT[CX(
M3KYD;IRY'#K?KA>!FQQG>S5W)*3"W,<U-TI3(GB8((((8)TKHCIH8NS[ZN4*
M;28KJQCT',U _2SA-#9G;<=E7[PM?Z_;^VG"6O/"W1&G>TZ]WFXX)R$D =>N
MUXRB_9\G[Z:@5_)@0$)<F"]M(=)\^=VF4V-PH#&;$HK!O(D GBG7G ?DN*6H
M)%LY>3U<Q^+VOSBZ5-:=A#\>1@!+G9(AK1PP%[15\A3(,=$6\X[5CL&$!:IM
MSIG!DXSC/--3!RA.T_PI5];!\%5L<V^2"XPR83>CKW(1'3FU$;?FH?PA>99V
M^3Y>D(4_-;;VXSW.UW!_Y#II^GR<T2+=,<6,U^G)D_5'8T<4E:459;)5SM\_
M-T6EZ:XH#8A965@Z9D:7@>[N&_!W+>7?Z?H6WGBEH[L[NRQ8+Y?L5DE(OOE#
M'HD0;(T560THT75(#SZ32V*0B#-?_UJW7_S6C01K6BU/QG&"J* L@+!?7V"D
MB$.B=."C:\6XX#OGZ38/;GFYY9%)>CHQ@:S<6 :[>/:0YH^IUP'9%_BVB2]-
M]ZC9^PK;]_0=4N1)+I6YX?@#1<PFU7Y?5!@#INA8VC\==_&1![#4+@K<1>;D
M*=P^]!I/)]07\@ 8K,@URL>8X .OEG,%U GT(J]"4F?X[#<<6$]=E&+DC-9%
MG!:L\ X)*&M*530=L3J#7KV4L/2/.1_@":A0W]:KB/XB^$;*\*6QUH/A99(4
M_R(+A9?;"Q-$'D3RVR4U?M\ZIN0J-3WH5 CBTXODQ7"EJ O#L*740?4\UQ/#
M>8'TM[J.DYL9F3_G6;5*G$95LIVC[LXM!- 4&O.=ISKMFG' (B6B)4'#(MK\
M+JIUF%\DKH#"4?2,K<-&J KN1_JI=TM?%&+E=,1*5N#&NB&6EJQ[Q#*#VXN)
M+^N<HLTNW^.X,$^%LR& T:P#FKB4N(,-Y]&W7H73[9$947%B+VX>0H-\-56]
M[W_?*UZNK2N=XRRJG>JUBSF^&V+9A/&=UHA]W)K!%VTODP!XA=FH_NW=S+$&
M M"N?IQ"E)F4G%&R<F:SZJ"1DNATK^2C:?>I1<;=/(9JPXOGL#4*>ULTY&I/
M^@)-J4R>9-*4E,6=M(D'J%+D_H?^6RFQ[KIW3(?41(R80RKP+@[C/8SL[;TM
MUTH:)3T%,J]3)C%+*4)&Y=EI4,.*ML92.SF7I$$K8$@A*^(/MZL^L6%)'>1#
M 'AJ$S.;W!JRL;%E.KHRJ_+\K?4C2%V62X)'%^0:O6.<P86THS1>_).[HY*Q
M^C713G?-D?<!P;5L8,M7^]N&LUE^4^9#!"#C.&[()-^]?M.6WSF_VIM@8.\$
MQ</-L&R:F_W+%!H*"A6O(*:T4MJ*R]CE(:X652IG;/'<@H6S%P*8#PH4G#L7
M.T8 %2;0R$;WI>J-D)'L<@E4-V>U 0E%6Z#0HQ]_784/VQSK:]NY7D]J=\CL
MP6O%& &^C^+H<IHNW+G%0@UN-$LXWX\UZ]N&'#"0+DPN0N3/BT[D+TX&ER"B
MXPB@,^(P]_0 >G?N8\3H1K,OGSOKF,$GX]M9[WW0%.6ENQH/5(+UHH0ST/5@
M;,EK"("TUX#59[GAU>5JI8NK^XZ2SX^P]E!C%#S@0EN#H:6HH /9#Y!4'(>7
M<=]F/_8'I[;ADJM"NV$].0<PEWL& Q4%W6L;9[:0YZDKLE<282?R)RJG=88F
M&<)WO&O!+-E()1E);9J;D9[[&6=3*&GN"VO]DU-<FH-A*#-D'HQ)#_'C85MU
M.[V?A0Q"%R2&^,BSS";.647+6O 8.3 7D^+[Y\%8Z1YB'L95]#8<+U3[PAIV
M NL0PU Y>.W'&8PF)@9XBZ:*X98.??KO /(=KDNM8W6]/?AUIMA?HRYDL5XU
M&$:*N^Y"I7,R8'P.QH8CUEG5R1%8G^=WR-;&-K2O<?OVCZ<O)MJ8[A*^=**N
MA-IU(H#69C$$\+)PCA9V.^)<I'CL6C68->8( 2P6?$I/'=DX9=U4AL0?0%?M
M$,!^D 4CO.1+?+,H.0)XFP''@F+E3!\(YES/SRU:?$J/T,.$- 8-KQ\W@ZBB
M9PD!?!+42'5HEX3.ZL)+,ZX8.S;.N+K%$8 ;&@+ T@[ \2 X@WI@YC_-S#HK
MC[BB#1^"Z^.Q0S]+((#[=)WA0XVAJ?$(0*/^-MTI9!;JZO42*MAT%'$E#\[3
M*C1$ +Z8<#J%ZYREUU>7S(G0.I!>N*J>&-D7L+S +!".I3DK.>1% #MS^#ES
M^\<FUZ,(8#N,?#_&-588 00:0G9+$0#*#R[HH0(PE,T3?F5HT 4)%/:(:!):
MN)^\ $*19I!/"=BCLVYX=1L/B'2\H =<XPH2Y7DP!."':: )]VZN!5?07D%'
MU^.[SJ$GN0@@($R_><MQ:QD!^+">C^F)D<1"4_<QC=X@@-14/S[<\Y@,LD\Z
M):-<H(+SQ<Z#/Z8TF^D6ZEZ[;ZKC-AWZG^ ^4)^"S%8'-^72K13 NG=!0F3]
MV$V35\WS[^\L70,G-;'>GRHEF_CWMYR:J;8P4F&R%E6Q.<VSGZIL"AGAN ],
M-9Y>[[!\O;8:@M%56F_]V("D)NLTXPQR1,\:"A.>X:*&*00=YZE^<7_@.#P/
MT\0YW>][,^-8H-M*P<"]'^<WX_@5"DB<9)S-ZKZ!5B( EP,:76S3HJ&7Y3!C
M!<7BVLSFF>'M_L$%2$<NCU^#X(SC"(S:[MK\T3YM4(0,GFYF/YQ3I]KH/.!
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M_G+V:GKQ-;1OR96NSCPQINP85F3S^:@ $]W"# '<:C57*&IW5ISV2B-\>LO
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MU;VD9Z4#6@_*< <6@0INN2O?)_K+Z[B[\G<0P->Y## F')-?LEELW+YH;D4
MASQ@3#^Y1H.':ER*-MGPP:F%,(N^0@,@+\!M6H5#_]DIG[%%&!1']#=Q0J3/
MZO;E@W4/7U1"KHP00'IT8VCJ^=[0B81_"@*HEX#)')HP@R8^G$KTJ\MY0%K
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MG]7?6];=0T*9:]15&7X8\TTM6BVC^D*KFI6"E/\, 3S*CI4N+1#VJ#D>N+B
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M(0>B5 +Z6%DGW$T+.L<(YX2VJAL@ ,%BR!Z(QXB6Z4K>PB>^G.G:'0MN;R&
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M>P/#'S,>"X,6P+R+@747 ]4,@   XQK&+_8W@8"!B85][3K.C9NXM] -RNX
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MJ*"9^'>@2W469.B(/9KSX;C-0HCAFWT&?C;LT#JV=?!SZJ'HJ3=& =]Y%H1
MB00:E\_$TDF$DWSY0)W5S& 2B=O38"A=M+JFXNL.C5--"K/]Z*R,L"3Z >./
M^'A[#O7S%Z,KB0O!(*6&\KH@*=ARP@=#;\G"><WFZ]AWP]RH3_/D)!LO'F9$
M1_3HAZ& +BEAL7-\@H5'#B,AO<CT X-'" Y%7<^K341P%3@8!;S3TAGDVT.6
M]I$?P2O7CW:@(I((AJK>R(.SP&=VOGDG*,#U(G188;O2F]NV7;BLXR?:P+N2
MQN*&YC,L \Z/;]@J\A$@2N*7H(4X>_EA#AQ\1'G&9."61+8<W( ]5URFU.QO
M_[4[AX2Q^.,EYK<1T@V$0*D:=\[9ZO/BR/;BZ>RIR+<4% 6P&12 -T)0=%;8
MG+Q_R3:P-8G4:#MM/]T]#S_*TS&;&1@YIXAH$464CG$>H "AX!ZM%G[5X$J;
M K%NZ'*0'B=2.#D$3'"IUHRD6Y0J)3=.@W4US[J%6H4N0<E_#+X&I9L+Z/(*
MGK<ARI-7^$XHK]DH+N5 _<==]%8@IIJ%^PR=U1!TYJ*+&4+<-,2K-Q_)B%2J
M$BQY_F+J2@!)/R9'84YH22&5'<!&) $@'@VKAF61OF::221WBOJ2AUX\&MD*
MXH3 OUG&\@E?7G^2-B]$HM21U'%/# 6PT)P_.-H\&^5!T)+71;BZ.6J%OW3R
M68Q"IAT5= 9T*NLS>EHXRM^2L8T;]1H-W>.=/9/AO@(%P\3-Z2A-R]>/A20/
M\JT%6OD?IKV)"<3^<,:*AE,25',J+U&RB5PX*]+9D H=#@O=@P>'E##R),WP
M,YTK6'>HJ6YR([@0>JBW9(E))J)X0]!'8$#;THU388BT_OUQSA?*9YP).8B*
M*R8T @.;JZ#D,Z$GGS]H;-<*O>" 1E&-MRT&U]^YZ/JP_VHL:7-/@!F,]6*_
MW#];WWODQ)Q@3_MV<J'\*#Q\]!E>$)D\M6^8I7HOAUI@Y0#NM^Q"''NSU("T
MIW\'1.Z4GM:$G"U1<[SN_,FS:NDI^Z1I*'F1S)J:W/@U0H7G_[I-DDA,:8QK
MFU9HPF_PF7U8;!?/@"17O+1.Y",)Y@,7\8OW&P<SG5C<2_N-I!N#;)B5#_=?
ME!14AC:16])KM$WLX&"M3YY?,6OI87EEVCLO:)T[WZRO('U'-;X9F@D&62PC
MN&'"'R"CQDHR[/7Q [#&\VMC(=Y#?&5[(^^JWJ& 6691@M?.;6-$]\ZT-,;4
MI1>\I",>KVY%K[X]WD8@RT8GQB=_--"4^/#241)S \K#GHR0!8%S)X)<F<RR
M#!A#*@KP/60RCZ-*3)>$RY=)A;#ID9E<%*T4#HA;1<BT;P09$IGE4O]GMQ 3
M"V'*0>?G\5VDL7V(4H6R>O:>5_4^K*6G'&Z.&DG#J\+*6<PPR,9M%RY5Q8R;
M F4Y?8+<CZK+"IW3>&>W^PC7IBPN%&=%^7NLQS;LDY? 8O+[O?ZO16NVS1F=
M*A[ ]G>2\YU4DK/-^'6S"2;S4L-#]Q=OHP O? MW9LGY*#0>^\;5/NRMPA[!
MXB"2M'*D;HDZ#](>M4.#^2O.!6\Q?'JOA[\Q1BR?<&XSKG06NG&;YU*K90)"
MGA07]PD\J@6KO8#M<WFJ@4*>(,0V[_W$9-P(+'G.15F-1W^QAWR_7)YN7+8_
M;_-M<O;B88L36P]1LX$4O?3+(Z-7(@AQ<[)6V"V>+,U$<3>!!/S:S'@YBY-+
MG:+*FN*HM^\W9@S(?\"JSYT7\L_*AV0KAA8K(?;.,%=REB!O?48X#2S)R^)J
MU3?Z4"-"LKI"A]_.*&[:E%HPHV2(=#+H<B5/UTVX=U-1ZP=:'3%(C7)=<C5B
M,I$V+-*%>BP[99C3PP57/V0/#P:,')]O(M784H?HAVM$#%,W!VO")]:_BY&&
M!>\F..-$8&PB>WAD KZO-NXR?F0U\92]%6OX[%!JAHV-=RFIXF),Q'[^@=8G
M.(>>!<@,+B'BQ'BU^8A^/IXB1.I"B?4U2>:4^4FT)4/WW8D2#M)TH(3"V)]Z
M:5^R*,(5?IRU!%+-CK=X=%%[4NS]SOM:<75)/\'$::KL(S<#[^S/I(@K:&N.
M6T&W^((._F9O[(3EVIBAL ( /I6T.N;.87RWO<-U_GCGF$5FA2?<:)J[=46Q
M<H[":?5<J4P/=W+C=-/5'I8MT2XF$?X<LU6"[Z5(XR)?KM/RUO"]B=;B-.BK
M'*9MF_JQH\Z)D+(\](XK]S R;7)"2G5*KLJAB6+N2/ 8L\0:89@G%)64QAV5
M^J.+]VUGB6V? ]^<\W%!])B8SY R^9NX!8V6KY/WP>^GTD#LBPPA_"/B>U$^
M:]_6#;1":<D0Q]9=%7#!^T&&R3(4S' G%%#PEEG]_:3B[H76,0\Z%6T(W?GC
M#6L>H>4I>+&Q'N/:E3F.K6$0-3=3W([_E/%;WT'>AO)2<#=X5%F_>Z1W(6"%
M>W/;HJOIIKNEL_GG!=4XM];MI;#K#1)LC@DCJ\B1NH''],5U[P>6_(PJ$A?P
M)92I2+*T!T\"3K[55JW82T^#KU9ZB%8'W$K4J:C,&>*$ME^S1%RE/<!<9/AV
MG;<M2]0+;-JD.3+26^F5J6-Q9T,:]R9ME3^1&#Z'L*X ,HJ]\"97C!*3X:->
M&>8+%* W)I:=6EE(MD%>'I-YE2N71$HCE_(Y<_W6_2!  FA;5(,@)*W3Q5Y!
M#),T('<^';Q\(H459%JI'Z12%2Z7U3^^0$,FPS$XBI"+ W\6%A["MFD=19!.
M6G4MX37U"MO8\2U4J2]II$K3"80/<R2_-&]--]TKSAG-4IISI10G5(GS(QRG
METHS9W!^IA#1;8>SJ-V;LIA+:GSY))(P+G%@7O6.R^KF[-[U5!4Z O]8Y?P7
M$373(:G?CFU)ULE?*$HCT/MSD>\*WZG0-4,48.R6W/QZX]3P>:GMN>N'W;N[
MOHB^>:TX>;_2_ >6FI,XGV%=YMZF""$HGNKK8\:]7-9=1)!0AD5]4RCS#IIA
M(;JAY6Z%S0D:HER>3]!2H]CK0*@:^=3+ AD[9\W1*R]\5I[F\$)3^EP;!50C
M^0JB RR";-TM$&T4CR$]"H=0Z,$/<15QW#?,;]\ #82E"EJ4_TK==@U\]>#%
M"&'@):\)= ;\'K1'T^-8XH:GV6[2SRT0?Q-:71$E//4*Z5Y0%]"KG,*BR9;S
M(4-A1E;WROLP&-F_'Q*( D#E"A;?(!HTES\0?"B@S6(Z--0I,.:@4'"2K,2G
M) NXDCQN<3H64QG(*_/4H*WV>>(BFOOHJ08^O^^V0H<B%+ON$&*HF8S.OXR%
MBY51MHNUQ*N*Q.;TN97E>;V?)80J>R47P.F%C\O///.>9!9I/[:?O'Y>@/W&
M1^B#]M730J6<%/X(^0GP?=\<W=28\N!J]*:MPVCWASSHKT4-L@#V<E@YT]#,
MSV^)6F,6/)/U2K[5=>_Z=?=&H1YG0N47@ANM*N:74@=PP^BZO9TL%' CL>Y#
MEIS9P!98,.;!6T8[?3C9;E+=<-?V_6:UI ?P(?&>( EHA%S0O%$00'@_:+7
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M0_<H8=]K'^-S\.K:&'M.'@LF=&$\-H4\SK=$H@4GW2HS>&WV[%F-$ IX*DN
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MDW*?26^6F6%IDF[VQ%B K8/ZI&,Q#DL4MGW)<*BS(H;[,<B:U-5=L#$*0_1
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M82W@B9&H+ +Y]Y5DTT##PQ"'DB\\Q/KL.>L]6@$GKR>#!.Y0IK'@3<<[K#J
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MPG(?-<*IG)*F,EIS-_((-Q)ZW \5F;LQYGBTO3HEMN^AK-J:G -",I3ZH+=
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MT1GT+XS'PH4M\1RZC^.R<!V><!;=<'S.WGSSRV.K,EW)_X)I57X!4$L#!!0
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M9IG2)(MM <5:JACLBYCHPO-7=:&="'N'US!LA[#GX\"K+Q5U.C6$5G9(P6$
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M2P$"% ,4    " ")@'A6$-$8""X#  !9#@  $0              @ %D6P$
M:&%L;RTR,#(S,#,R-"YX<V102P$"% ,4    " ")@'A6 !GOT;$#   F$P
M%0              @ '!7@$ :&%L;RTR,#(S,#,R-%]D968N>&UL4$L! A0#
M%     @ B8!X5FPSHW]730  ')8  !0              ( !I6(! &AA;&\M
M,C R,S S,C1?9S$N:G!G4$L! A0#%     @ B8!X5I[0*E3D0P  JVT  !4
M             ( !+K ! &AA;&\M,C R,S S,C1?9S$P+FIP9U!+ 0(4 Q0
M   ( (F >%9\ZSZ1]BD" %FI @ 5              "  47T 0!H86QO+3(P
M,C,P,S(T7V<Q,2YJ<&=02P$"% ,4    " ")@'A6RD4T_^P= 0!RFP$ %0
M            @ %N'@0 :&%L;RTR,#(S,#,R-%]G,3(N:G!G4$L! A0#%
M  @ B8!X5IDHA'NE-   ;GL  !0              ( !C3P% &AA;&\M,C R
M,S S,C1?9S(N:G!G4$L! A0#%     @ B8!X5O?2TG@C#@  :!   !0
M         ( !9'$% &AA;&\M,C R,S S,C1?9S,N:G!G4$L! A0#%     @
MB8!X5I!$Z2F")0  Q$8  !0              ( !N7\% &AA;&\M,C R,S S
M,C1?9S0N:G!G4$L! A0#%     @ B8!X5D,SW.ZG4@  )(0  !0
M     ( !;:4% &AA;&\M,C R,S S,C1?9S4N:G!G4$L! A0#%     @ B8!X
M5N8=[E;75@  9X4  !0              ( !1O@% &AA;&\M,C R,S S,C1?
M9S8N:G!G4$L! A0#%     @ B8!X5G6[XK?$<P  9,T  !0
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M!P!H86QO+3(P,C,P,S(T7W!R92YX;6Q02P4&     !$ $0!B!   Z%<'

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
